
<html lang="en"     class="pb-page"  data-request-id="67e97b4c-ab9f-4c22-94cc-8233f4cd244a"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;article:article:10.1021/jm300667v;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2012.55.issue-22;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Repositioning HIV-1 Integrase Inhibitors for Cancer Therapeutics: 1,6-Naphthyridine-7-carboxamide as a Promising Scaffold with Drug-like Properties" /></meta><meta name="dc.Creator" content="Li-Fan  Zeng" /></meta><meta name="dc.Creator" content="Yong  Wang" /></meta><meta name="dc.Creator" content="Roza  Kazemi" /></meta><meta name="dc.Creator" content="Shili  Xu" /></meta><meta name="dc.Creator" content="Zhong-Liang  Xu" /></meta><meta name="dc.Creator" content="Tino W.  Sanchez" /></meta><meta name="dc.Creator" content="Liu-Meng  Yang" /></meta><meta name="dc.Creator" content="Bikash  Debnath" /></meta><meta name="dc.Creator" content="Srinivas  Odde" /></meta><meta name="dc.Creator" content="Hua  Xie" /></meta><meta name="dc.Creator" content="Yong-Tang  Zheng" /></meta><meta name="dc.Creator" content="Jian  Ding" /></meta><meta name="dc.Creator" content="Nouri  Neamati" /></meta><meta name="dc.Creator" content="Ya-Qiu  Long" /></meta><meta name="dc.Description" content="Among a large number of HIV-1 integrase (IN) inhibitors, the 8-hydroxy-[1,6]naphthyridines (i.e., L-870,810) were one of the promising class of antiretroviral drugs developed by Merck Laboratories...." /></meta><meta name="Description" content="Among a large number of HIV-1 integrase (IN) inhibitors, the 8-hydroxy-[1,6]naphthyridines (i.e., L-870,810) were one of the promising class of antiretroviral drugs developed by Merck Laboratories...." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="November 7, 2012" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm300667v" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Â© 2012 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm300667v" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm300667v" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm300667v" /></link>
        
    
    

<title>Repositioning HIV-1 Integrase Inhibitors for Cancer Therapeutics: 1,6-Naphthyridine-7-carboxamide as a Promising Scaffold with Drug-like Properties | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm300667v" /></meta><meta property="og:title" content="Repositioning HIV-1 Integrase Inhibitors for Cancer Therapeutics: 1,6-Naphthyridine-7-carboxamide as a Promising Scaffold with Drug-like Properties" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300667v/production/images/large/jm-2012-00667v_0008.jpeg" /></meta><meta property="og:description" content="Among a large number of HIV-1 integrase (IN) inhibitors, the 8-hydroxy-[1,6]naphthyridines (i.e., L-870,810) were one of the promising class of antiretroviral drugs developed by Merck Laboratories. In spite of its remarkable potency and efficacy, unfortunately upon completion of phase I clinical studies, development of L-870,810 was halted. Because of its desirable pharmacological and pharmaceutical properties we were intrigued to design novel analogues of L-870,810 with goals to (1) improve upon limitations of naphthyridine-7-carboxamides as antiviral agents and (2) to reposition their use as innovative cytotoxic agents for cancer therapeutics. Herein, we report on the design and synthesis of a series of 1,6-naphthyridine-7-carboxamides with various substitutions at the 5- and 8-positions. All the new 5-substituted-8-hydroxy-[1,6]naphthyridines were potent IN inhibitors and the 5-substituted-8-amino-[1,6]naphthyridines were significantly cytotoxic. Further optimization of the 5,8-disubstituted-[1,6]naphthyridines with structural variation on 7-carboxamide delivered novel compounds with significant cytotoxicity in a panel of cancer cell lines and effective inhibition against select oncogenic kinases." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm300667v"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm300667v">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=âtrueâ></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=âtrueâ></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=âtrueâ></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=âtrueâ></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-14/achre4.2021.54.issue-14/20210720/achre4.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-29/aamick.2021.13.issue-29/20210728/aamick.2021.13.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-14/acncdm.2021.12.issue-14/20210721/acncdm.2021.12.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-7/amlcef.2021.3.issue-7/20210705/amlcef.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-29/acsodf.2021.6.issue-29/20210727/acsodf.2021.6.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-29/ascecg.2021.9.issue-29/20210726/ascecg.2021.9.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-29/ancham.2021.93.issue-29/20210727/ancham.2021.93.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-29/bichaw.2021.60.issue-29/20210727/bichaw.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-27/cgeabj.2021.99.issue-27/20210726-01/cgeabj.2021.99.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-7/cgdefu.2021.21.issue-7/20210707/cgdefu.2021.21.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-14/esthag.2021.55.issue-14/20210720/esthag.2021.55.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-29/iecred.2021.60.issue-29/20210728/iecred.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-14/inocaj.2021.60.issue-14/20210719/inocaj.2021.60.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-29/jafcau.2021.69.issue-29/20210728/jafcau.2021.69.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-29/jacsat.2021.143.issue-29/20210728/jacsat.2021.143.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-7/jamsef.2021.32.issue-7/20210707/jamsef.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-29/langd5.2021.37.issue-29/20210727/langd5.2021.37.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-7/mpohbp.2021.18.issue-7/20210705/mpohbp.2021.18.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm300667v&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm300667v&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm300667v&amp;href=/doi/10.1021/jm300667v" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2012</span><span class="cit-fg-volume">, 55</span><span class="cit-fg-issue">, 22</span><span class="cit-fg-pageRange">, 9492-9509</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/55/22" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm300618u" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm300710j" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Repositioning HIV-1 Integrase Inhibitors for Cancer Therapeutics: 1,6-Naphthyridine-7-carboxamide as a Promising Scaffold with Drug-like Properties</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Li-Fan++Zeng">Li-Fan Zeng</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yong++Wang">Yong Wang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Roza++Kazemi">Roza Kazemi</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â¡</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Shili++Xu">Shili Xu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â¡</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Zhong-Liang++Xu">Zhong-Liang Xu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Tino+W.++Sanchez">Tino W. Sanchez</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â¡</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Liu-Meng++Yang">Liu-Meng Yang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>Â§</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Bikash++Debnath">Bikash Debnath</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â¡</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Srinivas++Odde">Srinivas Odde</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â¡</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hua++Xie">Hua Xie</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yong-Tang++Zheng">Yong-Tang Zheng</a></span><span class="author-xref-symbol author-aff-symbol"><sup>Â§</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jian++Ding">Jian Ding</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Nouri++Neamati">Nouri Neamati</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>â¡</sup></span></span></li><span class="comma-separator">,Â andÂ </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ya-Qiu++Long">Ya-Qiu Long</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">â </span> <span class="aff-text">State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, 555 Zuchongzhi Road, Shanghai 201203, China</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">â¡</span> <span class="aff-text">Department of Pharmacology and Pharmaceutical Sciences, School of Pharmacy, University of Southern California, 1985 Zonal Avenue, Los Angeles, California 90089, United States</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">Â§</span> <span class="aff-text">Key Laboratory of Animal Models and Human Disease Mechanisms of Chinese Academy of Sciences and Yunnan Province, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming 650223, China</span></div><div class="corresp-info"><strong>*</strong>For Y.-Q.L.: phone, 86-21-50806876; fax, +86-21-50806876; E-mail, <a href="/cdn-cgi/l/email-protection#156c64797a7b725578747c793b667d767b763b74763b767b"><span class="__cf_email__" data-cfemail="fb828a9794959cbb969a9297d58893989598d59a98d59895">[emailÂ protected]</span></a>. For N.N.: phone, 323-442-2341; fax, 323-442-1390; E-mail: <a href="/cdn-cgi/l/email-protection#dfb1babeb2beabb69faaacbcf1babbaa"><span class="__cf_email__" data-cfemail="88e6ede9e5e9fce1c8fdfbeba6edecfd">[emailÂ protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm300667v&amp;href=/doi/10.1021%2Fjm300667v" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2012</span></span><span class="cit-volume">, 55</span><span class="cit-issue">, 22</span><span class="cit-pageRange">, 9492â9509</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">October 26, 2012</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>21 May 2012</li><li><span class="item_label"><b>Published</b> online</span>7 November 2012</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 26 November 2012</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm300667v" title="DOI URL">https://doi.org/10.1021/jm300667v</a></div><div class="article_header-article-copyright"><strong>Copyright Â© 2012 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D9492%26pageCount%3D18%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DLi-Fan%2BZeng%252C%2BYong%2BWang%252C%2BRoza%2BKazemi%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D55%26issueNum%3D22%26contentID%3Djm300667v%26title%3DRepositioning%2BHIV-1%2BIntegrase%2BInhibitors%2Bfor%2BCancer%2BTherapeutics%253A%2B1%252C6-Naphthyridine-7-carboxamide%2Bas%2Ba%2BPromising%2BScaffold%2Bwith%2BDrug-like%2BProperties%26numPages%3D18%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D9509%26publicationDate%3DNovember%2B2012">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm300667v"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2310</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">35</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm300667v" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Repositioning HIV-1 Integrase Inhibitors for Cancer Therapeutics: 1,6-Naphthyridine-7-carboxamide as a Promising Scaffold with Drug-like Properties&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Li-Fan&quot;,&quot;last_name&quot;:&quot;Zeng&quot;},{&quot;first_name&quot;:&quot;Yong&quot;,&quot;last_name&quot;:&quot;Wang&quot;},{&quot;first_name&quot;:&quot;Roza&quot;,&quot;last_name&quot;:&quot;Kazemi&quot;},{&quot;first_name&quot;:&quot;Shili&quot;,&quot;last_name&quot;:&quot;Xu&quot;},{&quot;first_name&quot;:&quot;Zhong-Liang&quot;,&quot;last_name&quot;:&quot;Xu&quot;},{&quot;first_name&quot;:&quot;Tino&quot;,&quot;last_name&quot;:&quot;W. Sanchez&quot;},{&quot;first_name&quot;:&quot;Liu-Meng&quot;,&quot;last_name&quot;:&quot;Yang&quot;},{&quot;first_name&quot;:&quot;Bikash&quot;,&quot;last_name&quot;:&quot;Debnath&quot;},{&quot;first_name&quot;:&quot;Srinivas&quot;,&quot;last_name&quot;:&quot;Odde&quot;},{&quot;first_name&quot;:&quot;Hua&quot;,&quot;last_name&quot;:&quot;Xie&quot;},{&quot;first_name&quot;:&quot;Yong-Tang&quot;,&quot;last_name&quot;:&quot;Zheng&quot;},{&quot;first_name&quot;:&quot;Jian&quot;,&quot;last_name&quot;:&quot;Ding&quot;},{&quot;first_name&quot;:&quot;Nouri&quot;,&quot;last_name&quot;:&quot;Neamati&quot;},{&quot;first_name&quot;:&quot;Ya-Qiu&quot;,&quot;last_name&quot;:&quot;Long&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2012&quot;,&quot;month&quot;:&quot;11&quot;,&quot;day&quot;:&quot;07&quot;,&quot;issue&quot;:&quot;22&quot;,&quot;volume&quot;:&quot;55&quot;,&quot;pages&quot;:&quot;9492-9509&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm300667v&quot;},&quot;abstract&quot;:&quot;Among a large number of HIV-1 integrase (IN) inhibitors, the 8-hydroxy-[1,6]naphthyridines (i.e., L-870,810) were one of the promising class of antiretroviral drugs developed by Merck Laboratories. In spite of its remarkable potency and efficacy, unfortunately upon completion of phase I clinical studies, development of L-870,810 was halted. Because of its desirable pharmacological and pharmaceutical properties we were intrigued to design novel analogues of L-870,810 with goals to (1) improve upon limitations of naphthyridine-7-carboxamides as antiviral agents and (2) to reposition their use as innovative cytotoxic agents for cancer therapeutics. Herein, we report on the design and synthesis of a series of 1,6-naphthyridine-7-carboxamides with various substitutions at the 5- and 8-positions. All the new 5-substituted-8-hydroxy-[1,6]naphthyridines were potent IN inhibitors and the 5-substituted-8-amino-[1,6]naphthyridines were significantly cytotoxic. Further optimization of the 5,8-disubstituted-[1,6]naphthyri&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm300667v&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm300667v" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm300667v&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm300667v" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm300667v&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm300667v" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm300667v&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm300667v&amp;href=/doi/10.1021/jm300667v" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm300667v" /></input><a href="/doi/pdf/10.1021/jm300667v" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (5 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm300667v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm300667v%26sid%3Dliteratum%253Aachs%26pmid%3D23098137%26genre%3Darticle%26aulast%3DZeng%26date%3D2012%26atitle%3DRepositioning%2BHIV-1%2BIntegrase%2BInhibitors%2Bfor%2BCancer%2BTherapeutics%253A%2B1%252C6-Naphthyridine-7-carboxamide%2Bas%2Ba%2BPromising%2BScaffold%2Bwith%2BDrug-like%2BProperties%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D55%26issue%3D22%26spage%3D9492%26epage%3D9509%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292201" title="Scaffolds">Scaffolds</a>,</li><li><a href="/action/doSearch?ConceptID=290896" title="Cells">Cells</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=290808" title="Toxicity">Toxicity</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/55/22" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jmcmar.2012.55.issue-22/production/jmcmar.2012.55.issue-22.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300667v/production/images/medium/jm-2012-00667v_0008.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300667v/production/images/large/jm-2012-00667v_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300667v&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Among a large number of HIV-1 integrase (IN) inhibitors, the 8-hydroxy-[1,6]naphthyridines (i.e., L-870,810) were one of the promising class of antiretroviral drugs developed by Merck Laboratories. In spite of its remarkable potency and efficacy, unfortunately upon completion of phase I clinical studies, development of L-870,810 was halted. Because of its desirable pharmacological and pharmaceutical properties we were intrigued to design novel analogues of L-870,810 with goals to (1) improve upon limitations of naphthyridine-7-carboxamides as antiviral agents and (2) to reposition their use as innovative cytotoxic agents for cancer therapeutics. Herein, we report on the design and synthesis of a series of 1,6-naphthyridine-7-carboxamides with various substitutions at the 5- and 8-positions. All the new 5-substituted-8-hydroxy-[1,6]naphthyridines were potent IN inhibitors and the 5-substituted-8-amino-[1,6]naphthyridines were significantly cytotoxic. Further optimization of the 5,8-disubstituted-[1,6]naphthyridines with structural variation on 7-carboxamide delivered novel compounds with significant cytotoxicity in a panel of cancer cell lines and effective inhibition against select oncogenic kinases.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div class="extra-info-sec articleNote"><h4><span>â¥</span>Â Author Contributions</h4><p class="last">These authors equally contributed to this work.</p></div><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_40787" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_40787" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Over the past several years, the concept of drug repositioning (aka drug repurposing, reprofiling, and indication switch: finding a new use for an existing drug) has gained considerable attention. This concept has also been considered for target repositioning, and it is expected to produce many more surprising new drugs for different diseases.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1, 2)</a> Drug repositioning is most effective when it is applied during all phases of clinical development. Historically, this approach was accomplished through serendipitous discoveries and unintended side effects, however, computational repositioning strategies are becoming increasingly popular because the benefit of such discoveries can be enormous.<a onclick="showRef(event, 'ref3 ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref3 ref4 ref5">(3-5)</a></div><div class="NLM_p">Quite often, when a drug fails early phase clinical development there is no further appetite to investigate potential off-targets and reasons for failure. In cases when a backup compound wins the competition for development, the earlier drugs are often dropped from the radar screen. One such agent, L-870,810, showed favorable pharmacological and pharmaceutical properties but was proven not to be an ideal candidate for antiviral drug development.<a onclick="showRef(event, 'ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref6 ref7">(6, 7)</a> Because of our previous success in repositioning our earlier discovered hydrazide class of IN inhibitors<a onclick="showRef(event, 'ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref8 ref9">(8, 9)</a> we hypothesized that 1,6-naphthyridine-7-carboxamides could serve as a promising new scaffold for further optimization into cytotoxic compounds useful as anticancer therapeutics (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>). In fact, it was previously reported that the 1,6-naphthyridines inhibit FGFR-1 and VEGFR-2 kinases when substituted at positions 2 and 7 by amino and 3 by aryl groups, suggesting that various substitutions on this active scaffold could confer diverse biological activities.<a onclick="showRef(event, 'ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref10 ref11">(10, 11)</a> Indeed, L-870,810 was used as an effective prototype to develop a series of structurally novel CGRP antagonists with good pharmacokinetic properties.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300667v/production/images/medium/jm-2012-00667v_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300667v/production/images/large/jm-2012-00667v_0010.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Repurposing HIV-1 IN inhibitors 5,8-substitutions of 1,6-naphthyridine-7-carboxamide into novel cytotoxic agents useful for preclinical development for cancer treatment.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300667v/production/images/large/jm-2012-00667v_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300667v&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">HIV integrase (IN) is an attractive target for the development of anti-AIDS drugs because it is an essential enzyme for the replication of the virus and has no cellular counterparts.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> IN catalyzes the integration of viral DNA into the host genome in a two-step process, 3â²-processing and strand transfer. Among a large number of synthetic IN inhibitors,<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> aryl diketoacid and its bioisosteres are the most developed class that selectively inhibit the strand transfer step by metal chelation mechanism.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> The 8-hydroxy-7-carboxy-1,6-naphthyridine serves as the bioisostere of aryl diketoacid with better bioavailability, affording potent in vivo antiviral potency.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> Previous 1,6-naphthyridine-based SAR studies only focused on the substitutions at the 5- and 7-position with respect to the IN inhibition.<a onclick="showRef(event, 'ref6 ref7 ref16 ref17 ref18 ref19 ref20 ref21 ref22 ref23 ref24 ref25 ref26 ref27 ref28'); return false;" href="javascript:void(0);" class="ref ref6 ref7 ref16 ref17 ref18 ref19 ref20 ref21 ref22 ref23 ref24 ref25 ref26 ref27 ref28">(6, 7, 16-28)</a> These later studies led to the discovery of highly potent IN inhibitors; however, to our knowledge none of these compounds were pursued as anticancer agents. Other earlier reports included the use of similar 1,6-naphthyridines as potent and selective inhibitors of human cytomegalovirus.<a onclick="showRef(event, 'ref29 ref30 ref31'); return false;" href="javascript:void(0);" class="ref ref29 ref30 ref31">(29-31)</a> The above-mentioned antitumor 1,6-naphthyridines employed a different substitution pattern with ureido at the 2-position, aryl at the 3-position, and amino at the 7-position.</div><div class="NLM_p last">Herein, we designed, synthesized, and provided biological activities of a novel 1,6-naphthyridine-7-carboxamide-based focused library with variation on the 5- and 8-substituents (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>). Our study shows that 1,6-naphthyridine scaffold is especially suitable for optimization of compounds that not only inhibit the catalytic activities of IN but also display significant cytotoxicity. This latter property was further pursued to develop novel agents useful for development as potential anticancer agents.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_41634" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_41634" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Chemistry</h3><div class="NLM_p">An efficient synthesis to build the 1,6-naphthyridine-7-carboxyamide-based focused library with variation on 5- and 8-substitution was established by modifying the reaction conditions reported previously.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> As depicted in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>, starting from quinolinic anhydride, treatment with refluxing isopropanol provided the mono acid <b>2</b>, which was converted to the corresponding acyl chloride <b>3</b> by refluxing with thionyl chloride. An optimization was made on this transformation due to the troublesome workup with a large amount of thionyl chloride and the hydrolysis of the acyl chloride <b>3</b> under moisture produced by the thionyl chloride. By employing dichloromethane as a solvent and thionyl chloride (1.5 equiv) as a reagent, we performed the transformation with ease and good yield. Consequently, refluxing the solution of acid <b>2</b> (1 equiv) and thionyl chloride (1.5 equiv) in dichloromethane with a catalytic amount of DMF smoothly afforded the acyl chloride <b>3</b> that was reduced to the alcohol <b>4</b> with sodium borohydride. Subsequent Mitsunobu reaction with the phenylsulfonamide of glycine methyl ester followed by a Dieckmann cyclization in the presence of sodium methoxide yielded the core structure 8-hydroxy-1,6-naphthyridine <b>6</b>. During the Mitsunobu reaction, the use of anhydrous MgSO<sub>4</sub> as an additive accelerated this reaction, probably due to the contribution to the anhydrous reaction condition that was beneficial for the subsequent cyclization reaction in a one-pot reaction. Further bromination at the 5-position and amidation at the 7-position afforded the key intermediate <b>I</b>-<b>1</b>, from which 5-amino substituted- and 8-amino substituted-1,6-naphthyridine-7-carboxamides were obtained via nucleophilic aromatic substitution by various amines. Specifically, <b>I</b>-<b>1</b> was heated to 135 Â°C with hexane-1,6-diamine or 2-(1<i>H</i>-indol-3-yl)ethanamine in DMPU to afford <b>I</b>-<b>7</b> and <b>I</b>-<b>8</b>, respectively, and the direct refluxing of <b>I</b>-<b>1</b> in different amino alcohol provided <b>I</b>-<b>9</b>â<b>I</b>-<b>11</b>. The 5-sulfonamide substituted analogues (<b>I</b>-<b>4</b>â<b>I</b>-<b>6</b>) were synthesized by refluxing <b>I</b>-<b>1</b> in pyridine with different sulfonamides in the presence of cuprous oxide. In addition, structurally diverse analogues with variation on 8-amino substituent (<b>I</b>-<b>12</b>â<b>I</b>-<b>20</b>, <b>II</b>-<b>1</b>â<b>II</b>-<b>15</b>) were synthesized from the 8-mesylate or tosylate intermediate (<b>I</b>-<b>2</b> or <b>I</b>-<b>3</b>) by nucleophilic substitution of various amines in refluxing THF solution.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300667v/production/images/medium/jm-2012-00667v_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300667v/production/images/large/jm-2012-00667v_0015.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. General Synthetic Route toward the 5,8-Substituted 1,6-Naphthyridine-7-carboxamides<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300667v/production/images/large/jm-2012-00667v_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300667v&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <i>i</i>-PrOH, reflux, 16 h, 78%; (b) SOCl<sub>2</sub> (1.5 equiv), CH<sub>2</sub>Cl<sub>2</sub>, cat. DMF, reflux, 3 h; (c) NaBH<sub>4</sub>, THF, 0 Â°C, 40â50 min, overall yield 73% for two steps; (d) TsNHCH<sub>2</sub>COOCH<sub>3</sub>, DEAD, PPh<sub>3</sub>, anhydrous MgSO<sub>4</sub>, THF, 0 Â°C, 2 h; (e) NaOMe, CH<sub>3</sub>OH, 0 Â°C to rt, 3 h, overall yield 65% for two steps; (f) NBS, CH<sub>2</sub>Cl<sub>2</sub>, rt, 1 h, 85%; (g) 4-fluoro-benzylamine or other amines, toluene, reflux, 20 h, 65â98%, or 1N LiOH, methanol, reflux, 5 h, then bis(trichloromethyl)carbonate, DIPEA, aniline, DMF, 0 Â°C, 2h (for the preparation of (<b>III</b>-<b>15</b>)-<b>8</b>); (h) TsCl or MsCl, TEA, CH<sub>2</sub>Cl<sub>2</sub>, 5 h, 90%; (i) NHR<sub>1</sub>R<sub>2</sub>, THF, reflux, 8 h, 50â95%; (j) Râ²SO<sub>2</sub>NRH, pyridine, cuprous oxide, reflux, 16 h, 35â65%; (k) alcohol amine (neat), 130 Â°C, 9 h (for the preparation of <b>I</b>-<b>9</b>â<b>I</b>-<b>11</b>); RNH<sub>2</sub>, DMPU, 135 Â°C, 48 h (for the preparation of <b>I</b>-<b>7, I</b>-<b>8</b>); (l) <i>tert</i>-butyl (1<i>r</i>,4<i>r</i>)-4-aminocyclohexylcarbamate, Et<sub>3</sub>N, THF, reflux, 8 h, 70%; then piperidine, 110 Â°C, 48 h, 89%; finally, TFA, DCM, 2h, rt, 95%; (m)1N LiOH, THF, rt, 12 h; then Boc-protected amine, EDCI, HOBT, DIPEA, DCM, 3 h; finally, TFA, DCM, 2 h.</p></p></figure><div class="NLM_p last">The 7-substituted analogues with 4-aminocyclohexylamino group held constant at the 8-position (<b>III</b>-<b>1</b>â<b>III</b>-<b>16</b>) were synthesized in a similar fashion by incorporating various amines into the 7-carboxamide position [<b>III</b>-(<b>1</b>â<b>16</b>)-<b>8</b>] followed by installation of the <i>trans</i>-cyclohexane-1,4-diamino at the 8-position. The 7-carboxylate substituted analog (<b>III</b>-<b>17</b>) was synthesized analogously by direct amination at the 8-position of the intermediate <b>10</b>. However, the 7,8-substituents interchanged analogue, <b>III</b>-<b>18</b>, was synthesized in a different reaction sequence, i.e., 8-nucleophilic aromatic substitution occurred prior to the 7-amidation because the cyclohexane-1,4-diamino group was suitable for introducing into the 7-carboxamide position at the final step of the synthesis.</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> New 1,6-Naphthyridine Derivatives are Potent IN Inhibitors and Display Significant Antiviral Activities</h3><div class="NLM_p">We first evaluated the IN inhibitory activity of these synthetic 5,8-disubstituted-1,6-naphthyridine derivatives. Interestingly, the substitutions at the 5- and 8-positions were found to play different roles in the bioactivity of the 1,6-naphthyridine chemotype. As shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>, the 5-substitution on the 8-hydroxy-1,6-naphthyridine-7-carboxamide just tuned the IN strand transfer activity (<b>I</b>-<b>1</b>â<b>I</b>-<b>11</b>), while the 8-substitution on the 1,6-naphthyridine-7-carboxamide was critical for retaining the IN inhibitory activity (compounds <b>I</b>-<b>12</b> to <b>I</b>-<b>20</b> vs <b>I</b>-<b>1</b> to <b>I</b>-<b>11)</b>. It is clear that the presence of the hydroxyl group at the 8-position is essential for strand transfer activity, which is consistent with the original design of 8-hydroxy-1,6-naphthyridine-7-carboxamide scaffold as the bioisostere of the aryl diketoacid active structure.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> The conversion of hydroxyl into methylsulfonate (<b>I</b>-<b>2</b>) or 4-methylbenzenesulfonate (<b>I</b>-<b>3</b>) resulted in a remarkable decrease in the potency of 3â²-processing and strand transfer. Furthermore, the replacement of the hydroxyl group with an amino substitution at the 8-position caused a substantial loss of IN inhibitory activity (<b>I</b>-<b>12</b>â<b>I</b>-<b>20</b>) that might be attributed to the loss of the chelation binding motif of the Î²-ketoâenol, an essential pharmacophore for strand transfer inhibition.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a></div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Inhibition of HIV-1 Integrase Catalytic Activities and Antiviral Activities of the Lead Compounds</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300667v/production/images/medium/jm-2012-00667v_0001.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300667v/production/images/medium/jm-2012-00667v_0002.gif" alt="" id="fx2" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>Table a</sup><p class="last">IC<sub>50</sub>: the drug concentration that produced 50% inhibition of the enzyme function.</p></div><div class="footnote" id="t1fn2"><sup>Table b</sup><p class="last">EC<sub>50</sub>: effective concentration required to protect C8166 cells against the cytopathogenicity of HIV-1 by 50%.</p></div><div class="footnote" id="t1fn3"><sup>Table c</sup><p class="last">CC<sub>50</sub>: cytotoxic concentration required to reduce C8166 cell proliferation by 50% tested by MTT method.</p></div><div class="footnote" id="t1fn4"><sup>Table d</sup><p class="last">TI: therapeutic index is a ratio of the CC<sub>50</sub> value/EC<sub>50</sub> value.</p></div><div class="footnote" id="t1fn5"><sup>Table e</sup><p class="last">ND: not determined.</p></div></div><div></div></div><div class="NLM_p last">When the 8-hydroxy substituent was held constant, the amino substitution at the 5-position of 8-hydroxy-1,6-naphthyridine-7-carboxamide was generally beneficial for antiviral activity (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>, <b>I</b>-<b>4</b>â<b>I</b>-<b>11</b>), conferring submicromolar IC<sub>50</sub> values in inhibiting the IN strand transfer reaction. Furthermore, all these 5-amino-substituted 8-hydroxy-1,6-naphthyridine-7-carboxamides displayed potent antiviral activity and a high therapeutic index. It is worth noting that the structurally simple 2-hydroxy ethylamino turned out to be an optimal substituent for both3â²-processing and the strand transfer inhibition comparable with the sulfonamide substituent in L-870,810 (<b>I</b>-<b>9</b>â<b>I</b>-<b>11</b> vs <b>I</b>-<b>4</b>). Moreover, the chirality of the 2-methyl on the 1-hydroxypropan-2-yl-amino substituent had a subtle effect on the antiviral potency with <i>S</i>-configuration being favored (<b>I</b>-<b>10</b> vs <b>I</b>-<b>9</b>, <b>I</b>-<b>11</b>). However, the sulfonamide-substituted analogues displayed an overall superior antiviral effect in terms of the EC<sub>50</sub> value and therapeutic index. Our investigation on the effect of the 5,8-substitution on the HIV-1 IN inhibitory activity of 1,6-naphthyridine shed new light on the design and understanding of the 1,6-naphthyridine-based IN inhibitors, which will be helpful for the evolution of this scaffold into clinically useful antiviral drugs.</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Active Compounds Chelate Divalent Metals on the IN Active Site</h3><div class="NLM_p">Several active and inactive compounds were docked on the IN catalytic site using GOLD (Cambridge Crystallographic Data Center, Cambridge, UK) to explore mechanisms behind structureâactivity relationships. Given the lack of a full length crystal structure of HIV-1 IN, a homology model was built based on the X-ray crystal structure of prototype foamy virus (PFV) intasome (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3OYA">3OYA</a>),<a onclick="showRef(event, 'ref34 ref35'); return false;" href="javascript:void(0);" class="ref ref34 ref35">(34, 35)</a> a retro-lentivirus belonging to the same viral genus as HIV. Binding modes of Raltegravir, <b>I</b>-<b>1</b>, <b>I</b>-<b>4</b> (L-970,810), <b>I</b>-<b>9</b>, <b>I</b>-<b>12</b>, and <b>I</b>-<b>14</b> are shown in Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>. Like raltegravir, deprotonated hydroxyl groups of active compounds, <b>I</b>-<b>1</b>, <b>I</b>-<b>4</b>, and <b>I</b>-<b>9</b>, formed strong metal chelating interactions with two Mg<sup>2+</sup> ions along with Asp64, Asp116, and Glu152. Phenyl groups of these compounds formed stacking interactions with DC16 from DNA. Sulfonyl oxygen atoms of <b>I</b>-<b>4</b> forms H-bonds with Asn117. Thus, these compounds potentially displace the reactive 3â²OH of DNA from the active site to cause deactivation of the intasome. Although <b>I</b>-<b>12</b> docked in a similar fashion as <b>I</b>-<b>1</b>, the <i>N</i>-methyl group of <b>I</b>-<b>12</b> created steric hindrance into the binding site to generate weaker interactions with Mg<sup>2+</sup> ions. Another inactive compound, <b>I</b>-<b>14</b>, was docked completely in the reverse position. Substitution with benzyl on the NH group blocked chelating interaction with Mg<sup>2+</sup> ions. These observations are further comfirmed by docking scores. The GOLD score of these active compounds are around 100, while that of inactive compounds are less than 70.</div><figure id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300667v/production/images/medium/jm-2012-00667v_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300667v/production/images/large/jm-2012-00667v_0011.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Binding modes of Raltegravir, <b>I</b>-<b>1</b>, <b>I</b>-<b>4</b>, <b>I</b>-<b>9</b>, <b>I</b>-<b>12</b>, and <b>I</b>-<b>14</b> on the modeled IN active site based on the X-ray crystal structure of prototype foamy virus (PFV) intasome (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3OYA">3OYA</a>).<a onclick="showRef(event, 'ref34 ref35'); return false;" href="javascript:void(0);" class="ref ref34 ref35">(34, 35)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300667v/production/images/large/jm-2012-00667v_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300667v&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Repositioning of Novel Derivatives for Anticancer Properties</h3><div class="NLM_p">Because the 5,8-substitutions were shown to steer the biological profile of 1,6-naphthyridine-7-carboxamide scaffold, we were interested to test the 5,8-substituted 1,6-naphthyridine-7-carboxamides in a panel of cancer cell lines to better understand their biological activities. Interestingly, some of the 8-aliphatic diamino substituted analogues that were totally inactive in our IN assay displayed distinct cytotoxicity (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>, <b>I</b>-<b>18</b>, <b>I</b>-<b>20</b>). However, the 1,6-naphthyridine-7-carboxamides bearing aryl or alkyl substituted monoamino groups at the 8-position were not cytotoxic (i.e., <b>I</b>-<b>13</b>â<b>I</b>-<b>17</b>). On the other hand, the 5-sulfoxamide substituted 8-hydroxy-1,6-naphthyridines displayed low micromolar cytotoxicity against the tested tumor cell lines (i.e., <b>I</b>-<b>4</b>-<b>6</b>), whereas the 5-alkylamino substituted counterparts were inactive in inhibiting the cell growth even at the concentration of 20 Î¼M (<b>I</b>-<b>8</b>-<b>11</b>). Because of these encouraging preliminary observations, further SAR and structural optimization were conducted around the 8-amino substituted-1,6-naphthyridine-7-carboxamide scaffold to select compounds for repurposing in our cancer program.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Cytotoxicity of the First Generation 8-Substituted-1,6-naphthyridine-7-carboxamide Derivatives</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300667v/production/images/medium/jm-2012-00667v_0003.gif" alt="" id="fx3" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>Table a</sup><p class="last">IC<sub>50</sub>: Inhibitory concentrations at 50% in Î¼M were measured by MTT assay after 72 h continuous drug exposure. Standard deviations are from three independent experiments run in triplicates.</p></div><div class="footnote" id="t2fn2"><sup>Table b</sup><p class="last">ND: not determined.</p></div></div><div></div></div><div class="NLM_p">Our initial cytotoxicity data indicated that the diamino structure was an important functionality at the 8-position of 1,6-naphthyridine-7-carboxamide for maintaining antiproliferative activity (exemplified by <b>I</b>-<b>18</b>, <b>I</b>-<b>20</b> vs <b>I</b>-<b>12</b>â<b>I</b>-<b>17</b>). Therefore, during the lead optimization campaign, the open chain alkyl diamino, the aryl diamino, and the aliphatic cyclic diamino groups were examined as the 8-substituent in the second generation of the cytotoxic 1,6-naphthyridine series (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>). As shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>, the aliphatic cyclic diamino structures generally exhibited significant antiproliferative activity against a panel of cancer cell lines with the 4-aminopiperidine and <i>trans</i>-1,4-diaminocyclohexane being of special interest (<b>II</b>-<b>10</b>, <b>II</b>-<b>13</b>). When the terminal amino group was protected by an acyl group (<b>II</b>-<b>3</b>, <b>II</b>-<b>5</b>, <b>II</b>-<b>9</b>, <b>II</b>-<b>11</b>), the loss of the free NâH resulted in decreased potency. This suggests that the amino substituent bearing a free terminal amino group at the 8-position is important for the cytotoxicity of the 1,6-naphthyridine scaffold. Setting <i>trans</i>-1,4-diaminocyclohexane as the privileged structure at the 8-position, the optimal substituent at 5-position was simply explored. The replacement of the original bromo group by a hydrogen (<b>II</b>-<b>1</b>), piperidine (<b>II</b>-<b>14</b>), or sultam (<b>II</b>-<b>15</b>) at the 5-position all led to a loss of cytotoxicity to a similar extent, although the amino substituent at the 5-position was beneficial for the IN inhibition. Therefore, the (1<i>r</i>,4<i>r</i>)-4-aminocyclohexylamino and the bromo groups were maintained at positions 8 and 5, respectively, for the following SAR study of the third generation series.</div><figure id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300667v/production/images/medium/jm-2012-00667v_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300667v/production/images/large/jm-2012-00667v_0012.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Structural optimization of hit compounds for their cytotoxic property with focus on amino substituent at the position 8.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300667v/production/images/large/jm-2012-00667v_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300667v&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Cytotoxicity of the Second Generation 8-Amino Substituted-1,6-naphthyridine-7-carboxamide Derivatives with Variation on 8-Amino Substitution</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300667v/production/images/medium/jm-2012-00667v_0004.gif" alt="" id="fx4" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300667v/production/images/medium/jm-2012-00667v_0005.gif" alt="" id="fx5" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>Table a</sup><p class="last">IC<sub>50</sub>: Inhibitory concentrations at 50% in Î¼M were measured by MTT assay after 72 h continuous drug exposure. Standard deviations are from three independent experiments run in triplicate. Entries with two values are from two independent experiments run in triplicate.</p></div><div class="footnote" id="t3fn2"><sup>Table b</sup><p class="last">ND: not determined.</p></div></div><div></div></div><div class="NLM_p">As antiproliferative agents, four representative compounds <b>I</b>-<b>18</b>, <b>II</b>-<b>6</b>, <b>II</b>-<b>10</b>, and <b>II</b>-<b>13</b>, were selected for colony formation assay. Encouragingly, these cellular active 8-amino-1,6-naphthyridine-7-carboxamides significantly inhibited the colony formation of highly invasive breast cancer cells MDA-MB-435 (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>), consistent with their antiproliferative activity. Especially, the most potent compound <b>II</b>-<b>13</b> significantly blocked the colony formation of MDA-MB-435 cells in a dose-dependent manner, with a submicromolar IC<sub>50</sub> value.</div><figure id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300667v/production/images/medium/jm-2012-00667v_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300667v/production/images/large/jm-2012-00667v_0013.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. 8-Amino derivatives of 1,6-naphthyridine-7-carboxamide decrease cell proliferation and arrest cells in G<sub>0</sub>/G<sub>1</sub> phase. Colony formation assay was performed using highly invasive MDA-MB-435 cells treated continuously for 7 days with <b>I</b>-<b>18</b>, <b>II</b>-<b>6</b>, <b>II</b>-<b>10</b>, and <b>II</b>-<b>13</b>, at 10 Î¼M (A) and at various doses with <b>II</b>-<b>13</b> (B). DNA content was analyzed in propidium iodide stained MDA-MB-435. Cells were treated with 2 Ã IC<sub>50</sub> values of <b>I</b>-<b>18</b> (C) and <b>II</b>-<b>13</b> (D) at indicated time. Dark-blue bars represent the G<sub>0</sub>/G<sub>1</sub> fraction, light-cyan bars represent cells in S phase, and brown bars correspond to cells in the G<sub>2</sub>/M phase of the cell cycle.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300667v/production/images/large/jm-2012-00667v_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300667v&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Starting from the evolved compound <b>II</b>-<b>13</b>, further structural optimization effort was focused on the 7-carboxamide substitution of the 1,6-naphthyridine framework while the (1<i>r</i>,4<i>r</i>)-4-aminocyclohexylamino moiety at the 8-position was held constant. As shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>, the third generation of cytotoxic 8-((4-aminocyclohexyl)amino)-1,6-naphthyridine-7-carboxamide series were synthesized and assessed with structural variation on the 7-carboxamide portion. The original 4-fluorobenzylamino group was examined with various substitutions on the phenyl ring or the methylene bridge (<b>III</b>-<b>1</b>â<b>III</b>-<b>10</b>). Furthermore, the effect of heteroaromatic or aliphatic cyclic amine or the methoxy replacement at 7-carboxamide (<b>III</b>-<b>11</b>â<b>III</b>-<b>13</b>, <b>III</b>-<b>16</b>, <b>III</b>-<b>17</b>) on cytotoxicity was investigated. The chain length of the arylamino moiety was investigated as well (i.e., <b>III</b>-<b>14</b>, <b>III</b>-<b>15</b> vs <b>II</b>-<b>13</b>). Interestingly, this scaffold well tolerated the structural variation on the arylamino group at the 7-carboxamide position. Except for the rigid (<i>S</i>)-1-(4-fluorophenyl)ethanamino, the furan-2-ylmethanamino, cyclohexanamino, and methoxy substitutions (<b>III</b>-<b>4</b>, <b>III</b>-<b>11</b>, <b>III</b>-<b>16</b>, <b>III</b>-<b>17</b>) that were detrimental to the antiproliferative activity, all other structural displacement exerted slight impact on the inhibitory potency against various tumor cell lines. The electron-donating group and halogen were favored substitutions on the benzyl ring. In addition, the interchange of 8-((4-aminocyclohexyl)amino and 7-<i>N</i>-(4-fluorobenzyl) carboxamide (<b>III</b>-<b>18</b> vs <b>II</b>-<b>13</b>) marginally decreased cytotoxicity. It is clear that <i>N</i>-(halogen substituted benzyl)carboxamide at 7-position is an important motif for cytotoxicity of 8-((4-aminocyclohexyl)amino-1,6-naphthyridine chemotype.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Cytotoxicity of the Third Generation 8-Amino Substituted-1,6-naphthyridine-7-carboxamide Derivatives with Variation on the 7-Carboxamide Moiety</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300667v/production/images/medium/jm-2012-00667v_0006.gif" alt="" id="fx6" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300667v/production/images/medium/jm-2012-00667v_0007.gif" alt="" id="fx7" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>Table a</sup><p class="last">IC<sub>50</sub>: inhibitory concentrations at 50% in Î¼M were measured by MTT assay after 72 h continuous drug exposure. Standard deviations are from three independent experiments run in triplicate.</p></div><div class="footnote" id="t4fn2"><sup>Table b</sup><p class="last">ND: not determined.</p></div></div><div></div></div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Select 8-Amino-1,6-naphthyridine-7-carboxamides Arrest Cells in G<sub>0</sub>/G<sub>1</sub> and Show Multiple Kinase Inhibitory Activity</h3><div class="NLM_p">8-Amino-1,6-naphthyridine-7-carboxamide represents a new class of antiproliferative agents and warrants further investigation. Compounds <b>II</b>-<b>6</b>, <b>II</b>-<b>10</b>, and <b>II</b>-<b>13</b> completely blocked colony formation of highly aggressive MDA-MB-435 cancer cells at 10 Î¼M (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>A). The IC<sub>50</sub> value range for <b>II</b>-<b>13</b> in the same cell line was between 0.1 and 1 Î¼M (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>B). <b>I</b>-<b>18</b> blocked cells in G<sub>0</sub>/G<sub>1</sub> as early as 12 h, and this block persisted till 48 h with 61% of cells in G<sub>0</sub>/G<sub>1</sub> versus 36% in control cells (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>C). Similarly, <b>II</b>-<b>13</b> arrested the cells in G<sub>0</sub>/G<sub>1</sub> (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>D).</div><div class="NLM_p">So far, starting from L-870810, we established a focused library based on the 1,6-naphthyridine core structure with variations on 5,7,8-substitutions and discovered a new class of antiproliferative agents. Our initial target identification effort was directed at the tyrosine kinases important for cancer progression.</div><div class="NLM_p">Some representative 5,8-substituted-1,6-naphthyridine-7-carboxamides that were active in our cytotoxicity assays were chosen to test their inhibitory activities against in-house tyrosine kinases including EGFR, erbB-2, c-Src, and KDR (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>). The 8-hydroxy-5-amino substituted analogues (<b>I</b>-<b>4</b>, <b>I</b>-<b>7</b>) were inactive in the kinase assay, whereas some 8-((1,4)-<i>trans</i>-4-aminocyclohexyl)amino)-5-bromo-<i>N</i>-(substituted-benzyl)-1,6-naphthyridine-7-carboxamide displayed effective inhibition against the EGFR, c-Src, and/or KDR kinases at the concentration of 10 Î¼M (<b>III</b>-<b>2</b>, <b>III</b>-<b>8</b>, <b>III</b>-<b>9</b>). Furthermore, the substitution at the 7-carboxamide was found to significantly affect the kinase inhibitory activity although these 7-variously substituted analogues all displayed marked antiproliferative effect on the tumor cell lines tested. The phenethylamino or anilinyl or 1,4-<i>trans</i>-cyclohexyldiamino substitution at the 7-carboxamide portion resulted in no inhibition against these kinases (<b>III</b>-<b>14</b>, <b>III</b>-<b>15</b>, <b>III</b>-<b>18</b>). Therefore, the 8-((1,4)-<i>trans</i>-4-aminocyclohexyl)amino)-5-bromo-<i>N</i>-(substituted-benzyl)-1,6-naphthyridine-7-carboxamides are a new class of pan-tyrosine kinase inhibitors. The chloro or alkoxy substituent at 4â²- or 2â²-position of the benzyl group was beneficial for the kinase inhibition, consistent with the antiproliferative activity in the tumor cells.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Inhibition of EGFR, ErbB2, Src, and KDR Kinase Activities by Selected 5,8-Substituted-1,6-naphthyridine-7-carboxamide Derivatives</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">Â </th><th class="rowsep1 colsep0" colspan="4" align="center">% kinase inhibition at 10 Î¼M for each compound<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">EGFR</th><th class="colsep0 rowsep0" align="center">ErbB2</th><th class="colsep0 rowsep0" align="center">Src</th><th class="colsep0 rowsep0" align="center">KDR</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>I</b>-<b>4</b></td><td class="colsep0 rowsep0" align="center">1</td><td class="colsep0 rowsep0" align="center">8</td><td class="colsep0 rowsep0" align="center">13</td><td class="colsep0 rowsep0" align="center">ND<a class="ref internalNav" href="#t5fn2" aria-label="b">b</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>I</b>-<b>7</b></td><td class="colsep0 rowsep0" align="center">30</td><td class="colsep0 rowsep0" align="center">11</td><td class="colsep0 rowsep0" align="center">23</td><td class="colsep0 rowsep0" align="center">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>II</b>-<b>1</b></td><td class="colsep0 rowsep0" align="center">10</td><td class="colsep0 rowsep0" align="center">ND</td><td class="colsep0 rowsep0" align="center">15</td><td class="colsep0 rowsep0" align="center">10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>II</b>-<b>4</b></td><td class="colsep0 rowsep0" align="center">0</td><td class="colsep0 rowsep0" align="center">ND</td><td class="colsep0 rowsep0" align="center">17</td><td class="colsep0 rowsep0" align="center">0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>II</b>-<b>6</b></td><td class="colsep0 rowsep0" align="center">0</td><td class="colsep0 rowsep0" align="center">ND</td><td class="colsep0 rowsep0" align="center">18</td><td class="colsep0 rowsep0" align="center">0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>II</b>-<b>7</b></td><td class="colsep0 rowsep0" align="center">7</td><td class="colsep0 rowsep0" align="center">1</td><td class="colsep0 rowsep0" align="center">7</td><td class="colsep0 rowsep0" align="center">8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>II</b>-<b>10</b></td><td class="colsep0 rowsep0" align="center">5</td><td class="colsep0 rowsep0" align="center">1</td><td class="colsep0 rowsep0" align="center">9</td><td class="colsep0 rowsep0" align="center">0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>II</b>-<b>12</b></td><td class="colsep0 rowsep0" align="center">0</td><td class="colsep0 rowsep0" align="center">ND</td><td class="colsep0 rowsep0" align="center">29</td><td class="colsep0 rowsep0" align="center">4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>II</b>-<b>13</b></td><td class="colsep0 rowsep0" align="center">21</td><td class="colsep0 rowsep0" align="center">7</td><td class="colsep0 rowsep0" align="center">13</td><td class="colsep0 rowsep0" align="center">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>III</b>-<b>1</b></td><td class="colsep0 rowsep0" align="center">20</td><td class="colsep0 rowsep0" align="center">0</td><td class="colsep0 rowsep0" align="center">ND</td><td class="colsep0 rowsep0" align="center">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>III</b>-<b>2</b></td><td class="colsep0 rowsep0" align="center"><b>51</b></td><td class="colsep0 rowsep0" align="center"><b>0</b></td><td class="colsep0 rowsep0" align="center"><b>76</b></td><td class="colsep0 rowsep0" align="center"><b>2</b></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>III</b>-<b>3</b></td><td class="colsep0 rowsep0" align="center">0</td><td class="colsep0 rowsep0" align="center">0</td><td class="colsep0 rowsep0" align="center">ND</td><td class="colsep0 rowsep0" align="center">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>III</b>-<b>6</b></td><td class="colsep0 rowsep0" align="center">22</td><td class="colsep0 rowsep0" align="center">0</td><td class="colsep0 rowsep0" align="center">ND</td><td class="colsep0 rowsep0" align="center">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>III</b>-<b>8</b></td><td class="colsep0 rowsep0" align="center"><b>59</b></td><td class="colsep0 rowsep0" align="center"><b>0</b></td><td class="colsep0 rowsep0" align="center"><b>70</b></td><td class="colsep0 rowsep0" align="center"><b>34</b></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>III</b>-<b>9</b></td><td class="colsep0 rowsep0" align="center"><b>68</b></td><td class="colsep0 rowsep0" align="center"><b>13</b></td><td class="colsep0 rowsep0" align="center"><b>90</b></td><td class="colsep0 rowsep0" align="center"><b>41</b></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>III</b>-<b>14</b></td><td class="colsep0 rowsep0" align="center">0</td><td class="colsep0 rowsep0" align="center">0</td><td class="colsep0 rowsep0" align="center">ND</td><td class="colsep0 rowsep0" align="center">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>III</b>-<b>15</b></td><td class="colsep0 rowsep0" align="center">0</td><td class="colsep0 rowsep0" align="center">0</td><td class="colsep0 rowsep0" align="center">ND</td><td class="colsep0 rowsep0" align="center">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>III</b>-<b>18</b></td><td class="colsep0 rowsep0" align="center">5</td><td class="colsep0 rowsep0" align="center">3</td><td class="colsep0 rowsep0" align="center">0</td><td class="colsep0 rowsep0" align="center">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Lapatinib<a class="ref internalNav" href="#t5fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="center">96</td><td class="colsep0 rowsep0" align="center">92</td><td class="colsep0 rowsep0" align="center">Â </td><td class="colsep0 rowsep0" align="center">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PP2<a class="ref internalNav" href="#t5fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="center">Â </td><td class="colsep0 rowsep0" align="center">Â </td><td class="colsep0 rowsep0" align="center">94</td><td class="colsep0 rowsep0" align="center">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">SU11248<a class="ref internalNav" href="#t5fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="center">Â </td><td class="colsep0 rowsep0" align="center">Â </td><td class="colsep0 rowsep0" align="center">Â </td><td class="colsep0 rowsep0" align="center">76</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>a</sup><p class="last">The inhibitory rate of tyrosine kinase in the presence of the fixed concentration of the drug was detected using enzyme-linked-immunosorbent assay (ELISA) in the presence of 10 Î¼M of ATP.</p></div><div class="footnote" id="t5fn2"><sup>b</sup><p class="last">ND: not determined.</p></div><div class="footnote" id="t5fn3"><sup>c</sup><p class="last">The reference compound for the kinase assay: Lapatinib for EGFR and ErbB-2, PP2 for Src, SU11248 for KDR, tested at 10 Î¼M.</p></div></div></div><div class="NLM_p">On the basis of the promising kinase inhibitory activity results, further kinase profiling assays were conducted against 31 oncology kinases (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>).<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> Three compounds, <b>III</b>-<b>2</b>, <b>III</b>-<b>8</b>, and <b>III</b>-<b>9</b>, which were active in the preliminary tyrosine kinase screening, were selected for the kinase selectivity assay. Interestingly, the 2â²-chloro and 2â²,4â²-dichloro substituted <i>N</i>-benzyl-1,6-naphthyridine-7-carboxamide derivatives (<b>III</b>-<b>8</b>, <b>III</b>-<b>9</b>) displayed significant inhibition against several oncogenic kinases such as IGF-1R, FGFR1,Aurora-A, LCK, and Abl(T315I) at 10 Î¼M, whereas the 4â²-methoxy substituted analogue (<b>III</b>-<b>2</b>) showed moderate inhibition against KDR, Met, FGFR1, Tie2, and IGF-1R kinases, as shown in Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>. Structural variation on the phenyl ring at 7-carboxamide was responsible for kinase selectivity and inhibitory potency. This suggests that the 8-((1,4)-<i>trans</i>-4-aminocyclohexyl)amino)-1,6-naphthyridine-7-carboxamide is an attractive scaffold for further structural optimization and development into targeted cancer therapeutics.</div><figure id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300667v/production/images/medium/jm-2012-00667v_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300667v/production/images/large/jm-2012-00667v_0014.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Inhibition rate of compounds <b>III</b>-<b>2</b>, <b>III</b>-<b>8</b>, and <b>III</b>-<b>9</b> against 31 oncogenic kinases at the drug concentration of 10 Î¼M and at the <i>K</i><sub>m</sub> value for ATP for each kinase, by using KinaseProfiler techniques. All data are expressed as mean values of two independent experiments.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300667v/production/images/large/jm-2012-00667v_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300667v&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_04625" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_04625" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Starting from a well-known 8-hydroxy-[1,6]naphthyridine scaffold, we successfully identified novel IN inhibitors with significant antiviral activities. Furthermore, by varying the substituent at the 8-position, we showed for the first time that a subset of this class of compounds is quite useful for repurposing as innovative cytotoxic agents. The lead compounds disclosed in this study show significant cytotoxicity in a panel of cancer cell lines, arrest cells in G<sub>0</sub>/G<sub>1</sub>, and inhibit select kinases. Several of these compounds are interesting and warrant further preclinical development, and the results presented in this study validate our previous studies in repurposing select IN inhibitors for anticancer development. In-depth mechanistic studies are currently in progress in our laboratory and will be published in due course.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_24225" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_24225" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Materials, Chemicals, and Enzymes</h3><div class="NLM_p last">All compounds were dissolved in DMSO, and the stock solutions were stored at â20 Â°C. The Î³-[<sup>32</sup>P]ATP was purchased from either Amersham Biosciences or ICN. The expression system for the wild-type IN was a generous gift of Dr. Robert Craigie, Laboratory of Molecular Biology, NIDDK, NIH (Bethesda, MD).</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Preparation of Oligonucleotide Substrates</h3><div class="NLM_p last">The oligonucleotides 21top, 5â²-GTGTGGAAAATCTCTAGCAGT-3â², and 21bot,5â²-ACTGCTAGAGATTTTCCACAC-3â², were purchased from Norris Cancer Center Microsequencing Core Facility (University of Southern California) and purified by UV shadowing on polyacrylamide gel. To analyze the extent of 3â²-processing and strand transfer using 5â²-end-labeled substrates, 21top was 5â²-end-labeled using T<sub>4</sub> polynucleotide kinase (Epicenter, Madison, WI) and Î³-[<sup>32</sup>P]ATP (Amersham Biosciences or ICN). The kinase was heat-inactivated, and 21bot was added in 1.5 M excess. The mixture was heated at 95 Â°C, allowed to cool slowly to room temperature, and processed through a spin 25 minicolumn (USA Scientific, Ocala, FL) to separate annealed double-stranded oligonucleotide from unincorporated material.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> IN Assays</h3><div class="NLM_p">To determine the extent of 3â²-processing and strand transfer, wild-type IN was preincubated at a final concentration of 200 nM with the inhibitor in reaction buffer (50 mM NaCl, 1 mM HEPES, pH 7.5, 50 Î¼M EDTA, 50 Î¼M dithiothreitol, 10% glycerol (w/v), 7.5 mM MnCl<sub>2</sub>, 0.1 mg/mL bovine serum albumin, 10 mM 2-mercaptoethanol, 10% dimethyl sulfoxide, and 25 mM MOPS, pH 7.2) at 30 Â°C for 30 min. Then, a 20 nM concentration of the 5â²-end <sup>32</sup>P-labeled linear oligonucleotide substrate was added, and incubation was continued for an additional 1 h. Reactions were quenched by the addition of half the sample volume (8 Î¼L) of loading dye (98% deionized formamide, 10 mM EDTA, 0.025% xylene cyanol, and 0.025% bromophenol blue). An aliquot was electrophoresed on a denaturing 20% polyacrylamide gel (0.09 M tris-borate, pH 8.3, 2 mM EDTA, 20% acrylamide, and 8 M urea).</div><div class="NLM_p last">Gels were dried, exposed in a PhosphorImager cassette, and analyzed using a Typhoon 8610 variable mode imager (Amersham Biosciences, Piscataway, NJ) and quantitated using ImageQuant 5.2. The percent inhibition (% <i>I</i>) was calculated using the following equation<span class="NLM_disp-formula" id="eq1"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300667v/production/images/jm-2012-00667v_m001.gif" alt="" /></img><span class="labelSpan">(1)</span></span>where <i>C</i>, <i>N</i>, and <i>D</i> are the fractions of 21-mer substrate converted to 19-mer (3â²-processing product) or strand transfer products for DNA alone, DNA plus IN, and IN plus drug, respectively. The IC<sub>50</sub> values were determined by plotting the logarithm of drug concentration versus percent inhibition to obtain the concentration that produced 50% inhibition.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Antiviral Assay.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a></h3><div class="NLM_p">C8166 cells were maintained in RPMI-1640 supplemented with 10% heat-inactivated fetal calf serum (Gibco). The cells used in all experiments were in log-phase growth.</div><div id="sec4_4_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> Syncytium Reduction Assay</h4><div class="NLM_p last">In the presence of 100 Î¼L of various concentrations of compounds, C8166 cells (4 Ã 10<sup>5</sup> mL<sup>â1</sup>) were infected with HIV-1<sub>IIIB</sub> at a multiplicity of infection (MOI) of 0.06. The final volume per well was 200 Î¼L. AZT was used as a positive control. After 3 days of culture, the cytopathic effect (CPE) was measured by counting the number of syncytia (multinucleated giant cell) in each well under an inverted microscope. Percentage inhibition of syncytial cell number in treated culture to that in infected control culture and 50% effective concentration (EC<sub>50</sub>) was calculated.</div></div><div id="sec4_4_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> Cytotoxicity Assay</h4><div class="NLM_p last">: The cellular toxicity of compounds on C8166 cells was assessed by a 3-(4,5-dimethylthiazol-2-yl)-2,5- diphenyltetrazoliumbromide (MTT) method. Briefly, cells were seeded on a 96-well microplate in the absence or presence of various concentrations of compounds in triplicate and incubated at 37 Â°C in a humid atmosphere of 5% CO<sub>2</sub> for 72 h. The supernatants were discarded, and MTT reagent (5 mg/mL in PBS) was added to each well and then incubated for 4 h and 100 Î¼L of 50% DMF-20% SDS was added. After the formazan was dissolved completely, the plates were read on a Bio-Tek EL x 800 ELISA reader at 595/630 nm. The cytotoxic concentration that caused the reduction of viable cells by 50% (CC<sub>50</sub>) was calculated from doseâresponse curve. TI (therapeutic index) value is a ratio of the CC<sub>50</sub> value/EC<sub>50</sub> value.</div></div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> Binding Mechanism Prediction</h3><div class="NLM_p last">Given the lack of a full length crystal structure of HIV-1 IN, a homology model was built based on the X-ray crystal structure of prototype foamy virus (PFV) intasome (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3OYA">3OYA</a>),<a onclick="showRef(event, 'ref34 ref35'); return false;" href="javascript:void(0);" class="ref ref34 ref35">(34, 35)</a> a retro-lentivirus belonging to the same viral genus as HIV. Select compounds were docked in the catalytic binding site of the homology model of IN reported earlier<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> using GOLD (genetic optimization for ligand docking) software package, version 4.0 (CambridgeCrystallographic Data Centre, Cambridge, U.K.). GOLD uses a genetic algorithm (GA) to explore the conformational space of a compound inside the binding site of a protein.<a onclick="showRef(event, 'ref39 ref40'); return false;" href="javascript:void(0);" class="ref ref39 ref40">(39, 40)</a> The active site was defined as the collection of protein residues with a sphere of 15 Ã radius. Before docking different possible stereoisomers, ionized forms and conformations of ligands were prepared by LigPrep (Schrodinger, LLC).<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> Ionization option, Epik,<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> was used to ionize ligands at pH 7.0 Â± 0.2. Docking studies were performed using the standard default settings with 100 GA runs on each molecule. For each of the 100 independent GA runs, a maximum of 100000 operations were performed on a set of five groups with a population of 100 individuals. With respect to ligand flexibility special care has been taken by including options such as flipping of ring corners, amides, pyramidal nitrogens, secondary and tertiary amines, and rotation of carboxylate groups, as well as torsion angle distribution and postprocess rotatable bonds as default. The annealing parameters were used as default cutoff values of 3.0 Ã for hydrogen bonds and 4.0 Ã for van der Waals interactions. Hydrophobic fitting points were calculated to facilitate the correct starting orientation of the compound for docking by placing the hydrophobic atoms appropriately in the corresponding areas of the active site. When the top three solutions attained root-mean-square deviation (rmsd) values within 1.5 Ã, docking was terminated. GOLD-Score, a scoring function of the software, is a dimensionless fitness value that takes into account the intra- and intermolecular hydrogen bonding interaction energy, van der Waals energy, and ligand torsion energy.<a onclick="showRef(event, 'ref39 ref40'); return false;" href="javascript:void(0);" class="ref ref39 ref40">(39, 40)</a></div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> Cell Culture</h3><div class="NLM_p last">MDA-MB-435 and MCF7 breast cancer, LNCaP prostate cancer, and HT29 colon cancer cell lines were obtained from Dr. Alan Epstein (USC) or purchased from the American Type Cell Culture (Manassas, VA). HCT116 p53<sup>+/+</sup> and HCT116 p53<sup>â/â</sup> colon cancer cell lines were kindly provided by Dr. Bert Vogelstein (Johns Hopkins University, Baltimore, MD). Cell lines were maintained in the appropriate growth media (DMEM for MDA-MB-435, MCF7 and LNCaP, RPMI for the HT29 and HCT116 cell lines) containing 10% heat-inactivated fetal bovine serum and supplemented with 2 mM <span class="smallcaps smallerCapital">l</span>-gutamine at 37 Â°C in a humidified atmosphere of 5% CO<sub>2</sub>. For subculture and experiments, cells were washed with 1Ã PBS, detached using 0.025% Trypsin-EDTA (Cellgro, Mediatech, Mannassas, VA), collected in growth media, and centrifuged. All experiments were performed in growth media using subconfluent cells in the exponential growth phase. For use in tissue culture experiments, compounds were prepared at 10 mM concentration in sterile dimethylsulfoxide (DMSO) (EMD Chemicals, Gibbstown, NJ) and stored at â20 Â°C when not in use.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> Cytotoxicity Assay</h3><div class="NLM_p last">Cytotoxicity was assessed by MTT assay as previously described.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> Cells were seeded in 96-well tissue culture treated dishes and allowed to adhere overnight. Cells were subsequently treated with a continuous exposure to drugs for 72 h. An MTT solution was added to each well to give a final concentration of 0.3 mg/mL MTT. Cells were incubated with MTT for 3â4 h at 37 Â°C. After removal of the supernatant, DMSO was added and the absorbance was read at 570 nm. All assays were done in triplicate. The IC<sub>50</sub> was then determined for each drug from a plot of log (drug concentration) versus percentage of cell kill.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> Colony Formation Assay</h3><div class="NLM_p last">Colony formation assay was performed as previously described to further assess drug toxicity.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> Briefly, cells were seeded in 6-well tissue culture dishes at a density of 500 cells per well in growth media and allowed to adhere overnight. Cells were subsequently treated with varying concentrations of compound for 24 h. Following treatment, monolayers were washed with 1Ã PBS and incubated in growth media for a period of 7â10 days, allowing sufficient time for colonies to form in control wells. To visualize the extent of colony formation, cells were fixed and stained in a 2% solution of crystal violet containing 1% glutaraldehyde. Excess stain was removed through multiple washes in distilled water and allowed to air-dry. Stained plates were imaged using Quantity One software running on the VersaDoc imaging platform (BioRAD).</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> Cell Cycle Analysis</h3><div class="NLM_p last">Cells were seeded in 100 mm tissue culture dishes at a density of 1 Ã 10<sup>6</sup> cells/plate in growth media and allowed to adhere overnight. The following day cells were treated with 2 Ã IC<sub>50</sub> concentrations of tested compounds or DMSO alone as vehicle control for 12â48 h. After treatment, cells were detached with trypsin, and both media and cells were collected by centrifugation. Cells were washed and resuspended in 1Ã PBS prior to fixation in ethanol overnight at â20 Â°C. Fixed cells were treated with 10 Î¼g/mL RNase A (Sigma-Aldrich, St. Louis, MO) and stained in a 50 Î¼g/mL solution of propidium iodide (Sigma-Aldrich, St. Louis, MO). DNA content was determined by flow cytometry using the BD LSR II (BD Biosciences, San Jose, CA) equipped with a 488 nM Sapphire argon-ion laser and PE emission detector.</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> Tyrosine Kinase Assay</h3><div class="NLM_p last">The activity of tyrosine kinases were detected using enzyme-linked-immunosorbent assay (ELISA). Briefly, 20 Î¼g/mL Poly(Glu,Tyr)<sub>4:1</sub> (Sigma, St. Louis, MO) was precoated in 96-well ELISA plates as substrate. Each well was treated with 50 Î¼L of 10 Î¼mol/L ATP solution, which was diluted in kinase reaction buffer (50 mM HEPES pH 7.4, 20 mM MgCl<sub>2</sub>, 0.1 mM MnCl<sub>2</sub>, 0.2 mM Na<sub>3</sub>VO<sub>4</sub>, 1 mM DTT). Then 1 Î¼L of various concentrations of test compounds or reference compound dissolved in DMSO were added to each reaction well. Experiments at each concentration were performed in duplicate. The reaction was initiated by adding tyrosine kinase diluted in kinase reaction buffer. After incubation at 37 Â°C for 60 min, the wells were washed three times with phosphate buffered saline (PBS) containing 0.1% Tween 20 (T-PBS). Next, 100 Î¼L of antiphosphotyrosine (PY99) antibody (1:1000, Santa Cruz Biotechnology, Santa Cruz, CA) diluted in T-PBS containing 5 mg/mL BSA was added, and the plate was incubated at 37 Â°C for 30 min. After the plate was washed three times, 100 Î¼L of horseradish peroxidase-conjugated goat antimouse IgG (1:2000, Calbiochem, SanDiego, CA) diluted in T-PBS containing 5 mg/mL BSA was added and the plate was incubated at 37 Â°C for 30 min. The plate was washed, and then 100 Î¼L of citrate buffer (0.1 M, pH5.5) containing 0.03% H<sub>2</sub>O<sub>2</sub> and 2 mg/mL<i>o</i>-phenylenediamine was added and samples were incubated at room temperature until color emerged. The reaction was terminated by adding 50 Î¼L of 2 M H<sub>2</sub>SO<sub>4</sub>, and the plate was read using a multiwell spectrophotometer (VERSAmax, Molecular Devices, Sunnyvale, CA, USA) at 492 nm. The inhibitory rate (%) was calculated with the formula: [1 â(A<sub>492</sub> treated/A<sub>492</sub> control)] Ã 100%.</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> General Synthetic Methods</h3><div class="NLM_p">Unless otherwise stated, the <sup>1</sup>H NMR spectra were recorded on a Varian 300 MHz or 400 MHz spectrometer and <sup>13</sup>C NMR spectra on a Varian Mercury 100 MHz spectrometer. The data are reported in parts per million relative to TMS and referenced to the solvent. Melting points (uncorrected) were determined on a Buchi-510 capillary apparatus. The MS and HRMS (ESI) spectra were obtained on an APEXIII 7.0 T FTMS mass spectrometer. Rotate power was detected by P-1030 (A012360639) automatic polarimeter. The flash column chromatography was performed on silica gel H (10â40 Î¼m). Anhydrous solvents were obtained by standard procedures. The purity of all target compounds was â¥95% determined by elemental analysis or analytical HPLC. Elemental analyses were obtained using Elementar Vario EL II elemental analyzer. Analytical HPLC was performed on JASCO LC-1500 with Vydac C18 reversed-phase column (10 mm Ã 250 mm) and UV detector at 254 nm, using two solvent systems as indicated below.</div><div class="NLM_p">Solvent system I: A, 0.05% TFA in water; B, methanol, gradient 30â90% of solvent B in A over 20 min at 2 mL/min;</div><div class="NLM_p last">Solvent system II: A, 0.05% TFA in water; C, 0.05% TFA in 90% acetonitrile in water, gradient 30â90% C in A over 20 min at 2 mL/min.</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> Pyridine-2,3-dicarboxylic Acid 2-Isopropyl Ester (<b>2</b>)</h3><div class="NLM_p last">A suspension of quinolinic anhydride (48.1 g, 0.32 mol) in 100 mL of2-propanol was warmed to reflux for 16 h, cooled to room temperature, and concentrated in vacuo. The resulting yellow solid was recrystallized from ethyl acetate to give the desired monoester <b>2</b> as a white solid (52.7 g, 78.3%); mp 140â141 Â°C. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 300 MHz): Î´ 8.87 (d, <i>J</i> = 4.2 Hz, 1H), 8.35 (d, <i>J</i> = 7.8 Hz, 1H), 7.55 (dd, <i>J</i> = 5.1, 8.1 Hz, 1 H), 5.36 (septet, <i>J</i> = 6.3 Hz, 1H), 1.41 (d, <i>J</i> = 6.3 Hz, 6H).</div></div><div id="sec4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> 3-Hydroxymethyl-pyridine-2-carboxylic Acid Isopropyl Ester (<b>4</b>)</h3><div class="NLM_p last">To a solution of <b>2</b> (5.0 g, 23.9 mmol) in 25 mL of DCM was added thionyl chloride (2.5 mL, 35.85 mmol) and a catalytic amount of DMF (0.5 mL, 0.53 mmol). The suspension mixture was heated to reflux for 3 h and then concentrated in vacuum. The remaining thionyl chloride was removed by dissolving the residue in THF and then concentrating the resultant solution. This process was repeated twice. The resulting chloride was dissolved in 20 mL of THF and cooled to 0 Â°C. Sodium borohydride (1.2 g, 31.58 mmol) was added, and the reaction mixture was stirred at 0 Â°C for 40â50 min. The reaction solution was carefully poured into ice (foaming) and extracted with CH<sub>2</sub>C1<sub>2</sub>. The organic phase was dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuum. Purification by flash chromatography gave <b>4</b> as a yellow oil. (3.4 g, overall yield 73% for two steps). <sup>1</sup>H NMR (CDC1<sub>3</sub>, 300 MHz) Î´ 8.69 (dd, <i>J</i> = 1.5, 4.7 Hz, 1H), 7.88 (dd, <i>J</i> = 1.5, 7.7 Hz, 1H), 7.46 (dd, <i>J</i> = 4.7, 7.8 Hz, 1 H), 5.35 (septet, <i>J</i> = 6.4 Hz, 1H), 4.81 (m, 2 H), 1.45 (d, <i>J</i> = 6.3 Hz, 6H). EI-MS <i>m</i>/<i>z</i>: 195 (M)<sup>+</sup>.</div></div><div id="sec4_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> Isopropyl 3-((<i>N</i>-(2-Methoxy-2-oxoethyl)-4-methylphenylsulfonamido)methyl)picolinate (<b>5</b>)</h3><div class="NLM_p last">Isopropyl 3-(hydroxymethyl) pyridine-2-carboxylate (1.734 g, 8.89 mmol), methyl 2-(tosylamino)acetate (2.163 g, 8.89 mmol), anhydrous MgSO<sub>4</sub> (1.066 g, 8.89 mmol), and triphenylphosphine (3.499 g, 13.338 mmol) were dissolved in dry THF (100 mL) and cooled to 0 Â°C under nitrogen. DEAD (2.165 mL, 13.338 mmol) in 10 mL of dry THF was added dropwise. The ice bath was removed, and the solution was stirred for 2 h at rt followed by concentration in vacuo. The redâorange oil was directly used for the next reaction without further purification.</div></div><div id="sec4_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> Methyl 8-Hydroxy-1,6-naphthyridine-7-carboxylate (<b>6</b>)</h3><div class="NLM_p last">To the solution of the crude product <b>5</b> (8.89 mmol) in dry methanol (50 mL) at 0 Â°C was added sodium methoxide (1.681 g, 31.123 mmol) slowly. After addition, the reaction mixture was stirred at rt for 3 h. The solvent was removed in vacuo to obtain redâorange oil, which was partitioned between water (20 mL) and ethyl acetate (20 mL). The organic layer was back-extracted with saturated sodium bicarbonate solution. The pH of the aqueous layer was adjusted to 7, and then the aqueous layer was extracted with methylene chloride. The organic layer was dried over sodium sulfate. Purification by flash chromatography afforded <b>6</b> as an off-white solid. (1.19 g, 65% two steps); mp 179â180 Â°C. <sup>1</sup>H NMR (CDC1<sub>3</sub>, 300 MHz): Î´ 11.79 (s, 1H), 9.20 (s, 1H), 8.85 (s, 1H), 8.32 (d, <i>J</i> = 8.2 Hz, 1H), 7.71 (dd, <i>J</i> = 4.1, 8.2 Hz, 1H), 4.12 (s, 3H).</div></div><div id="sec4_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> Methyl 5-Bromo-8-hydroxy-1,6-naphthyridine-7-carboxylate (<b>7</b>)</h3><div class="NLM_p last">To a solution of <b>6</b> (34 mg, 0.167 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (1 mL) at room temperature was added NBS (30 mg, 0.167 mmol). The reaction mixture was stirred for 1 h. The solids were collected by filtration and dried in vacuo to afford <b>7</b> (30 mg, yield 64%) as a white solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 300 MHz): Î´ 9.26 (dd, <i>J</i> = 1.5, 4.2 Hz, 1H), 8.59 (dd, <i>J</i> = 1.6, 8.4 Hz, 1H), 8.00 (dd, <i>J</i> = 4.2, 8.4 Hz, 1 H), 3.94 (s, 3 H).</div></div><div id="sec4_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> 5-Bromo-8-hydroxy-<i>N</i>-(4-fluorobenzyl)-1,6-naphthyridine-7-carboxamide (<b>I</b>-<b>1</b>)</h3><div class="NLM_p last">A slurry of <b>7</b> (25 mg, 0.0883 mmol) and4-fluorobenzylamine (12 mg, 0.0883 mmol) in toluene (2 mL) were heated at reflux for 20 h. Upon cooling to rt, the resulting solids were collected by filtration and washed with methanol (0.5 mL) to afford <b>I</b>-<b>1</b> as a white solid (yield 78%); mp 178â180 Â°C. <sup>1</sup>H NMR (300 MHz, CDC1<sub>3</sub>): Î´ 13.31 (s, 1H), 9.20 (dd, <i>J</i> = 1.4, 4.2 Hz, 1H), 8.54 (dd, <i>J</i> = 1.4, 8.8 Hz, 1H), 8.17 (m, 1H), 7.74 (dd, <i>J</i> = 4.4, 8.6 Hz, 1H), 7.38 (dd, <i>J</i> = 5.4, 8.4 Hz, 2H), 7.07 (t, <i>J</i> = 8.4 Hz, 2H), 4.67 (d, <i>J</i> = 6.3 Hz, 2H).EI-MS <i>m</i>/<i>z</i>: 375 (M)<sup>+</sup>, 377 (M + 2)<sup>+</sup>. Anal. Calcd for C<sub>16</sub>H<sub>11</sub>BrFN<sub>3</sub>O<sub>2</sub>: C 51.08, H 2.95, N 11.17. Found: C 51.45, H 3.05, N 11.03.</div></div><div id="sec4_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> Toluene-4-sulfonic Acid 5-Bromo-7-(4-fluoro-benzylcarbamoyl)-1,6-naphthyridin-8-yl Ester (<b>I</b>-<b>3</b>)</h3><div class="NLM_p last"><i>p</i>-Toluenesulfonyl chloride (268 mg,1.4 mmol) was added to a solution of <b>I</b>-<b>1</b> (283 mg, 0.75 mmol) and triethylamine (161.92 mg, 1.6 mmol) in chloroform (5 mL) over 10 min in 50 Â°C.The solution was stirred for 5 h and then washed by saturated aqueous NH<sub>4</sub>Cl and brine and dried over Na<sub>2</sub>SO<sub>4</sub>, and the solution was removed under vacuum. Purification by flash chromatography (DCM:methanol = 40:1) to give <b>I</b>-<b>3</b> as a white solid. (360 mg, 91%); mp 152â154 Â°C. <sup>1</sup>H NMR (CDCl<sub>3</sub>): Î´ 9.03 (dd, 1H, <i>J</i> = 1.5, 4.2 Hz), 8.58 (dd, 1H, <i>J</i> = 1.5, 8.7 Hz), 7.96 (m, 1H), 7.94 (d, 2H, <i>J</i> = 8.1 Hz), 7.69 (dd, 1H, <i>J</i> = 4.2, 8.7 Hz), 7.36 (m, 2H), 7.32 (d, 2H, <i>J</i> = 8.1 Hz), 7.04 (t, 2H, <i>J</i> = 8.7 Hz), 4.60 (d, <i>J</i> = 6.6 Hz, 2H), 2.47 (s, 3H). EI-MS <i>m</i>/<i>z</i>: 530 (M + 1)<sup>+</sup>, 532 (M + 3)<sup>+</sup>. Anal. Calcd for C<sub>24</sub>H<sub>20</sub>BrFN<sub>4</sub>O: C 52.09, H 3.23, N 7.92. Found: C 51.94, H 3.17, N 7.94.</div></div><div id="sec4_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> 7-(4-Fluorobenzylcarbamoyl)-5-bromo-1,6-naphthyridin-8-yl Methanesulfonate (<b>I</b>-<b>2</b>)</h3><div class="NLM_p last"><b>I</b>-<b>2</b> was prepared according to the same procedure described for <b>I</b>-<b>3</b>. White solid, yield 83%; mp 150â152 Â°C. <sup>1</sup>H NMR (300 MHz, CDC1<sub>3</sub>) Î´ 9.32 (d, <i>J</i> = 4.2 Hz, 1H), 8.62 (d, <i>J</i> = 8.7 Hz, 1H), 8.22 (m, 1H), 7.79 (dd, <i>J</i> = 4.2, 9.0 Hz, 1H), 7.38 (m, 2H), 7.05 (t, <i>J</i> = 8.4 Hz, 1H), 4.68 (d, <i>J</i> = 5.7 Hz, 2H), 3.70 (s, 1H). EI-MS <i>m</i>/<i>z</i>: 454 (M + 1)<sup>+</sup>, 456 (M + 3)<sup>+</sup>. Anal. Calcd. for C<sub>17</sub>H<sub>13</sub>BrFN<sub>3</sub>O<sub>4</sub>SÂ·AcOEt: C 46.50, H 3.90, N 7.75. Found: C 47.44, H 3.75, N 8.10.</div></div><div id="sec4_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> 5-(1,1-Dioxido-1,2-thiazinan-2-yl)-<i>N</i>-(4-fluorobenzyl)-8-hydroxy-1,6-naphthyridine-7-carboxamide (<b>I</b>-<b>4</b>)</h3><div class="NLM_p last"><b>I</b>-<b>4</b> was prepared according to the same procedure described in patent WO 2002030931 A2, giving a yellow solid, yield 65%. <sup>1</sup>H NMR (300 MHz, CDC1<sub>3</sub>) Î´ 13.34 (br, 1H), 9.19 (dd, <i>J</i> = 1.5, 4.2 Hz, 1H), 8.61 (d, <i>J</i> = 1.5, 8.7 Hz, 1H), 7.96 (m, 1H), 7.69 (dd, <i>J</i> = 4.8, 8.7 Hz, 1H), 7.37 (m, 2H), 7.07 (t, <i>J</i> = 8.6 Hz, 2H), 4.67 (m, 2H), 3.93 (m, 2H), 3.30 (t, <i>J</i> = 6.3 Hz, 2H), 2.45â2.36 (m, 2H), 2.18â2.15 (m, 1H), 1.85â1.82 (m, 1H). EI-MS <i>m</i>/<i>z</i>: 430 (M)<sup>+</sup>. Anal. HPLC <i>t</i><sub>R</sub> = 17.04 min, 100% (solvent system I); <i>t</i><sub>R</sub> = 12.35 min, 99.45% (solvent system II).</div></div><div id="sec4_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> <i>N</i>-(4-Fluorobenzyl)-8-hydroxy-5-(<i>N</i>-(3-(methylsulfonamido)propyl)methylsulfonamido)-1,6-naphthyridine-7-carboxamid (<b>I</b>-<b>5</b>)</h3><div class="NLM_p last"><i>N</i>-(3-Methanesulfonylamino-propyl)-methanesulfonamide (115 mg, 0.5 mmol) was added to a solution of <b>I</b>-<b>1</b> (187.5 mg, 0.5 mmol) and cuprous oxide (86 mg, 0.6 mmol) in pyridine (5 mL). After refluxing for 10 h, the solution was evaporated at vacuum, diluted with dichloromethane, and then filtered to remove the solids. The filtrate was stirred with a slurry of EDTA (400 mg) in water (50 mL). After 16 h, the dichloromethane extracts were dried over Na<sub>2</sub>SO<sub>4</sub>. After filtering, the solution was concentrated under vacuum. The residue was purified by flash chromatography on silica gel (DCM:methanol = 50:1) to give <b>I</b>-<b>5</b> as a yellow solid, yield 54%; mp 205â208 Â°C. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) Î´ 9.13 (d, <i>J</i> = 3.3 Hz, 1H), 8.80 (d, <i>J</i> = 7.8 Hz, 1H), 7.86 (dd, <i>J</i> = 3.6, 8.7 Hz, 1H), 7.44 (m, 2H), 7.07 (t, <i>J</i> = 9.0 Hz, 2H), 4.70 (s, 2H), 4.05 (m, 2H), 3.10 (m, 2H), 3.08 (s, 3H), 2.90 (s, 3H), 2.08â1.94 (m, 2H). EI-MS <i>m</i>/<i>z</i>: 525 (M)<sup>+</sup>. Anal. HPLC <i>t</i><sub>R</sub> = 14.54 min, 100% (solvent system I); <i>t</i><sub>R</sub> = 10.84 min, 99.79% (solvent system II).</div></div><div id="sec4_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> <i>N</i>-(4-Fluorobenzyl)-8-hydroxy-5-(<i>N</i>-(6-(methylsulfonamido)hexyl)methylsulfonamido)-1,6-naphthyridine-7-carboxamide (<b>I</b>-<b>6</b>)</h3><div class="NLM_p last"><b>I</b>-<b>6</b> was prepared according to the same procedure described for <b>I</b>-<b>5,</b> giving a yellow solid, yield 35%; mp 178â182 Â°C. <sup>1</sup>H NMR (300 MHz, CDC1<sub>3</sub>) Î´ 13.51 (br, 1H), 9.20 (dd, <i>J</i> = 1.5, 4.2 Hz, 1H), 8.69 (d, <i>J</i> = 1.5, 8.7 Hz, 1H), 8.01 (t, <i>J</i> = 6.0 Hz, 1H), 7.73 (dd, <i>J</i> = 4.5, 8.4 Hz, 1H), 7.36 (m, 2H), 7.05 (t, <i>J</i> = 8.6 Hz, 2H), 4.69 (d, <i>J</i> = 6.0 Hz, 2H), 4.36 (m, 1H), 3.81 (t, <i>J</i> = 6.9 Hz, 2H), 3.10 (m, 2H), 3.01 (s, 3H), 2.91 (s, 3H), 1.5â1.2 (m, 8H). EI-MS <i>m</i>/<i>z</i>: 567 (M)<sup>+</sup>. Anal. HPLC <i>t</i><sub>R</sub> = 16.117 min, 98.56% (solvent system I); <i>t</i><sub>R</sub> = 6.192 min, 96.20% (solvent system II).</div></div><div id="sec4_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> <i>N</i>-(4-Fluorobenzyl)-5-((6-formamidohexyl)amino)-8-hydroxy-1,6-naphthyridine-7-carboxamide (<b>I</b>-<b>7</b>)</h3><div class="NLM_p last">Hexane-1,3-diamine (167 mg, 1.44 mmol) was added to a solution of <b>I</b>-<b>1</b> (100 mg, 0.27 mmol) in DMPU (5 mL). After the solution was heated under 135 Â°C for 48 h, the solution was cooled to room temperature and the usual workup was performed. Purification by RP-HPLC (Vydac C18 column (10 mm Ã 250 mm), <i>t</i><sub>R</sub> = 19 min, gradient (water:nitrile = 70:30 to 35:65 over 30 min, with 0.05% TFA, UV detector, 254 nm) gave <b>I</b>-<b>7</b> as a red solid, yield 30%; mp 88â91 Â°C. <sup>1</sup>H NMR (300 MHz, CDC1<sub>3</sub>) Î´ 12.31 (s, 1H), 9.06 (d, <i>J</i> = 4.2 Hz, 1H), 8.27 (m, 1H), 8.25 (d, <i>J</i> = 8.3 Hz, 1H), 8.15 (s, 1H), 7.51 (dd, <i>J</i> = 5.4, 8.6 Hz, 1H), 7.35 (m, 2H), 7.04 (t, <i>J</i> = 8.6 Hz, 2H), 4.65 (d, <i>J</i> = 6.2 Hz, 2H). EI-MS <i>m</i>/<i>z</i>: 439 (M)<sup>+</sup>, ESI-MS <i>m</i>/<i>z</i>: 440 (M + 1)<sup>+</sup>. Analytical HPLC <i>t</i><sub>R</sub> = 5.650 min, 100% (solvent system I); <i>t</i><sub>R</sub> = 13.500 min, 98.36% (solvent system II).</div></div><div id="sec4_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> 5-(2-(2<i>H</i>-Indol-3-yl)ethylamino)-<i>N</i>-(4-fluorobenzyl)-8-hydroxy-1,6-naphthyridine-7-carboxamide (<b>I</b>-<b>8</b>)</h3><div class="NLM_p last">2-(1<i>H</i>-Indol-3-yl)ethanamine (240 mg, 1.5 mmol) was added to a solution of <b>I</b>-<b>1</b> (112.5 mg, 0.3 mmol) in DMPU (5 mL). After heating at 135 Â°C for 48 h, the solution was cooled to room temperature, diluted with dichloromethane, and then washed by saturated aqueous NH<sub>4</sub>Cl and brine. Usual workup followed by purification by flash chromatography on silica gel (DCM:methanol = 100:1) afforded <b>I</b>-<b>8</b> as a red solid, yield 38%; mp 101â103 Â°C. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 300 MHz) Î´ 12.35 (s, 1H), 9.05 (dd, 1H, <i>J</i> = 1.5, 4.2 Hz), 8.64 (s, 1H), 8.25 (m, 1H), 7.96 (d, 1H, <i>J</i> = 8.4 Hz), 7.60 (d, 1H, <i>J</i> = 7.8 Hz), 7.45â7.30 (m, 4H), 7.17â6.98 (m, 5H), 5.25 (brs, 1H), 3.79 (m, 2H), 3.16 (t, 2H, <i>J</i> = 6.9 Hz). EI-MS <i>m</i>/<i>z</i>: 455 (M)<sup>+</sup>. Anal. HPLC <i>t</i><sub>R</sub> = 19.692 min, 100% (solvent system I); <i>t</i><sub>R</sub> = 13.667 min, 98.97% (solvent system II).</div></div><div id="sec4_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> <i>N</i>-(4-Fluorobenzyl)-8-hydroxy-5-(2-hydroxyethylamino)-1,6-naphthyridine-7-carboxamide (<b>I</b>-<b>9</b>)</h3><div class="NLM_p last"><b>I</b>-<b>1</b> (37.5 mg, 0.13 mmol) was added to 2-aminoethanol, then heated to 130 Â°C for 9 h, and the solution was cooled to room temperature, diluted with dichloromethane, and then washed by saturated aqueous NH<sub>4</sub>Cl and brine and dried over Na<sub>2</sub>SO<sub>4</sub>, and then the solution was removed under vacuum. The residue was purified by RP-HPLC (Vydac C18 column (10 mm Ã 250 mm), <i>R</i><sub>t</sub> = 7.35 min, gradient (water:nitrile = 70:30 to 10:90 over 30 min, with 0.05% TFA, UV detector, 254 nm), giving <b>I</b>-<b>9</b> as a yellow solid, yield 51%; mp 121â124 Â°C. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>COCD<sub>3</sub>) Î´ 9.08 (m, 1H), 8.72 (m, 1H), 7.67(m, 1H), 7.45 (m, 2H), 7.09 (t, <i>J</i> = 8.1 Hz, 2H), 4.63 (s, 2H), 3.68 (m, 2H), 3.58 (m, 2H). EI-MS <i>m</i>/<i>z</i>: 356 (M)<sup>+</sup>. Anal. HPLC <i>t</i><sub>R</sub> = 14.483 min, 100% (solvent system I); <i>t</i><sub>R</sub> = 9.95 min, 97.43% (solvent system II).</div></div><div id="sec4_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> (<i>S</i>)-<i>N</i>-(4-Fluorobenzyl)-8-hydroxy-5-((1-hydroxypropan-2-yl)amino)-1,6-naphthyridine-7-carboxamide (<b>I</b>-<b>10</b>)</h3><div class="NLM_p last"><b>I</b>-<b>10</b> was prepared according to the same procedure described for <b>I</b>-<b>9</b>, giving a yellow solid, yield 41%; mp 117â120 Â°C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) Î´ 9.23 (d, <i>J</i> = 7.5 Hz, 1H), 9.07 (d, <i>J</i> = 3.9 Hz, 1H), 8.13 (m, 1H), 7.73 (dd, <i>J</i> = 3.9, 7.5 Hz, 1H), 7.32 (m, 2H), 7.02 (t, <i>J</i> = 8.4 Hz, 2H), 4.64 (d, <i>J</i> = 5.7 Hz, 2H), 4.16 (m, 1H), 3.96 (d, <i>J</i> = 4.8 Hz, 2H), 1.39 (d, <i>J</i> = 6.0 Hz, 3H). EI-MS <i>m</i>/<i>z</i>: 370 (M)<sup>+</sup>. HPLC <i>t</i><sub>R</sub> = 15.317 min, 100% (solvent system I); <i>t</i><sub>R</sub> = 10.258 min, 95.61% (solvent system II); [Î±]<sub class="stack">D</sub><sup class="stack">22</sup> = +10.2Â° (<i>c</i> = 2.4200 g/100 mL, EtOH).</div></div><div id="sec4_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> (<i>R</i>)-<i>N</i>-(4-Fluorobenzyl)-8-hydroxy-5-((1-hydroxypropan-2-yl)amino)-1,6-naphthyridine-7-carboxamide (<b>I</b>-<b>11</b>)</h3><div class="NLM_p last"><b>I</b>-<b>11</b>was prepared according to the same procedure described for <b>I-9,</b> giving a yellow solid, yield 33%; mp 115â118 Â°C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) Î´ 9.23 (d, <i>J</i> = 7.5 Hz, 1H), 9.07 (d, <i>J</i> = 3.9 Hz, 1H), 8.13 (m, 1H), 7.73 (dd, <i>J</i> = 3.9, 7.5 Hz,1H), 7.32 (m, 2H), 7.02 (t, <i>J</i> = 8.4 Hz, 2H), 4.64 (d, <i>J</i> = 5.7 Hz, 2H), 4.16 (m, 1H), 3.96 (d, <i>J</i> = 4.8 Hz, 2H), 1.39 (d, <i>J</i> = 6.0 Hz, 3H). EI-MS <i>m</i>/<i>z</i>: 370 (M)<sup>+</sup>. HPLC <i>t</i><sub>R</sub> = 15.808 min, 100% (solvent system I); <i>t</i><sub>R</sub> = 10.108 min, 98.94% (solvent system II); [Î±]<sub class="stack">D</sub><sup class="stack">22</sup> = â20.1Â° (<i>c</i> = 2.1050 g/100 mL, EtOH).</div></div><div id="sec4_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> 5-Bromo-8-methylamino-<i>N</i>-(4-fluorobenzyl)-1,6-naphthyridine-7-carboxamide (<b>I</b>-<b>12</b>)</h3><div class="NLM_p last">Methylamine (5 mL) in alcohol was added to a solution of <b>I</b>-<b>3</b> (26 mg, 0.05 mmol) and triethylamine (15 mg, 0.15 mmol) in THF (5 mL). After refluxing for 8 h, the solution was evaporated at vacuum, and the residue was diluted with dichloromethane, then washed by saturated aqueous Na<sub>2</sub>CO<sub>3</sub>, saturated aqueous NH<sub>4</sub>Cl, and brine, respectively. Usual workup and purification by flash chromatography on silica gel (petroleum:ethyl acetate = 8:1) gave <b>I</b>-<b>12</b> as a yellow solid, yield 52%; mp: 136â140 Â°C. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 300 MHz): Î´ 8.92 (d, 1H, <i>J</i> = 3 Hz), 8.40 (d, 1H, <i>J</i> = 8.4 Hz), 8.28 (m,1H), 7.57 (dd, 1H, <i>J</i> = 4.5,8.4 Hz), 7.34 (m, 2H), 7.03 (t, 2H, <i>J</i> = 8.5 Hz), 4.59 (d, 2H, <i>J</i> = 6.0 Hz), 3.61 (s, 3H). EI-MS <i>m</i>/<i>z</i>: 388 (M â 1)<sup>+</sup>, 390 (M + 1)<sup>+</sup>. Anal. HPLC <i>t</i><sub>R</sub> = 21.750 min, 100% (solvent system I); <i>t</i><sub>R</sub> = 16.758 min, 99.57% (solvent system II).</div></div><div id="sec4_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> 5-Bromo-8-(2-hydroxy-ethylamino)-<i>N</i>-(4-fluorobenzyl)-1,6-naphthyridine-7-carboxamide (<b>I</b>-<b>13</b>)</h3><div class="NLM_p last"><b>I</b>-<b>13</b> was prepared according to the same procedure described for <b>I</b>-<b>12,</b> giving a yellow solid, yield 54%; mp 103â105 Â°C. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 300 MHz): Î´ 8.92 (d, 1H, <i>J</i> = 2.4 Hz), 8.46 (d, 1H, <i>J</i> = 8.4 Hz), 8.34 (m, 1H), 7.62 (dd, 1H, <i>J</i> = 4.5, 8.4 Hz), 7.34 (m, 2H), 7.03 (t, 2H, <i>J</i> = 8.5 Hz), 4.60 (d, 2H, <i>J</i> = 6.3 Hz), 4.23 (t, 2H, <i>J</i> = 4.8 Hz), 3.94 (t, 2H, <i>J</i> = 4.8 Hz). EI-MS <i>m</i>/<i>z</i>: 418 (M)<sup>+</sup>, 420 (M + 2)<sup>+</sup>. Anal. HPLC <i>t</i><sub>R</sub> = 19.575 min, 100% (solvent system I); <i>t</i><sub>R</sub> = 6.517 min, 100% (solvent system II).</div></div><div id="sec4_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> 8-Benzylamino-5-bromo-<i>N</i>-(4-fluorobenzyl)-1,6-naphthyridine-7-carboxamide (<b>I</b>-<b>14</b>)</h3><div class="NLM_p last"><b>I</b>-<b>14</b> was prepared according to the same procedure described for <b>I-12,</b> giving a greenâyellow solid, yield 57%; mp 142â144 Â°C. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 300 MHz): Î´ 8.94 (d, 1H, <i>J</i> = 4.8 Hz), 8.41 (d, 1H, <i>J</i> = 8.1 Hz), 8.31 (m, 1H),7.59 (dd, 1H, <i>J</i> = 4.5, 8.7 Hz), 7.40â7.19 (m, 7H), 7.04 (t, 2H, <i>J</i> = 8.7 Hz), 5.40 (s, 2H), 4.60 (d, 2H, <i>J</i> = 6.3 Hz). Anal. HPLC <i>t</i><sub>R</sub> = 23.867 min, 100% (solvent system I); <i>t</i><sub>R</sub> = 19.550 min, 100% (solvent system II).</div></div><div id="sec4_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> 5-Bromo-8-((<i>S</i>)-1-phenyl-ethylamino)-<i>N</i>-(4-fluorobenzyl)-1,6-naphthyridine-7-carboxamide (<b>I</b>-<b>15</b>)</h3><div class="NLM_p last"><b>I</b>-<b>15</b> was prepared according to the same procedure described for <b>I</b>-<b>12</b>, giving a yellow solid, yield 64%; mp 102â104 Â°C. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 300 MHz): Î´ 8.88 (d, 1H, <i>J</i> = 4.2 Hz), 8.33 (d, 1H, <i>J</i> = 8.4 Hz), 8.33 (m, 1H),7.51 (dd, 1H, <i>J</i> = 4.2, 8.4 Hz), 7.40â7.35 (m, 4H), 7.21 (t, 2H, <i>J</i> = 7.5 Hz), 7.12 (d, 1H, <i>J</i> = 7.2 Hz), 7.05 (t, 2H, <i>J</i> = 8.7 Hz), 6.45 (q, 1H, <i>J</i> = 6.9 Hz), 4.69â4.61 (m, 2H), 1.65 (d, 3H, <i>J</i> = 6.9 Hz). Anal. HPLC <i>t</i><sub>R</sub> = 23.800 min, 100% (solvent system I); <i>t</i><sub>R</sub> = 18.608 min, 96.93% (solvent system II).</div></div><div id="sec4_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> 5-Bromo-8-((<i>R</i>)-1-phenyl-ethylamino)-<i>N</i>-(4-fluorobenzyl)-1,6-naphthyridine-7-carboxamide (<b>I</b>-<b>16</b>)</h3><div class="NLM_p last"><b>I</b>-<b>16</b> was prepared according to the same procedure described for <b>I</b>-<b>12</b>, giving a greenâyellow solid, yield 55%; mp 107â108 Â°C. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 300 MHz): Î´ 8.88 (d, 1H, <i>J</i> = 4.2 Hz), 8.33 (d, 1H, <i>J</i> = 8.4 Hz), 8.33 (m, 1H),7.51 (dd, 1H, <i>J</i> = 4.2, 8.4 Hz), 7.40â7.35 (m, 4H), 7.21 (t, 2H, <i>J</i> = 7.5 Hz), 7.12 (d, 1H, <i>J</i> = 7.2 Hz), 7.05 (t, 2H, <i>J</i> = 8.7 Hz), 6.45 (q, 1H, <i>J</i> = 6.9 Hz), 4.69â4.61 (m,2H), 1.65 (d, 3H, <i>J</i> = 6.9 Hz). EI-MS <i>m</i>/<i>z</i>: 478 (M)<sup>+</sup>, 480 (M + 2)<sup>+</sup>. Anal. HPLC <i>t</i><sub>R</sub> = 23.983 min, 96.18% (solvent system I); <i>t</i><sub>R</sub> = 18.967 min, 100% (solvent system II).</div></div><div id="sec4_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> 5-Bromo-<i>N</i>-(4-fluorobenzyl)-8-((4-fluorobenzyl)amino)-1,6-naphthyridine-7-carboxamide (<b>I</b>-<b>17</b>)</h3><div class="NLM_p last"><b>I</b>-<b>17</b> was prepared according to the same procedure described for <b>I</b>-<b>12</b>, giving a yellow solid, yield 68%; mp 136â138 Â°C. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 300 MHz): Î´ 8.93 (dd, 1H, <i>J</i> = 1.5, 4.2 Hz), 8.42 (dd, 1H, <i>J</i> = 1.5, 8.4 Hz), 8.33 (m, 1H), 7.59 (dd, 1H, <i>J</i> = 4.2, 8.4 Hz), 7.38â7.32 (m, 4H), 7.04 (t, 2H, <i>J</i> = 8.4 Hz), 6.96 (t, 2H, <i>J</i> = 8.4 Hz), 5.35 (s, 2H), 4.60 (d, 2H, <i>J</i> = 6.6 Hz). EI-MS <i>m</i>/<i>z</i>: 482 (M)<sup>+</sup>, 484 (M + 2)<sup>+</sup>. Anal. HPLC <i>t</i><sub>R</sub> = 24.492 min, 100% (solvent system I); <i>t</i><sub>R</sub> = 19.458 min, 100% (solvent system II).</div></div><div id="sec4_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> 8-(3-Amino-propylamino)-5-bromo-<i>N</i>-(4-fluorobenzyl)-1,6-naphthyridine-7-carboxamide (<b>I</b>-<b>18</b>)</h3><div class="NLM_p last">Propane-1,3-diamine (22 mg, 0.3 mmol) was added to a solution of <b>I</b>-<b>3</b> (53 mg, 0.1 mmol) and triethylamine (30 mg, 0.3 mmol) in THF (5 mL). After refluxing for 8 h, the solution was evaporated at vacuum, and the residue was diluted with dichloromethane, washed by saturated aqueous Na<sub>2</sub>CO<sub>3</sub>, saturated aqueous NH<sub>4</sub>Cl, and brine, and dried over Na<sub>2</sub>SO<sub>4</sub>. The filtrate was concentrated under vacuum. Purification by flash chromatography on basic aluminum oxide (DCM:methanol = 50:1) afforded<b>I</b>-<b>18</b> as a yellow solid, yield 58%; mp 78â80 Â°C. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 300 MHz): Î´ 9.60 (t, 1H, <i>J</i> = 5.4 Hz), 8.97 (d, 1H, <i>J</i> = 3 Hz), 8.42 (d, 1H, <i>J</i> = 8.4 Hz), 8.32 (t, 1H, <i>J</i> = 6.0 Hz), 7.60 (dd, 1H, <i>J</i> = 4.5, 8.4 Hz), 7.36 (m, 2H), 7.04 (t, 2H, <i>J</i> = 8.7 Hz), 4.60 (d, 2H, <i>J</i> = 6.6 Hz), 4.19 (q, 2H, <i>J</i> = 6.3 Hz), 3.96 (t, 2H, <i>J</i> = 6.6 Hz), 1.93 (m, 2H). EI-MS <i>m</i>/<i>z</i>: 431(M)<sup>+</sup>, 433 (M + 2)<sup>+</sup>. Anal. HPLC <i>t</i><sub>R</sub> = 19.083 min, 100% (solvent system I); <i>t</i><sub>R</sub> = 12.928 min, 100% (solvent system II).</div></div><div id="sec4_35" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> 8,8â²-(Propane-1,3-diylbis(azanediyl))bis(5-bromo-<i>N</i>-(4-fluorobenzyl)-1,6-naphthyridine-7-carboxamide) (<b>I</b>-<b>19</b>)</h3><div class="NLM_p last"><b>I</b>-<b>19</b> was prepared according to the same procedure described for <b>I</b>-<b>12</b>, giving a yellow solid, yield 75%; mp 169â171 Â°C. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 300 MHz): Î´ 9.72 (2H, brs), 8.82 (dd, 2H, <i>J</i> = 1.8, 4.2 Hz), 8.35 (dd, 2H, <i>J</i> = 1.8, 8.4 Hz), 8.22 (m, 2H), 7.50 (dd, 2H, <i>J</i> = 4.2, 8.4 Hz), 7.35 (m, 4H), 7.03 (t, 4H, <i>J</i> = 8.5 Hz), 4.57 (d, 4H, <i>J</i> = 6.0 Hz), 4.35 (t, 4H, <i>J</i> = 6.6 Hz), 2.15 (t, 2H, <i>J</i> = 6.6 Hz). EI-MS <i>m</i>/<i>z</i>: 788 (M)<sup>+</sup>, 790 (M + 2)<sup>+</sup>. Anal. HPLC <i>t</i><sub>R</sub> = 25.642 min, 95.27% (solvent system I); <i>t</i><sub>R</sub> = 5.933 min, 100% (solvent system II).</div></div><div id="sec4_36" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> 8-((2-Aminoethyl)amino)-5-bromo-<i>N</i>-(4-fluorobenzyl)-1,6-naphthyridine-7-carboxamide (<b>I</b>-<b>20</b>)</h3><div class="NLM_p last"><b>I</b>-<b>20</b> was prepared according to the same procedure described for <b>I</b>-<b>18</b>, giving a yellow solid, yield 50%; mp 82â84 Â°C. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 300 MHz): Î´ 9.73 (m, 1H), 8.94 (d, 1H, <i>J</i> = 3 Hz), 8.40 (d, 1H, <i>J</i> = 8.4 Hz), 8.30 (m, 1H), 7.57 (dd, 1H, <i>J</i> = 4.5, 8.4 Hz), 7.33 (m, 2H), 7.02 (t, 2H, <i>J</i> = 8.4 Hz), 4.59 (d, 2H, <i>J</i> = 6.6 Hz), 4.19 (q, 2H, <i>J</i> = 6.3 Hz), 3.09 (t, 2H, <i>J</i> = 6.3 Hz). EI-MS <i>m</i>/<i>z</i>: 417 (M)<sup>+</sup>, 419 (M + 2)<sup>+</sup>. Anal. HPLC <i>t</i><sub>R</sub> = 19.475 min, 100% (solvent system I); <i>t</i><sub>R</sub> = 11.792 min, 99.29% (solvent system II).</div></div><div id="sec4_37" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> 8-((3-Aminopropyl)amino)-<i>N</i>-(4-fluorobenzyl)-1,6-naphthyridine-7-carboxamide (<b>II</b>-<b>1</b>)</h3><div class="NLM_p last"><b>II</b>-<b>1</b> was prepared according to the same procedure described for <b>I</b>-<b>18</b>, giving a light-yellow solid, yield 73%; mp 62â64 Â°C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): Î´ 9.59 (d, 1H, <i>J</i> = 7.5 Hz), 8.91 (dd, 1H, <i>J</i> = 1.5, 3.9 Hz), 8.62 (t, 1H, <i>J</i> = 6.3 Hz), 8.19 (s, 1H), 8.08 (dd, 1H, <i>J</i> = 1.5, 8.4 Hz), 7.48 (dd, 1H, <i>J</i> = 4.2, 8.4 Hz), 7.34 (m, 2H), 7.02 (t, 2H, <i>J</i> = 8.7 Hz), 4.60 (d, 2H, <i>J</i> = 6.3 Hz), 4.23 (q, 2H, <i>J</i> = 6.6 Hz), 2.91 (t, 2H, <i>J</i> = 6.6 Hz), 2.00 (s, 2H). EI-MS <i>m</i>/<i>z</i>: 353 (M)<sup>+</sup>. Anal. HPLC <i>t</i><sub>R</sub> = 18.167 min, 100% (solvent system I); <i>t</i><sub>R</sub> = 12.742 min, 98.29% (solvent system II).</div></div><div id="sec4_38" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> Methyl 2-((5-Bromo-7-((4-fluorobenzyl)carbamoyl)-1,6-naphthyridin-8-yl)amino)acetate (<b>II</b>-<b>2</b>)</h3><div class="NLM_p last"><b>II</b>-<b>2</b> was prepared according to the same procedure described for <b>I</b>-<b>18</b>, giving a greenâyellow solid, yield 71%; mp 184â185 Â°C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): Î´ 10.17 (br, 1H), 8.86 (dd, 1H, <i>J</i> = 1.5, 4.2 Hz), 8.43 (dd, 1H, <i>J</i> = 1.5, 8.4 Hz), 8.34 (t, 1H, <i>J</i> = 6.0 Hz), 7.58 (dd, 1H, <i>J</i> = 4.2, 8.4 Hz), 7.36 (m, 2H), 7.04 (t, 2H, <i>J</i> = 8.7 Hz), 4.82 (s, 2H), 4.63 (d, 2H, <i>J</i> = 6.3 Hz), 3.73 (s, 3H). EI-MS <i>m</i>/<i>z</i>: 446 (M)<sup>+</sup>, 448 (M + 2)<sup>+</sup>. Anal. HPLC <i>t</i><sub>R</sub> = 21.025 min, 100% (solvent system I); <i>t</i><sub>R</sub> = 16.158 min, 100% (solvent system II).</div></div><div id="sec4_39" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> 5-Bromo-<i>N</i>-(4-fluorobenzyl)-8-((3-(methylsulfonamido)propyl)amino)-1,6-naphthyridine-7-carboxamide (<b>II</b>-<b>3</b>)</h3><div class="NLM_p last"><b>II</b>-<b>3</b> was prepared according to the same procedure described for <b>I</b>-<b>18</b>, affording a yellow solid, yield 85%; mp 153â155 Â°C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): Î´ 9.21 (m, 1H), 9.11 (dd, 1H, <i>J</i> = 1.8, 4.2 Hz), 8.53 (dd, 1H, <i>J</i> = 1.5, 8.4 Hz), 8.40 (t, 1H, <i>J</i> = 6.3 Hz), 7.68 (dd, 1H, <i>J</i> = 4.2, 8.4 Hz), 7.35 (m, 2H), 7.05 (t, 2H, <i>J</i> = 8.7 Hz), 6.61 (t, 1H, <i>J</i> = 6.0 Hz), 4.61 (d, 2H, <i>J</i> = 6.0 Hz), 4.14 (m, 2H), 3.42 (q, 2H, <i>J</i> = 6.0 Hz), 2.91 (s, 3H), 2.01 (m, 2H). EI-MS <i>m</i>/<i>z</i>: 509 (M)<sup>+</sup>, 511 (M + 2)<sup>+</sup>. Anal. HPLC <i>t</i><sub>R</sub> = 20.833 min, 100% (solvent system I); <i>t</i><sub>R</sub> = 6.067 min, 99.46% (solvent system II).</div></div><div id="sec4_40" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> 5-Bromo-8-((3-(dimethylamino)propyl)amino)-<i>N</i>-(4-fluorobenzyl)-1,6-naphthyridine-7-carboxamide (<b>II</b>-<b>4</b>)</h3><div class="NLM_p last"><b>II</b>-<b>4</b> was prepared according to the same procedure described for <b>I</b>-<b>18</b>, affording a light-yellow solid, yield 91%; mp 60â62 Â°C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): Î´ 9.74 (t, 1H, <i>J</i> = 6.6 Hz), 8.94 (dd, 1H, <i>J</i> = 1.8, 4.2 Hz), 8.42 (dd, 1H, <i>J</i> = 1.5, 8.4 Hz), 8.31 (t, 1H, <i>J</i> = 6.3 Hz), 7.68 (dd, 1H, <i>J</i> = 4.2, 8.4 Hz), 7.35 (m, 2H), 7.04 (t, 2H, <i>J</i> = 8.7 Hz), 4.61 (d, 2H, <i>J</i> = 6.0 Hz), 4.17 (q, 2H, <i>J</i> = 6.6 Hz), 2.54 (m, 2H), 1.96 (m, 2H). EI-MS <i>m</i>/<i>z</i>: 459 (M)<sup>+</sup>, 461 (M + 2)<sup>+</sup>. Anal. HPLC <i>t</i><sub>R</sub> = 18.867 min, 100% (solvent system I); <i>t</i><sub>R</sub> = 12.808 min, 100% (solvent system II).</div></div><div id="sec4_41" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> 8-((3-Benzamidopropyl)amino)-5-bromo-<i>N</i>-(4-fluorobenzyl)-1,6-naphthyridine-7-carboxamide (<b>II</b>-<b>5</b>)</h3><div class="NLM_p last"><b>II</b>-<b>5</b> was prepared according to the same procedure described for <b>I</b>-<b>18</b>, giving a brown solid, yield 57%; mp 144â146 Â°C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): Î´ 9.63 (br, 1H), 8.83 (dd, 1H, <i>J</i> = 1.8, 4.2 Hz), 8.43 (dd, 1H, <i>J</i> = 1.5, 8.4 Hz), 8.34 (t, 1H, <i>J</i> = 6.3 Hz), 7.75 (d, 2H, <i>J</i> = 6.9 Hz), 7.57 (dd, 1H, <i>J</i> = 4.2, 8.4 Hz), 7.50â7.32 (m, 5H), 7.04 (t, 2H, <i>J</i> = 8.7 Hz), 6.68 (br, 1H), 4.59 (d, 2H, <i>J</i> = 6.6 Hz), 4.26 (t, 2H, <i>J</i> = 6.6 Hz), 3.66 (q, 2H, <i>J</i> = 6.3 Hz), 2.08 (m, 2H). EI-MS <i>m</i>/<i>z</i>: 535 (M)<sup>+</sup>, 537 (M + 2)<sup>+</sup>. Anal. HPLC <i>t</i><sub>R</sub> = 6.408 min, 100% (solvent system I); <i>t</i><sub>R</sub> = 6.208 min, 100% (solvent system II).</div></div><div id="sec4_42" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> 8-((6-Aminohexyl)amino)-5-bromo-<i>N</i>-(4-fluorobenzyl)-1,6-naphthyridine-7-carboxamide (<b>II</b>-<b>6</b>)</h3><div class="NLM_p last"><b>II</b>-<b>6</b> was prepared according to the same procedure described for <b>I</b>-<b>18</b>, giving a greenâyellow solid, yield 48%; mp 108â112 Â°C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): Î´ 9.65 (br, 1H), 8.91 (dd, 1H, <i>J</i> = 1.8, 4.2 Hz), 8.38 (dd, 1H, <i>J</i> = 1.5, 8.4 Hz), 8.30 (t, 1H, <i>J</i> = 6.3 Hz), 7.56 (dd, 1H, <i>J</i> = 4.2, 8.4 Hz), 7.35 (m, 2H), 7.03 (t, 2H, <i>J</i> = 8.7 Hz), 4.60 (d, 2H, <i>J</i> = 6.6 Hz), 4.26 (m, 2H), 2.75 (m, 2H), 1.8â1.15 (m, 8H). EI-MS <i>m</i>/<i>z</i>: 473 (M)<sup>+</sup>, 475 (M + 2)<sup>+</sup>. Anal. HPLC <i>t</i><sub>R</sub> = 19.558 min, 100% (solvent system I); <i>t</i><sub>R</sub> = 13.508 min, 96.32% (solvent system II).</div></div><div id="sec4_43" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> 8-(4-Aminophenylamino)-5-bromo-<i>N</i>-(4-fluorobenzyl)-1,6-naphthyridine-7-carboxamide (<b>II</b>-<b>7</b>)</h3><div class="NLM_p last"><b>II</b>-<b>7</b> was prepared according to the same procedure described for <b>I</b>-<b>18</b>, giving a carmine solid, yield 46%; mp 190â192 Â°C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): Î´ 10.64 (s, 1H), 8.73 (dd, 1H, <i>J</i> = 1.8, 4.2 Hz), 8.44 (dd, 1H, <i>J</i> = 1.5, 8.4 Hz), 8.38 (t, 1H, <i>J</i> = 6.3 Hz), 7.54 (dd, 1H, <i>J</i> = 4.2, 8.4 Hz), 7.36 (m, 2H), 7.03 (t, 2H, <i>J</i> = 8.7 Hz), 6.80 (d, 2H, <i>J</i> = 8.4 Hz), 6.56 (d, 2H, <i>J</i> = 8.4 Hz), 4.60 (d, 2H, <i>J</i> = 6.6 Hz). EI-MS <i>m</i>/<i>z</i>: 465 (M)<sup>+</sup>, 467 (M + 2)<sup>+</sup>. Anal. HPLC <i>t</i><sub>R</sub> = 16.067 min, 100% (solvent system I); <i>t</i><sub>R</sub> = 10.667 min, 99.18% (solvent system II).</div></div><div id="sec4_44" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> 8-(3-Aminophenylamino)-5-bromo-<i>N</i>-(4-fluorobenzyl)-1,6-naphthyridine-7-carboxamide (<b>II</b>-<b>8</b>)</h3><div class="NLM_p last"><b>II</b>-<b>8</b> was prepared according to the same procedure described for <b>I</b>-<b>18</b>, giving a yellow solid, yield 44%; mp 167â169 Â°C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): Î´ 10.54 (s, 1H), 8.85 (dd, 1H, <i>J</i> = 1.8, 4.2 Hz), 8.47 (dd, 1H, <i>J</i> = 1.5, 8.4 Hz), 8.38 (t, 1H, <i>J</i> = 6.3 Hz), 7.59 (dd, 1H, <i>J</i> = 4.2, 8.4 Hz), 7.35 (m, 2H), 7.04 (t, 2H, <i>J</i> = 8.7 Hz), 6.95 (t, 1H, <i>J</i> = 8.0 Hz), 6.36 (d, 1H, <i>J</i> = 8.0 Hz), 6.28 (m, 2H), 4.61 (d, 2H, <i>J</i> = 6.3 Hz), 3.56 (br, 2H). EI-MS <i>m</i>/<i>z</i>: 465 (M)<sup>+</sup>, 467 (M + 2)<sup>+</sup>. Analytical HPLC <i>t</i><sub>R</sub> = 16.292 min, 100% (solvent system I); <i>t</i><sub>R</sub> = 11.067 min, 100% (solvent system II).</div></div><div id="sec4_45" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> <i>tert</i>-Butyl 4-((5-Bromo-7-((4-fluorobenzyl)carbamoyl)-1,6-naphthyridin-8-yl)amino)piperidine-1-carboxylate (<b>II</b>-<b>9</b>)</h3><div class="NLM_p last"><b>II</b>-<b>9</b> was prepared according to the same procedure described for <b>I</b>-<b>18</b>, giving a yellow solid, yield 75%; mp 134â137 Â°C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): Î´ 8.96 (dd, 1H, <i>J</i> = 1.5, 3.9 Hz), 8.44 (dd, 1H, <i>J</i> = 1.5, 8.4 Hz), 8.32 (t, 1H, <i>J</i> = 6.0 Hz), 7.61 (dd, 1H, <i>J</i> = 4.2, 8.4 Hz), 7.35 (m, 2H), 7.04 (t, 2H, <i>J</i> = 8.7 Hz), 5.18 (m, 1H), 4.60 (d, 2H, <i>J</i> = 6.0 Hz), 3.99 (m, 2H), 3.05 (m, 2H), 2.06 (m, 2H), 1.62 (m, 2H), 1.45 (s, 9H). EI-MS <i>m</i>/<i>z</i>: 557 (M)<sup>+</sup>, 559 (M + 2)<sup>+</sup>. Anal. HPLC <i>t</i><sub>R</sub> = 23.967 min, 100% (solvent system I); <i>t</i><sub>R</sub> = 19.517 min, 100% (solvent system II).</div></div><div id="sec4_46" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> 5-Bromo-<i>N</i>-(4-fluorobenzyl)-8-(piperidin-4-ylamino)-1,6-naphthyridine-7-carboxamide (<b>II</b>-<b>10</b>)</h3><div class="NLM_p last"><b>II</b>-<b>10</b> was prepared according to the same procedure described for <b>I</b>-<b>18</b>, giving a greenâyellow solid, yield 46%; mp >200 Â°C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): Î´ 8.94 (dd, 1H, <i>J</i> = 2.1, 4.2 Hz), 8.46 (dd, 1H, <i>J</i> = 1.8, 8.4 Hz), 8.32 (t, 1H, <i>J</i> = 6.0 Hz), 7.63 (dd, 1H, <i>J</i> = 4.2, 8.4 Hz), 7.33 (m, 2H), 7.02 (t, 2H, <i>J</i> = 8.7 Hz), 5.27 (m, 1H), 4.56 (d, 2H, <i>J</i> = 6.0 Hz), 3.39 (m, 2H), 2.31 (m, 2H), 1.84 (m, 2H). EI-MS <i>m</i>/<i>z</i>: 457 (M)<sup>+</sup>, 459 (M + 2)<sup>+</sup>. Anal. HPLC <i>t</i><sub>R</sub> = 6.292 min, 100% (solvent system I); <i>t</i><sub>R</sub> = 12.658 min, 100% (solvent system II).</div></div><div id="sec4_47" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> <i>tert</i>-Butyl 4-(5-Bromo-7-(4-fluorobenzylcarbamoyl)-1,6-naphthyridin-8-yl)piperazine-1-carboxylate (<b>II</b>-<b>11</b>)</h3><div class="NLM_p last"><b>II</b>-<b>11</b> was prepared according to the same procedure described for <b>I</b>-<b>18</b>, giving a yellow solid, yield 64%; mp 118â122 Â°C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): Î´ 9.02 (dd, 1H, <i>J</i> = 1.5, 4.2 Hz), 8.47 (dd, 1H, <i>J</i> = 1.8, 8.4 Hz), 8.18 (t, 1H, <i>J</i> = 8.7 Hz), 7.59 (dd, 1H, <i>J</i> = 4.2, 8.4 Hz), 7.35 (m, 2H), 6.99 (t, 2H, <i>J</i> = 8.7 Hz), 4.61 (d, 2H, <i>J</i> = 6.3 Hz), 3.59 (s, 4H), 3.47 (s, 4H), 1.49 (s, 9H). EI-MS <i>m</i>/<i>z</i>: 543 (M)<sup>+</sup>, 545 (M + 2)<sup>+</sup>. Anal. HPLC <i>t</i><sub>R</sub> = 20.483 min, 100% (solvent system I); <i>t</i><sub>R</sub> = 14.767 min, 99.35% (solvent system II).</div></div><div id="sec4_48" class="NLM_sec NLM_sec_level_2"><div id="ac_i66" class="anchor-spacer"></div><h3 class="article-section__title" id="_i66"> 5-Bromo-<i>N</i>-(4-fluorobenzyl)-8-(piperazin-1-yl)-1,6-naphthyridine-7-carboxamide (<b>II</b>-<b>12</b>)</h3><div class="NLM_p last"><b>II</b>-<b>12</b> was prepared according to the same procedure described for <b>I</b>-<b>18</b>, giving a brown solid, yield 38%; mp 191â195 Â°C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): Î´ 9.07 (dd, 1H, <i>J</i> = 1.5, 4.2 Hz), 8.59 (t, 1H, <i>J</i> = 6.0 Hz), 8.53 (dd, 1H, <i>J</i> = 1.5, 8.4 Hz), 7.63 (dd, 1H, <i>J</i> = 4.2, 8.4 Hz), 7.39 (m, 2H), 7.04 (t, 2H, <i>J</i> = 8.7 Hz), 4.66 (d, 2H, <i>J</i> = 6.3 Hz), 3.59 (t, 4H, <i>J</i> = 4.5 Hz), 3.13 (t, 4H, <i>J</i> = 4.5 Hz), 2.74 (br, 1H). EI-MS <i>m</i>/<i>z</i>: 443 (M)<sup>+</sup>, 445 (M + 2)<sup>+</sup>. Anal. HPLC <i>t</i><sub>R</sub> = 19.808 min, 100% (solvent system I); <i>t</i><sub>R</sub> = 12.050 min, 96.48% (solvent system II).</div></div><div id="sec4_49" class="NLM_sec NLM_sec_level_2"><div id="ac_i67" class="anchor-spacer"></div><h3 class="article-section__title" id="_i67"> 8-(((1<i>r</i>,4<i>r</i>)-4-Aminocyclohexyl)amino)-5-bromo-<i>N</i>-(4-fluorobenzyl)-1,6-naphthyridine-7-carboxamide (<b>II</b>-<b>13</b>)</h3><div class="NLM_p last"><b>II</b>-<b>13</b> was prepared according to the same procedure described for <b>I</b>-<b>18</b>, giving a light-yellow solid, yield 81%; mp 147â152 Â°C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): Î´ 9.63 (d, 1H, <i>J</i> = 7.5 Hz), 8.94 (dd, 1H, <i>J</i> = 1.5, 3.9 Hz), 8.40 (dd, 1H, <i>J</i> = 1.5, 8.4 Hz), 8.33 (t, 1H, <i>J</i> = 6.0 Hz), 7.58 (dd, 1H, <i>J</i> = 4.2, 8.4 Hz), 7.35 (m, 2H), 7.04 (t, 2H, <i>J</i> = 8.7 Hz), 4.97 (m, 1H), 4.60 (d, 2H, <i>J</i> = 6.0 Hz), 2.76 (m, 1H), 2.18 (m, 2H), 1.92 (m, 4H), 1.42 (m, 4H). EI-MS <i>m</i>/<i>z</i>: 471 (M)<sup>+</sup>, 473 (M + 2)<sup>+</sup>. HRMS calcd for C<sub>22</sub>H<sub>23</sub>BrFN<sub>5</sub>O (M)<sup>+</sup>: 471.1070. Found: 471.1063. Anal. HPLC <i>t</i><sub>R</sub> = 5.325 min, 93.63% (solvent system I); <i>t</i><sub>R</sub> = 12.692 min, 99.60% (solvent system II).</div></div><div id="sec4_50" class="NLM_sec NLM_sec_level_2"><div id="ac_i68" class="anchor-spacer"></div><h3 class="article-section__title" id="_i68"> 8-(((1<i>r</i>,4<i>r</i>)-4-Aminocyclohexyl)amino)-<i>N</i>-(4-fluorobenzyl)-5-(piperidin-1-yl)-1,6-naphthyridine-7-carboxamide (<b>II</b>-<b>14</b>)</h3><div class="NLM_p">Following the procedure as the preparation of compound <b>I</b>-<b>18</b>, the reaction of <i>tert</i>-butyl ((1<i>r</i>,4<i>r</i>)-4-aminocyclohexyl)carbamate (65 mg, 0.3 mmol) with <b>I</b>-<b>3</b> (53 mg, 0.1 mmol) and triethylamine (30 mg, 0.3 mmol) gave <i>tert</i>-butyl ((1<i>r</i>,4<i>r</i>)-4-((5-bromo-7-((4-fluorobenzyl)carbamoyl)-1,6-naphthyridin-8-yl)amino)cyclohexyl)carbamate as a yellow solid, yield 70%. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): Î´ 9.65 (d, 1H, <i>J</i> = 7.5 Hz), 8.93 (dd, 1H, <i>J</i> = 1.5, 3.9 Hz), 8.42 (dd, 1H, <i>J</i> = 1.5, 8.4 Hz), 8.30 (m, 1H), 7.59 (dd, 1H, <i>J</i> = 4.2, 8.4 Hz), 7.35 (m, 2H), 7.04 (t, 2H), 4.96 (m, 1H), 4.60 (d, 2H, <i>J</i> = 6.3 Hz), 4.38 (m, 1H), 3.48 (m, 1H), 2.20 (m, 2H), 2.06 (m, 2H), 1.45 (s, 9H), 1.32 (m, 4H). EI-MS <i>m</i>/<i>z</i>: 571 (M)<sup>+</sup>, 573 (M + 2)<sup>+</sup>.</div><div class="NLM_p"><i>tert</i>-Butyl ((1<i>r</i>,4<i>r</i>)-4-((5-bromo-7-((4-fluorobenzyl)carbamoyl)-1,6-naphthyridin-8-yl)amino)cyclohexyl)carbamate (29 mg, 0.05 mmol) was added to a solution of piperidine (1 mL). After heating at 110 Â°C for 48 h, the solution was cooled to room temperature, diluted with dichloromethane, and then washed with saturated aqueous NH<sub>4</sub>Cl and brine. Usual workup followed by purification by flash chromatography on silica gel (DCM:methanol = 100:1) afforded <i>tert</i>-butyl ((1<i>r</i>,4<i>r</i>)-4-((7-((4-fluorobenzyl)carbamoyl)-5-(piperidin-1-yl)-1,6-naphthyridin-8-yl)amino)cyclohexyl)carbamate as a yellow solid, yield 89%. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): Î´ 8.93 (d, 1H, <i>J</i> = 1.5 Hz), 8.53 (m, 1H), 8.36 (dd, 1H, <i>J</i> = 1.5, 8.4 Hz), 7.47 (dd, 1H, <i>J</i> = 4.2, 8.4 Hz), 7.34 (m, 2H), 7.03 (m, 2H), 4.74 (m, 1H), 4.62 (d, 2H, <i>J</i> = 6.0 Hz), 4.30 (m, 1H), 3.74 (m, 1H), 3.46 (m, 1H), 3.11 (m, 4H), 2.14 (m, 2H), 1.84 (m, 4H), 1.69 (m, 4H), 1.44 (s, 9H), 1.45â1.23 (m, 4H).</div><div class="NLM_p last">The resultant <i>tert</i>-butyl ((1<i>r</i>,4<i>r</i>)-4-((7-((4-fluorobenzyl)carbamoyl)-5-(piperidin-1-yl)-1,6-naphthyridin-8-yl)amino)cyclohexyl)carbamate was deprotected in 20% TFAâDCM solution to give the target compound <b>II</b>-<b>14</b> as a yellow solid, yield 95%. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): Î´ 8.94 (d, 1H, <i>J</i> = 2.7 Hz), 8.70 (m, 1H), 8.54 (m, 1H), 8.35 (d, 1H, <i>J</i> = 9.0 Hz), 7.46 (dd, 1H, <i>J</i> = 3.9, 8.1 Hz), 7.34 (m, 2H), 7.03 (m, 2H), 4.75 (m, 1H), 4.62 (d, 2H, <i>J</i> = 6.3 Hz), 3.11 (m, 4H), 2.75 (m, 1H), 2.13 (m, 2H), 2.05 (m, 3H), 1.72 (m, 5H), 1.45â1.23 (m, 4H). EI-MS <i>m</i>/<i>z</i>: 476 (M)<sup>+</sup>. Anal. HPLC <i>t</i><sub>R</sub> = 13.843 min, 96.19% (solvent system I); <i>t</i><sub>R</sub> = 6.577 min, 99.29% (solvent system II).</div></div><div id="sec4_51" class="NLM_sec NLM_sec_level_2"><div id="ac_i69" class="anchor-spacer"></div><h3 class="article-section__title" id="_i69"> 8-(((1<i>r</i>,4<i>r</i>)-4-Aminocyclohexyl)amino)-5-(1,1-dioxido-1,2-thiazinan-2-yl)-<i>N</i>-(4-fluorobenzyl)-1,6-naphthyridine-7-carboxamide (<b>II</b>-<b>15</b>)</h3><div class="NLM_p">Following the procedure as the preparation of compound <b>I</b>-<b>3</b>, the treatment of <b>I</b>-<b>4</b> (43 mg, 0.1 mmol) with methylbenzenesulfonyl chloride (75 mg, 0.4 mmol) and triethylamine (40 mg, 0.4 mmol) gave 5-(1,1-dioxido-1,2-thiazinan-2-yl)-7-((4-fluorobenzyl)carbamoyl)-1,6-naphthyridin-8-yl 4-methylbenzenesulfonate as a white solid, yield 82%. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): Î´ 8.92 (d, 1H, <i>J</i> = 3.9 Hz), 8.60 (d, 1H, <i>J</i> = 8.4 Hz), 7.93 (d, 2H, <i>J</i> = 8.1 Hz), 7.59 (dd, 1H, <i>J</i> = 4.2, 8.7 Hz), 7.49 (m, 1H), 7.36 (m, 4H), 7.05 (t, 2H, <i>J</i> = 8.7 Hz), 4.63 (d, 2H, <i>J</i> = 6.0 Hz), 4.03 (m, 2H), 3.31 (m, 2H), 2.47 (s, 3H), 2.36 (m, 2H), 1.66 (m, 2H). EI-MS <i>m</i>/<i>z</i>: 584 (M)<sup>+</sup>.</div><div class="NLM_p last"><b>II</b>-<b>15</b> was prepared in a similar fashion as described for <b>I</b>-<b>18</b> from the precursor above, giving a yellow solid, yield 54%; mp 173â176 Â°C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): Î´ 9.65 (d, 1H, <i>J</i> = 7.8 Hz), 8.92 (m, 1H), 8.48 (dd, 1H, <i>J</i> = 1.5, 8.7 Hz), 8.07 (m, 1H), 7.54 (dd, 1H, <i>J</i> = 4.2, 8.4 Hz), 7.34 (dd, 2H, <i>J</i> = 5.4, 8.4 Hz), 7.04 (t, 2H, <i>J</i> = 8.4 Hz), 5.00 (m, 1H), 4.56 (m, 2H), 3.92 (m, 1H), 3.74 (m, 1H), 3.24 (m, 2H), 2.75 (m, 1H), 2.40 (m, 1H), 2.20 (m, 4H), 1.90 (m, 2H), 1.65 (m, 2H), 1.43 (m, 4H). EI-MS <i>m</i>/<i>z</i>: 526 (M)<sup>+</sup>. Anal. HPLC <i>t</i><sub>R</sub> = 17.875 min, 95.23% (solvent system I); <i>t</i><sub>R</sub> = 7.375 min, 100% (solvent system II).</div></div><div id="sec4_52" class="NLM_sec NLM_sec_level_2"><div id="ac_i70" class="anchor-spacer"></div><h3 class="article-section__title" id="_i70"> <i>N</i>-Benzyl-5-bromo-8-hydroxy-1,6-naphthyridine-7-carboxamide (<b>III</b>-<b>1</b>-<b>8</b>)</h3><div class="NLM_p last"><b>III</b>-<b>1</b>-<b>8</b> was prepared in a similar fashion as described for <b>I</b>-<b>1</b>, giving a white solid (yield: 72%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) Î´ 9.19 (d, <i>J</i> = 4.2 Hz, 1H), 8.54 (d, <i>J</i> = 7.8 Hz, 1H), 8.21 (m, 1H), 7.74 (dd, <i>J</i> = 4.2, 7.8 Hz, 1H), 7.40â7.29 (m, 5H), 4.70 (d, <i>J</i> = 6.0 Hz, 2H).</div></div><div id="sec4_53" class="NLM_sec NLM_sec_level_2"><div id="ac_i71" class="anchor-spacer"></div><h3 class="article-section__title" id="_i71"> 7-(Benzylcarbamoyl)-5-bromo-1,6-naphthyridin-8-yl 4-Methylbenzenesulfonate (<b>III</b>-<b>1</b>-<b>9</b>)</h3><div class="NLM_p last"><b>III</b>-<b>1</b>-<b>9</b> was prepared in a similar fashion as described for <b>I</b>-<b>3</b>, giving a white solid (yield: 83%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) Î´ 9.04 (dd, <i>J</i> = 1.5, 4.2 Hz, 1H), 8.56 (d, <i>J</i> = 1.8, 7.8 Hz, 1H), 7.93 (m, 3H), 7.68 (dd, <i>J</i> = 4.5, 8.7 Hz, 1H), 7.38â7.30 (m, 7H), 4.62 (d, <i>J</i> = 6.0 Hz, 2H), 2.46 (s, 3H).</div></div><div id="sec4_54" class="NLM_sec NLM_sec_level_2"><div id="ac_i72" class="anchor-spacer"></div><h3 class="article-section__title" id="_i72"> 8-(((1<i>r</i>,4<i>r</i>)-4-Aminocyclohexyl)amino)-<i>N</i>-benzyl-5-bromo-1,6-naphthyridine-7-carboxamide (<b>III</b>-<b>1</b>)</h3><div class="NLM_p last"><b>III</b>-<b>1</b> was prepared in a similar fashion as described for <b>I</b>-<b>18</b>, giving a yellow solid, yield 56%; mp 123â126 Â°C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): Î´ 9.62 (d, 1H, <i>J</i> = 7.5 Hz), 8.94 (dd, 1H, <i>J</i> = 1.5, 3.9 Hz), 8.41 (d, 1H, <i>J</i> = 8.4 Hz), 8.31 (m, 1H), 7.58 (dd, 1H, <i>J</i> = 4.2, 8.4 Hz), 7.37â7.27 (m, 5H), 4.97 (m, 1H), 4.63 (d, 2H, <i>J</i> = 6.0 Hz), 2.76 (m, 1H), 2.18 (m, 1H), 1.92 (m, 4H), 1.42 (m, 4H). EI-MS <i>m</i>/<i>z</i>: 453 (M)<sup>+</sup>, 455 (M + 2)<sup>+</sup>. Anal. HPLC <i>t</i><sub>R</sub> = 5.8 min, 100% (solvent system I); <i>t</i><sub>R</sub> = 8.79 min, 95.72% (solvent system II).</div></div><div id="sec4_55" class="NLM_sec NLM_sec_level_2"><div id="ac_i73" class="anchor-spacer"></div><h3 class="article-section__title" id="_i73"> 5-Bromo-8-hydroxy-<i>N</i>-(4-methoxybenzyl)-1,6-naphthyridine-7-carboxamide (<b>III</b>-<b>2</b>-<b>8</b>)</h3><div class="NLM_p last"><b>III</b>-<b>2</b>-<b>8</b> was prepared according to the same procedure described for <b>I</b>-<b>1</b>, giving a white solid (yield: 65%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) Î´ 9.19 (d, <i>J</i> = 4.2 Hz, 1H), 8.53 (d, <i>J</i> = 8.1 Hz, 1H), 8.12 (m, 1H), 7.72 (dd, <i>J</i> = 4.2, 7.8 Hz, 1H), 7.33 (d, <i>J</i> = 8.4 Hz, 2H), 6.91 (t, <i>J</i> = 8.7 Hz, 2H), 4.63 (d, <i>J</i> = 6.6 Hz, 2H), 3.80 (s, 3H). Anal. HPLC <i>t</i><sub>R</sub> = 22.47 min, 99.99% (solvent system I); <i>t</i><sub>R</sub> = 14.81 min, 99.81% (solvent system II).</div></div><div id="sec4_56" class="NLM_sec NLM_sec_level_2"><div id="ac_i74" class="anchor-spacer"></div><h3 class="article-section__title" id="_i74"> 5-Bromo-7-((4-methoxybenzyl)carbamoyl)-1,6-naphthyridin-8-yl 4-Methylbenzenesulfonate (<b>III</b>-<b>2</b>-<b>9</b>)</h3><div class="NLM_p last"><b>III</b>-<b>2</b>-<b>9</b> was prepared according to the same procedure described for <b>I</b>-<b>3</b>, giving a white solid (yield: 62%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) Î´ 8.98 (dd, <i>J</i> = 1.5, 4.2 Hz, 1H), 8.52 (dd, <i>J</i> = 1.5, 8.7 Hz, 1H), 7.90 (d, <i>J</i> = 8.4 Hz, 2H), 7.87 (m, 1H), 7.65 (dd, <i>J</i> = 4.2, 8.4 Hz, 1H), 7.31â7.27 (m, 4H), 6.87 (d, <i>J</i> = 8.4 Hz, 2H), 4.52 (d, <i>J</i> = 5.7 Hz, 2H), 3.78 (s, 3H), 2.44 (s, 3H).</div></div><div id="sec4_57" class="NLM_sec NLM_sec_level_2"><div id="ac_i75" class="anchor-spacer"></div><h3 class="article-section__title" id="_i75"> 8-(((1<i>r</i>,4<i>r</i>)-4-Aminocyclohexyl)amino)-5-bromo-<i>N</i>-(4-methoxybenzyl)-1,6-naphthyridine-7-carboxamide (<b>III</b>-<b>2</b>)</h3><div class="NLM_p last"><b>III</b>-<b>2</b> was prepared according to the same procedure described for <b>I</b>-<b>18</b>, giving a yellow solid, yield 78%; mp 96â99 Â°C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): Î´ 9.64 (d, 1H, <i>J</i> = 8.1 Hz), 8.93 (dd, 1H, <i>J</i> = 1.2, 4.2 Hz), 8.40 (dd, 1H, <i>J</i> = 1.2, 8.4 Hz), 8.23 (m, 1H), 7.58 (dd, 1H, <i>J</i> = 4.2, 8.4 Hz), 7.30 (d, 2H, <i>J</i> = 8.4 Hz), 6.89 (d, 2H, <i>J</i> = 8.4 Hz), 4.95 (m, 1H), 4.56 (d, 2H, <i>J</i> = 6.3 Hz), 3.80 (s, 3H), 2.75 (m, 1H), 2.63 (m, 1H), 2.18 (m, 2H), 1.85 (m, 4H), 1.34 (m, 4H). EI-MS <i>m</i>/<i>z</i>: 483 (M)<sup>+</sup>, 485 (M + 2)<sup>+</sup>. Anal. HPLC <i>t</i><sub>R</sub> = 22.367 min, 97.28% (solvent system I); <i>t</i><sub>R</sub> = 13.950 min, 97.37% (solvent system II).</div></div><div id="sec4_58" class="NLM_sec NLM_sec_level_2"><div id="ac_i76" class="anchor-spacer"></div><h3 class="article-section__title" id="_i76"> <i>N</i>-(Benzo[<i>d</i>][1,3]dioxol-5-ylmethyl)-5-bromo-8-hydroxy-1,6-naphthyridine-7-carboxamide (<b>III</b>-<b>3</b>-<b>8</b>)</h3><div class="NLM_p last"><b>III</b>-<b>3</b>-<b>8</b> was prepared according to the same procedure described for <b>I</b>-<b>1</b>, giving a white solid (yield: 77%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) Î´ 13.32 (s, 1H), 9.20 (dd, <i>J</i> = 1.5, 3.9 Hz, 1H), 8.54 (dd, <i>J</i> = 1.2, 8.4 Hz, 1H), 8.11 (m, 1H), 7.72 (dd, <i>J</i> = 4.2, 8.4 Hz, 1H), 6.89â6.79 (m, 3H), 5.97 (s, 2H), 4.60 (d, <i>J</i> = 6.3 Hz, 2H).</div></div><div id="sec4_59" class="NLM_sec NLM_sec_level_2"><div id="ac_i77" class="anchor-spacer"></div><h3 class="article-section__title" id="_i77"> 7-((Benzo[<i>d</i>][1,3]dioxol-5-ylmethyl)carbamoyl)-5-bromo-1,6-naphthyridin-8-yl 4-Methylbenzenesulfonate (<b>III</b>-<b>3</b>-<b>9</b>)</h3><div class="NLM_p last"><b>III</b>-<b>3</b>-<b>9</b> was prepared according to the same procedure described for <b>I</b>-<b>3</b>, giving a white solid (yield: 68%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) Î´ 9.01 (dd, <i>J</i> = 1.2, 4.2 Hz, 1H), 8.54 (dd, <i>J</i> = 1.5, 8.7 Hz, 1H), 7.91 (d, <i>J</i> = 8.1 Hz, 2H), 7.87 (m, 1H), 7.67 (dd, <i>J</i> = 4.2, 8.4 Hz, 1H), 7.33 (d, <i>J</i> = 8.1 Hz, 2H), 6.86â6.75 (m, 3H), 5.94 (s, 2H), 4.51 (d, <i>J</i> = 6.0 Hz, 2H), 2.46 (s, 3H).</div></div><div id="sec4_60" class="NLM_sec NLM_sec_level_2"><div id="ac_i78" class="anchor-spacer"></div><h3 class="article-section__title" id="_i78"> 8-(((1<i>r</i>,4<i>r</i>)-4-Aminocyclohexyl)amino)-<i>N</i>-(benzo[<i>d</i>][1,3]dioxol-5-ylmethyl)-5-bromo-1,6-naphthyridine-7-carboxamide (<b>III</b>-<b>3</b>)</h3><div class="NLM_p last"><b>III</b>-<b>3</b> was prepared according to the same procedure described for <b>I</b>-<b>18</b>, giving a yellow solid, yield 43%; mp 131â134 Â°C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): Î´ 9.62 (d, 1H, <i>J</i> = 8.4 Hz), 8.93 (dd, 1H, <i>J</i> = 1.2, 4.2 Hz), 8.40 (dd, 1H, <i>J</i> = 1.2, 8.4 Hz), 8.23 (m, 1H), 7.58 (dd, 1H, <i>J</i> = 4.2, 8.4 Hz), 6.87â6.76 (m, 3H), 5.94 (s, 2H), 4.95 (m, 1H), 4.53 (d, 2H, <i>J</i> = 6.0 Hz), 2.75 (m, 1H), 2.18 (m, 2H), 1.92 (m, 4H), 1.34 (m, 4H). EI-MS <i>m</i>/<i>z</i>: 401 (M)<sup>+</sup>, 403 (M + 2)<sup>+</sup>. Anal. HPLC <i>t</i><sub>R</sub> = 14.43 min, 100% (solvent system I); <i>t</i><sub>R</sub> = 5.54 min, 100% (solvent system II).</div></div><div id="sec4_61" class="NLM_sec NLM_sec_level_2"><div id="ac_i79" class="anchor-spacer"></div><h3 class="article-section__title" id="_i79"> (<i>S</i>)-5-Bromo-<i>N</i>-(1-(4-fluorophenyl)ethyl)-8-hydroxy-1,6-naphthyridine-7-carboxamide (<b>III</b>-<b>4</b>-<b>8</b>)</h3><div class="NLM_p last"><b>III</b>-<b>4</b>-<b>8</b>was prepared according to the same procedure described for <b>I</b>-<b>1</b>, giving a white solid (yield: 82%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) Î´ 13.30 (s, 1H), 9.17 (dd, <i>J</i> = 1.5, 4.2 Hz, 1H), 8.53 (dd, <i>J</i> = 1.5, 8.4 Hz, 1H), 8.03 (d, <i>J</i> = 8.1 Hz, 1H), 7.71 (dd, <i>J</i> = 4.2, 8.4 Hz, 1H), 7.40 (m, 2H), 7.06 (d, <i>J</i> = 8.7 Hz, 2H), 5.30 (m, 1H), 1.67 (d, <i>J</i> = 6.9 Hz, 3H).</div></div><div id="sec4_62" class="NLM_sec NLM_sec_level_2"><div id="ac_i80" class="anchor-spacer"></div><h3 class="article-section__title" id="_i80"> (<i>S</i>)-5-Bromo-7-((1-(4-fluorophenyl)ethyl)carbamoyl)-1,6-naphthyridin-8-yl 4-methylbenzenesulfonate (<b>III</b>-<b>4</b>-<b>9</b>)</h3><div class="NLM_p last"><b>III</b>-<b>4</b>-<b>9</b> was prepared according to the same procedure described for <b>I</b>-<b>3</b>, giving a white solid (yield: 79%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) Î´ 9.01 (dd, <i>J</i> = 1.2, 4.2 Hz, 1H), 8.56 (d, <i>J</i> = 8.7 Hz, 1H), 7.88 (d, <i>J</i> = 8.1 Hz, 2H), 7.84 (m, 1H), 7.67 (dd, <i>J</i> = 4.5, 8.7 Hz, 1H), 7.40 (m, 2H), 7.28 (d, <i>J</i> = 8.7 Hz, 2H), 5.26 (m, 1H), 2.45 (s, 3H), 1.60 (d, <i>J</i> = 6.9 Hz, 3H).</div></div><div id="sec4_63" class="NLM_sec NLM_sec_level_2"><div id="ac_i81" class="anchor-spacer"></div><h3 class="article-section__title" id="_i81"> 8-(((1<i>r</i>,4<i>r</i>)-4-Aminocyclohexyl)amino)-5-bromo-<i>N</i>-((<i>S</i>)-1-(4-fluorophenyl)ethyl)-1,6-naphthyridine-7-carboxamide (<b>III</b>-<b>4</b>)</h3><div class="NLM_p last"><b>III</b>-<b>4</b> was prepared according to the same procedure described for <b>I</b>-<b>18</b>, giving a yellow solid, yield 66%; mp 129â131 Â°C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): Î´ 9.57 (d, 1H, <i>J</i> = 7.5 Hz), 8.93 (dd, 1H, <i>J</i> = 1.5, 3.9 Hz), 8.41 (dd, 1H, <i>J</i> = 1.5, 8.4 Hz), 8.21 (m, 1H), 7.58 (dd, 1H, <i>J</i> = 4.2, 8.4 Hz), 7.37 (m, 2H), 7.01 (t, 2H, <i>J</i> = 8.7 Hz), 5.24 (m, 1H), 4.97 (m, 1H), 4.93 (m, 1H), 2.76 (m, 1H), 2.18 (m, 2H), 1.92 (m, 2H), 1.60 (d, 3H, <i>J</i> = 6.9 Hz), 1.42 (m, 4H). EI-MS <i>m</i>/<i>z</i>: 485 (M)<sup>+</sup>, 487 (M + 2)<sup>+</sup>. Anal. HPLC <i>t</i><sub>R</sub> = 14.31 min, 94.70% (solvent system I); <i>t</i><sub>R</sub> = 8.33 min, 100% (solvent system II).</div></div><div id="sec4_64" class="NLM_sec NLM_sec_level_2"><div id="ac_i82" class="anchor-spacer"></div><h3 class="article-section__title" id="_i82"> 5-Bromo-8-hydroxy-<i>N</i>-(4-(dimethylamino)benzyl)-1,6-naphthyridine-7-carboxamide (<b>III</b>-<b>5</b>-<b>8</b>)</h3><div class="NLM_p last"><b>III</b>-<b>5</b>-<b>8</b> was prepared according to the same procedure described for <b>I</b>-<b>1</b>, giving the desired crude product as a brown solid (yield: 85%) that was used for the next step directly.</div></div><div id="sec4_65" class="NLM_sec NLM_sec_level_2"><div id="ac_i83" class="anchor-spacer"></div><h3 class="article-section__title" id="_i83"> 5-Bromo-7-(4-(dimethylamino)benzylcarbamoyl)-1,6-naphthyridin-8-yl 4-Methylbenzenesulfonate (<b>III</b>-<b>5</b>-<b>9</b>)</h3><div class="NLM_p last"><b>III</b>-<b>5</b>-<b>9</b> was prepared according to the same procedure described for <b>I</b>-<b>3</b>, giving a white solid (yield: 48%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): Î´ 9.03 (d, <i>J</i> = 4.5 Hz, 1H), 8.55 (d, <i>J</i> = 6.9 Hz, 1H), 7.94 (d, <i>J</i> = 8.4 Hz, 2H), 7.76 (m, 1H), 7.67 (dd, <i>J</i> = 4.5, 6.9 Hz, 1H), 7.34 (d, <i>J</i> = 8.4 Hz, 2H), 7.25 (m, 2H), 6.74 (d, <i>J</i> = 9 Hz, 2H), 4.49 (d, <i>J</i> = 5.7 Hz, 2H), 2.95 (s, 6H), 2.47 (s, 3H).</div></div><div id="sec4_66" class="NLM_sec NLM_sec_level_2"><div id="ac_i84" class="anchor-spacer"></div><h3 class="article-section__title" id="_i84"> 8-((1<i>r</i>,4<i>r</i>)-4-Aminocyclohexylamino)-<i>N</i>-(4-(dimethylamino)benzyl)-5-bromo-1,6-naphthyridine-7-carboxamide (<b>III</b>-<b>5</b>)</h3><div class="NLM_p last"><b>III</b>-<b>5</b> was prepared according to the same procedure described for <b>I</b>-<b>18</b>, giving a yellow solid, yield 62%. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): Î´ 9.72 (d, <i>J</i> = 8.1 Hz, 1H), 8.95 (d, 1H, <i>J</i> = 2.4 Hz), 8.39 (d, 1H, <i>J</i> = 8.7 Hz), 8.20 (t, <i>J</i> = 5.7 Hz, 1H), 7.56 (dd, 1H, <i>J</i> = 2.4, 8.7 Hz), 7.24â7.27 (m, 2H), 6.73 (d, 2H, <i>J</i> = 8.7 Hz), 5.03 (m, 1H), 4.52 (d, <i>J</i> = 5.7 Hz, 2H), 3.24 (m, 1H), 2.94 (s, 6H), 2.29 (br s, 4H), 1.77 (m, 2H), 1.47 (m, 2H). MS-EI <i>m</i>/<i>z</i>: 496 (M)<sup>+</sup>, 498 (M + 2)<sup>+</sup>. Anal. Calcd for C<sub>24</sub>H<sub>29</sub>BrN<sub>6</sub>OÂ·1/4CF<sub>3</sub>COOHÂ·3H<sub>2</sub>O: C 50.74, H 6.13, N 14.49. Found: C 50.71, H 6.22, N 14.22.</div></div><div id="sec4_67" class="NLM_sec NLM_sec_level_2"><div id="ac_i85" class="anchor-spacer"></div><h3 class="article-section__title" id="_i85"> 5-Bromo-8-hydroxy-<i>N</i>-(3-methoxybenzyl)-1,6-naphthyridine-7-carboxamide (<b>III</b>-<b>6</b>-<b>8</b>)</h3><div class="NLM_p last"><b>III</b>-<b>6</b>-<b>8</b> was prepared according to the same procedure described for <b>I</b>-<b>1</b>, giving a white solid (yield: 65%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) Î´ 9.14 (dd, <i>J</i> = 1.5, 4.2 Hz, 1H), 8.48 (dd, <i>J</i> = 1.5, 8.4 Hz, 1H), 8.26 (m, 1H), 7.68 (dd, <i>J</i> = 4.2, 8.4 Hz, 1H), 7.23 (m, 2H), 6.84 (m, 2H), 4.64 (d, <i>J</i> = 6.0 Hz, 2H), 3.78 (s, 3H).</div></div><div id="sec4_68" class="NLM_sec NLM_sec_level_2"><div id="ac_i86" class="anchor-spacer"></div><h3 class="article-section__title" id="_i86"> 5-Bromo-7-((3-methoxybenzyl)carbamoyl)-1,6-naphthyridin-8-yl 4-Methylbenzenesulfonate (<b>III</b>-<b>6</b>-<b>9</b>)</h3><div class="NLM_p last"><b>III</b>-<b>6</b>-<b>9</b> was prepared according to the same procedure described for <b>I</b>-<b>3</b>, giving a white solid (yield: 82%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) Î´ 8.97 (dd, <i>J</i> = 1.5, 4.2 Hz, 1H), 8.50 (dd, <i>J</i> = 1.8, 7.5 Hz, 1H), 7.94 (m, 1H), 7.88 (d, <i>J</i> = 8.4 Hz, 2H), 7.64 (dd, <i>J</i> = 4.2, 8.4 Hz, 1H), 7.28 (d, <i>J</i> = 8.4 Hz, 2H), 7.25 (m, 1H), 6.92 (m, 2H), 6.80 (m, 1H), 4.68 (d, <i>J</i> = 6.0 Hz, 2H), 3.78 (s, 3H), 2.42 (s, 3H).</div></div><div id="sec4_69" class="NLM_sec NLM_sec_level_2"><div id="ac_i87" class="anchor-spacer"></div><h3 class="article-section__title" id="_i87"> 8-(((1<i>r</i>,4<i>r</i>)-4-Aminocyclohexyl)amino)-5-bromo-<i>N</i>-(3-methoxybenzyl)-1,6-naphthyridine-7-carboxamide (<b>III</b>-<b>6</b>)</h3><div class="NLM_p last"><b>III</b>-<b>6</b> was prepared according to the same procedure described for <b>I</b>-<b>18</b>, giving a yellow solid, yield 44%; mp 84â87 Â°C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): Î´ 9.62 (d, 1H, <i>J</i> = 8.4 Hz), 8.92 (dd, 1H, <i>J</i> = 1.5, 4.2 Hz), 8.39 (dd, 1H, <i>J</i> = 1.5, 8.4 Hz), 8.31 (m, 1H), 7.56 (dd, 1H, <i>J</i> = 4.2, 8.4 Hz), 7.30 (d, 2H, <i>J</i> = 8.4 Hz), 6.89 (d, 2H, <i>J</i> = 8.4 Hz), 4.95 (m, 1H), 4.56 (d, 2H, <i>J</i> = 6.3 Hz), 3.80 (s, 3H), 2.75 (m, 1H), 2.63 (m, 1H), 2.18 (m, 2H), 1.85 (m, 4H), 1.34 (m, 4H). EI-MS <i>m</i>/<i>z</i>: 483 (M)<sup>+</sup>, 485 (M + 2)<sup>+</sup>. Anal. HPLC <i>t</i><sub>R</sub> = 5.71 min, 100% (solvent system I); <i>t</i><sub>R</sub> = 8.80 min, 99.27% (solvent system II).</div></div><div id="sec4_70" class="NLM_sec NLM_sec_level_2"><div id="ac_i88" class="anchor-spacer"></div><h3 class="article-section__title" id="_i88"> 5-Bromo-8-hydroxy-<i>N</i>-(4-phenoxybenzyl)-1,6-naphthyridine-7-carboxamide (<b>III</b>-<b>7</b>-<b>8</b>)</h3><div class="NLM_p last"><b>III</b>-<b>7</b>-<b>8</b> was prepared according to the same procedure described for <b>I</b>-<b>1</b>, giving the crude product as a brown solid (yield: 90%) that was used for the next step directly.</div></div><div id="sec4_71" class="NLM_sec NLM_sec_level_2"><div id="ac_i89" class="anchor-spacer"></div><h3 class="article-section__title" id="_i89"> 5-Bromo-7-(4-phenoxybenzylcarbamoyl)-1,6-naphthyridin-8-yl 4-Methylbenzenesulfonate (<b>III</b>-<b>7</b>-<b>9</b>)</h3><div class="NLM_p last"><b>III</b>-<b>7</b>-<b>9</b> was prepared according to the same procedure described for <b>I</b>-<b>3</b>, giving a white solid (yield: 20%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): Î´ 9.03 (d, <i>J</i> = 4.2 Hz, 1H), 8.65 (d, <i>J</i> = 8.4 Hz, 1H), 7.93 (m, 3H), 7.68 (dd, <i>J</i> = 4.2, 8.4 Hz, 1H), 7.31â7.37 (m, 6H), 7.10 (t, <i>J</i> = 6 Hz, 1H), 6.98â7.03 (m, 4H), 4.60 (d, <i>J</i> = 6 Hz, 2H), 2.47 (s, 3H).</div></div><div id="sec4_72" class="NLM_sec NLM_sec_level_2"><div id="ac_i90" class="anchor-spacer"></div><h3 class="article-section__title" id="_i90"> 8-((1<i>r</i>,4<i>r</i>)-4-Aminocyclohexylamino)-5-bromo-<i>N</i>-(4-phenoxybenzyl)-1,6-naphthyridine-7-carboxamide (<b>III</b>-<b>7</b>)</h3><div class="NLM_p last"><b>III</b>-<b>7</b> was prepared according to the same procedure described for <b>I</b>-<b>18</b>, giving a yellow solid, yield 61%. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): Î´ 9.65 (d, <i>J</i> = 7.8 Hz, 1H), 8.94 (d, <i>J</i> = 3.9 Hz, 1H), 8.42 (d, <i>J</i> = 8.7 Hz, 1H), 8.31 (t, <i>J</i> = 6 Hz, 1H), 7.59 (dd, <i>J</i> = 3.9, 8.7 Hz, 1H), 7.26â7.36 (m, 5H), 7.10 (t, <i>J</i> = 6.9 Hz, 1H), 6.98â7.03 (m, 3H), 4.99 (m, 1H), 4.61 (d, <i>J</i> = 6 Hz, 2H), 2.77 (m, 1H), 2.18 (d, <i>J</i> = 12.9 Hz, 2H), 1.91 (d, <i>J</i> = 12.3 Hz, 2H), 1.25â1.49 (m, 4H). MS-EI <i>m</i>/<i>z</i>: 545 (M)<sup>+</sup>, 547 (M + 2)<sup>+</sup>. HRMS calcd for C<sub>28</sub>H<sub>28</sub>BrN<sub>5</sub>O<sub>2</sub> (M)<sup>+</sup>, 545.1426; found, 545.1427. Anal. Calcd for C<sub>28</sub>H<sub>28</sub>BrN<sub>5</sub>O<sub>2</sub>: C 61.58, H 5.13, N 12.71. Found: C 61.54, H 5.16, N 12.82.</div></div><div id="sec4_73" class="NLM_sec NLM_sec_level_2"><div id="ac_i91" class="anchor-spacer"></div><h3 class="article-section__title" id="_i91"> 5-Bromo-<i>N</i>-(4-chlorobenzyl)-8-hydroxy-1,6-naphthyridine-7-carboxamide (<b>III</b>-<b>8</b>-<b>8</b>)</h3><div class="NLM_p last"><b>III</b>-<b>8</b>-<b>8</b> was prepared according to the same procedure described for <b>I</b>-<b>1</b>, giving a white solid (yield: 89%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) Î´ 9.20 (d, <i>J</i> = 3.9 Hz, 1H), 8.54 (d, <i>J</i> = 9 Hz, 1H), 8.19 (m, 1H), 7.74 (dd, <i>J</i> = 4.2, 8.4 Hz, 1H), 7.35â7.23 (m, 8H), 4.67 (d, <i>J</i> = 6.3 Hz, 2H).</div></div><div id="sec4_74" class="NLM_sec NLM_sec_level_2"><div id="ac_i92" class="anchor-spacer"></div><h3 class="article-section__title" id="_i92"> 5-Bromo-7-((4-chlorobenzyl)carbamoyl)-1,6-naphthyridin-8-yl 4-Methylbenzenesulfonate (<b>III</b>-<b>8</b>-<b>9</b>)</h3><div class="NLM_p last"><b>III</b>-<b>8</b>-<b>9</b> was prepared according to the same procedure described for <b>I</b>-<b>3</b>, giving a white solid (yield: 38%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) Î´ 9.01 (dd, <i>J</i> = 1.5, 4.2 Hz, 1H), 8.56 (dd, <i>J</i> = 1.5, 8.7 Hz, 1H), 7.98 (m, 1H), 7.92 (d, <i>J</i> = 8.4 Hz, 2H), 7.68 (dd, <i>J</i> = 4.2, 8.7 Hz, 1H), 7.32â7.30 (m, 6H), 4.61 (d, <i>J</i> = 6.0 Hz, 2H), 2.46 (s, 3H).</div></div><div id="sec4_75" class="NLM_sec NLM_sec_level_2"><div id="ac_i93" class="anchor-spacer"></div><h3 class="article-section__title" id="_i93"> 8-(((1<i>r</i>,4<i>r</i>)-4-Aminocyclohexyl)amino)-5-bromo-<i>N</i>-(4-chlorobenzyl)-1,6-naphthyridine-7-carboxamide (<b>III</b>-<b>8</b>)</h3><div class="NLM_p last"><b>III</b>-<b>8</b> was prepared according to the same procedure described for <b>I</b>-<b>18</b>, giving a yellow solid, yield 58.5%; mp 128â130 Â°C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): Î´ 9.60 (d, 1H, <i>J</i> = 8.1 Hz), 9.30 (dd, 1H, <i>J</i> = 1.5, 4.2 Hz), 8.40 (dd, 1H, <i>J</i> = 4.2, 8.7 Hz), 8.33 (m, 1H), 7.58 (dd, 1H, <i>J</i> = 4.2, 8.4 Hz), 7.30 (s, 4H), 4.96 (m, 1H), 4.59 (d, 2H, <i>J</i> = 6.0 Hz), 2.77 (m, 1H), 2.17 (m, 2H), 1.94 (m, 2H), 1.43â1.24 (m, 4H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) Î´ 167.83 (s), 150.97 (s), 150.64 (s), 144.90 (s), 144.58 (s), 137.01 (s), 136.54 (s), 133.15 (s), 128.98 (s), 128.93 (s), 128.82 (s), 126.71 (s), 124.89 (s), 124.59 (s), 124.46 (s), 123.69 (s), 52.57 (s), 50.38 (s), 42.35 (s), 32.34 (s), 30.28 (s). EI-MS <i>m</i>/<i>z</i>: 487 (M)<sup>+</sup>, 489 (M + 2)<sup>+</sup>. HR-EIMS calcd for C<sub>22</sub>H<sub>23</sub>N<sub>5</sub>OClBr, 487.0775; found, 487.0774. Anal. HPLC <i>t</i><sub>R</sub> = 30.39 min, 95.29% (solvent system I); <i>t</i><sub>R</sub> = 20.43 min, 100% (solvent system II).</div></div><div id="sec4_76" class="NLM_sec NLM_sec_level_2"><div id="ac_i94" class="anchor-spacer"></div><h3 class="article-section__title" id="_i94"> 5-Bromo-<i>N</i>-(2,4-dichlorobenzyl)-8-hydroxy-1,6-naphthyridine-7-carboxamide (<b>III</b>-<b>9</b>-<b>8</b>)</h3><div class="NLM_p last"><b>III</b>-<b>9</b>-<b>8</b> was prepared according to the same procedure described for <b>I</b>-<b>1</b>, giving a white solid (yield: 82%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) Î´ 9.20 (d, <i>J</i> = 4.2 Hz, 1H), 8.55 (d, <i>J</i> = 7.8 Hz, 1H), 8.27 (m, 1H), 7.75 (dd, <i>J</i> = 4.2, 8.4 Hz, 1H), 7.42 (m, 3H), 4.76 (d, <i>J</i> = 6.3 Hz, 2H).</div></div><div id="sec4_77" class="NLM_sec NLM_sec_level_2"><div id="ac_i95" class="anchor-spacer"></div><h3 class="article-section__title" id="_i95"> 5-Bromo-7-((2,4-dichlorobenzyl)carbamoyl)-1,6-naphthyridin-8-yl 4-Methylbenzenesulfonate (<b>III</b>-<b>9</b>-<b>9</b>)</h3><div class="NLM_p last"><b>III</b>-<b>9</b>-<b>9</b> was prepared according to the same procedure described for <b>I</b>-<b>3</b>, giving a white solid (yield: 44%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) Î´ 9.02 (dd, <i>J</i> = 1.5, 4.2 Hz, 1H), 8.57 (dd, <i>J</i> = 1.8, 8.7 Hz, 1H), 8.08 (m, 1H), 7.90 (d, <i>J</i> = 8.4 Hz, 2H), 7.68 (dd, <i>J</i> = 4.2, 8.7 Hz, 1H), 7.42 (m, 2H), 7.32 (d, <i>J</i> = 8.4 Hz, 2H), 7.24 (m, 1H), 4.67 (d, <i>J</i> = 6.3 Hz, 2H), 2.47 (s, 3H).</div></div><div id="sec4_78" class="NLM_sec NLM_sec_level_2"><div id="ac_i96" class="anchor-spacer"></div><h3 class="article-section__title" id="_i96"> 8-(((1<i>r</i>,4<i>r</i>)-4-Aminocyclohexyl)amino)-5-bromo-<i>N</i>-(2,4-dichlorobenzyl)-1,6-naphthyridine-7-carboxamide (<b>III</b>-<b>9</b>)</h3><div class="NLM_p last"><b>III</b>-<b>9</b> was prepared according to the same procedure described for <b>I</b>-<b>18</b>, giving a yellow solid, yield 80.3%; mp 72â74 Â°C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): Î´ 9.55 (d, 1H, <i>J</i> = 7.8 Hz), 8.94 (dd, 1H, <i>J</i> = 1.5, 3.9 Hz), 8.41 (d, 1H, <i>J</i> = 7.2 Hz), 8.40 (m, 1H), 7.59 (dd, 1H, <i>J</i> = 1.5, 8.7 Hz), 7.37 (s, 2H), 7.23 (m, 1H), 4.96 (m, 1H), 4.67 (d, 2H, <i>J</i> = 6.0 Hz), 2.76 (m, 1H), 2.18 (m, 2H), 1.87 (m, 2H), 1.37 (m, 4H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) Î´ 167.96 (s), 150.83 (s), 144.97 (s), 144.80 (s), 136.50 (s), 134.56 (s), 134.03 (s), 133.68 (s), 129.98 (s), 129.34 (s), 127.29 (s), 126.79 (s), 124.64 (s), 124.57 (s), 123.51 (s), 53.16 (s), 50.20 (s), 40.42 (s), 32.79 (s), 32.69 (s). EI-MS <i>m</i>/<i>z</i>: 521 (M)<sup>+</sup>. HR-EIMS calcd for C<sub>22</sub>H<sub>22</sub>N<sub>5</sub>OCl<sub>2</sub>Br, 521.0385; found, 521.0388. Anal. HPLC <i>t</i><sub>R</sub> = 29.56 min, 94.27% (solvent system I); <i>t</i><sub>R</sub> = 23.65 min, 95.94% (solvent system II).</div></div><div id="sec4_79" class="NLM_sec NLM_sec_level_2"><div id="ac_i97" class="anchor-spacer"></div><h3 class="article-section__title" id="_i97"> 5-Bromo-<i>N</i>-(3-(trifluoromethyl)benzyl)-8-hydroxy-1,6-naphthyridine-7-carboxamide (<b>III</b>-<b>10</b>-<b>8</b>)</h3><div class="NLM_p last"><b>III</b>-<b>10</b>-<b>8</b> was prepared according to the same procedure described for <b>I</b>-<b>1</b>, giving a white solid (yield: 71%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) Î´ 9.20 (d, <i>J</i> = 1.5, 4.2 Hz, 1H), 8.55 (d, <i>J</i> = 1.5, 7.8 Hz, 1H), 8.25 (m, 1H), 7.74 (dd, <i>J</i> = 4.5, 8.7 Hz, 1H), 7.64â7.44 (m, 4H), 4.76 (d, <i>J</i> = 6.6 Hz, 2H).</div></div><div id="sec4_80" class="NLM_sec NLM_sec_level_2"><div id="ac_i98" class="anchor-spacer"></div><h3 class="article-section__title" id="_i98"> 5-Bromo-7-((3-(trifluoromethyl))carbamoyl)-1,6-naphthyridin-8-yl 4-Methylbenzenesulfonate (<b>III</b>-<b>10</b>-<b>9</b>)</h3><div class="NLM_p last"><b>III</b>-<b>10</b>-<b>9</b> was prepared according to the same procedure described for <b>I</b>-<b>3</b>, giving a white solid (yield: 48%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) Î´ 9.02 (dd, <i>J</i> = 1.5, 4.2 Hz, 1H), 8.57 (dd, <i>J</i> = 1.5, 8.4 Hz, 1H), 8.06 (m, 1H), 7.92 (d, <i>J</i> = 8.4 Hz, 2H), 7.69 (dd, <i>J</i> = 4.2, 8.4 Hz, 1H), 7.71â7.48 (m, 4H), 7.31 (d, <i>J</i> = 8.1 Hz, 2H), 4.70 (d, <i>J</i> = 6.6 Hz, 2H), 2.47 (s, 3H).</div></div><div id="sec4_81" class="NLM_sec NLM_sec_level_2"><div id="ac_i99" class="anchor-spacer"></div><h3 class="article-section__title" id="_i99"> 8-(((1<i>r</i>,4<i>r</i>)-4-Aminocyclohexyl)amino)-5-bromo-<i>N</i>-(3-(trifluoromethyl)benzyl)-1,6-naphthyridine-7-carboxamide (<b>III</b>-<b>10</b>)</h3><div class="NLM_p last"><b>III</b>-<b>10</b> was prepared according to the same procedure described for <b>I</b>-<b>18</b>, giving a yellow solid, yield 74%; mp 94â96 Â°C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): Î´ 9.59 (d, 1H, <i>J</i> = 8.1 Hz), 8.59 (s, 1H), 8.42 (m, 2H), 7.61â7.44 (m, 4H), 4.97 (m, 1H), 4.69 (d, 2H, <i>J</i> = 6.0 Hz), 2.78 (m, 1H), 2.17 (m, 2H), 2.00â1.83 (m, 4H), 1.43â1.25 (m, 4H). EI-MS <i>m</i>/<i>z</i>: 521 (M)<sup>+</sup>, 523 (M + 2)<sup>+</sup>. Anal. HPLC <i>t</i><sub>R</sub> = 13.11 min, 100% (solvent system I); <i>t</i><sub>R</sub> = 9.94 min, 95.0% (solvent system II).</div></div><div id="sec4_82" class="NLM_sec NLM_sec_level_2"><div id="ac_i100" class="anchor-spacer"></div><h3 class="article-section__title" id="_i100"> 5-Bromo-<i>N</i>-(furan-2-ylmethyl)-8-hydroxy-1,6-naphthyridine-7-carboxamide (<b>III</b>-<b>11</b>-<b>8</b>)</h3><div class="NLM_p last"><b>III</b>-<b>11</b>-<b>8</b> was prepared according to the same procedure described for <b>I</b>-<b>1</b>, giving a white solid (yield: 78%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) Î´ 13.20 (brs, 1H), 9.19 (dd, <i>J</i> = 1.5, 4.2 Hz, 1H), 8.54 (dd, <i>J</i> = 1.5, 8.4 Hz, 1H), 8.13 (m, 1H), 7.73 (dd, <i>J</i> = 4.2, 8.4 Hz, 1H), 7.42 (m, 1H), 6.37 (m, 2H), 4.70 (d, <i>J</i> = 6.0 Hz, 2H). EI-MS <i>m</i>/<i>z</i>: 347 (M)<sup>+</sup>, 349 (M + 2)<sup>+</sup>.</div></div><div id="sec4_83" class="NLM_sec NLM_sec_level_2"><div id="ac_i101" class="anchor-spacer"></div><h3 class="article-section__title" id="_i101"> 5-Bromo-7-((furan-2-ylmethyl)carbamoyl)-1,6-naphthyridin-8-yl 4-Methylbenzenesulfonate (<b>III</b>-<b>11</b>-<b>9</b>)</h3><div class="NLM_p last"><b>III</b>-<b>11</b>-<b>9</b> was prepared according to the same procedure described for <b>I</b>-<b>3</b>, giving a white solid (yield: 88%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) Î´ 9.03 (dd, <i>J</i> = 1.5, 4.2 Hz, 1H), 8.56 (dd, <i>J</i> = 1.5, 8.7 Hz, 1H), 7.91 (d, <i>J</i> = 8.1 Hz, 2H), 7.89 (m, 1H), 7.68 (dd, <i>J</i> = 4.2, 8.7 Hz, 1H), 7.40 (m, 1H), 7.32 (d, <i>J</i> = 8.1 Hz, 2H), 6.33 (m, 2H), 4.58 (d, <i>J</i> = 6.0 Hz, 2H), 2.47 (s, 3H).</div></div><div id="sec4_84" class="NLM_sec NLM_sec_level_2"><div id="ac_i102" class="anchor-spacer"></div><h3 class="article-section__title" id="_i102"> 8-(((1<i>r</i>,4<i>r</i>)-4-Aminocyclohexyl)amino)-5-bromo-<i>N</i>-(furan-2-ylmethyl)-1,6-naphthyridine-7-carboxamide (<b>III</b>-<b>11</b>)</h3><div class="NLM_p last"><b>III</b>-<b>11</b> was prepared according to the same procedure described for <b>I</b>-<b>18</b>, giving a yellow solid, yield 46%; mp 96â98 Â°C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): Î´ 9.56 (d, 1H, <i>J</i> = 8.1 Hz), 8.90 (dd, 1H, <i>J</i> = 1.5, 3.9 Hz), 8.37 (d, 1H, <i>J</i> = 8.4 Hz), 8.23 (m, 1H), 7.54 (dd, 1H, <i>J</i> = 4.2, 8.4 Hz), 7.36 (s, 1H), 6.30 (m, 2H), 4.93 (m, 1H), 4.57 (d, 2H, <i>J</i> = 6.0 Hz), 2.71 (m, 1H), 2.18 (m, 2H), 1.92 (m, 4H), 1.42 (m, 4H). EI-MS <i>m</i>/<i>z</i>: 443 (M)<sup>+</sup>, 445 (M + 2)<sup>+</sup>. Anal. HPLC <i>t</i><sub>R</sub> = 5.91 min, 100% (solvent system I); <i>t</i><sub>R</sub> = 6.55 min, 100% (solvent system II).</div></div><div id="sec4_85" class="NLM_sec NLM_sec_level_2"><div id="ac_i103" class="anchor-spacer"></div><h3 class="article-section__title" id="_i103"> 5-Bromo-8-hydroxy-<i>N</i>-(thiophen-2-ylmethyl)-1,6-naphthyridine-7-carboxamide (<b>III</b>-<b>12</b>-<b>8</b>)</h3><div class="NLM_p last"><b>III</b>-<b>12</b>-<b>8</b> was prepared according to the same procedure described for <b>I</b>-<b>1</b>, giving the desired crude product as a brown solid (yield: 98%) that was carried onto the next step directly.</div></div><div id="sec4_86" class="NLM_sec NLM_sec_level_2"><div id="ac_i104" class="anchor-spacer"></div><h3 class="article-section__title" id="_i104"> 5-Bromo-7-(thiophen-2-ylmethylcarbamoyl)-1,6-naphthyridin-8-yl 4-Methylbenzenesulfonate (<b>III</b>-<b>12</b>-<b>9</b>)</h3><div class="NLM_p last"><b>III</b>-<b>12</b>-<b>9</b> was prepared according to the same procedure described for <b>I</b>-<b>3</b>, giving a white solid (yield: 48%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): Î´ 9.05 (d, <i>J</i> = 2.4 Hz, 1H), 8.57 (d, <i>J</i> = 8.7 Hz, 1H), 7.94 (d, <i>J</i> = 8.1 Hz, 2H), 7.68 (dd, <i>J</i> = 2.4, 8.7 Hz, 1H), 7.34 (d, <i>J</i> = 8.1 Hz, 2H), 7.25â7.27 (m, 1H), 7.07 (m, 1H), 6.99 (m, 1H), 4.77 (d, <i>J</i> = 4.5 Hz, 2H), 2.48 (s, 3H).</div></div><div id="sec4_87" class="NLM_sec NLM_sec_level_2"><div id="ac_i105" class="anchor-spacer"></div><h3 class="article-section__title" id="_i105"> 8-((1<i>r</i>,4<i>r</i>)-4-Aminocyclohexylamino)-5-bromo-<i>N</i>-(thiophen-2-ylmethyl)-1,6-naphthyridine-7-carboxamide (<b>III</b>-<b>12</b>)</h3><div class="NLM_p last"><b>III</b>-<b>12</b> was prepared according to the same procedure described for <b>I</b>-<b>18</b>, giving a yellow solid, yield 43%. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): Î´ 9.60 (d, <i>J</i> = 7.8 Hz, 1H), 8.95 (d, <i>J</i> = 4.5 Hz, 1H), 8.42 (d, <i>J</i> = 8.4 Hz, 1H), 8.32 (t, <i>J</i> = 6 Hz, 1H), 7.59 (dd, <i>J</i> = 4.5, 8.4 Hz, 1H), 7.23â7.25 (m, 1H), 7.07 (m, 1H), 6.98 (m, 1H), 4.98 (m, 1H), 4.80 (d, <i>J</i> = 6 Hz, 2H), 2.81 (m, 1H), 2.19 (d, <i>J</i> = 11.4 Hz, 2H), 1.94 (d, <i>J</i> = 12.3 Hz, 2H), 1.31â1.49 (m, 4H). MS-EI <i>m</i>/<i>z</i>: 459 (M)<sup>+</sup>, 461 (M + 2)<sup>+</sup>. Anal. Calcd for C<sub>20</sub>H<sub>22</sub>BrN<sub>5</sub>OÂ·1/2H<sub>2</sub>O: C 51.68, H 5.08, N 14.70. Found: C 51.71, H 4.85, N 14.46.</div></div><div id="sec4_88" class="NLM_sec NLM_sec_level_2"><div id="ac_i106" class="anchor-spacer"></div><h3 class="article-section__title" id="_i106"> 5-Bromo-8-hydroxy-<i>N</i>-(pyridin-2-ylmethyl)-1,6-naphthyridine-7-carboxamide (<b>III</b>-<b>13</b>-<b>8</b>)</h3><div class="NLM_p last"><b>III</b>-<b>13</b>-<b>8</b> was prepared according to the same procedure described for <b>I</b>-<b>1</b>, giving the crude product as a brown solid (yield: 90%) that was used for the next step directly.</div></div><div id="sec4_89" class="NLM_sec NLM_sec_level_2"><div id="ac_i107" class="anchor-spacer"></div><h3 class="article-section__title" id="_i107"> 5-Bromo-7-(pyridin-2-ylmethylcarbamoyl)-1,6-naphthyridin-8-yl 4-Methylbenzenesulfonate (<b>III</b>-<b>13</b>-<b>9</b>)</h3><div class="NLM_p last"><b>III</b>-<b>13</b>-<b>9</b> was prepared according to the same procedure described for <b>I</b>-<b>3</b>, giving a white solid (yield: 52%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): Î´ 9.05 (d, <i>J</i> = 4.2 Hz, 1H), 8.57â8.60 (m, 2H), 8.51 (t, <i>J</i> = 5.7 Hz, 1H), 7.90 (d, <i>J</i> = 8.1 Hz, 2H), 7.68 (m, 1H), 7.36 (d, 1H), 7.29 (m, 2H), 7.21 (m, 1H), 4.69 (d, <i>J</i> = 5.7 Hz, 2H), 2.43(s, 3H).</div></div><div id="sec4_90" class="NLM_sec NLM_sec_level_2"><div id="ac_i108" class="anchor-spacer"></div><h3 class="article-section__title" id="_i108"> 8-((1<i>r</i>,4<i>r</i>)-4-Aminocyclohexylamino)-5-bromo-<i>N</i>-(pyridin-2-ylmethyl)-1,6-naphthyridine-7-carboxamide (<b>III</b>-<b>13</b>)</h3><div class="NLM_p last"><b>III</b>-<b>13</b> was prepared according to the same procedure described for <b>I</b>-<b>18</b>, giving a yellow solid, yield 45%. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): Î´ 9.6 (d, <i>J</i> = 8.4 Hz, 1H), 8.94 (d, <i>J</i> = 3.9 Hz, 1H), 8.73 (t, <i>J</i> = 6 Hz, 1H), 8.61 (d, <i>J</i> = 4.8 Hz, 1H), 8.43 (d, <i>J</i> = 10.2 Hz, 1H), 7.68 (t, 1H), 7.58 (dd, <i>J</i> = 3.9, 10.2 Hz, 1H), 7.36 (d, <i>J</i> = 7.8 Hz, 1H), 7.2 (t, 2H), 4.95 (m, 1H), 4.77 (d, <i>J</i> = 6 Hz, 2H), 2.74 (m, 1H), 2.16 (d, <i>J</i> = 13.5 Hz, 2H), 1.9 (d, <i>J</i> = 12.6 Hz, 2H), 1.23â1.43 (m, 4H). MS-EI <i>m</i>/<i>z</i>: 454 (M)<sup>+</sup>, 456 (M + 2)<sup>+</sup>. Anal. Calcd for C<sub>21</sub>H<sub>23</sub>BrN<sub>6</sub>OÂ·1/2CF<sub>3</sub>COOHÂ·CH<sub>3</sub>OH: C 50.74, H 5.09, N 15.44. Found: C 50.81, H 4.95, N 15.29.</div></div><div id="sec4_91" class="NLM_sec NLM_sec_level_2"><div id="ac_i109" class="anchor-spacer"></div><h3 class="article-section__title" id="_i109"> 5-Bromo-8-hydroxy-<i>N</i>-phenethyl-1,6-naphthyridine-7-carboxamide (<b>III</b>-<b>14</b>-<b>8</b>)</h3><div class="NLM_p last"><b>III</b>-<b>14</b>-<b>8</b> was prepared according to the same procedure described for <b>I</b>-<b>1</b>, giving a white solid (yield: 77%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) Î´ 9.18 (dd, <i>J</i> = 1.5, 4.2 Hz, 1H), 8.53 (dd, <i>J</i> = 1.5, 8.4 Hz, 1H), 7.93 (m, 1H), 7.71 (dd, <i>J</i> = 4.2, 8.4 Hz, 1H), 7.73â7.18 (m, 10H), 3.75 (q, <i>J</i> = 6.9 Hz, 2H), 2.98 (m, 4H), 2.76 (m, 2H). EI-MS <i>m</i>/<i>z</i>: 371 (M)<sup>+</sup>, 373 (M + 2)<sup>+</sup>.</div></div><div id="sec4_92" class="NLM_sec NLM_sec_level_2"><div id="ac_i110" class="anchor-spacer"></div><h3 class="article-section__title" id="_i110"> 5-Bromo-7-(phenethylcarbamoyl)-1,6-naphthyridin-8-yl 4-Methylbenzenesulfonate (<b>III</b>-<b>14</b>-<b>9</b>)</h3><div class="NLM_p last"><b>III</b>-<b>14</b>-<b>9</b> was prepared according to the same procedure described for <b>I</b>-<b>3</b>, giving a white solid (yield: 86%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) Î´ 8.98 (d, <i>J</i> = 3.6 Hz, 1H), 8.51 (d, <i>J</i> = 8.4 Hz, 1H), 7.90 (d, <i>J</i> = 7.8 Hz, 2H), 7.65 (dd, <i>J</i> = 4.2, 8.4 Hz, 1H), 7.64 (m, 1H), 7.35â7.21 (m, 7H), 3.63 (q, <i>J</i> = 6.9 Hz, 2H), 2.90 (t, <i>J</i> = 8.1 Hz, 2H), 2.44 (s, 3H).</div></div><div id="sec4_93" class="NLM_sec NLM_sec_level_2"><div id="ac_i111" class="anchor-spacer"></div><h3 class="article-section__title" id="_i111"> 8-(((1<i>r</i>,4<i>r</i>)-4-Aminocyclohexyl)amino)-5-bromo-<i>N</i>-phenethyl-1,6-naphthyridine-7-carboxamide (<b>III</b>-<b>14</b>)</h3><div class="NLM_p last"><b>III</b>-<b>14</b> was prepared according to the same procedure described for <b>I</b>-<b>18</b>, giving a yellow solid, yield 41%; mp 64â65 Â°C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): Î´ 9.60 (d, 1H, <i>J</i> = 8.4 Hz), 8.93 (d, 1H, <i>J</i> = 3.9 Hz), 8.40 (d, 1H, <i>J</i> = 8.4 Hz), 8.11 (m, 1H), 7.57 (dd, 1H, <i>J</i> = 4.2, 8.4 Hz), 7.36â7.24 (m, 5H), 4.93 (m, 1H), 3.65 (m, 2H), 2.95 (m, 2H), 2.75 (m, 1H), 2.18 (m, 2H), 1.94 (m, 2H), 1.42 (m, 4H). EI-MS <i>m</i>/<i>z</i>: 467 (M)<sup>+</sup>, 469 (M + 2)<sup>+</sup>. Anal. HPLC <i>t</i><sub>R</sub> = 15.05 min, 97.78% (solvent system I); <i>t</i><sub>R</sub> = 8.30 min, 99.26% (solvent system II).</div></div><div id="sec4_94" class="NLM_sec NLM_sec_level_2"><div id="ac_i112" class="anchor-spacer"></div><h3 class="article-section__title" id="_i112"> 5-Bromo-8-hydroxy-<i>N</i>-phenyl-1,6-naphthyridine-7-carboxamide (<b>III</b>-<b>15</b>-<b>8</b>)</h3><div class="NLM_p">Compound <b>7</b> (150 mg, 0.735 mmol) was dissolved in 1N LiOH (2 mL) and MeOH (4 mL). The solution was heated to reflux for 5 h. After cooling to rt, the pH of the reaction mixture was adjusted to 3 with 1N HCl solution. The mixture was filtered to give crude product as a tan solid 0.116 g (yield: 81%). <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD): Î´ 9.21 (s, 1H), 8.57 (d, 1H, <i>J</i> = 7.8 Hz), 7.97 (s, 1H). EI-MS <i>m</i>/<i>z</i>: 269 (M)<sup>+</sup>.</div><div class="NLM_p last">Triphosgene (150 mg, 0.735 mmol) was added to DMF solution of 5-bromo-8-hydroxy-1,6-naphthyridine-7-carboxylic acid (45 mg, 0.234 mmol) and DIPEA (0.16 mL, 0.398 mmol) at 0 Â°C. The solution was stirred for 60 min at rt. And then excess aniline was added. After the reaction was completed, the mixture was diluted with DCM. The organic layer was washed with saturated NaCl solution. The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub> and evaporated to yield crude <b>III</b>-<b>15</b>-<b>8</b>, which was used for the next step directly.</div></div><div id="sec4_95" class="NLM_sec NLM_sec_level_2"><div id="ac_i113" class="anchor-spacer"></div><h3 class="article-section__title" id="_i113"> 5-Bromo-7-(phenylcarbamoyl)-1,6-naphthyridin-8-yl-4-methylbenzenesulfonate (<b>III</b>-<b>15</b>-<b>9</b>)</h3><div class="NLM_p last"><b>III</b>-<b>15</b>-<b>9</b> was prepared according to the same procedure described for <b>I</b>-<b>3</b>, giving a white solid (overall yield: 65%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) Î´ 9.36 (s, 1H), 9.14 (dd, <i>J</i> = 1.5, 4.2 Hz, 1H), 8.59 (dd, <i>J</i> = 1.8, 8.4 Hz, 1H), 7.88 (d, <i>J</i> = 8.1 Hz, 2H), 7.73 (dd, <i>J</i> = 4.2, 8.4 Hz, 1H), 7.63 (d, <i>J</i> = 8.1 Hz, 2H), 7.34 (m, 4H), 7.13 (m, 1H), 2.35 (s, 3H).</div></div><div id="sec4_96" class="NLM_sec NLM_sec_level_2"><div id="ac_i114" class="anchor-spacer"></div><h3 class="article-section__title" id="_i114"> 8-(((1<i>r</i>,4<i>r</i>)-4-Aminocyclohexyl)amino)-5-bromo-<i>N</i>-phenyl-1,6-naphthyridine-7-carboxamide (<b>III</b>-<b>15</b>)</h3><div class="NLM_p last"><b>III</b>-<b>15</b> was prepared according to the same procedure described for <b>I</b>-<b>18</b>, giving a yellow solid, yield 48%; mp 208â210 Â°C. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD): Î´ 10.12 (s, 1H), 9.02 (d, 1H, <i>J</i> = 4.2 Hz), 8.55 (d, 1H, <i>J</i> = 8.7 Hz), 7.77 (dd, 1H, <i>J</i> = 4.2, 8.7 Hz), 7.71 (m, 2H), 7.31 (m, 2H), 7.14 (m, 1H), 4.98 (m, 1H), 3.18 (m, 1H), 2.33 (m, 2H), 2.11 (m, 2H), 1.53 (m, 4H). EI-MS <i>m</i>/<i>z</i>: 439 (M)<sup>+</sup>, 441 (M + 2)<sup>+</sup>. Anal. HPLC <i>t</i><sub>R</sub> = 15.07 min, 97.83% (solvent system I); <i>t</i><sub>R</sub> = 9.25 min, 94.67% (solvent system II).</div></div><div id="sec4_97" class="NLM_sec NLM_sec_level_2"><div id="ac_i115" class="anchor-spacer"></div><h3 class="article-section__title" id="_i115"> 5-Bromo-8-hydroxy-<i>N</i>-cyclohexyl-1,6-naphthyridine-7-carboxamide (<b>III</b>-<b>16</b>-<b>8</b>)</h3><div class="NLM_p last"><b>III</b>-<b>16</b>-<b>8</b> was prepared according to the same procedure described for <b>I</b>-<b>1</b>, giving the crude product as a brown solid (yield: 75%) that was used for the next step directly.</div></div><div id="sec4_98" class="NLM_sec NLM_sec_level_2"><div id="ac_i116" class="anchor-spacer"></div><h3 class="article-section__title" id="_i116"> 5-Bromo-7-(cyclohexylcarbamoyl)-1,6-naphthyridin-8-yl 4-Methylbenzenesulfonate (<b>III</b>-<b>16</b>-<b>9</b>)</h3><div class="NLM_p last"><b>III</b>-<b>16</b>-<b>9</b> was prepared according to the same procedure described for <b>I</b>-<b>3</b>, giving the desired crude product as a brown solid (yield: 40%) that was carried onto the next step directly.</div></div><div id="sec4_99" class="NLM_sec NLM_sec_level_2"><div id="ac_i117" class="anchor-spacer"></div><h3 class="article-section__title" id="_i117"> 8-(((1<i>r</i>,4<i>r</i>)-4-Aminocyclohexyl)amino)-5-bromo-<i>N</i>-cyclohexyl-1,6-naphthyridine-7-carboxamide (<b>III</b>-<b>16</b>)</h3><div class="NLM_p last"><b>III</b>-<b>16</b> was prepared according to the same procedure described for <b>I</b>-<b>18</b>, giving a yellow solid, yield 61%. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): Î´ 9.68 (d, 1H, <i>J</i> = 7.8 Hz), 8.93 (d, 1H, <i>J</i> = 2.7 Hz), 8.41 (d, 1H, <i>J</i> = 8.4 Hz), 7.87 (d, 1H, <i>J</i> = 8.4 Hz), 7.57 (dd, 1H, <i>J</i> = 3.9, 8.4 Hz), 4.92 (m, 1H), 3.87 (m, 1H), 2.73 (m, 1H), 2.16 (m, 2H), 2.03 (m, 2H), 1.90 (m, 2H), 1.81 (m, 3H), 1.45â1.26 (m, 9H). EI-MS <i>m</i>/<i>z</i>: 445 (M)<sup>+</sup>, 447 (M + 2)<sup>+</sup>. Anal. HPLC <i>t</i><sub>R</sub> = 15.46 min, 95.0% (solvent system I); <i>t</i><sub>R</sub> = 10.92 min, 97.8% (solvent system II).</div></div><div id="sec4_100" class="NLM_sec NLM_sec_level_2"><div id="ac_i118" class="anchor-spacer"></div><h3 class="article-section__title" id="_i118"> Methyl 8-(((1<i>r</i>,4<i>r</i>)-4-Aminocyclohexyl)amino)-5-bromo-1,6-naphthyridine-7-carboxylate (<b>III</b>-<b>17</b>)</h3><div class="NLM_p">Following the procedure as compound <b>I</b>-<b>18</b>, <i>tert</i>-butyl ((1<i>r</i>,4<i>r</i>)-4-aminocyclohexyl)carbamate (65 mg, 0.3 mmol), <b>10</b> (44 mg, 0.1 mmol), and triethylamine (30 mg, 0.3 mmol) gave methyl 5-bromo-8-(((1<i>r</i>,4<i>r</i>)-4-((<i>tert</i>-butoxycarbonyl)amino)cyclohexyl)amino)-1,6-naphthyridine-7-carboxylate as a yellow solid, yield 70%. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): Î´ 8.95 (dd, 1H, <i>J</i> = 1.5, 4.2 Hz), 8.88 (d, 1H, <i>J</i> = 7.5 Hz), 8.47 (dd, 1H, <i>J</i> = 1.5, 8.4 Hz), 7.64 (dd, 1H, <i>J</i> = 4.2, 8.4 Hz), 4.92 (m, 1H), 4.42 (m, 1H), 3.97 (s, 3H), 3.47 (m, 1H), 2.20 (m, 2H), 2.05 (m, 2H), 1.45 (s, 9H), 1.43â1.23 (m, 4H). EI-MS <i>m</i>/<i>z</i>: 478 (M)<sup>+</sup>, 480 (M + 2)<sup>+</sup>.</div><div class="NLM_p last">The resultant methyl 5-bromo-8-(((1<i>r</i>,4<i>r</i>)-4-((<i>tert</i>-butoxycarbonyl)amino)cyclohexyl)amino)-1,6-naphthyridine-7-carboxylate was deprotected in 20% TFAâDCM solution to give the target compound <b>III</b>-<b>17</b> as a yellow solid, yield 70%; mp 178â182 Â°C. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD): Î´ 9.01 (dd, 1H, <i>J</i> = 1.5, 4.2 Hz), 8.49 (dd, 1H, <i>J</i> = 1.5, 8.4 Hz), 7.78 (dd, 1H, <i>J</i> = 4.2, 8.4 Hz), 4.94 (m, 1H), 3.93 (s, 3H), 3.19 (m, 1H), 2.31 (m, 2H), 2.13 (m, 2H), 1.68â1.39 (m, 4H). EI-MS <i>m</i>/<i>z</i>: 378 (M)<sup>+</sup>, 380 (M + 2)<sup>+</sup>. Anal. HPLC <i>t</i><sub>R</sub> = 10.366 min, 100% (solvent system I); <i>t</i><sub>R</sub> = 5.847 min, 100% (solvent system II).</div></div><div id="sec4_101" class="NLM_sec NLM_sec_level_2"><div id="ac_i119" class="anchor-spacer"></div><h3 class="article-section__title" id="_i119"> Methyl 5-Bromo-8-(tosyloxy)-1,6-naphthyridine-7-carboxylate (<b>10</b>)</h3><div class="NLM_p last">The intermediate <b>10</b> was prepared according to the same procedure described for <b>I</b>-<b>3</b>, giving a white solid (yield: 77%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) Î´ 9.06 (dd, <i>J</i> = 1.5, 4.2 Hz, 1H), 8.60 (dd, <i>J</i> = 1.5, 8.7 Hz, 1H), 7.86 (d, <i>J</i> = 8.4 Hz, 2H), 7.72 (dd, <i>J</i> = 4.2, 8.4 Hz, 1H), 7.34 (d, <i>J</i> = 8.4 Hz, 2H), 3.83 (s, 3H), 2.47 (s, 3H). EI-MS <i>m</i>/<i>z</i>: 436 (M)<sup>+</sup>.</div></div><div id="sec4_102" class="NLM_sec NLM_sec_level_2"><div id="ac_i120" class="anchor-spacer"></div><h3 class="article-section__title" id="_i120"> Methyl 5-Bromo-8-((4-fluorobenzyl)amino)-1,6-naphthyridine-7-carboxylate (<b>11</b>)</h3><div class="NLM_p last">Compound <b>11</b> was prepared according to the same procedure described for <b>I</b>-<b>18</b>, giving a yellow solid, yield 61%. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD): Î´ 9.15 (m, 1H), 8.93 (dd, 1H, <i>J</i> = 1.5, 4.2 Hz), 8.48 (dd, 1H, <i>J</i> = 1.8, 8.4 Hz), 7.64 (dd, 1H, <i>J</i> = 4.2, 8.7 Hz), 7.37â7.32 (m, 2H), 7.02 (m, 2H), 5.30 (d, 2H, <i>J</i> = 6.0 Hz), 3.97 (s, 3H).</div></div><div id="sec4_103" class="NLM_sec NLM_sec_level_2"><div id="ac_i121" class="anchor-spacer"></div><h3 class="article-section__title" id="_i121"> <i>N</i>-((1<i>r</i>,4<i>r</i>)-4-Aminocyclohexyl)-5-bromo-8-((4-fluorobenzyl)amino)-1,6-naphthyridine-7-carboxamide (<b>III</b>-<b>18</b>)</h3><div class="NLM_p">Compound <b>11</b>was dissolved in 1N LiOH (2 mL) and THF (2 mL). The solution was stirred under nitrogen at rt. After the reaction was completed, the reaction mixture was concentrated. The residue was then partitioned between H<sub>2</sub>O and DCM. The pH of the H<sub>2</sub>O phase was adjusted to 3 and was extracted with DCM 3 times. The DCM layer was dried over Na<sub>2</sub>SO<sub>4</sub> and evaporated to give crude product as a tan solid, yield 92%. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): Î´ 9.37 (m, 1H), 8.96 (dd, 1H, <i>J</i> = 1.5, 4.2 Hz), 8.48 (dd, 1H, <i>J</i> = 1.8, 8.4 Hz), 7.67 (dd, 1H, <i>J</i> = 4.5, 8.4 Hz), 7.35 (m, 2H), 6.99 (m, 2H), 5.42 (d, 2H, <i>J</i> = 5.7 Hz).</div><div class="NLM_p">The resulting 5-bromo-8-((4-fluorobenzyl)amino)-1,6-naphthyridine-7-carboxylic acid (37.6 mg, 0.1 mmol), <i>tert</i>-butyl ((1<i>r</i>,4<i>r</i>)-4-aminocyclohexyl)carbamate (33.6 mg, 0.15 mmol), EDCI (40 mg, 0.2 mmol), HOBt (27 mg, 0.2 mmol), and DIPEA (26 mg, 0.2 mmol) were dissolved in dry DCM (15 mL), and the solution was stirred for 3 h at rt. After the reaction was completed, the mixture was diluted with DCM. The organic layer was washed with saturated NaHCO<sub>3</sub> solution and saturated NaCl solution. Usual workup and purification by column chromatography on silica gel eluting with PE:EtOAc (4:1) gave a yellow solid (50 mg, yield 95%); mp 189â191 Â°C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): Î´ 8.90 (dd, 1H, <i>J</i> = 1.5, 3.9 Hz), 8.42 (dd, 1H, <i>J</i> = 1.5, 8.4 Hz), 7.81 (m, 1H), 7.57 (dd, 1H, <i>J</i> = 4.2, 8.4 Hz), 7.37 (m, 2H), 6.97 (m, 2H), 5.33 (s, 2H), 4.40 (m, 1H), 3.80 (m, 1H), 3.48 (m, 2H), 2.06 (m, 4H), 1.45 (s, 9H), 1.36 (m, 4H).</div><div class="NLM_p last">The resultant <i>tert</i>-butyl ((1<i>r</i>,4<i>r</i>)-4-(5-bromo-8-((4-fluorobenzyl)amino)-1,6-naphthyridine-7-carboxamido)cyclohexyl)carbamate was deprotected in 20% TFAâDCM solution to give the target compound <b>III</b>-<b>18</b> as a yellow solid, yield 95%; mp 210â213 Â°C. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): Î´ 9.07 (d, 1H, <i>J</i> = 3 Hz), 8.47 (d, 1H, <i>J</i> = 8.7 Hz), 8.25 (d, 1H, <i>J</i> = 7.8 Hz), 7.86 (dd, 1H, <i>J</i> = 4.2, 8.4 Hz), 7.40 (m, 2H), 7.15 (m, 2H), 5.26 (s, 2H), 3.72 (m, 2H), 2.99 (m, 2H), 2.73 (m, 1H), 1.93 (m, 4H), 1.48 (m, 4H). EI-MS <i>m</i>/<i>z</i>: 471 (M)<sup>+</sup>, 473 (M + 2)<sup>+</sup>. Anal. HPLC <i>t</i><sub>R</sub> = 26.14 min, 100% (solvent system I); <i>t</i><sub>R</sub> = 29.26 min, 100% (solvent system II).</div></div></div><div class="NLM_back"><div class="article_supporting-info" id=""></div><div class="testing" data-doi="10.1021/jm300667v" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_56277" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_56277" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nouri Neamati</span> - <span class="hlFld-Affiliation affiliation">Department of Pharmacology and Pharmaceutical
Sciences, School of Pharmacy, University of Southern California, 1985
Zonal Avenue, Los Angeles, California 90089, United States</span>;Â 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#2851594447464f6845494144065b404b464b06494b064b4608464d4945495c41685d5b4b064d4c5d"><span class="__cf_email__" data-cfemail="b4cdc5d8dbdad3f4d9d5ddd89ac7dcd7dad79ad5d79ad7da">[emailÂ protected]</span> <span class="__cf_email__" data-cfemail="9cf2f9fdf1fde8f5dce9efffb2f9f8e9">[emailÂ protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ya-Qiu Long</span> - <span class="hlFld-Affiliation affiliation">State Key Laboratory of Drug Research, Shanghai Institute of Materia
Medica, Shanghai Institutes for Biological Sciences, Chinese Academy
of Sciences, 555 Zuchongzhi Road, Shanghai 201203, China</span>;Â 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#6e171f020100092e030f0702401d060d000d400f0d400d004e000b0f030f1a072e1b1d0d400b0a1b"><span class="__cf_email__" data-cfemail="3841495457565f7855595154164b505b565b16595b165b56">[emailÂ protected]</span> <span class="__cf_email__" data-cfemail="7a141f1b171b0e133a0f0919541f1e0f">[emailÂ protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Li-Fan Zeng</span> - <span class="hlFld-Affiliation affiliation">State Key Laboratory of Drug Research, Shanghai Institute of Materia
Medica, Shanghai Institutes for Biological Sciences, Chinese Academy
of Sciences, 555 Zuchongzhi Road, Shanghai 201203, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yong Wang</span> - <span class="hlFld-Affiliation affiliation">State Key Laboratory of Drug Research, Shanghai Institute of Materia
Medica, Shanghai Institutes for Biological Sciences, Chinese Academy
of Sciences, 555 Zuchongzhi Road, Shanghai 201203, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Roza Kazemi</span> - <span class="hlFld-Affiliation affiliation">Department of Pharmacology and Pharmaceutical
Sciences, School of Pharmacy, University of Southern California, 1985
Zonal Avenue, Los Angeles, California 90089, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shili Xu</span> - <span class="hlFld-Affiliation affiliation">Department of Pharmacology and Pharmaceutical
Sciences, School of Pharmacy, University of Southern California, 1985
Zonal Avenue, Los Angeles, California 90089, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zhong-Liang Xu</span> - <span class="hlFld-Affiliation affiliation">State Key Laboratory of Drug Research, Shanghai Institute of Materia
Medica, Shanghai Institutes for Biological Sciences, Chinese Academy
of Sciences, 555 Zuchongzhi Road, Shanghai 201203, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tino W. Sanchez</span> - <span class="hlFld-Affiliation affiliation">Department of Pharmacology and Pharmaceutical
Sciences, School of Pharmacy, University of Southern California, 1985
Zonal Avenue, Los Angeles, California 90089, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Liu-Meng Yang</span> - <span class="hlFld-Affiliation affiliation">Key Laboratory of Animal Models and Human Disease Mechanisms of Chinese Academy of Sciences and Yunnan Province, Kunming
Institute of Zoology, Chinese Academy of Sciences, Kunming 650223,
China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bikash Debnath</span> - <span class="hlFld-Affiliation affiliation">Department of Pharmacology and Pharmaceutical
Sciences, School of Pharmacy, University of Southern California, 1985
Zonal Avenue, Los Angeles, California 90089, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Srinivas Odde</span> - <span class="hlFld-Affiliation affiliation">Department of Pharmacology and Pharmaceutical
Sciences, School of Pharmacy, University of Southern California, 1985
Zonal Avenue, Los Angeles, California 90089, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hua Xie</span> - <span class="hlFld-Affiliation affiliation">State Key Laboratory of Drug Research, Shanghai Institute of Materia
Medica, Shanghai Institutes for Biological Sciences, Chinese Academy
of Sciences, 555 Zuchongzhi Road, Shanghai 201203, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yong-Tang Zheng</span> - <span class="hlFld-Affiliation affiliation">Key Laboratory of Animal Models and Human Disease Mechanisms of Chinese Academy of Sciences and Yunnan Province, Kunming
Institute of Zoology, Chinese Academy of Sciences, Kunming 650223,
China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jian Ding</span> - <span class="hlFld-Affiliation affiliation">State Key Laboratory of Drug Research, Shanghai Institute of Materia
Medica, Shanghai Institutes for Biological Sciences, Chinese Academy
of Sciences, 555 Zuchongzhi Road, Shanghai 201203, China</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d5129e8618-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i122">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_26538" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_26538" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This study was supported in part by the National Natural Science Foundation of China nos. 81021062, 81072527, and 81123004 (Y-Q.L.), 81102483 (L-M. Y); the Key Scientific and Technological Program of China (2012ZX10001-006) (Y.T.Z); and the Sharon and William Cockrell Endowed Cancer Research Fund (N.N.).</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i123" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i123"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i124" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i124"> Abbreviations Used</h2><tr><td class="NLM_term">AIDS</td><td class="NLM_def"><p class="first last">acquired immune deficiency syndrome</p></td></tr><tr><td class="NLM_term">DCM</td><td class="NLM_def"><p class="first last">dichloromethane</p></td></tr><tr><td class="NLM_term">DEAD</td><td class="NLM_def"><p class="first last">diethyl azodicarboxylate</p></td></tr><tr><td class="NLM_term">DIPEA</td><td class="NLM_def"><p class="first last">diisopropylethylamine</p></td></tr><tr><td class="NLM_term">DMF</td><td class="NLM_def"><p class="first last">dimethylformamide</p></td></tr><tr><td class="NLM_term">DMPU</td><td class="NLM_def"><p class="first last">1,3-dimethyl-3,4,5,6-tetrahydro-2(1<i>H</i>)-pyrimidinone</p></td></tr><tr><td class="NLM_term">EDCI</td><td class="NLM_def"><p class="first last">1-ethyl-3-(3-dimethylaminopropyl) carbodiimide</p></td></tr><tr><td class="NLM_term">EDTA</td><td class="NLM_def"><p class="first last">ethylenediaminetetraacetic acid</p></td></tr><tr><td class="NLM_term">EGFR</td><td class="NLM_def"><p class="first last">epidermal growth factor receptor</p></td></tr><tr><td class="NLM_term">ErbB2</td><td class="NLM_def"><p class="first last">human epidermal growth factor receptor 2</p></td></tr><tr><td class="NLM_term">HIV-1</td><td class="NLM_def"><p class="first last">human immunodeficiency virus type 1</p></td></tr><tr><td class="NLM_term">HOBt</td><td class="NLM_def"><p class="first last">hydroxybenzotriazole</p></td></tr><tr><td class="NLM_term">IC<sub>50</sub></td><td class="NLM_def"><p class="first last">half-maximal inhibitory concentration</p></td></tr><tr><td class="NLM_term">IN</td><td class="NLM_def"><p class="first last">HIV-1 integrase</p></td></tr><tr><td class="NLM_term">KDR</td><td class="NLM_def"><p class="first last">kinase insert domain containing receptor</p></td></tr><tr><td class="NLM_term">NBS</td><td class="NLM_def"><p class="first last"><i>N</i>-bromosuccinimide</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structureâactivity relationship</p></td></tr><tr><td class="NLM_term">c-Src</td><td class="NLM_def"><p class="first last">cellular proto-oncogene tyrosine kinase</p></td></tr><tr><td class="NLM_term">TFA</td><td class="NLM_def"><p class="first last">trifluoroacetic acid</p></td></tr><tr><td class="NLM_term">THF</td><td class="NLM_def"><p class="first last">tetrahydrofuran</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i125">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_88227" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_88227" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 44 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Ashburn, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thor, K. B.</span><span> </span><span class="NLM_article-title">Drug repositioning: identifying and developing new uses for existing drugs</span> <span class="citation_source-journal">Nature Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">673</span><span class="NLM_x">â</span> <span class="NLM_lpage">683</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=673-683&author=T.+T.+Ashburnauthor=K.+B.+Thor&title=Drug+repositioning%3A+identifying+and+developing+new+uses+for+existing+drugs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAshburn%26aufirst%3DT.%2BT.%26aulast%3DThor%26aufirst%3DK.%2BB.%26atitle%3DDrug%2520repositioning%253A%2520identifying%2520and%2520developing%2520new%2520uses%2520for%2520existing%2520drugs%26jtitle%3DNature%2520Rev.%2520Drug%2520Discovery%26date%3D2004%26volume%3D3%26spage%3D673%26epage%3D683" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Boguski, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandl, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sukhatme, V. P.</span><span> </span><span class="NLM_article-title">Drug discovery. Repurposing with a difference</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">324</span><span class="NLM_x">, </span> <span class="NLM_fpage">1394</span><span class="NLM_x">â</span> <span class="NLM_lpage">1395</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=324&publication_year=2009&pages=1394-1395&author=M.+S.+Boguskiauthor=K.+D.+Mandlauthor=V.+P.+Sukhatme&title=Drug+discovery.+Repurposing+with+a+difference"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBoguski%26aufirst%3DM.%2BS.%26aulast%3DMandl%26aufirst%3DK.%2BD.%26aulast%3DSukhatme%26aufirst%3DV.%2BP.%26atitle%3DDrug%2520discovery.%2520Repurposing%2520with%2520a%2520difference%26jtitle%3DScience%26date%3D2009%26volume%3D324%26spage%3D1394%26epage%3D1395" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Andronis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharma, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Virvilis, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deftereos, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Persidis, A.</span><span> </span><span class="NLM_article-title">Literature mining, ontologies and information visualization for drug repurposing</span> <span class="citation_source-journal">Briefings Bioinf.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">357</span><span class="NLM_x">â</span> <span class="NLM_lpage">368</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm300667v&amp;key=10.1093%2Fbib%2Fbbr005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm300667v&amp;key=21712342" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm300667v&amp;key=1%3ACAS%3A528%3ADC%252BC3MXptl2js74%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2011&pages=357-368&author=C.+Andronisauthor=A.+Sharmaauthor=V.+Virvilisauthor=S.+Deftereosauthor=A.+Persidis&title=Literature+mining%2C+ontologies+and+information+visualization+for+drug+repurposing"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Literature mining, ontologies and information visualization for drug repurposing</span></div><div class="casAuthors">Andronis, Christos; Sharma, Anuj; Virvilis, Vassilis; Deftereos, Spyros; Persidis, Aris</div><div class="citationInfo"><span class="NLM_cas:title">Briefings in Bioinformatics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">357-368</span>CODEN:
                <span class="NLM_cas:coden">BBIMFX</span>;
        ISSN:<span class="NLM_cas:issn">1467-5463</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">A review.  The immense growth of MEDLINE coupled with the realization that a vast amt. of biomedical knowledge is recorded in free-text format, has led to the appearance of a large no. of literature mining techniques aiming to ext. biomedical terms and their inter-relations from the scientific literature.  Ontologies have been extensively utilized in the biomedical domain either as controlled vocabularies or to provide the framework for mapping relations between concepts in biol. and medicine.  Literature-based approaches and ontologies have been used in the past for the purpose of hypothesis generation in connection with drug discovery.  Here, we review the application of literature mining and ontol. modeling and traversal to the area of drug repurposing (DR).  In recent years, DR has emerged as a noteworthy alternative to the traditional drug development process, in response to the decreased productivity of the biopharmaceutical industry.  Thus, systematic approaches to DR have been developed, involving a variety of in silico, genomic and high-throughput screening technologies.  Attempts to integrate literature mining with other types of data arising from the use of these technologies as well as visualization tools assisting in the discovery of novel assocns. between existing drugs and new indications will also be presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrV8oxc96asEbVg90H21EOLACvtfcHk0lgahYdpbLl2cA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXptl2js74%253D&md5=f6f295e81e79091d8cf38218f9f56471</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1093%2Fbib%2Fbbr005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fbib%252Fbbr005%26sid%3Dliteratum%253Aachs%26aulast%3DAndronis%26aufirst%3DC.%26aulast%3DSharma%26aufirst%3DA.%26aulast%3DVirvilis%26aufirst%3DV.%26aulast%3DDeftereos%26aufirst%3DS.%26aulast%3DPersidis%26aufirst%3DA.%26atitle%3DLiterature%2520mining%252C%2520ontologies%2520and%2520information%2520visualization%2520for%2520drug%2520repurposing%26jtitle%3DBriefings%2520Bioinf.%26date%3D2011%26volume%3D12%26spage%3D357%26epage%3D368" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Dudley, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deshpande, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butte, A. J.</span><span> </span><span class="NLM_article-title">Exploiting drugâdisease relationships for computational drug repositioning</span> <span class="citation_source-journal">Briefings Bioinf.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">303</span><span class="NLM_x">â</span> <span class="NLM_lpage">311</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm300667v&amp;key=10.1093%2Fbib%2Fbbr013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm300667v&amp;key=21690101" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm300667v&amp;key=1%3ACAS%3A528%3ADC%252BC3MXptl2js70%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2011&pages=303-311&author=J.+T.+Dudleyauthor=T.+Deshpandeauthor=A.+J.+Butte&title=Exploiting+drug%E2%80%93disease+relationships+for+computational+drug+repositioning"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Exploiting drug-disease relationships for computational drug repositioning</span></div><div class="casAuthors">Dudley, Joel T.; Deshpande, Tarangini; Butte, Atul J.</div><div class="citationInfo"><span class="NLM_cas:title">Briefings in Bioinformatics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">303-311</span>CODEN:
                <span class="NLM_cas:coden">BBIMFX</span>;
        ISSN:<span class="NLM_cas:issn">1467-5463</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">A review.  Finding new uses for existing drugs, or drug repositioning, has been used as a strategy for decades to get drugs to more patients.  As the ability to measure mols. in high-throughput ways has improved over the past decade, it is logical that such data might be useful for enabling drug repositioning through computational methods.  Many computational predictions for new indications have been borne out in cellular model systems, though extensive animal model and clin. trial-based validation are still pending.  In this review, we show that computational methods for drug repositioning can be classified in two axes: drug based, where discovery initiates from the chem. perspective, or disease based, where discovery initiates from the clin. perspective of disease or its pathol.  Newer algorithms for computational drug repositioning will likely span these two axes, will take advantage of newer types of mol. measurements, and will certainly play a role in reducing the global burden of disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnt1U_gM2MorVg90H21EOLACvtfcHk0lhk5cTuknIE2w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXptl2js70%253D&md5=94aa56229700289fcdfe16bb04448d7a</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1093%2Fbib%2Fbbr013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fbib%252Fbbr013%26sid%3Dliteratum%253Aachs%26aulast%3DDudley%26aufirst%3DJ.%2BT.%26aulast%3DDeshpande%26aufirst%3DT.%26aulast%3DButte%26aufirst%3DA.%2BJ.%26atitle%3DExploiting%2520drug%25E2%2580%2593disease%2520relationships%2520for%2520computational%2520drug%2520repositioning%26jtitle%3DBriefings%2520Bioinf.%26date%3D2011%26volume%3D12%26spage%3D303%26epage%3D311" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Haupt, V. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schroeder, M.</span><span> </span><span class="NLM_article-title">Old friends in new guise: repositioning of known drugs with structural bioinformatics</span> <span class="citation_source-journal">Briefings Bioinf.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">312</span><span class="NLM_x">â</span> <span class="NLM_lpage">326</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm300667v&amp;key=10.1093%2Fbib%2Fbbr011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm300667v&amp;key=21441562" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm300667v&amp;key=1%3ACAS%3A528%3ADC%252BC3MXptl2jsrc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2011&pages=312-326&author=V.+J.+Hauptauthor=M.+Schroeder&title=Old+friends+in+new+guise%3A+repositioning+of+known+drugs+with+structural+bioinformatics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Old friends in new guise: repositioning of known drugs with structural bioinformatics</span></div><div class="casAuthors">Haupt, V. Joachim; Schroeder, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Briefings in Bioinformatics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">312-326</span>CODEN:
                <span class="NLM_cas:coden">BBIMFX</span>;
        ISSN:<span class="NLM_cas:issn">1467-5463</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">A review.  Developing a drug de novo is a laborious and costly endeavor.  Thus, the repositioning of already approved drugs for the treatment of new diseases is promising and valuable.  One computational approach to repositioning exploits the structural similarity of binding sites of known and new targets.  Here, we review computational methods to represent and align binding sites.  We review available tools, present success stories and discuss limits of the approach.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpeO0NDH5GZrrVg90H21EOLACvtfcHk0lhk5cTuknIE2w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXptl2jsrc%253D&md5=e50e0f4752302d91263af4803ef0f14d</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1093%2Fbib%2Fbbr011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fbib%252Fbbr011%26sid%3Dliteratum%253Aachs%26aulast%3DHaupt%26aufirst%3DV.%2BJ.%26aulast%3DSchroeder%26aufirst%3DM.%26atitle%3DOld%2520friends%2520in%2520new%2520guise%253A%2520repositioning%2520of%2520known%2520drugs%2520with%2520structural%2520bioinformatics%26jtitle%3DBriefings%2520Bioinf.%26date%3D2011%26volume%3D12%26spage%3D312%26epage%3D326" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Hazuda, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guare, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anthony, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomez, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wai, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacca, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Handt, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Motzel, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klein, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dornadula, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danovich, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witmer, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, K. A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tussey, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schleif, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabryelski, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, L. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casimiro, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emini, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiver, J. W.</span><span> </span><span class="NLM_article-title">Integrase inhibitors and cellular immunity suppress retroviral replication in rhesus macaques</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">305</span><span class="NLM_x">, </span> <span class="NLM_fpage">528</span><span class="NLM_x">â</span> <span class="NLM_lpage">532</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=305&publication_year=2004&pages=528-532&author=D.+J.+Hazudaauthor=S.+D.+Youngauthor=J.+P.+Guareauthor=N.+J.+Anthonyauthor=R.+P.+Gomezauthor=J.+S.+Waiauthor=J.+P.+Vaccaauthor=L.+Handtauthor=S.+L.+Motzelauthor=H.+J.+Kleinauthor=G.+Dornadulaauthor=R.+M.+Danovichauthor=M.+V.+Witmerauthor=K.+A.+A.+Wilsonauthor=L.+Tusseyauthor=W.+A.+Schleifauthor=L.+S.+Gabryelskiauthor=L.+X.+Jinauthor=M.+D.+Millerauthor=D.+R.+Casimiroauthor=E.+A.+Eminiauthor=J.+W.+Shiver&title=Integrase+inhibitors+and+cellular+immunity+suppress+retroviral+replication+in+rhesus+macaques"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHazuda%26aufirst%3DD.%2BJ.%26aulast%3DYoung%26aufirst%3DS.%2BD.%26aulast%3DGuare%26aufirst%3DJ.%2BP.%26aulast%3DAnthony%26aufirst%3DN.%2BJ.%26aulast%3DGomez%26aufirst%3DR.%2BP.%26aulast%3DWai%26aufirst%3DJ.%2BS.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26aulast%3DHandt%26aufirst%3DL.%26aulast%3DMotzel%26aufirst%3DS.%2BL.%26aulast%3DKlein%26aufirst%3DH.%2BJ.%26aulast%3DDornadula%26aufirst%3DG.%26aulast%3DDanovich%26aufirst%3DR.%2BM.%26aulast%3DWitmer%26aufirst%3DM.%2BV.%26aulast%3DWilson%26aufirst%3DK.%2BA.%2BA.%26aulast%3DTussey%26aufirst%3DL.%26aulast%3DSchleif%26aufirst%3DW.%2BA.%26aulast%3DGabryelski%26aufirst%3DL.%2BS.%26aulast%3DJin%26aufirst%3DL.%2BX.%26aulast%3DMiller%26aufirst%3DM.%2BD.%26aulast%3DCasimiro%26aufirst%3DD.%2BR.%26aulast%3DEmini%26aufirst%3DE.%2BA.%26aulast%3DShiver%26aufirst%3DJ.%2BW.%26atitle%3DIntegrase%2520inhibitors%2520and%2520cellular%2520immunity%2520suppress%2520retroviral%2520replication%2520in%2520rhesus%2520macaques%26jtitle%3DScience%26date%3D2004%26volume%3D305%26spage%3D528%26epage%3D532" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Hazuda, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anthony, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomez, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jolly, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wai, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhuang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Embrey, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guare, J. P.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egbertson, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacca, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huff, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felock, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witmer, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stillmock, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danovich, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grobler, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Espeseth, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, I. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kassahun, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellis, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pearson, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schleif, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cortese, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emini, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Summa, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holloway, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, S. D.</span><span> </span><span class="NLM_article-title">A naphthyridine carboxamide provides evidence for discordant resistance between mechanistically identical inhibitors of HIV-1 integrase</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">101</span><span class="NLM_x">, </span> <span class="NLM_fpage">11233</span><span class="NLM_x">â</span> <span class="NLM_lpage">11238</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm300667v&amp;key=10.1073%2Fpnas.0402357101" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm300667v&amp;key=15277684" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm300667v&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmvVKgtrY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2004&pages=11233-11238&author=D.+J.+Hazudaauthor=N.+J.+Anthonyauthor=R.+P.+Gomezauthor=S.+M.+Jollyauthor=J.+S.+Waiauthor=L.+Zhuangauthor=T.+E.+Fisherauthor=M.+Embreyauthor=J.+P.+Guareauthor=M.+S.+Egbertsonauthor=J.+P.+Vaccaauthor=J.+R.+Huffauthor=P.+J.+Felockauthor=M.+V.+Witmerauthor=K.+A.+Stillmockauthor=R.+Danovichauthor=J.+Groblerauthor=M.+D.+Millerauthor=A.+S.+Espesethauthor=L.+Jinauthor=I.+W.+Chenauthor=J.+H.+Linauthor=K.+Kassahunauthor=J.+D.+Ellisauthor=B.+K.+Wongauthor=W.+Xuauthor=P.+G.+Pearsonauthor=W.+A.+Schleifauthor=R.+Corteseauthor=E.+Eminiauthor=V.+Summaauthor=M.+K.+Hollowayauthor=S.+D.+Young&title=A+naphthyridine+carboxamide+provides+evidence+for+discordant+resistance+between+mechanistically+identical+inhibitors+of+HIV-1+integrase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">A naphthyridine carboxamide provides evidence for discordant resistance between mechanistically identical inhibitors of HIV-1 integrase</span></div><div class="casAuthors">Hazuda, Daria J.; Anthony, Neville J.; Gomez, Robert P.; Jolly, Samson M.; Wai, John S.; Zhuang, Linghang; Fisher, Thorsten E.; Embrey, Mark; Guare, James P., Jr.; Egbertson, Melissa S.; Vacca, Joseph P.; Huff, Joel R.; Felock, Peter J.; Witmer, Marc V.; Stillmock, Kara A.; Danovich, Robert; Grobler, Jay; Miller, Michael D.; Espeseth, Amy S.; Jin, Lixia; Chen, I-Wu; Lin, Jiunn H.; Kassahun, Kelem; Ellis, Joan D.; Wong, Bradley K.; Xu, Wei; Pearson, Paul G.; Schleif, William A.; Cortese, Riccardo; Emini, Emilio; Summa, Vincenzo; Holloway, M. Katharine; Young, Steven D.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue">31</span>),
    <span class="NLM_cas:pages">11233-11238</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The increasing incidence of resistance to current HIV-1 therapy underscores the need to develop antiretroviral agents with new mechanisms of action.  Integrase, one of three viral enzymes essential for HIV-1 replication, presents an important yet unexploited opportunity for drug development.  The authors describe here the identification and characterization of L-870,810, a small-mol. inhibitor of HIV-1 integrase with potent antiviral activity in cell culture and good pharmacokinetic properties.  L-870,810 is an inhibitor with an 8-hydroxy-(1,6)-naphthyridine-7-carboxamide pharmacophore.  The compd. inhibits HIV-1 integrase-mediated strand transfer, and its antiviral activity in vitro is a direct consequence of this ascribed effect on integration.  L-870,810 is mechanistically identical to previously described inhibitors from the diketo acid series; however, viruses selected for resistance to L-870,810 contain mutations (integrase residues 72, 121, and 125) that uniquely confer resistance to the naphthyridine.  Conversely, mutations assocd. with resistance to the diketo acid do not engender naphthyridine resistance.  Importantly, the mutations assocd. with resistance to each of these inhibitors map to distinct regions within the integrase active site.  Therefore, the authors propose a model of the two inhibitors that is consistent with this observation and suggests specific interactions with discrete binding sites for each ligand.  These studies provide a structural basis and rationale for developing integrase inhibitors with the potential for unique and nonoverlapping resistance profiles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRpHqKKxVFjLVg90H21EOLACvtfcHk0lg_OY1ElqgN6w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmvVKgtrY%253D&md5=a94bedb2c16c751c5a9298708504fa4d</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0402357101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0402357101%26sid%3Dliteratum%253Aachs%26aulast%3DHazuda%26aufirst%3DD.%2BJ.%26aulast%3DAnthony%26aufirst%3DN.%2BJ.%26aulast%3DGomez%26aufirst%3DR.%2BP.%26aulast%3DJolly%26aufirst%3DS.%2BM.%26aulast%3DWai%26aufirst%3DJ.%2BS.%26aulast%3DZhuang%26aufirst%3DL.%26aulast%3DFisher%26aufirst%3DT.%2BE.%26aulast%3DEmbrey%26aufirst%3DM.%26aulast%3DGuare%26aufirst%3DJ.%2BP.%26aulast%3DEgbertson%26aufirst%3DM.%2BS.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26aulast%3DHuff%26aufirst%3DJ.%2BR.%26aulast%3DFelock%26aufirst%3DP.%2BJ.%26aulast%3DWitmer%26aufirst%3DM.%2BV.%26aulast%3DStillmock%26aufirst%3DK.%2BA.%26aulast%3DDanovich%26aufirst%3DR.%26aulast%3DGrobler%26aufirst%3DJ.%26aulast%3DMiller%26aufirst%3DM.%2BD.%26aulast%3DEspeseth%26aufirst%3DA.%2BS.%26aulast%3DJin%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DI.%2BW.%26aulast%3DLin%26aufirst%3DJ.%2BH.%26aulast%3DKassahun%26aufirst%3DK.%26aulast%3DEllis%26aufirst%3DJ.%2BD.%26aulast%3DWong%26aufirst%3DB.%2BK.%26aulast%3DXu%26aufirst%3DW.%26aulast%3DPearson%26aufirst%3DP.%2BG.%26aulast%3DSchleif%26aufirst%3DW.%2BA.%26aulast%3DCortese%26aufirst%3DR.%26aulast%3DEmini%26aufirst%3DE.%26aulast%3DSumma%26aufirst%3DV.%26aulast%3DHolloway%26aufirst%3DM.%2BK.%26aulast%3DYoung%26aufirst%3DS.%2BD.%26atitle%3DA%2520naphthyridine%2520carboxamide%2520provides%2520evidence%2520for%2520discordant%2520resistance%2520between%2520mechanistically%2520identical%2520inhibitors%2520of%2520HIV-1%2520integrase%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2004%26volume%3D101%26spage%3D11233%26epage%3D11238" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Plasencia, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dayam, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinski, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burke, T. R.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quinn, D. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neamati, N.</span><span> </span><span class="NLM_article-title">Discovery and preclinical evaluation of a novel class of small-molecule compounds in hormone-dependent and -independent cancer cell lines</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">1105</span><span class="NLM_x">â</span> <span class="NLM_lpage">1113</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm300667v&amp;key=10.1158%2F1535-7163.MCT-04-0288" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm300667v&amp;key=16020668" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm300667v&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmtFSlt74%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2005&pages=1105-1113&author=C.+Plasenciaauthor=R.+Dayamauthor=Q.+Wangauthor=J.+Pinskiauthor=T.+R.+Burkeauthor=D.+I.+Quinnauthor=N.+Neamati&title=Discovery+and+preclinical+evaluation+of+a+novel+class+of+small-molecule+compounds+in+hormone-dependent+and+-independent+cancer+cell+lines"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and preclinical evaluation of a novel class of small-molecule compounds in hormone-dependent and -independent cancer cell lines</span></div><div class="casAuthors">Plasencia, Carmen; Dayam, Raveendra; Wang, Qingcai; Pinski, Jacek; Burke, Terrence R., Jr.; Quinn, David I.; Neamati, Nouri</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1105-1113</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">We discovered a series of salicylhydrazide class of compds. with remarkable anticancer activity against a panel of hormone receptor-pos. and -neg. cell lines.  In the present study, we evaluated the in vitro activity of SC21 and SC23 against a range of human tumor cell types and the in vivo efficacy of compd. SC21 in a PC3 human prostate cancer xenograft model in mice.  We also detd. the effects of SC21 on cell cycle regulation and apoptosis.  Our in vitro results show that salicylhydrazides are highly potent compds. effective in both hormone receptor-pos. and -neg. cancer cells.  SC21 induced apoptosis and blocked the cell cycle in G0/G1 or S phase, depending on the cell lines used and irresp. of p53, p21, pRb, and p16 status.  SC21 effectively reduced the tumor growth in mice without apparent toxicity.  Although the mechanism of action of SC21 is not completely elucidated, the effect on cell cycle, the induction of apoptosis and the activity against a panel of tumor cell lines of different origins prompted us to carry out an in-depth preclin. evaluation of SC21.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6w649-H6m2bVg90H21EOLACvtfcHk0lg_OY1ElqgN6w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmtFSlt74%253D&md5=078b17b2737c9a65b651bb673d3cd743</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-04-0288&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-04-0288%26sid%3Dliteratum%253Aachs%26aulast%3DPlasencia%26aufirst%3DC.%26aulast%3DDayam%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DPinski%26aufirst%3DJ.%26aulast%3DBurke%26aufirst%3DT.%2BR.%26aulast%3DQuinn%26aufirst%3DD.%2BI.%26aulast%3DNeamati%26aufirst%3DN.%26atitle%3DDiscovery%2520and%2520preclinical%2520evaluation%2520of%2520a%2520novel%2520class%2520of%2520small-molecule%2520compounds%2520in%2520hormone-dependent%2520and%2520-independent%2520cancer%2520cell%2520lines%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2005%26volume%3D4%26spage%3D1105%26epage%3D1113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Cao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plasencia, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanzaki, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burke, T. R.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neamati, N.</span><span> </span><span class="NLM_article-title">Elucidation of the molecular mechanisms of a salicylhydrazide class of compounds by proteomic analysis</span> <span class="citation_source-journal">Curr. Cancer Drug Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">189</span><span class="NLM_x">â</span> <span class="NLM_lpage">201</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm300667v&amp;key=10.2174%2F156800909787580971" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm300667v&amp;key=19275759" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm300667v&amp;key=1%3ACAS%3A528%3ADC%252BD1MXks1Wjs7w%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=189-201&author=X.+Caoauthor=C.+Plasenciaauthor=A.+Kanzakiauthor=A.+Yangauthor=T.+R.+Burkeauthor=N.+Neamati&title=Elucidation+of+the+molecular+mechanisms+of+a+salicylhydrazide+class+of+compounds+by+proteomic+analysis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Elucidation of the molecular mechanisms of a salicylhydrazide class of compounds by proteomic analysis</span></div><div class="casAuthors">Cao, Xuefei; Plasencia, Carmen; Kanzaki, Atsuko; Yang, Austin; Burke, Terrence R., Jr.; Neamati, Nouri</div><div class="citationInfo"><span class="NLM_cas:title">Current Cancer Drug Targets</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">189-201</span>CODEN:
                <span class="NLM_cas:coden">CCDTB9</span>;
        ISSN:<span class="NLM_cas:issn">1568-0096</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Previously, we described a series of salicylhydrazide compds. with potent anti-cancer activities against a panel of human cancer cell lines derived from different origins.  Preclin. evaluation showing efficacy both in vitro and in vivo in human cancer models indicated that these agents may represent a promising class of anticancer drugs.  In the present study, we performed an in-depth investigation on the underlying mol. mechanisms of the most potent compds., SC21 and SC23, using a proteomic method and bioinformatics tools.  We demonstrated that SC23 induced apoptosis through multiple signaling pathways.  In particular, SC23 regulated the expression of Bcl-2, p21, acetylated histone H3 and Î²-tubulin and the combined modulation of these proteins may result in the induction of apoptosis.  We also examd. the effect of SC21 and SC23 on cell cycle progression and found that both compds. arrested cells in S-phase in most cell lines tested.  To better understand the signaling networks involved, we analyzed the SC21- and SC23-treated cell lysates by the Kinexus 628 antibody microarray.  The results were interpreted with the aid of Ingenuity Pathway Anal. (IPA) software.  It was found that SC21 interfered with JAK/STAT signaling and elicited apoptosis through Fas and caspases pathways.  Unlike SC21, SC23 induced RAR activation and caused cell cycle arrest.  The signaling networks identified by this work may provide the basis for future mechanistic studies.  The validation of the proposed pathways and the elucidation of the signaling cross-talk are currently under way.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotr1-VS2bzm7Vg90H21EOLACvtfcHk0lg_OY1ElqgN6w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXks1Wjs7w%253D&md5=dc0df4565ed00bdf04c7c2f7bcf88797</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.2174%2F156800909787580971&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156800909787580971%26sid%3Dliteratum%253Aachs%26aulast%3DCao%26aufirst%3DX.%26aulast%3DPlasencia%26aufirst%3DC.%26aulast%3DKanzaki%26aufirst%3DA.%26aulast%3DYang%26aufirst%3DA.%26aulast%3DBurke%26aufirst%3DT.%2BR.%26aulast%3DNeamati%26aufirst%3DN.%26atitle%3DElucidation%2520of%2520the%2520molecular%2520mechanisms%2520of%2520a%2520salicylhydrazide%2520class%2520of%2520compounds%2520by%2520proteomic%2520analysis%26jtitle%3DCurr.%2520Cancer%2520Drug%2520Targets%26date%3D2009%26volume%3D9%26spage%3D189%26epage%3D201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Thompson, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Connolly, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamby, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boushelle, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartl, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amar, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kraker, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Driscoll, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinkampf, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patmore, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vincent, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elliott, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klohs, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leopold, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Showalter, H. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denny, W. A.</span><span> </span><span class="NLM_article-title">3-(3,5-Dimethoxyphenyl)-1,6-naphthyridine-2,7-diamines and related 2-urea derivatives are potent and selective inhibitors of the FGF receptor-1 tyrosine kinase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">4200</span><span class="NLM_x">â</span> <span class="NLM_lpage">4211</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm000161d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=4200-4211&author=A.+M.+Thompsonauthor=C.+J.+Connollyauthor=J.+M.+Hambyauthor=S.+Boushelleauthor=B.+G.+Hartlauthor=A.+M.+Amarauthor=A.+J.+Krakerauthor=D.+L.+Driscollauthor=R.+W.+Steinkampfauthor=S.+J.+Patmoreauthor=P.+W.+Vincentauthor=B.+J.+Robertsauthor=W.+L.+Elliottauthor=W.+Klohsauthor=W.+R.+Leopoldauthor=H.+D.+Showalterauthor=W.+A.+Denny&title=3-%283%2C5-Dimethoxyphenyl%29-1%2C6-naphthyridine-2%2C7-diamines+and+related+2-urea+derivatives+are+potent+and+selective+inhibitors+of+the+FGF+receptor-1+tyrosine+kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1021%2Fjm000161d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm000161d%26sid%3Dliteratum%253Aachs%26aulast%3DThompson%26aufirst%3DA.%2BM.%26aulast%3DConnolly%26aufirst%3DC.%2BJ.%26aulast%3DHamby%26aufirst%3DJ.%2BM.%26aulast%3DBoushelle%26aufirst%3DS.%26aulast%3DHartl%26aufirst%3DB.%2BG.%26aulast%3DAmar%26aufirst%3DA.%2BM.%26aulast%3DKraker%26aufirst%3DA.%2BJ.%26aulast%3DDriscoll%26aufirst%3DD.%2BL.%26aulast%3DSteinkampf%26aufirst%3DR.%2BW.%26aulast%3DPatmore%26aufirst%3DS.%2BJ.%26aulast%3DVincent%26aufirst%3DP.%2BW.%26aulast%3DRoberts%26aufirst%3DB.%2BJ.%26aulast%3DElliott%26aufirst%3DW.%2BL.%26aulast%3DKlohs%26aufirst%3DW.%26aulast%3DLeopold%26aufirst%3DW.%2BR.%26aulast%3DShowalter%26aufirst%3DH.%2BD.%26aulast%3DDenny%26aufirst%3DW.%2BA.%26atitle%3D3-%25283%252C5-Dimethoxyphenyl%2529-1%252C6-naphthyridine-2%252C7-diamines%2520and%2520related%25202-urea%2520derivatives%2520are%2520potent%2520and%2520selective%2520inhibitors%2520of%2520the%2520FGF%2520receptor-1%2520tyrosine%2520kinase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D4200%26epage%3D4211" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Thompson, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delaney, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamby, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schroeder, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spoon, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crean, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Showalter, H. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denny, W. A.</span><span> </span><span class="NLM_article-title">Synthesis and structureâactivity relationships of soluble 7-substituted 3-(3,5-dimethoxyphenyl)-1,6-naphthyridin-2-amines and related ureas as dual inhibitors of the fibroblast growth factor receptor-1 and vascular endothelial growth factor receptor-2 tyrosine kinases</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">4628</span><span class="NLM_x">â</span> <span class="NLM_lpage">4653</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0500931" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=4628-4653&author=A.+M.+Thompsonauthor=A.+M.+Delaneyauthor=J.+M.+Hambyauthor=M.+C.+Schroederauthor=T.+A.+Spoonauthor=S.+M.+Creanauthor=H.+D.+Showalterauthor=W.+A.+Denny&title=Synthesis+and+structure%E2%80%93activity+relationships+of+soluble+7-substituted+3-%283%2C5-dimethoxyphenyl%29-1%2C6-naphthyridin-2-amines+and+related+ureas+as+dual+inhibitors+of+the+fibroblast+growth+factor+receptor-1+and+vascular+endothelial+growth+factor+receptor-2+tyrosine+kinases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Fjm0500931&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0500931%26sid%3Dliteratum%253Aachs%26aulast%3DThompson%26aufirst%3DA.%2BM.%26aulast%3DDelaney%26aufirst%3DA.%2BM.%26aulast%3DHamby%26aufirst%3DJ.%2BM.%26aulast%3DSchroeder%26aufirst%3DM.%2BC.%26aulast%3DSpoon%26aufirst%3DT.%2BA.%26aulast%3DCrean%26aufirst%3DS.%2BM.%26aulast%3DShowalter%26aufirst%3DH.%2BD.%26aulast%3DDenny%26aufirst%3DW.%2BA.%26atitle%3DSynthesis%2520and%2520structure%25E2%2580%2593activity%2520relationships%2520of%2520soluble%25207-substituted%25203-%25283%252C5-dimethoxyphenyl%2529-1%252C6-naphthyridin-2-amines%2520and%2520related%2520ureas%2520as%2520dual%2520inhibitors%2520of%2520the%2520fibroblast%2520growth%2520factor%2520receptor-1%2520and%2520vascular%2520endothelial%2520growth%2520factor%2520receptor-2%2520tyrosine%2520kinases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D4628%26epage%3D4653" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Zartman, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bell, I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallicchio, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kane, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mallee, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rutledge, R. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salvatore, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacca, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, T. M.</span><span> </span><span class="NLM_article-title">Identification of a novel RAMP-independent CGRP receptor antagonist</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">6705</span><span class="NLM_x">â</span> <span class="NLM_lpage">6708</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=6705-6708&author=C.+B.+Zartmanauthor=I.+M.+Bellauthor=S.+N.+Gallicchioauthor=S.+L.+Grahamauthor=S.+A.+Kaneauthor=J.+J.+Malleeauthor=R.+Z.+Rutledgeauthor=C.+A.+Salvatoreauthor=J.+P.+Vaccaauthor=T.+M.+Williams&title=Identification+of+a+novel+RAMP-independent+CGRP+receptor+antagonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZartman%26aufirst%3DC.%2BB.%26aulast%3DBell%26aufirst%3DI.%2BM.%26aulast%3DGallicchio%26aufirst%3DS.%2BN.%26aulast%3DGraham%26aufirst%3DS.%2BL.%26aulast%3DKane%26aufirst%3DS.%2BA.%26aulast%3DMallee%26aufirst%3DJ.%2BJ.%26aulast%3DRutledge%26aufirst%3DR.%2BZ.%26aulast%3DSalvatore%26aufirst%3DC.%2BA.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26aulast%3DWilliams%26aufirst%3DT.%2BM.%26atitle%3DIdentification%2520of%2520a%2520novel%2520RAMP-independent%2520CGRP%2520receptor%2520antagonist%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D6705%26epage%3D6708" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Neamati, N.</span> <span class="citation_source-book">HIV-1 Integrase: Mechanism and Inhibitor Design</span>; <span class="NLM_publisher-name">Wiley</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm300667v&amp;key=10.1002%2F9781118015377" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=N.+Neamati&title=HIV-1+Integrase%3A+Mechanism+and+Inhibitor+Design"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1002%2F9781118015377&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F9781118015377%26sid%3Dliteratum%253Aachs%26aulast%3DNeamati%26aufirst%3DN.%26btitle%3DHIV-1%2520Integrase%253A%2520Mechanism%2520and%2520Inhibitor%2520Design%26pub%3DWiley%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Pendri, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meanwell, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peese, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, M. A.</span><span> </span><span class="NLM_article-title">New first and second generation inhibitors of human immunodeficiency virus-1 integrase</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">1173</span><span class="NLM_x">â</span> <span class="NLM_lpage">1189</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm300667v&amp;key=10.1517%2F13543776.2011.586631" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm300667v&amp;key=21599420" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm300667v&amp;key=1%3ACAS%3A528%3ADC%252BC3MXptVOrtL0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=1173-1189&author=A.+Pendriauthor=N.+A.+Meanwellauthor=K.+M.+Peeseauthor=M.+A.+Walker&title=New+first+and+second+generation+inhibitors+of+human+immunodeficiency+virus-1+integrase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">New first and second generation inhibitors of human immunodeficiency virus-1 integrase</span></div><div class="casAuthors">Pendri, Annapurna; Meanwell, Nicholas A.; Peese, Kevin M.; Walker, Michael A.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1173-1189</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: The use of inhibitors of HIV-1 integrase for treating HIV-1 infection has proven to be very beneficial.  Raltegravir, a strand transfer inhibitor, has been approved for use both as a first-line therapy and in treatment-experienced patients.  A second compd. in this class, elvitegravir, is in Phase III clin. trials and is being developed as part of a once daily fixed dose combination pill.  With widespread use of raltegravir, viral resistance has emerged with surprising facility.  Attempts to use raltegravir on a once daily dosing regimen have been unsuccessful while elvitegravir cannot be delivered daily without the aid of a pharmacokinetic (PK)-enhancing agent.  Thus, there is a need for second generation compds. to address these issues.Areas covered: Patent applications claiming compds. useful as inhibitors of HIV-1 integrase are reviewed in this paper, along with compds. related to the strand transfer inhibitors.Expert opinion: The field appears to be more focused on developing compds. which address the issues identified for the first generation compds., raltegravir and elvitegravir.  Patent activity around new strand transfer inhibitors claims compds. active against first generation resistant mutations and having PK profiles suitable for daily dosing.  Advancements in this area have been rapid and several compds. described in these patent applications are currently in clin. trials.  Bolstered by recent mechanistic discoveries, compds. inhibiting processes other than strand transfer have begun to emerge.  It is foreseeable that a second generation integrase inhibitor could be approved for treatment in the coming years.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlCiMRQTRcrrVg90H21EOLACvtfcHk0lhA_O9XUfx_qA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXptVOrtL0%253D&md5=61799f44a62db917d07a931c1c872727</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1517%2F13543776.2011.586631&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2011.586631%26sid%3Dliteratum%253Aachs%26aulast%3DPendri%26aufirst%3DA.%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26aulast%3DPeese%26aufirst%3DK.%2BM.%26aulast%3DWalker%26aufirst%3DM.%2BA.%26atitle%3DNew%2520first%2520and%2520second%2520generation%2520inhibitors%2520of%2520human%2520immunodeficiency%2520virus-1%2520integrase%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2011%26volume%3D21%26spage%3D1173%26epage%3D1189" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Egbertson, M.; Anthony, N. J.; Vincenzo Summa, V.</span> <span class="citation_source-book">HIV Integrase Inhibitors: From Diketoacids to Heterocyclic Templates: A History of HIV Integrase Medicinal Chemistry at Merck West Point and Merck Rome (IRBM) Leading to the Discovery of Raltegravir</span>; In HIV-1 Integrase: Mechanism and Inhibitor Design. Ed (Neamati, N). <span class="NLM_publisher-loc">Wiley: New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=M.+Egbertson&author=N.+J.+Anthony&author=V.+Vincenzo+Summa&title=HIV+Integrase+Inhibitors%3A+From+Diketoacids+to+Heterocyclic+Templates%3A+A+History+of+HIV+Integrase+Medicinal+Chemistry+at+Merck+West+Point+and+Merck+Rome+%28IRBM%29+Leading+to+the+Discovery+of+Raltegravir"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DEgbertson%26aufirst%3DM.%26btitle%3DHIV%2520Integrase%2520Inhibitors%253A%2520From%2520Diketoacids%2520to%2520Heterocyclic%2520Templates%253A%2520A%2520History%2520of%2520HIV%2520Integrase%2520Medicinal%2520Chemistry%2520at%2520Merck%2520West%2520Point%2520and%2520Merck%2520Rome%2520%2528IRBM%2529%2520Leading%2520to%2520the%2520Discovery%2520of%2520Raltegravir%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Egbertson, M. S.</span><span> </span><span class="NLM_article-title">HIV integrase inhibitors: from diketoacids to heterocyclic templates: a history of HIV integrase medicinal chemistry at Merck West Point and Merck Rome (IRBM)</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1251</span><span class="NLM_x">â</span> <span class="NLM_lpage">1272</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm300667v&amp;key=10.2174%2F156802607781212248" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm300667v&amp;key=17627556" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm300667v&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVKqtrvN" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2007&pages=1251-1272&author=M.+S.+Egbertson&title=HIV+integrase+inhibitors%3A+from+diketoacids+to+heterocyclic+templates%3A+a+history+of+HIV+integrase+medicinal+chemistry+at+Merck+West+Point+and+Merck+Rome+%28IRBM%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">HIV integrase inhibitors: from diketoacids to heterocyclic templates: a history of HIV integrase medicinal chemistry at merck west point and merck rome (IRBM)</span></div><div class="casAuthors">Egbertson, Melissa S.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1251-1272</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Replication of the human immunodeficiency virus (HIV) is dependent upon the enzyme HIV integrase (IN), one of three essential enzymes encoded in the viral genome.  HIV-1 IN catalyzes the insertion of the proviral DNA into the host genome (strand transfer).  HIV-1 IN therefore presents an attractive chemotherapeutic target for the treatment of HIV infection and AIDS that could provide patients and physicians with an addnl. option for treatment.  Assays were developed to identify inhibitors of IN strand transfer.  Diketoacid lead compds. were explored and developed into a variety of heterocyclic templates that are potent inhibitors of integrase strand transfer with suitable medicinal chem. properties for treating HIV infection and AIDS.  The 1,6-naphthyridine L-870810 (Antiviral activity in cells IC95 NHS = 102 nM, n = 237), was shown to be efficacious in reducing viral RNA by 1.7 log units after doses of 400mg BID to HIV infected patients.  Optimization of phys. properties led to L-900564, an inhibitor of HIV IN that has excellent cell potency in the presence of protein (Antiviral activity in cells IC95 NHS = 16 nM, n = 15), excellent activity against mutants raised to HIV integrase inhibitors, and a very good pharmacokinetic profile.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLnZK4Ww16-rVg90H21EOLACvtfcHk0lhA_O9XUfx_qA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVKqtrvN&md5=63978cc76f8e9036b73f0932d0470585</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.2174%2F156802607781212248&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802607781212248%26sid%3Dliteratum%253Aachs%26aulast%3DEgbertson%26aufirst%3DM.%2BS.%26atitle%3DHIV%2520integrase%2520inhibitors%253A%2520from%2520diketoacids%2520to%2520heterocyclic%2520templates%253A%2520a%2520history%2520of%2520HIV%2520integrase%2520medicinal%2520chemistry%2520at%2520Merck%2520West%2520Point%2520and%2520Merck%2520Rome%2520%2528IRBM%2529%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2007%26volume%3D7%26spage%3D1251%26epage%3D1272" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Egbertson, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moritz, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melamed, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perlow, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Embrey, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacca, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zrada, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cortes, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallace, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonard, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hazuda, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felock, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stillmock, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witmer, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schleif, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabryelski, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moyer, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellis, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braun, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kassahun, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsou, N. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, S. D.</span><span> </span><span class="NLM_article-title">A potent and orally active HIV-1 integrase inhibitor</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">1392</span><span class="NLM_x">â</span> <span class="NLM_lpage">1398</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm300667v&amp;key=10.1016%2Fj.bmcl.2006.11.080" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm300667v&amp;key=17194584" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm300667v&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhvVyjt7s%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=1392-1398&author=M.+S.+Egbertsonauthor=H.+M.+Moritzauthor=J.+Y.+Melamedauthor=W.+Hanauthor=D.+S.+Perlowauthor=M.+S.+Kuoauthor=M.+Embreyauthor=J.+P.+Vaccaauthor=M.+M.+Zradaauthor=A.+R.+Cortesauthor=A.+Wallaceauthor=Y.+Leonardauthor=D.+J.+Hazudaauthor=M.+D.+Millerauthor=P.+J.+Felockauthor=K.+A.+Stillmockauthor=M.+V.+Witmerauthor=W.+Schleifauthor=L.+J.+Gabryelskiauthor=G.+Moyerauthor=J.+D.+Ellisauthor=L.+Jinauthor=W.+Xuauthor=M.+P.+Braunauthor=K.+Kassahunauthor=N.+N.+Tsouauthor=S.+D.+Young&title=A+potent+and+orally+active+HIV-1+integrase+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">A potent and orally active HIV-1 integrase inhibitor</span></div><div class="casAuthors">Egbertson, Melissa S.; Moritz, H. Marie; Melamed, Jeffrey Y.; Han, Wei; Perlow, Debra S.; Kuo, Michelle S.; Embrey, Mark; Vacca, Joseph P.; Zrada, Matthew M.; Cortes, Amanda R.; Wallace, Audrey; Leonard, Yvonne; Hazuda, Daria J.; Miller, Michael D.; Felock, Peter J.; Stillmock, Kara A.; Witmer, Marc V.; Schleif, William; Gabryelski, Lori J.; Moyer, Gregory; Ellis, Joan D.; Jin, Lixia; Xu, Wei; Braun, Matthew P.; Kassahun, Kellem; Tsou, Nancy N.; Young, Steven D.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1392-1398</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A 1,6-naphthyridine inhibitor of HIV-1 integrase has been discovered with excellent inhibitory activity in cells, good pharmacokinetics, and an excellent ability to inhibit virus with mutant enzyme.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVTId1m0YgC7Vg90H21EOLACvtfcHk0lhA_O9XUfx_qA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhvVyjt7s%253D&md5=5b718b54eae1ddfc33430472a0c3169c</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2006.11.080&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2006.11.080%26sid%3Dliteratum%253Aachs%26aulast%3DEgbertson%26aufirst%3DM.%2BS.%26aulast%3DMoritz%26aufirst%3DH.%2BM.%26aulast%3DMelamed%26aufirst%3DJ.%2BY.%26aulast%3DHan%26aufirst%3DW.%26aulast%3DPerlow%26aufirst%3DD.%2BS.%26aulast%3DKuo%26aufirst%3DM.%2BS.%26aulast%3DEmbrey%26aufirst%3DM.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26aulast%3DZrada%26aufirst%3DM.%2BM.%26aulast%3DCortes%26aufirst%3DA.%2BR.%26aulast%3DWallace%26aufirst%3DA.%26aulast%3DLeonard%26aufirst%3DY.%26aulast%3DHazuda%26aufirst%3DD.%2BJ.%26aulast%3DMiller%26aufirst%3DM.%2BD.%26aulast%3DFelock%26aufirst%3DP.%2BJ.%26aulast%3DStillmock%26aufirst%3DK.%2BA.%26aulast%3DWitmer%26aufirst%3DM.%2BV.%26aulast%3DSchleif%26aufirst%3DW.%26aulast%3DGabryelski%26aufirst%3DL.%2BJ.%26aulast%3DMoyer%26aufirst%3DG.%26aulast%3DEllis%26aufirst%3DJ.%2BD.%26aulast%3DJin%26aufirst%3DL.%26aulast%3DXu%26aufirst%3DW.%26aulast%3DBraun%26aufirst%3DM.%2BP.%26aulast%3DKassahun%26aufirst%3DK.%26aulast%3DTsou%26aufirst%3DN.%2BN.%26aulast%3DYoung%26aufirst%3DS.%2BD.%26atitle%3DA%2520potent%2520and%2520orally%2520active%2520HIV-1%2520integrase%2520inhibitor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D1392%26epage%3D1398" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Embrey, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wai, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Funk, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Homnick, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perlow, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacca, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hazuda, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felock, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stillmock, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witmer, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moyer, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schleif, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabryelski, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, I. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellis, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonard, Y. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsou, N. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhuang, L.</span><span> </span><span class="NLM_article-title">A series of 5-(5,6)-dihydrouracil substituted 8-hydroxy-[1,6]naphthyridine-7-carboxylic acid 4-fluorobenzylamide inhibitors of HIV-1 integrase and viral replication in cells</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">4550</span><span class="NLM_x">â</span> <span class="NLM_lpage">4554</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=4550-4554&author=M.+W.+Embreyauthor=J.+S.+Waiauthor=T.+W.+Funkauthor=C.+F.+Homnickauthor=D.+S.+Perlowauthor=S.+D.+Youngauthor=J.+P.+Vaccaauthor=D.+J.+Hazudaauthor=P.+J.+Felockauthor=K.+A.+Stillmockauthor=M.+V.+Witmerauthor=G.+Moyerauthor=W.+A.+Schleifauthor=L.+J.+Gabryelskiauthor=L.+Jinauthor=I.+W.+Chenauthor=J.+D.+Ellisauthor=B.+K.+Wongauthor=J.+H.+Linauthor=Y.+M.+Leonardauthor=N.+N.+Tsouauthor=L.+Zhuang&title=A+series+of+5-%285%2C6%29-dihydrouracil+substituted+8-hydroxy-%5B1%2C6%5Dnaphthyridine-7-carboxylic+acid+4-fluorobenzylamide+inhibitors+of+HIV-1+integrase+and+viral+replication+in+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEmbrey%26aufirst%3DM.%2BW.%26aulast%3DWai%26aufirst%3DJ.%2BS.%26aulast%3DFunk%26aufirst%3DT.%2BW.%26aulast%3DHomnick%26aufirst%3DC.%2BF.%26aulast%3DPerlow%26aufirst%3DD.%2BS.%26aulast%3DYoung%26aufirst%3DS.%2BD.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26aulast%3DHazuda%26aufirst%3DD.%2BJ.%26aulast%3DFelock%26aufirst%3DP.%2BJ.%26aulast%3DStillmock%26aufirst%3DK.%2BA.%26aulast%3DWitmer%26aufirst%3DM.%2BV.%26aulast%3DMoyer%26aufirst%3DG.%26aulast%3DSchleif%26aufirst%3DW.%2BA.%26aulast%3DGabryelski%26aufirst%3DL.%2BJ.%26aulast%3DJin%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DI.%2BW.%26aulast%3DEllis%26aufirst%3DJ.%2BD.%26aulast%3DWong%26aufirst%3DB.%2BK.%26aulast%3DLin%26aufirst%3DJ.%2BH.%26aulast%3DLeonard%26aufirst%3DY.%2BM.%26aulast%3DTsou%26aufirst%3DN.%2BN.%26aulast%3DZhuang%26aufirst%3DL.%26atitle%3DA%2520series%2520of%25205-%25285%252C6%2529-dihydrouracil%2520substituted%25208-hydroxy-%255B1%252C6%255Dnaphthyridine-7-carboxylic%2520acid%25204-fluorobenzylamide%2520inhibitors%2520of%2520HIV-1%2520integrase%2520and%2520viral%2520replication%2520in%2520cells%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D4550%26epage%3D4554" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Espeseth, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felock, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolfe, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witmer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grobler, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anthony, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egbertson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melamed, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamill, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hazuda, D. J.</span><span> </span><span class="NLM_article-title">HIV-1 integrase inhibitors that compete with the target DNA substrate define a unique strand transfer conformation for integrase</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">97</span><span class="NLM_x">, </span> <span class="NLM_fpage">11244</span><span class="NLM_x">â</span> <span class="NLM_lpage">11249</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2000&pages=11244-11249&author=A.+S.+Espesethauthor=P.+Felockauthor=A.+Wolfeauthor=M.+Witmerauthor=J.+Groblerauthor=N.+Anthonyauthor=M.+Egbertsonauthor=J.+Y.+Melamedauthor=S.+Youngauthor=T.+Hamillauthor=J.+L.+Coleauthor=D.+J.+Hazuda&title=HIV-1+integrase+inhibitors+that+compete+with+the+target+DNA+substrate+define+a+unique+strand+transfer+conformation+for+integrase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEspeseth%26aufirst%3DA.%2BS.%26aulast%3DFelock%26aufirst%3DP.%26aulast%3DWolfe%26aufirst%3DA.%26aulast%3DWitmer%26aufirst%3DM.%26aulast%3DGrobler%26aufirst%3DJ.%26aulast%3DAnthony%26aufirst%3DN.%26aulast%3DEgbertson%26aufirst%3DM.%26aulast%3DMelamed%26aufirst%3DJ.%2BY.%26aulast%3DYoung%26aufirst%3DS.%26aulast%3DHamill%26aufirst%3DT.%26aulast%3DCole%26aufirst%3DJ.%2BL.%26aulast%3DHazuda%26aufirst%3DD.%2BJ.%26atitle%3DHIV-1%2520integrase%2520inhibitors%2520that%2520compete%2520with%2520the%2520target%2520DNA%2520substrate%2520define%2520a%2520unique%2520strand%2520transfer%2520conformation%2520for%2520integrase%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2000%26volume%3D97%26spage%3D11244%26epage%3D11249" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Guare, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wai, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomez, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anthony, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jolly, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cortes, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacca, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felock, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stillmock, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schleif, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moyer, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabryelski, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, I. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hazuda, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, S. D.</span><span> </span><span class="NLM_article-title">A series of 5-aminosubstituted 4-fluorobenzyl-8-hydroxy-[1,6]naphthyridine-7-carboxamide HIV-1 integrase inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">2900</span><span class="NLM_x">â</span> <span class="NLM_lpage">2904</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=2900-2904&author=J.+P.+Guareauthor=J.+S.+Waiauthor=R.+P.+Gomezauthor=N.+J.+Anthonyauthor=S.+M.+Jollyauthor=A.+R.+Cortesauthor=J.+P.+Vaccaauthor=P.+J.+Felockauthor=K.+A.+Stillmockauthor=W.+A.+Schleifauthor=G.+Moyerauthor=L.+J.+Gabryelskiauthor=L.+Jinauthor=I.+W.+Chenauthor=D.+J.+Hazudaauthor=S.+D.+Young&title=A+series+of+5-aminosubstituted+4-fluorobenzyl-8-hydroxy-%5B1%2C6%5Dnaphthyridine-7-carboxamide+HIV-1+integrase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGuare%26aufirst%3DJ.%2BP.%26aulast%3DWai%26aufirst%3DJ.%2BS.%26aulast%3DGomez%26aufirst%3DR.%2BP.%26aulast%3DAnthony%26aufirst%3DN.%2BJ.%26aulast%3DJolly%26aufirst%3DS.%2BM.%26aulast%3DCortes%26aufirst%3DA.%2BR.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26aulast%3DFelock%26aufirst%3DP.%2BJ.%26aulast%3DStillmock%26aufirst%3DK.%2BA.%26aulast%3DSchleif%26aufirst%3DW.%2BA.%26aulast%3DMoyer%26aufirst%3DG.%26aulast%3DGabryelski%26aufirst%3DL.%2BJ.%26aulast%3DJin%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DI.%2BW.%26aulast%3DHazuda%26aufirst%3DD.%2BJ.%26aulast%3DYoung%26aufirst%3DS.%2BD.%26atitle%3DA%2520series%2520of%25205-aminosubstituted%25204-fluorobenzyl-8-hydroxy-%255B1%252C6%255Dnaphthyridine-7-carboxamide%2520HIV-1%2520integrase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D2900%26epage%3D2904" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Gudmundsson, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johns, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weatherhead, J.</span><span> </span><span class="NLM_article-title">Pyrazolopyrimidines and pyrazolotriazines with potent activity against herpesviruses</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">5689</span><span class="NLM_x">â</span> <span class="NLM_lpage">5692</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=5689-5692&author=K.+S.+Gudmundssonauthor=B.+A.+Johnsauthor=J.+Weatherhead&title=Pyrazolopyrimidines+and+pyrazolotriazines+with+potent+activity+against+herpesviruses"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGudmundsson%26aufirst%3DK.%2BS.%26aulast%3DJohns%26aufirst%3DB.%2BA.%26aulast%3DWeatherhead%26aufirst%3DJ.%26atitle%3DPyrazolopyrimidines%2520and%2520pyrazolotriazines%2520with%2520potent%2520activity%2520against%2520herpesviruses%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D5689%26epage%3D5692" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Johns, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weatherhead, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garvey, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foster, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeffrey, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, W. H.</span><span> </span><span class="NLM_article-title">The use of oxadiazole and triazole substituted naphthyridines as HIV-1 integrase inhibitors. Part 1: Establishing the pharmacophore</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1802</span><span class="NLM_x">â</span> <span class="NLM_lpage">1806</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm300667v&amp;key=10.1016%2Fj.bmcl.2009.01.090" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm300667v&amp;key=19217781" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm300667v&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjtVSltb0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=1802-1806&author=B.+A.+Johnsauthor=J.+G.+Weatherheadauthor=S.+H.+Allenauthor=J.+B.+Thompsonauthor=E.+P.+Garveyauthor=S.+A.+Fosterauthor=J.+L.+Jeffreyauthor=W.+H.+Miller&title=The+use+of+oxadiazole+and+triazole+substituted+naphthyridines+as+HIV-1+integrase+inhibitors.+Part+1%3A+Establishing+the+pharmacophore"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">The use of oxadiazole and triazole substituted naphthyridines as HIV-1 integrase inhibitors. Part 1: Establishing the pharmacophore</span></div><div class="casAuthors">Johns, Brian A.; Weatherhead, Jason G.; Allen, Scott H.; Thompson, James B.; Garvey, Edward P.; Foster, Scott A.; Jeffrey, Jerry L.; Miller, Wayne H.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1802-1806</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of HIV-1 integrase inhibitors contg. a novel metal binding motif consisting of the 8-hydroxy-1,6-naphthyridine core and either an oxadiazole or triazole has been identified.  The design of the key structural components was based on a two-metal coordination pharmacophore.  This report presents initial structure-activity data that shows the new chelation architecture delivers potent inhibition in both enzymic and antiviral assays.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqu2rzx6WTsI7Vg90H21EOLACvtfcHk0lgelBqWD4xtBA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjtVSltb0%253D&md5=78e7d1b81f1a889c901bb08678b932a7</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.01.090&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.01.090%26sid%3Dliteratum%253Aachs%26aulast%3DJohns%26aufirst%3DB.%2BA.%26aulast%3DWeatherhead%26aufirst%3DJ.%2BG.%26aulast%3DAllen%26aufirst%3DS.%2BH.%26aulast%3DThompson%26aufirst%3DJ.%2BB.%26aulast%3DGarvey%26aufirst%3DE.%2BP.%26aulast%3DFoster%26aufirst%3DS.%2BA.%26aulast%3DJeffrey%26aufirst%3DJ.%2BL.%26aulast%3DMiller%26aufirst%3DW.%2BH.%26atitle%3DThe%2520use%2520of%2520oxadiazole%2520and%2520triazole%2520substituted%2520naphthyridines%2520as%2520HIV-1%2520integrase%2520inhibitors.%2520Part%25201%253A%2520Establishing%2520the%2520pharmacophore%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D1802%26epage%3D1806" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Johns, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weatherhead, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garvey, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foster, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeffrey, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, W. H.</span><span> </span><span class="NLM_article-title">1,3,4-Oxadiazole substituted naphthyridines as HIV-1 integrase inhibitors. Part 2: SAR of the C5 position</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1807</span><span class="NLM_x">â</span> <span class="NLM_lpage">1810</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=1807-1810&author=B.+A.+Johnsauthor=J.+G.+Weatherheadauthor=S.+H.+Allenauthor=J.+B.+Thompsonauthor=E.+P.+Garveyauthor=S.+A.+Fosterauthor=J.+L.+Jeffreyauthor=W.+H.+Miller&title=1%2C3%2C4-Oxadiazole+substituted+naphthyridines+as+HIV-1+integrase+inhibitors.+Part+2%3A+SAR+of+the+C5+position"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJohns%26aufirst%3DB.%2BA.%26aulast%3DWeatherhead%26aufirst%3DJ.%2BG.%26aulast%3DAllen%26aufirst%3DS.%2BH.%26aulast%3DThompson%26aufirst%3DJ.%2BB.%26aulast%3DGarvey%26aufirst%3DE.%2BP.%26aulast%3DFoster%26aufirst%3DS.%2BA.%26aulast%3DJeffrey%26aufirst%3DJ.%2BL.%26aulast%3DMiller%26aufirst%3DW.%2BH.%26atitle%3D1%252C3%252C4-Oxadiazole%2520substituted%2520naphthyridines%2520as%2520HIV-1%2520integrase%2520inhibitors.%2520Part%25202%253A%2520SAR%2520of%2520the%2520C5%2520position%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D1807%26epage%3D1810" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Melamed, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egbertson, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varga, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacca, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moyer, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabryelski, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felock, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stillmock, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witmer, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schleif, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hazuda, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonard, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellis, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, S. D.</span><span> </span><span class="NLM_article-title">Synthesis of 5-(1-H or 1-alkyl-5-oxopyrrolidin-3-yl)-8-hydroxy-[1,6]-naphthyridine-7-carboxamide inhibitors of HIV-1 integrase</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">5307</span><span class="NLM_x">â</span> <span class="NLM_lpage">5310</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=5307-5310&author=J.+Y.+Melamedauthor=M.+S.+Egbertsonauthor=S.+Vargaauthor=J.+P.+Vaccaauthor=G.+Moyerauthor=L.+Gabryelskiauthor=P.+J.+Felockauthor=K.+A.+Stillmockauthor=M.+V.+Witmerauthor=W.+Schleifauthor=D.+J.+Hazudaauthor=Y.+Leonardauthor=L.+Jinauthor=J.+D.+Ellisauthor=S.+D.+Young&title=Synthesis+of+5-%281-H+or+1-alkyl-5-oxopyrrolidin-3-yl%29-8-hydroxy-%5B1%2C6%5D-naphthyridine-7-carboxamide+inhibitors+of+HIV-1+integrase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMelamed%26aufirst%3DJ.%2BY.%26aulast%3DEgbertson%26aufirst%3DM.%2BS.%26aulast%3DVarga%26aufirst%3DS.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26aulast%3DMoyer%26aufirst%3DG.%26aulast%3DGabryelski%26aufirst%3DL.%26aulast%3DFelock%26aufirst%3DP.%2BJ.%26aulast%3DStillmock%26aufirst%3DK.%2BA.%26aulast%3DWitmer%26aufirst%3DM.%2BV.%26aulast%3DSchleif%26aufirst%3DW.%26aulast%3DHazuda%26aufirst%3DD.%2BJ.%26aulast%3DLeonard%26aufirst%3DY.%26aulast%3DJin%26aufirst%3DL.%26aulast%3DEllis%26aufirst%3DJ.%2BD.%26aulast%3DYoung%26aufirst%3DS.%2BD.%26atitle%3DSynthesis%2520of%25205-%25281-H%2520or%25201-alkyl-5-oxopyrrolidin-3-yl%2529-8-hydroxy-%255B1%252C6%255D-naphthyridine-7-carboxamide%2520inhibitors%2520of%2520HIV-1%2520integrase%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D5307%26epage%3D5310" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Wai, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egbertson, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Payne, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Embrey, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, L. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melamed, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langford, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guare, J. P.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhuang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grey, V. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacca, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holloway, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naylor-Olsen, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hazuda, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felock, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolfe, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stillmock, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schleif, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabryelski, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, S. D.</span><span> </span><span class="NLM_article-title">4-Aryl-2,4-dioxobutanoic acid inhibitors of HIV-1 integrase and viral replication in cells</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">4923</span><span class="NLM_x">â</span> <span class="NLM_lpage">4926</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm000176b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=4923-4926&author=J.+S.+Waiauthor=M.+S.+Egbertsonauthor=L.+S.+Payneauthor=T.+E.+Fisherauthor=M.+W.+Embreyauthor=L.+O.+Tranauthor=J.+Y.+Melamedauthor=H.+M.+Langfordauthor=J.+P.+Guareauthor=L.+Zhuangauthor=V.+E.+Greyauthor=J.+P.+Vaccaauthor=M.+K.+Hollowayauthor=A.+M.+Naylor-Olsenauthor=D.+J.+Hazudaauthor=P.+J.+Felockauthor=A.+L.+Wolfeauthor=K.+A.+Stillmockauthor=W.+A.+Schleifauthor=L.+J.+Gabryelskiauthor=S.+D.+Young&title=4-Aryl-2%2C4-dioxobutanoic+acid+inhibitors+of+HIV-1+integrase+and+viral+replication+in+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm000176b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm000176b%26sid%3Dliteratum%253Aachs%26aulast%3DWai%26aufirst%3DJ.%2BS.%26aulast%3DEgbertson%26aufirst%3DM.%2BS.%26aulast%3DPayne%26aufirst%3DL.%2BS.%26aulast%3DFisher%26aufirst%3DT.%2BE.%26aulast%3DEmbrey%26aufirst%3DM.%2BW.%26aulast%3DTran%26aufirst%3DL.%2BO.%26aulast%3DMelamed%26aufirst%3DJ.%2BY.%26aulast%3DLangford%26aufirst%3DH.%2BM.%26aulast%3DGuare%26aufirst%3DJ.%2BP.%26aulast%3DZhuang%26aufirst%3DL.%26aulast%3DGrey%26aufirst%3DV.%2BE.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26aulast%3DHolloway%26aufirst%3DM.%2BK.%26aulast%3DNaylor-Olsen%26aufirst%3DA.%2BM.%26aulast%3DHazuda%26aufirst%3DD.%2BJ.%26aulast%3DFelock%26aufirst%3DP.%2BJ.%26aulast%3DWolfe%26aufirst%3DA.%2BL.%26aulast%3DStillmock%26aufirst%3DK.%2BA.%26aulast%3DSchleif%26aufirst%3DW.%2BA.%26aulast%3DGabryelski%26aufirst%3DL.%2BJ.%26aulast%3DYoung%26aufirst%3DS.%2BD.%26atitle%3D4-Aryl-2%252C4-dioxobutanoic%2520acid%2520inhibitors%2520of%2520HIV-1%2520integrase%2520and%2520viral%2520replication%2520in%2520cells%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D4923%26epage%3D4926" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Wai, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhuang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Embrey, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Staas, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Culberson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyle, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacca, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hazuda, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felock, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schleif, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabryelski, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, I. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellis, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mallai, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, S. D.</span><span> </span><span class="NLM_article-title">Dihydroxypyridopyrazine-1,6-dione HIV-1 integrase inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">5595</span><span class="NLM_x">â</span> <span class="NLM_lpage">5599</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=5595-5599&author=J.+S.+Waiauthor=B.+Kimauthor=T.+E.+Fisherauthor=L.+Zhuangauthor=M.+W.+Embreyauthor=P.+D.+Williamsauthor=D.+D.+Staasauthor=C.+Culbersonauthor=T.+A.+Lyleauthor=J.+P.+Vaccaauthor=D.+J.+Hazudaauthor=P.+J.+Felockauthor=W.+A.+Schleifauthor=L.+J.+Gabryelskiauthor=L.+Jinauthor=I.+W.+Chenauthor=J.+D.+Ellisauthor=R.+Mallaiauthor=S.+D.+Young&title=Dihydroxypyridopyrazine-1%2C6-dione+HIV-1+integrase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWai%26aufirst%3DJ.%2BS.%26aulast%3DKim%26aufirst%3DB.%26aulast%3DFisher%26aufirst%3DT.%2BE.%26aulast%3DZhuang%26aufirst%3DL.%26aulast%3DEmbrey%26aufirst%3DM.%2BW.%26aulast%3DWilliams%26aufirst%3DP.%2BD.%26aulast%3DStaas%26aufirst%3DD.%2BD.%26aulast%3DCulberson%26aufirst%3DC.%26aulast%3DLyle%26aufirst%3DT.%2BA.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26aulast%3DHazuda%26aufirst%3DD.%2BJ.%26aulast%3DFelock%26aufirst%3DP.%2BJ.%26aulast%3DSchleif%26aufirst%3DW.%2BA.%26aulast%3DGabryelski%26aufirst%3DL.%2BJ.%26aulast%3DJin%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DI.%2BW.%26aulast%3DEllis%26aufirst%3DJ.%2BD.%26aulast%3DMallai%26aufirst%3DR.%26aulast%3DYoung%26aufirst%3DS.%2BD.%26atitle%3DDihydroxypyridopyrazine-1%252C6-dione%2520HIV-1%2520integrase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D5595%26epage%3D5599" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Wiscount, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, L. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Embrey, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherman, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Homnick, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donnette Staas, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyle, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wai, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacca, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felock, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stillmock, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witmer, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hazuda, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Day, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabryelski, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ecto, L. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schleif, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiStefano, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kochansky, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anari, M. R.</span><span> </span><span class="NLM_article-title">10-Hydroxy-7,8-dihydropyrazino[1â²,2â²:1,5]pyrrolo[2,3-<i>d</i>]pyridazine-1,9(2<i>H</i>,6<i>H</i>)-diones: potent, orally bioavailable HIV-1 integrase strand-transfer inhibitors with activity against integrase mutants</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">4581</span><span class="NLM_x">â</span> <span class="NLM_lpage">4583</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=4581-4583&author=C.+M.+Wiscountauthor=P.+D.+Williamsauthor=L.+O.+Tranauthor=M.+W.+Embreyauthor=T.+E.+Fisherauthor=V.+Shermanauthor=C.+F.+Homnickauthor=D.+Donnette+Staasauthor=T.+A.+Lyleauthor=J.+S.+Waiauthor=J.+P.+Vaccaauthor=Z.+Wangauthor=P.+J.+Felockauthor=K.+A.+Stillmockauthor=M.+V.+Witmerauthor=M.+D.+Millerauthor=D.+J.+Hazudaauthor=A.+M.+Dayauthor=L.+J.+Gabryelskiauthor=L.+T.+Ectoauthor=W.+A.+Schleifauthor=D.+J.+DiStefanoauthor=C.+J.+Kochanskyauthor=M.+R.+Anari&title=10-Hydroxy-7%2C8-dihydropyrazino%5B1%E2%80%B2%2C2%E2%80%B2%3A1%2C5%5Dpyrrolo%5B2%2C3-d%5Dpyridazine-1%2C9%282H%2C6H%29-diones%3A+potent%2C+orally+bioavailable+HIV-1+integrase+strand-transfer+inhibitors+with+activity+against+integrase+mutants"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWiscount%26aufirst%3DC.%2BM.%26aulast%3DWilliams%26aufirst%3DP.%2BD.%26aulast%3DTran%26aufirst%3DL.%2BO.%26aulast%3DEmbrey%26aufirst%3DM.%2BW.%26aulast%3DFisher%26aufirst%3DT.%2BE.%26aulast%3DSherman%26aufirst%3DV.%26aulast%3DHomnick%26aufirst%3DC.%2BF.%26aulast%3DDonnette%2BStaas%26aufirst%3DD.%26aulast%3DLyle%26aufirst%3DT.%2BA.%26aulast%3DWai%26aufirst%3DJ.%2BS.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DFelock%26aufirst%3DP.%2BJ.%26aulast%3DStillmock%26aufirst%3DK.%2BA.%26aulast%3DWitmer%26aufirst%3DM.%2BV.%26aulast%3DMiller%26aufirst%3DM.%2BD.%26aulast%3DHazuda%26aufirst%3DD.%2BJ.%26aulast%3DDay%26aufirst%3DA.%2BM.%26aulast%3DGabryelski%26aufirst%3DL.%2BJ.%26aulast%3DEcto%26aufirst%3DL.%2BT.%26aulast%3DSchleif%26aufirst%3DW.%2BA.%26aulast%3DDiStefano%26aufirst%3DD.%2BJ.%26aulast%3DKochansky%26aufirst%3DC.%2BJ.%26aulast%3DAnari%26aufirst%3DM.%2BR.%26atitle%3D10-Hydroxy-7%252C8-dihydropyrazino%255B1%25E2%2580%25B2%252C2%25E2%2580%25B2%253A1%252C5%255Dpyrrolo%255B2%252C3-d%255Dpyridazine-1%252C9%25282H%252C6H%2529-diones%253A%2520potent%252C%2520orally%2520bioavailable%2520HIV-1%2520integrase%2520strand-transfer%2520inhibitors%2520with%2520activity%2520against%2520integrase%2520mutants%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D4581%26epage%3D4583" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Zhuang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wai, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Embrey, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egbertson, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Payne, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guare, J. P.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacca, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hazuda, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felock, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolfe, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stillmock, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witmer, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moyer, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schleif, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabryelski, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonard, Y. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, J. J.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michelson, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, S. D.</span><span> </span><span class="NLM_article-title">Design and synthesis of 8-hydroxy-[1,6]naphthyridines as novel inhibitors of HIV-1 integrase in vitro and in infected cells</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">453</span><span class="NLM_x">â</span> <span class="NLM_lpage">456</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm025553u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm300667v&amp;key=1%3ACAS%3A528%3ADC%252BD3sXitVCrsA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=453-456&author=L.+Zhuangauthor=J.+S.+Waiauthor=M.+W.+Embreyauthor=T.+E.+Fisherauthor=M.+S.+Egbertsonauthor=L.+S.+Payneauthor=J.+P.+Guareauthor=J.+P.+Vaccaauthor=D.+J.+Hazudaauthor=P.+J.+Felockauthor=A.+L.+Wolfeauthor=K.+A.+Stillmockauthor=M.+V.+Witmerauthor=G.+Moyerauthor=W.+A.+Schleifauthor=L.+J.+Gabryelskiauthor=Y.+M.+Leonardauthor=J.+J.+Lynchauthor=S.+R.+Michelsonauthor=S.+D.+Young&title=Design+and+synthesis+of+8-hydroxy-%5B1%2C6%5Dnaphthyridines+as+novel+inhibitors+of+HIV-1+integrase+in+vitro+and+in+infected+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Synthesis of 8-Hydroxy-[1,6]Naphthyridines as Novel Inhibitors of HIV-1 Integrase in Vitro and in Infected Cells</span></div><div class="casAuthors">Zhuang, Linghang; Wai, John S.; Embrey, Mark W.; Fisher, Thorsten E.; Egbertson, Melissa S.; Payne, Linda S.; Guare, James P., Jr.; Vacca, Joseph P.; Hazuda, Daria J.; Felock, Peter J.; Wolfe, Abigail L.; Stillmock, Kara A.; Witmer, Marc V.; Moyer, Gregory; Schleif, William A.; Gabryelski, Lori J.; Leonard, Yvonne M.; Lynch, Joseph J., Jr.; Michelson, Stuart R.; Young, Steven D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">453-456</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Naphthyridine I inhibits the strand transfer of the integration process catalyzed by integrase with an IC50 of 10 nM and inhibits 95% of the spread of HIV-1 infection in cell culture at 0.39 Î¼M.  I does not exhibit cytotoxicity in cell culture at â¤12.5 Î¼M and shows a good pharmacokinetic profile when dosed orally to rats.  The antiviral activity of I and its effect on integration were confirmed using viruses with specific integrase mutations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOoGGcZHiJMLVg90H21EOLACvtfcHk0lhZle38T4Ks-A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXitVCrsA%253D%253D&md5=486db25666b872e6ae3613cf49c458f2</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fjm025553u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm025553u%26sid%3Dliteratum%253Aachs%26aulast%3DZhuang%26aufirst%3DL.%26aulast%3DWai%26aufirst%3DJ.%2BS.%26aulast%3DEmbrey%26aufirst%3DM.%2BW.%26aulast%3DFisher%26aufirst%3DT.%2BE.%26aulast%3DEgbertson%26aufirst%3DM.%2BS.%26aulast%3DPayne%26aufirst%3DL.%2BS.%26aulast%3DGuare%26aufirst%3DJ.%2BP.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26aulast%3DHazuda%26aufirst%3DD.%2BJ.%26aulast%3DFelock%26aufirst%3DP.%2BJ.%26aulast%3DWolfe%26aufirst%3DA.%2BL.%26aulast%3DStillmock%26aufirst%3DK.%2BA.%26aulast%3DWitmer%26aufirst%3DM.%2BV.%26aulast%3DMoyer%26aufirst%3DG.%26aulast%3DSchleif%26aufirst%3DW.%2BA.%26aulast%3DGabryelski%26aufirst%3DL.%2BJ.%26aulast%3DLeonard%26aufirst%3DY.%2BM.%26aulast%3DLynch%26aufirst%3DJ.%2BJ.%26aulast%3DMichelson%26aufirst%3DS.%2BR.%26aulast%3DYoung%26aufirst%3DS.%2BD.%26atitle%3DDesign%2520and%2520synthesis%2520of%25208-hydroxy-%255B1%252C6%255Dnaphthyridines%2520as%2520novel%2520inhibitors%2520of%2520HIV-1%2520integrase%2520in%2520vitro%2520and%2520in%2520infected%2520cells%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D453%26epage%3D456" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Chan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stefanac, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavallee, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falardeau, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bedard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">May, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuen, L.</span><span> </span><span class="NLM_article-title">Discovery of 1,6-naphthyridines as a novel class of potent and selective human cytomegalovirus inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">3023</span><span class="NLM_x">â</span> <span class="NLM_lpage">3025</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9902483" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=3023-3025&author=L.+Chanauthor=H.+Jinauthor=T.+Stefanacauthor=J.+F.+Lavalleeauthor=G.+Falardeauauthor=W.+Wangauthor=J.+Bedardauthor=S.+Mayauthor=L.+Yuen&title=Discovery+of+1%2C6-naphthyridines+as+a+novel+class+of+potent+and+selective+human+cytomegalovirus+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fjm9902483&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9902483%26sid%3Dliteratum%253Aachs%26aulast%3DChan%26aufirst%3DL.%26aulast%3DJin%26aufirst%3DH.%26aulast%3DStefanac%26aufirst%3DT.%26aulast%3DLavallee%26aufirst%3DJ.%2BF.%26aulast%3DFalardeau%26aufirst%3DG.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DBedard%26aufirst%3DJ.%26aulast%3DMay%26aufirst%3DS.%26aulast%3DYuen%26aufirst%3DL.%26atitle%3DDiscovery%2520of%25201%252C6-naphthyridines%2520as%2520a%2520novel%2520class%2520of%2520potent%2520and%2520selective%2520human%2520cytomegalovirus%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1999%26volume%3D42%26spage%3D3023%26epage%3D3025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Chan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stefanac, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavallee, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bedard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">May, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falardeau, G.</span><span> </span><span class="NLM_article-title">Design and synthesis of new potent human cytomegalovirus (HCMV) inhibitors based on internally hydrogen-bonded 1,6-naphthyridines</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">103</span><span class="NLM_x">â</span> <span class="NLM_lpage">105</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2001&pages=103-105&author=L.+Chanauthor=T.+Stefanacauthor=J.+F.+Lavalleeauthor=H.+Jinauthor=J.+Bedardauthor=S.+Mayauthor=G.+Falardeau&title=Design+and+synthesis+of+new+potent+human+cytomegalovirus+%28HCMV%29+inhibitors+based+on+internally+hydrogen-bonded+1%2C6-naphthyridines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChan%26aufirst%3DL.%26aulast%3DStefanac%26aufirst%3DT.%26aulast%3DLavallee%26aufirst%3DJ.%2BF.%26aulast%3DJin%26aufirst%3DH.%26aulast%3DBedard%26aufirst%3DJ.%26aulast%3DMay%26aufirst%3DS.%26aulast%3DFalardeau%26aufirst%3DG.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520new%2520potent%2520human%2520cytomegalovirus%2520%2528HCMV%2529%2520inhibitors%2520based%2520on%2520internally%2520hydrogen-bonded%25201%252C6-naphthyridines%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2001%26volume%3D11%26spage%3D103%26epage%3D105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Falardeau, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lachance, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">St-Pierre, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yannopoulos, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drouin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bedard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, L.</span><span> </span><span class="NLM_article-title">Design and synthesis of a potent macrocyclic 1,6-naphthyridine anti-human cytomegalovirus (HCMV) inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">1693</span><span class="NLM_x">â</span> <span class="NLM_lpage">1695</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=1693-1695&author=G.+Falardeauauthor=H.+Lachanceauthor=A.+St-Pierreauthor=C.+G.+Yannopoulosauthor=M.+Drouinauthor=J.+Bedardauthor=L.+Chan&title=Design+and+synthesis+of+a+potent+macrocyclic+1%2C6-naphthyridine+anti-human+cytomegalovirus+%28HCMV%29+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFalardeau%26aufirst%3DG.%26aulast%3DLachance%26aufirst%3DH.%26aulast%3DSt-Pierre%26aufirst%3DA.%26aulast%3DYannopoulos%26aufirst%3DC.%2BG.%26aulast%3DDrouin%26aufirst%3DM.%26aulast%3DBedard%26aufirst%3DJ.%26aulast%3DChan%26aufirst%3DL.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520a%2520potent%2520macrocyclic%25201%252C6-naphthyridine%2520anti-human%2520cytomegalovirus%2520%2528HCMV%2529%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D1693%26epage%3D1695" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Anthony, N. J.; Gomez, R. P.; Young, S. D.; Egbertson, M.; Wai, J. S.; Zhuang, L.; Embrey, M.; Tran, L.; Melamed, J. Y.; Langford, H. M.; Guare, J. P.; Fisher, T. E.; Jolly, S. M.; Kuo, M. S.; Perlow, D. S.; Bennett, J. J.; Funk, T. W.</span><span> </span><span class="NLM_article-title">Preparation of (Poly)azanaphthalenyl carboxamides as HIV Integrase Inhibitors</span>. Patent WO 2002/030930 A2<span class="NLM_x"> </span><span class="NLM_year">2002</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2002&author=N.+J.+Anthony&author=R.+P.+Gomez&author=S.+D.+Young&author=M.+Egbertson&author=J.+S.+Wai&author=L.+Zhuang&author=M.+Embrey&author=L.+Tran&author=J.+Y.+Melamed&author=H.+M.+Langford&author=J.+P.+Guare&author=T.+E.+Fisher&author=S.+M.+Jolly&author=M.+S.+Kuo&author=D.+S.+Perlow&author=J.+J.+Bennett&author=T.+W.+Funk&title=Preparation+of+%28Poly%29azanaphthalenyl+carboxamides+as+HIV+Integrase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAnthony%26aufirst%3DN.%2BJ.%26atitle%3DPreparation%2520of%2520%2528Poly%2529azanaphthalenyl%2520carboxamides%2520as%2520HIV%2520Integrase%2520Inhibitors%26date%3D2002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Pommier, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marchand, C.</span><span> </span><span class="NLM_article-title">Integrase inhibitors to treat HIV/AIDS</span> <span class="citation_source-journal">Nature Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">236</span><span class="NLM_x">â</span> <span class="NLM_lpage">248</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2005&pages=236-248&author=Y.+Pommierauthor=A.+A.+Johnsonauthor=C.+Marchand&title=Integrase+inhibitors+to+treat+HIV%2FAIDS"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPommier%26aufirst%3DY.%26aulast%3DJohnson%26aufirst%3DA.%2BA.%26aulast%3DMarchand%26aufirst%3DC.%26atitle%3DIntegrase%2520inhibitors%2520to%2520treat%2520HIV%252FAIDS%26jtitle%3DNature%2520Rev.%2520Drug%2520Discovery%26date%3D2005%26volume%3D4%26spage%3D236%26epage%3D248" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Hare, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gupta, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valkov, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engelman, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cherepanov, P.</span><span> </span><span class="NLM_article-title">Retroviral intasome assembly and inhibition of DNA strand transfer</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">464</span><span class="NLM_x">, </span> <span class="NLM_fpage">232</span><span class="NLM_x">â</span> <span class="NLM_lpage">236</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Fjm300667v&amp;key=10.1038%2Fnature08784" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Fjm300667v&amp;key=20118915" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm300667v&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1yntLg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=464&publication_year=2010&pages=232-236&author=S.+Hareauthor=S.+S.+Guptaauthor=E.+Valkovauthor=A.+Engelmanauthor=P.+Cherepanov&title=Retroviral+intasome+assembly+and+inhibition+of+DNA+strand+transfer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Retroviral intasome assembly and inhibition of DNA strand transfer</span></div><div class="casAuthors">Hare, Stephen; Gupta, Saumya Shree; Valkov, Eugene; Engelman, Alan; Cherepanov, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">464</span>
        (<span class="NLM_cas:issue">7286</span>),
    <span class="NLM_cas:pages">232-236</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Integrase is an essential retroviral enzyme that binds both termini of linear viral DNA and inserts them into a host cell chromosome.  The structure of full-length retroviral integrase, either sep. or in complex with DNA, has been lacking.  Furthermore, although clin. useful inhibitors of HIV integrase have been developed, their mechanism of action remains speculative.  Here the authors present a crystal structure of full-length integrase from the prototype foamy virus in complex with its cognate DNA.  The structure shows the organization of the retroviral intasome comprising an integrase tetramer tightly assocd. with a pair of viral DNA ends.  All three canonical integrase structural domains are involved in extensive protein-DNA and protein-protein interactions.  The binding of strand-transfer inhibitors displaces the reactive viral DNA end from the active site, disarming the viral nucleoprotein complex.  These findings define the structural basis of retroviral DNA integration, and will allow modeling of the HIV-1 intasome to aid in the development of antiretroviral drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqdEDTFdvZMbVg90H21EOLACvtfcHk0ljW7Lqej8L9iA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1yntLg%253D&md5=9551e74b6bc33494855651c3b157d753</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1038%2Fnature08784&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature08784%26sid%3Dliteratum%253Aachs%26aulast%3DHare%26aufirst%3DS.%26aulast%3DGupta%26aufirst%3DS.%2BS.%26aulast%3DValkov%26aufirst%3DE.%26aulast%3DEngelman%26aufirst%3DA.%26aulast%3DCherepanov%26aufirst%3DP.%26atitle%3DRetroviral%2520intasome%2520assembly%2520and%2520inhibition%2520of%2520DNA%2520strand%2520transfer%26jtitle%3DNature%26date%3D2010%26volume%3D464%26spage%3D232%26epage%3D236" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Hare, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vos, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clayton, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thuring, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cummings, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cherepanov, P.</span><span> </span><span class="NLM_article-title">Molecular mechanisms of retroviral integrase inhibition and the evolution of viral resistance</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">107</span><span class="NLM_x">, </span> <span class="NLM_fpage">20057</span><span class="NLM_x">â</span> <span class="NLM_lpage">20062</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Fjm300667v&amp;key=10.1073%2Fpnas.1010246107" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Fjm300667v&amp;key=21030679" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Fjm300667v&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVyntrnF" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2010&pages=20057-20062&author=S.+Hareauthor=A.+M.+Vosauthor=R.+F.+Claytonauthor=J.+W.+Thuringauthor=M.+D.+Cummingsauthor=P.+Cherepanov&title=Molecular+mechanisms+of+retroviral+integrase+inhibition+and+the+evolution+of+viral+resistance"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular mechanisms of retroviral integrase inhibition and the evolution of viral resistance</span></div><div class="casAuthors">Hare, Stephen; Vos, Ann M.; Clayton, Reginald F.; Thuring, Jan W.; Cummings, Maxwell D.; Cherepanov, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">107</span>
        (<span class="NLM_cas:issue">46</span>),
    <span class="NLM_cas:pages">20057-20062, S20057/1-S20057/7</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The development of HIV integrase (IN) strand transfer inhibitors (INSTIs) and understanding of viral resistance to these mols. have been hampered by a paucity of available structural data.  Co-crystal structures of the prototype foamy virus (PFV) intasome with raltegravir and elvitegravir were recently reported, establishing the general INSTI binding mode.  Now an expanded set of co-crystal structures contg. PFV intasomes complexed with first- and second-generation INSTIs at resolns. of up to 2.5 Ã is presented.  Importantly, the improved resoln. allowed the authors to refine the complete coordination spheres of the catalytic metal cations within the INSTI-bound intasome active site.  It is shown that like the Q148H/G140S and N155H HIV-1 IN variants, the analogous S217H and N224H PFV INs display reduced sensitivity to raltegravir in vitro.  Crystal structures of the mutant PFV intasomes in INSTI-free and -bound forms revealed that the amino acid substitutions necessitate considerable conformational rearrangements within the IN active site to accommodate an INSTI, thus explaining their adverse effects on raltegravir antiviral activity.  Furthermore, the structures predict phys. proximity and an interaction between HIV-1 IN mutant residues His148 and Ser/Ala140, rationalizing the co-evolution of Q148H and G140S/A mutations in drug-resistant viral strains.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovxU36XC1DQrVg90H21EOLACvtfcHk0ljTeoDW228Q-g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVyntrnF&md5=5d66aa03a9478dad36e878d43c408099</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1010246107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1010246107%26sid%3Dliteratum%253Aachs%26aulast%3DHare%26aufirst%3DS.%26aulast%3DVos%26aufirst%3DA.%2BM.%26aulast%3DClayton%26aufirst%3DR.%2BF.%26aulast%3DThuring%26aufirst%3DJ.%2BW.%26aulast%3DCummings%26aufirst%3DM.%2BD.%26aulast%3DCherepanov%26aufirst%3DP.%26atitle%3DMolecular%2520mechanisms%2520of%2520retroviral%2520integrase%2520inhibition%2520and%2520the%2520evolution%2520of%2520viral%2520resistance%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2010%26volume%3D107%26spage%3D20057%26epage%3D20062" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span>Millipore UK Corporation web site: <a href="http://www.millipore.com" class="extLink">www.millipore.com</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Millipore+UK+Corporation+web+site%3A+www.millipore.com."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Wang, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Y. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, Y. T.</span><span> </span><span class="NLM_article-title">Mangiferin, an anti-HIV agent targeting protease and effective against resistant strains.</span> <span class="citation_source-journal">Molecules</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">4264</span><span class="NLM_x">â</span> <span class="NLM_lpage">4277</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2011&pages=4264-4277&author=R.+R.+Wangauthor=Y.+D.+Gaoauthor=C.+H.+Maauthor=X.+J.+Zhangauthor=C.+G.+Huangauthor=J.+F.+Huangauthor=Y.+T.+Zheng&title=Mangiferin%2C+an+anti-HIV+agent+targeting+protease+and+effective+against+resistant+strains."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DR.%2BR.%26aulast%3DGao%26aufirst%3DY.%2BD.%26aulast%3DMa%26aufirst%3DC.%2BH.%26aulast%3DZhang%26aufirst%3DX.%2BJ.%26aulast%3DHuang%26aufirst%3DC.%2BG.%26aulast%3DHuang%26aufirst%3DJ.%2BF.%26aulast%3DZheng%26aufirst%3DY.%2BT.%26atitle%3DMangiferin%252C%2520an%2520anti-HIV%2520agent%2520targeting%2520protease%2520and%2520effective%2520against%2520resistant%2520strains.%26jtitle%3DMolecules%26date%3D2011%26volume%3D16%26spage%3D4264%26epage%3D4277" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Fan, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, F. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Al-Safi, R. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shabaik, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Debnath, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanchez, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Odde, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neamati, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Long, Y. Q.</span><span> </span><span class="NLM_article-title">Design of HIV-1 integrase inhibitors targeting the catalytic domain as well as its interaction with LEDGF/p75: a scaffold hopping approach using salicylate and catechol groups</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">4935</span><span class="NLM_x">â</span> <span class="NLM_lpage">4952</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2011&pages=4935-4952&author=X.+Fanauthor=F.+H.+Zhangauthor=R.+I.+Al-Safiauthor=L.+F.+Zengauthor=Y.+Shabaikauthor=B.+Debnathauthor=T.+W.+Sanchezauthor=S.+Oddeauthor=N.+Neamatiauthor=Y.+Q.+Long&title=Design+of+HIV-1+integrase+inhibitors+targeting+the+catalytic+domain+as+well+as+its+interaction+with+LEDGF%2Fp75%3A+a+scaffold+hopping+approach+using+salicylate+and+catechol+groups"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFan%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DF.%2BH.%26aulast%3DAl-Safi%26aufirst%3DR.%2BI.%26aulast%3DZeng%26aufirst%3DL.%2BF.%26aulast%3DShabaik%26aufirst%3DY.%26aulast%3DDebnath%26aufirst%3DB.%26aulast%3DSanchez%26aufirst%3DT.%2BW.%26aulast%3DOdde%26aufirst%3DS.%26aulast%3DNeamati%26aufirst%3DN.%26aulast%3DLong%26aufirst%3DY.%2BQ.%26atitle%3DDesign%2520of%2520HIV-1%2520integrase%2520inhibitors%2520targeting%2520the%2520catalytic%2520domain%2520as%2520well%2520as%2520its%2520interaction%2520with%2520LEDGF%252Fp75%253A%2520a%2520scaffold%2520hopping%2520approach%2520using%2520salicylate%2520and%2520catechol%2520groups%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2011%26volume%3D19%26spage%3D4935%26epage%3D4952" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Jones, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willett, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glen, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leach, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, R.</span><span> </span><span class="NLM_article-title">Development and validation of a genetic algorithm for flexible docking</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">267</span><span class="NLM_x">, </span> <span class="NLM_fpage">727</span><span class="NLM_x">â</span> <span class="NLM_lpage">748</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Fjm300667v&amp;key=10.1006%2Fjmbi.1996.0897" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Fjm300667v&amp;key=9126849" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm300667v&amp;key=1%3ACAS%3A528%3ADyaK2sXis1KntLo%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=267&publication_year=1997&pages=727-748&author=G.+Jonesauthor=P.+Willettauthor=R.+C.+Glenauthor=A.+R.+Leachauthor=R.+Taylor&title=Development+and+validation+of+a+genetic+algorithm+for+flexible+docking"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Development and validation of a genetic algorithm for flexible docking</span></div><div class="casAuthors">Jones, Gareth; Willett, Peter; Glen, Robert C.; Leach, Andrew R.; Taylor, Robin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">267</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">727-748</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Academic</span>)
        </div><div class="casAbstract">Prediction of small mol. binding modes to macromols. of known three-dimensional structure is a problem of paramount importance in rational drug design (the "docking" problem).  We report the development and validation of the program GOLD (Genetic Optimization for Ligand Docking).  GOLD is an automated ligand docking program that uses a genetic algorithm to explore the full range of ligand conformational flexibility with partial flexibility of the protein and satisfies the fundamental requirement that the ligand must displace loosely bound water on binding.  Numerous enhancements and modifications have been applied to the original technique resulting in a substantial increase in the reliability and the applicability of the algorithm.  The advanced algorithm has been tested on a dataset of 100 complexes extd. from the Brookhaven Protein Data Bank.  When used to dock the ligand back into the binding site, GOLD achieved a 71% success rate in identifying the exptl. binding mode.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrP3I60Rl2uorVg90H21EOLACvtfcHk0lh_2FCxsn59YQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXis1KntLo%253D&md5=476a2b1d8f80f3ba418052fe29d735ca</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1006%2Fjmbi.1996.0897&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fjmbi.1996.0897%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DG.%26aulast%3DWillett%26aufirst%3DP.%26aulast%3DGlen%26aufirst%3DR.%2BC.%26aulast%3DLeach%26aufirst%3DA.%2BR.%26aulast%3DTaylor%26aufirst%3DR.%26atitle%3DDevelopment%2520and%2520validation%2520of%2520a%2520genetic%2520algorithm%2520for%2520flexible%2520docking%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D1997%26volume%3D267%26spage%3D727%26epage%3D748" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Jones, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willett, P.</span><span> </span><span class="NLM_article-title">Docking small-molecule ligands into active sites</span> <span class="citation_source-journal">Curr. Opin. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">652</span><span class="NLM_x">â</span> <span class="NLM_lpage">656</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Fjm300667v&amp;key=10.1016%2F0958-1669%2895%2980107-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Fjm300667v&amp;key=8527835" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Fjm300667v&amp;key=1%3ACAS%3A528%3ADyaK2MXpvVSrtL4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1995&pages=652-656&author=G.+Jonesauthor=P.+Willett&title=Docking+small-molecule+ligands+into+active+sites"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Docking small-mol. ligands into active sites</span></div><div class="casAuthors">Jones, Gareth; Willett, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Biotechnology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">652-6</span>CODEN:
                <span class="NLM_cas:coden">CUOBE3</span>;
        ISSN:<span class="NLM_cas:issn">0958-1669</span>.
    
            (<span class="NLM_cas:orgname">Current Biology</span>)
        </div><div class="casAbstract">A review with 28 refs.  Docking involves the development of computer algorithms that evaluate the binding modes of putative ligands in receptor sites.  The principal advances of the past yr have been the development of new algorithmic approaches, several of which incorporate conformational flexibility, and the increased use of docking to identify leads in drug-discovery programs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHGU6KHOkaW7Vg90H21EOLACvtfcHk0lh_2FCxsn59YQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXpvVSrtL4%253D&md5=86d38c0c58611fb2e786b7ef6eb3eb04</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2F0958-1669%2895%2980107-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0958-1669%252895%252980107-3%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DG.%26aulast%3DWillett%26aufirst%3DP.%26atitle%3DDocking%2520small-molecule%2520ligands%2520into%2520active%2520sites%26jtitle%3DCurr.%2520Opin.%2520Biotechnol.%26date%3D1995%26volume%3D6%26spage%3D652%26epage%3D656" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span>LigPrep, <span class="NLM_edition">version 2.5</span>; <span class="NLM_publisher-name">SchrÃ¶dinger, LLC</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=LigPrep%2C+version+2.5%3B+Schr%C3%B6dinger%2C+LLC%3A+New+York%2C+2011."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DLigPrep%26pub%3DSchr%25C3%25B6dinger%252C%2520LLC%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span>Epik, <span class="NLM_edition">version 2.2</span>; <span class="NLM_publisher-name">SchrÃ¶dinger, LLC</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Epik%2C+version+2.2%3B+Schr%C3%B6dinger%2C+LLC%3A+New+York%2C+2011."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DEpik%26pub%3DSchr%25C3%25B6dinger%252C%2520LLC%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Carmichael, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeGraff, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gazdar, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minna, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitchell, J. B.</span><span> </span><span class="NLM_article-title">Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">936</span><span class="NLM_x">â</span> <span class="NLM_lpage">942</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Fjm300667v&amp;key=3802100" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Fjm300667v&amp;key=1%3ACAS%3A528%3ADyaL2sXhsVyrtb0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=1987&pages=936-942&author=J.+Carmichaelauthor=W.+G.+DeGraffauthor=A.+F.+Gazdarauthor=J.+D.+Minnaauthor=J.+B.+Mitchell&title=Evaluation+of+a+tetrazolium-based+semiautomated+colorimetric+assay%3A+assessment+of+chemosensitivity+testing"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of a tetrazolium-based semiautomated colorimetric assay:  assessment of chemosensitivity testing</span></div><div class="casAuthors">Carmichael, James; DeGraff, William G.; Gazdar, Adi F.; Minna, John D.; Mitchell, James B.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">936-42</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    </div><div class="casAbstract">Drug sensitivity assays were performed using a variation of a colorimetric thiazolyl blue (MTT)  [298-93-1] assay on V79, CHO-AuxB1, CHRC5, NCI-H460, and NCI-H249 cell lines following optimization of exptl. conditions for each cell line.  Results from this assay were compared with data assimilated simultaneously by clonogenic assay and by dye exclusion assay.  Good correlation was obsd. using the CHO-AuxB1 cell line and the pleiotropic drug-resistant mutant CHRC5, with similar degrees of relative resistance obsd. with both the MTT and clonogenic assays.  Good correlation was obsd. between the clonogenic and MTT assays for 1-h drug exposures, although the MTT assay was more sensitive to vinblastine.  In general, the clonogenic assay was more sensitive when continuous drug exposures were utilized, although this was primarily related to the increased drug exposure time.  While the use of the MTT assay in drug sensitivity testing of primary tumor samples is limited, since contaminating normal cells may also reduce the tetrazolium, the MTT assay can be semiautomated, and therefore it offers a valid, simple method of assessing chemosensitivity in established cell lines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpj92XstI7WtLVg90H21EOLACvtfcHk0lh7-2tca0No_w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2sXhsVyrtb0%253D&md5=2414230269c9f4d5f2910764c65fc042</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCarmichael%26aufirst%3DJ.%26aulast%3DDeGraff%26aufirst%3DW.%2BG.%26aulast%3DGazdar%26aufirst%3DA.%2BF.%26aulast%3DMinna%26aufirst%3DJ.%2BD.%26aulast%3DMitchell%26aufirst%3DJ.%2BB.%26atitle%3DEvaluation%2520of%2520a%2520tetrazolium-based%2520semiautomated%2520colorimetric%2520assay%253A%2520assessment%2520of%2520chemosensitivity%2520testing%26jtitle%3DCancer%2520Res.%26date%3D1987%26volume%3D47%26spage%3D936%26epage%3D942" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Munshi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hobbs, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyn, R. E.</span><span> </span><span class="NLM_article-title">Clonogenic cell survival assay</span> <span class="citation_source-journal">Methods Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">110</span><span class="NLM_x">, </span> <span class="NLM_fpage">21</span><span class="NLM_x">â</span> <span class="NLM_lpage">28</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Fjm300667v&amp;key=15901923" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Fjm300667v&amp;key=1%3ACAS%3A280%3ADC%252BD2M3mtFemtg%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2005&pages=21-28&author=A.+Munshiauthor=M.+Hobbsauthor=R.+E.+Meyn&title=Clonogenic+cell+survival+assay"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Clonogenic cell survival assay</span></div><div class="casAuthors">Munshi Anupama; Hobbs Marvette; Meyn Raymond E</div><div class="citationInfo"><span class="NLM_cas:title">Methods in molecular medicine</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">21-8</span>
        ISSN:<span class="NLM_cas:issn">1543-1894</span>.
    </div><div class="casAbstract">The clonogenic cell survival assay determines the ability of a cell to proliferate indefinitely, thereby retaining its reproductive ability to form a large colony or a clone.  This cell is then said to be clonogenic.  A cell survival curve is therefore defined as a relationship between the dose of the agent used to produce an insult and the fraction of cells retaining their ability to reproduce.  Although clonogenic cell survival assays were initially described for studying the effects of radiation on cells and have played an essential role in radiobiology, they are now widely used to examine the effects of agents with potential applications in the clinic.  These include, in addition to ionizing radiation, chemotherapy agents such as etoposide and cisplatin, antiangiogenic agents such as endostatin and angiostatin, and cytokines and their receptors, either alone or in combination therapy.  Survival curves have been generated for many established cell lines growing in culture.  One can use cell lines from various origins including humans and rodents; these cells can be neoplastic or normal.  Because survival curves have wide application in evaluating the reproductive integrity of different cells, we provide here the steps involved in setting up a typical experiment using an established cell line in culture.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTUBOE0LtKCR5QHPYJuLg8TfW6udTcc2eY94Z_Lxqh8Vbntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2M3mtFemtg%253D%253D&md5=4b3b285f5ed64f7804c52312361d013e</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMunshi%26aufirst%3DA.%26aulast%3DHobbs%26aufirst%3DM.%26aulast%3DMeyn%26aufirst%3DR.%2BE.%26atitle%3DClonogenic%2520cell%2520survival%2520assay%26jtitle%3DMethods%2520Mol.%2520Med.%26date%3D2005%26volume%3D110%26spage%3D21%26epage%3D28" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 35 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Ming-Shu Wang, Hong-Chuang Xu, Yi Gong, Ren-Yu Qu, Lin-Sheng Zhuo, <span class="NLM_string-name hlFld-ContribAuthor">Wei Huang</span>. </span><span class="cited-content_cbyCitation_article-title">Efficient Arylation of 2,7-Naphthyridin-1(2H)-one with Diaryliodonium Salts and Discovery of a New Selective MET/AXL Kinase Inhibitor. </span><span class="cited-content_cbyCitation_journal-name">ACS Combinatorial Science</span><span> <strong>2020,</strong> <em>22 </em>
                                    (9)
                                     , 457-467. <a href="https://doi.org/10.1021/acscombsci.0c00074" title="DOI URL">https://doi.org/10.1021/acscombsci.0c00074</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acscombsci.0c00074&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facscombsci.0c00074%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Combinatorial%2520Science%26atitle%3DEfficient%252BArylation%252Bof%252B2%25252C7-Naphthyridin-1%2525282H%252529-one%252Bwith%252BDiaryliodonium%252BSalts%252Band%252BDiscovery%252Bof%252Ba%252BNew%252BSelective%252BMET%25252FAXL%252BKinase%252BInhibitor%26aulast%3DWang%26aufirst%3DMing-Shu%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D03052020%26date%3D22062020%26date%3D10072020%26date%3D26062020%26volume%3D22%26issue%3D9%26spage%3D457%26epage%3D467" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Michael G. Thomas, Manu De Rycker, Richard J. Wall, Daniel Spinks, Ola Epemolu, Sujatha Manthri, Suzanne Norval, Maria Osuna-Cabello, Stephen Patterson, Jennifer Riley, Frederick R. C. Simeons, Laste Stojanovski, John Thomas, Stephen Thompson, Claire Naylor, Jose M. Fiandor, Paul G. Wyatt, Maria Marco, Susan Wyllie, Kevin D. Read, Timothy J. Miles, <span class="NLM_string-name hlFld-ContribAuthor">Ian H. Gilbert</span>. </span><span class="cited-content_cbyCitation_article-title">Identification and Optimization of a Series of 8-Hydroxy Naphthyridines with Potent In Vitro Antileishmanial Activity: Initial SAR and Assessment of In Vivo Activity. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (17)
                                     , 9523-9539. <a href="https://doi.org/10.1021/acs.jmedchem.0c00705" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00705</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00705&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00705%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIdentification%252Band%252BOptimization%252Bof%252Ba%252BSeries%252Bof%252B8-Hydroxy%252BNaphthyridines%252Bwith%252BPotent%252BIn%252BVitro%252BAntileishmanial%252BActivity%25253A%252BInitial%252BSAR%252Band%252BAssessment%252Bof%252BIn%252BVivo%252BActivity%26aulast%3DThomas%26aufirst%3DMichael%2BG.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D28042020%26date%3D13082020%26date%3D14072020%26volume%3D63%26issue%3D17%26spage%3D9523%26epage%3D9539" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Gaochan Wu, Tong Zhao, Dongwei Kang, Jian Zhang, Yuning Song, Vigneshwaran Namasivayam, Jacob Kongsted, Christophe Pannecouque, Erik De Clercq, Vasanthanathan Poongavanam, Xinyong Liu, <span class="NLM_string-name hlFld-ContribAuthor">Peng Zhan</span>. </span><span class="cited-content_cbyCitation_article-title">Overview of Recent Strategic Advances in Medicinal Chemistry. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (21)
                                     , 9375-9414. <a href="https://doi.org/10.1021/acs.jmedchem.9b00359" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00359</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00359&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b00359%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DOverview%252Bof%252BRecent%252BStrategic%252BAdvances%252Bin%252BMedicinal%252BChemistry%26aulast%3DWu%26aufirst%3DGaochan%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D26022019%26date%3D28052019%26date%3D03052019%26volume%3D62%26issue%3D21%26spage%3D9375%26epage%3D9414" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Takashi  Masaoka</span>, <span class="hlFld-ContribAuthor ">Haiyan  Zhao</span>, <span class="hlFld-ContribAuthor ">Danielle R.  Hirsch</span>, <span class="hlFld-ContribAuthor ">Michael P.  DâErasmo</span>, <span class="hlFld-ContribAuthor ">Christine  Meck</span>, <span class="hlFld-ContribAuthor ">Brittany  Varnado</span>, <span class="hlFld-ContribAuthor ">Ankit  Gupta</span>, <span class="hlFld-ContribAuthor ">Marvin J.  Meyers</span>, <span class="hlFld-ContribAuthor ">Joel  Baines</span>, <span class="hlFld-ContribAuthor ">John A.  Beutler</span>, <span class="hlFld-ContribAuthor ">Ryan P.  Murelli</span>, <span class="hlFld-ContribAuthor ">Liang  Tang</span>, and <span class="hlFld-ContribAuthor ">Stuart F. J.  Le Grice</span>  . </span><span class="cited-content_cbyCitation_article-title">Characterization of the C-Terminal Nuclease Domain of Herpes Simplex Virus pUL15 as a Target of Nucleotidyltransferase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Biochemistry</span><span> <strong>2016,</strong> <em>55 </em>
                                    (5)
                                     , 809-819. <a href="https://doi.org/10.1021/acs.biochem.5b01254" title="DOI URL">https://doi.org/10.1021/acs.biochem.5b01254</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.biochem.5b01254&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.biochem.5b01254%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemistry%26atitle%3DCharacterization%252Bof%252Bthe%252BC-Terminal%252BNuclease%252BDomain%252Bof%252BHerpes%252BSimplex%252BVirus%252BpUL15%252Bas%252Ba%252BTarget%252Bof%252BNucleotidyltransferase%252BInhibitors%26aulast%3DMasaoka%26aufirst%3DTakashi%26date%3D2016%26date%3D2016%26date%3D2015%26date%3D2015%26date%3D19112015%26date%3D29122015%26date%3D01022016%26date%3D09022016%26date%3D14012016%26volume%3D55%26issue%3D5%26spage%3D809%26epage%3D819" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Isravel  Muthukrishnan</span>, <span class="hlFld-ContribAuthor ">Perumal  Vinoth</span>, <span class="hlFld-ContribAuthor ">Thavaraj  Vivekanand</span>, <span class="hlFld-ContribAuthor ">Subbiah  Nagarajan</span>, <span class="hlFld-ContribAuthor ">C. Uma  Maheswari</span>, <span class="hlFld-ContribAuthor ">J. Carlos  MenÃ©ndez</span>, and <span class="hlFld-ContribAuthor ">Vellaisamy  Sridharan</span>  . </span><span class="cited-content_cbyCitation_article-title">Synthesis of 5,6-Dihydrodibenzo[b,h][1,6]naphthyridines via Copper Bromide Catalyzed Intramolecular [4 + 2] Hetero-DielsâAlder Reactions. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2016,</strong> <em>81 </em>
                                    (3)
                                     , 1116-1124. <a href="https://doi.org/10.1021/acs.joc.5b02669" title="DOI URL">https://doi.org/10.1021/acs.joc.5b02669</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.5b02669&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.5b02669%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DSynthesis%252Bof%252B5%25252C6-Dihydrodibenzo%25255Bb%25252Ch%25255D%25255B1%25252C6%25255Dnaphthyridines%252Bvia%252BCopper%252BBromide%252BCatalyzed%252BIntramolecular%252B%25255B4%252B%25252B%252B2%25255D%252BHetero-Diels%2525E2%252580%252593Alder%252BReactions%26aulast%3DMuthukrishnan%26aufirst%3DIsravel%26date%3D2016%26date%3D2015%26date%3D2015%26date%3D21112015%26date%3D29122015%26date%3D05022016%26date%3D22122015%26volume%3D81%26issue%3D3%26spage%3D1116%26epage%3D1124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Thangaraj  Devadoss</span>, <span class="hlFld-ContribAuthor ">Veldhi  Sowmya</span>, <span class="hlFld-ContribAuthor ">Ravali  Bastati</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of 1,6âNaphthyridine and Its Derivatives: A Systematic Review. </span><span class="cited-content_cbyCitation_journal-name">ChemistrySelect</span><span> <strong>2021,</strong> <em>6 </em>
                                    (15)
                                     , 3610-3641. <a href="https://doi.org/10.1002/slct.202004462" title="DOI URL">https://doi.org/10.1002/slct.202004462</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/slct.202004462&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fslct.202004462%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistrySelect%26atitle%3DSynthesis%252Bof%252B1%25252C6%2525E2%252580%252590Naphthyridine%252Band%252BIts%252BDerivatives%25253A%252BA%252BSystematic%252BReview%26aulast%3DDevadoss%26aufirst%3DThangaraj%26date%3D2021%26date%3D2021%26volume%3D6%26issue%3D15%26spage%3D3610%26epage%3D3641" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mallu  Lavanya</span>, <span class="hlFld-ContribAuthor ">Chong  Lin</span>, <span class="hlFld-ContribAuthor ">Jincheng  Mao</span>, <span class="hlFld-ContribAuthor ">Dhakshanamurthy  Thirumalai</span>, <span class="hlFld-ContribAuthor ">Sreenath Reddy  Aabaka</span>, <span class="hlFld-ContribAuthor ">Xiaojiang  Yang</span>, <span class="hlFld-ContribAuthor ">Jinhua  Mao</span>, <span class="hlFld-ContribAuthor ">Zhiyu  Huang</span>, <span class="hlFld-ContribAuthor ">Jinzhou  Zhao</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Anticancer Properties of Functionalized 1,6-Naphthyridines. </span><span class="cited-content_cbyCitation_journal-name">Topics in Current Chemistry</span><span> <strong>2021,</strong> <em>379 </em>
                                    (2)
                                     <a href="https://doi.org/10.1007/s41061-020-00314-6" title="DOI URL">https://doi.org/10.1007/s41061-020-00314-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s41061-020-00314-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs41061-020-00314-6%26sid%3Dliteratum%253Aachs%26jtitle%3DTopics%2520in%2520Current%2520Chemistry%26atitle%3DSynthesis%252Band%252BAnticancer%252BProperties%252Bof%252BFunctionalized%252B1%25252C6-Naphthyridines%26aulast%3DLavanya%26aufirst%3DMallu%26date%3D2021%26date%3D2021%26volume%3D379%26issue%3D2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">K. N.  Vennila</span>, <span class="hlFld-ContribAuthor ">B.  Selvakumar</span>, <span class="hlFld-ContribAuthor ">V.  Satish</span>, <span class="hlFld-ContribAuthor ">D.  Sunny</span>, <span class="hlFld-ContribAuthor ">S.  Madhuri</span>, <span class="hlFld-ContribAuthor ">K. P.  Elango</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-based design, synthesis, biological evaluation, and molecular docking of novel 10-methoxy dibenzo[b,h][1,6]naphthyridinecarboxamides. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Chemistry Research</span><span> <strong>2021,</strong> <em>30 </em>
                                    (1)
                                     , 133-141. <a href="https://doi.org/10.1007/s00044-020-02645-x" title="DOI URL">https://doi.org/10.1007/s00044-020-02645-x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00044-020-02645-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00044-020-02645-x%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Chemistry%2520Research%26atitle%3DStructure-based%252Bdesign%25252C%252Bsynthesis%25252C%252Bbiological%252Bevaluation%25252C%252Band%252Bmolecular%252Bdocking%252Bof%252Bnovel%252B10-methoxy%252Bdibenzo%25255Bb%25252Ch%25255D%25255B1%25252C6%25255Dnaphthyridinecarboxamides%26aulast%3DVennila%26aufirst%3DK.%2BN.%26date%3D2021%26date%3D2020%26volume%3D30%26issue%3D1%26spage%3D133%26epage%3D141" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ming-Shu  Wang</span>, <span class="hlFld-ContribAuthor ">Yi  Gong</span>, <span class="hlFld-ContribAuthor ">Zhi-Cheng  Yu</span>, <span class="hlFld-ContribAuthor ">Yan-Guang  Tian</span>, <span class="hlFld-ContribAuthor ">Lin-Sheng  Zhuo</span>, <span class="hlFld-ContribAuthor ">Wei  Huang</span>, <span class="hlFld-ContribAuthor ">Neng-Fang  She</span>. </span><span class="cited-content_cbyCitation_article-title">Grignard Reagent Utilization Enables a Practical and Scalable Construction of 3-Substituted 5-Chloro-1,6-naphthyridin-4-one Derivatives. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2020,</strong> <em>25 </em>
                                    (23)
                                     , 5667. <a href="https://doi.org/10.3390/molecules25235667" title="DOI URL">https://doi.org/10.3390/molecules25235667</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules25235667&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules25235667%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DGrignard%252BReagent%252BUtilization%252BEnables%252Ba%252BPractical%252Band%252BScalable%252BConstruction%252Bof%252B3-Substituted%252B5-Chloro-1%25252C6-naphthyridin-4-one%252BDerivatives%26aulast%3DWang%26aufirst%3DMing-Shu%26date%3D2020%26date%3D2020%26volume%3D25%26issue%3D23%26spage%3D5667" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mehdi  Ghandi</span>, <span class="hlFld-ContribAuthor ">Rasoul  Rashid</span>, <span class="hlFld-ContribAuthor ">Alireza  Abbasi</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of Novel Tetrahydropyrimido[4,5-B][1,6]Naphthyridines via Condensation of 1-benzyl-3,5-bis[(E)-arylmethylidene]tetrahydropyridin-4(1H)-ones with 6-aminouracils. </span><span class="cited-content_cbyCitation_journal-name">Chemistry of Heterocyclic Compounds</span><span> <strong>2020,</strong> <em>56 </em>
                                    (11)
                                     , 1473-1476. <a href="https://doi.org/10.1007/s10593-020-02840-z" title="DOI URL">https://doi.org/10.1007/s10593-020-02840-z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10593-020-02840-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10593-020-02840-z%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520of%2520Heterocyclic%2520Compounds%26atitle%3DSynthesis%252Bof%252BNovel%252BTetrahydropyrimido%25255B4%25252C5-B%25255D%25255B1%25252C6%25255DNaphthyridines%252Bvia%252BCondensation%252Bof%252B1-benzyl-3%25252C5-bis%25255B%252528E%252529-arylmethylidene%25255Dtetrahydropyridin-4%2525281H%252529-ones%252Bwith%252B6-aminouracils%26aulast%3DGhandi%26aufirst%3DMehdi%26date%3D2020%26date%3D2020%26volume%3D56%26issue%3D11%26spage%3D1473%26epage%3D1476" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ming-Shu  Wang</span>, <span class="hlFld-ContribAuthor ">Lin-Sheng  Zhuo</span>, <span class="hlFld-ContribAuthor ">Fan-Peng  Yang</span>, <span class="hlFld-ContribAuthor ">Wen-Jie  Wang</span>, <span class="hlFld-ContribAuthor ">Wei  Huang</span>, <span class="hlFld-ContribAuthor ">Guang-Fu  Yang</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological evaluation of new MET inhibitors with 1,6-naphthyridinone scaffold. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>185 </em>, 111803. <a href="https://doi.org/10.1016/j.ejmech.2019.111803" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.111803</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.111803&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.111803%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bnew%252BMET%252Binhibitors%252Bwith%252B1%25252C6-naphthyridinone%252Bscaffold%26aulast%3DWang%26aufirst%3DMing-Shu%26date%3D2020%26volume%3D185%26spage%3D111803" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaoyi  Zhang</span>, <span class="hlFld-ContribAuthor ">Wenling  Niu</span>, <span class="hlFld-ContribAuthor ">Tang  Tang</span>, <span class="hlFld-ContribAuthor ">Chengfei  Hou</span>, <span class="hlFld-ContribAuthor ">Yajie  Guo</span>, <span class="hlFld-ContribAuthor ">Ren  Kong</span>. </span><span class="cited-content_cbyCitation_article-title">A Strategy to Find Novel Candidate DKAs Inhibitors Using Modified QSAR Model with Favorable Druggability Properties. </span><span class="cited-content_cbyCitation_journal-name">Chemical Research in Chinese Universities</span><span> <strong>2019,</strong> <em>35 </em>
                                    (6)
                                     , 1111-1118. <a href="https://doi.org/10.1007/s40242-019-9183-5" title="DOI URL">https://doi.org/10.1007/s40242-019-9183-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s40242-019-9183-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs40242-019-9183-5%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Research%2520in%2520Chinese%2520Universities%26atitle%3DA%252BStrategy%252Bto%252BFind%252BNovel%252BCandidate%252BDKAs%252BInhibitors%252BUsing%252BModified%252BQSAR%252BModel%252Bwith%252BFavorable%252BDruggability%252BProperties%26aulast%3DZhang%26aufirst%3DXiaoyi%26date%3D2019%26date%3D2019%26volume%3D35%26issue%3D6%26spage%3D1111%26epage%3D1118" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ilaria  Frasson</span>, <span class="hlFld-ContribAuthor ">Virginia  SpanÃ²</span>, <span class="hlFld-ContribAuthor ">Simona  Di Martino</span>, <span class="hlFld-ContribAuthor ">Matteo  Nadai</span>, <span class="hlFld-ContribAuthor ">Filippo  Doria</span>, <span class="hlFld-ContribAuthor ">Barbara  Parrino</span>, <span class="hlFld-ContribAuthor ">Anna  Carbone</span>, <span class="hlFld-ContribAuthor ">Stella Maria  Cascioferro</span>, <span class="hlFld-ContribAuthor ">Patrizia  Diana</span>, <span class="hlFld-ContribAuthor ">Girolamo  Cirrincione</span>, <span class="hlFld-ContribAuthor ">Mauro  Freccero</span>, <span class="hlFld-ContribAuthor ">Paola  Barraja</span>, <span class="hlFld-ContribAuthor ">Sara N.  Richter</span>, <span class="hlFld-ContribAuthor ">Alessandra  Montalbano</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and photocytotoxic activity of [1,2,3]triazolo[4,5-h][1,6]naphthyridines and [1,3]oxazolo[5,4-h][1,6]naphthyridines. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>162 </em>, 176-193. <a href="https://doi.org/10.1016/j.ejmech.2018.10.071" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.10.071</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.10.071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.10.071%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bphotocytotoxic%252Bactivity%252Bof%252B%25255B1%25252C2%25252C3%25255Dtriazolo%25255B4%25252C5-h%25255D%25255B1%25252C6%25255Dnaphthyridines%252Band%252B%25255B1%25252C3%25255Doxazolo%25255B5%25252C4-h%25255D%25255B1%25252C6%25255Dnaphthyridines%26aulast%3DFrasson%26aufirst%3DIlaria%26date%3D2019%26volume%3D162%26spage%3D176%26epage%3D193" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Puchakayala  Bharath Kumar Reddy</span>, <span class="hlFld-ContribAuthor ">Kanakaraju  Ravi</span>, <span class="hlFld-ContribAuthor ">Kukkamudi  Mahesh</span>, <span class="hlFld-ContribAuthor ">Panaganti  Leelavathi</span>. </span><span class="cited-content_cbyCitation_article-title">Intramolecular Heck reaction: A facile sequential one-pot synthesis of 1,2,3,4-tetrahydrobenzo[b][1,6]naphthyridines. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2018,</strong> <em>59 </em>
                                    (45)
                                     , 4039-4043. <a href="https://doi.org/10.1016/j.tetlet.2018.09.068" title="DOI URL">https://doi.org/10.1016/j.tetlet.2018.09.068</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2018.09.068&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2018.09.068%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DIntramolecular%252BHeck%252Breaction%25253A%252BA%252Bfacile%252Bsequential%252Bone-pot%252Bsynthesis%252Bof%252B1%25252C2%25252C3%25252C4-tetrahydrobenzo%25255Bb%25255D%25255B1%25252C6%25255Dnaphthyridines%26aulast%3DBharath%2BKumar%2BReddy%26aufirst%3DPuchakayala%26date%3D2018%26volume%3D59%26issue%3D45%26spage%3D4039%26epage%3D4043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sudarshan  Debnath</span>, <span class="hlFld-ContribAuthor ">Shovan  Mondal</span>. </span><span class="cited-content_cbyCitation_article-title">Sultams: Recent Syntheses and Applications. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2018,</strong> <em>2018 </em>
                                    (8)
                                     , 933-956. <a href="https://doi.org/10.1002/ejoc.201701491" title="DOI URL">https://doi.org/10.1002/ejoc.201701491</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.201701491&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.201701491%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DSultams%25253A%252BRecent%252BSyntheses%252Band%252BApplications%26aulast%3DDebnath%26aufirst%3DSudarshan%26date%3D2018%26date%3D2018%26volume%3D2018%26issue%3D8%26spage%3D933%26epage%3D956" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Majdah  AL-Johani</span>, <span class="hlFld-ContribAuthor ">Khadijah  Al-Zaydi</span>, <span class="hlFld-ContribAuthor ">Sameera  Mousally</span>, <span class="hlFld-ContribAuthor ">Norah  Alqahtani</span>, <span class="hlFld-ContribAuthor ">Noha  Elnagdi</span>, <span class="hlFld-ContribAuthor ">Mohamed  Elnagdi</span>. </span><span class="cited-content_cbyCitation_article-title">Multi Component Reactions under Increased Pressure: On the Mechanism of Formation of Pyridazino[5,4,3-de][1,6]naphthyridine Derivatives by the Reaction of Malononitrile, Aldehydes and 2-Oxoglyoxalarylhydrazones in Q-Tubes. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2017,</strong> <em>22 </em>
                                    (12)
                                     , 2114. <a href="https://doi.org/10.3390/molecules22122114" title="DOI URL">https://doi.org/10.3390/molecules22122114</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules22122114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules22122114%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DMulti%252BComponent%252BReactions%252Bunder%252BIncreased%252BPressure%25253A%252BOn%252Bthe%252BMechanism%252Bof%252BFormation%252Bof%252BPyridazino%25255B5%25252C4%25252C3-de%25255D%25255B1%25252C6%25255Dnaphthyridine%252BDerivatives%252Bby%252Bthe%252BReaction%252Bof%252BMalononitrile%25252C%252BAldehydes%252Band%252B2-Oxoglyoxalarylhydrazones%252Bin%252BQ-Tubes%26aulast%3DAL-Johani%26aufirst%3DMajdah%26date%3D2017%26date%3D2017%26volume%3D22%26issue%3D12%26spage%3D2114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yadavalli  Suneel Kumar</span>, <span class="hlFld-ContribAuthor ">Fazlur-Rahman  Nawaz Khan</span>. </span><span class="cited-content_cbyCitation_article-title">Chemo-selective SuzukiâMiyaura reactions: Synthesis of highly substituted [1,6]-naphthyridines. </span><span class="cited-content_cbyCitation_journal-name">Chinese Chemical Letters</span><span> <strong>2017,</strong> <em>28 </em>
                                    (7)
                                     , 1607-1612. <a href="https://doi.org/10.1016/j.cclet.2017.02.007" title="DOI URL">https://doi.org/10.1016/j.cclet.2017.02.007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cclet.2017.02.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cclet.2017.02.007%26sid%3Dliteratum%253Aachs%26jtitle%3DChinese%2520Chemical%2520Letters%26atitle%3DChemo-selective%252BSuzuki%2525E2%252580%252593Miyaura%252Breactions%25253A%252BSynthesis%252Bof%252Bhighly%252Bsubstituted%252B%25255B1%25252C6%25255D-naphthyridines%26aulast%3DSuneel%2BKumar%26aufirst%3DYadavalli%26date%3D2017%26volume%3D28%26issue%3D7%26spage%3D1607%26epage%3D1612" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Emre  Hoplamaz</span>, <span class="hlFld-ContribAuthor ">Selbi  Keskin</span>, <span class="hlFld-ContribAuthor ">Metin  Balci</span>. </span><span class="cited-content_cbyCitation_article-title">Regioselective Synthesis of Benzo[
              h
              ][1,6]-naphthyridines and Chromenopyrazinones through Alkyne Cyclization. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2017,</strong> <em>2017 </em>
                                    (11)
                                     , 1489-1497. <a href="https://doi.org/10.1002/ejoc.201601661" title="DOI URL">https://doi.org/10.1002/ejoc.201601661</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.201601661&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.201601661%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DRegioselective%252BSynthesis%252Bof%252BBenzo%25255B%252Bh%252B%25255D%25255B1%25252C6%25255D-naphthyridines%252Band%252BChromenopyrazinones%252Bthrough%252BAlkyne%252BCyclization%26aulast%3DHoplamaz%26aufirst%3DEmre%26date%3D2017%26date%3D2017%26volume%3D2017%26issue%3D11%26spage%3D1489%26epage%3D1497" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">A.M.  Magesh Selva Kumar</span>, <span class="hlFld-ContribAuthor ">B.  Vijaya Pandiyan</span>, <span class="hlFld-ContribAuthor ">S.  Mohana Roopan</span>, <span class="hlFld-ContribAuthor ">S.P.  Rajendran</span>. </span><span class="cited-content_cbyCitation_article-title">Efficient synthesis, fluorescence and DFT studies of different substituted 2-chloroquinoline-4-amines and benzo[g][1,8]naphthyridine derivatives. </span><span class="cited-content_cbyCitation_journal-name">Journal of Photochemistry and Photobiology A: Chemistry</span><span> <strong>2017,</strong> <em>332 </em>, 72-86. <a href="https://doi.org/10.1016/j.jphotochem.2016.08.014" title="DOI URL">https://doi.org/10.1016/j.jphotochem.2016.08.014</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jphotochem.2016.08.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jphotochem.2016.08.014%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Photochemistry%2520and%2520Photobiology%2520A%253A%2520Chemistry%26atitle%3DEfficient%252Bsynthesis%25252C%252Bfluorescence%252Band%252BDFT%252Bstudies%252Bof%252Bdifferent%252Bsubstituted%252B2-chloroquinoline-4-amines%252Band%252Bbenzo%25255Bg%25255D%25255B1%25252C8%25255Dnaphthyridine%252Bderivatives%26aulast%3DMagesh%2BSelva%2BKumar%26aufirst%3DA.M.%26date%3D2017%26volume%3D332%26spage%3D72%26epage%3D86" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kalpana  Mishra</span>, <span class="hlFld-ContribAuthor ">Jay Bahadur  Singh</span>, <span class="hlFld-ContribAuthor ">Tanu  Gupta</span>, <span class="hlFld-ContribAuthor ">Radhey M.  Singh</span>. </span><span class="cited-content_cbyCitation_article-title">Ag(
              i
              )-Catalyzed one-pot synthesis of 4-fluorobenzo[b][1,6] naphthyridines and 4-fluoroisoquinolines via iminofluorination of alkynes with Selectfluor. </span><span class="cited-content_cbyCitation_journal-name">Organic Chemistry Frontiers</span><span> <strong>2017,</strong> <em>4 </em>
                                    (9)
                                     , 1794-1798. <a href="https://doi.org/10.1039/C7QO00346C" title="DOI URL">https://doi.org/10.1039/C7QO00346C</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C7QO00346C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC7QO00346C%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Chemistry%2520Frontiers%26atitle%3DAg%252528%252Bi%252B%252529-Catalyzed%252Bone-pot%252Bsynthesis%252Bof%252B4-fluorobenzo%25255Bb%25255D%25255B1%25252C6%25255D%252Bnaphthyridines%252Band%252B4-fluoroisoquinolines%252Bvia%252Biminofluorination%252Bof%252Balkynes%252Bwith%252BSelectfluor%26aulast%3DMishra%26aufirst%3DKalpana%26date%3D2017%26date%3D2017%26volume%3D4%26issue%3D9%26spage%3D1794%26epage%3D1798" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jeremy C.  Dobrowolski</span>, <span class="hlFld-ContribAuthor ">Alice  Katen</span>, <span class="hlFld-ContribAuthor ">Benjamin H.  Fraser</span>, <span class="hlFld-ContribAuthor ">Mohan  Bhadbhade</span>, <span class="hlFld-ContribAuthor ">David StC.  Black</span>, <span class="hlFld-ContribAuthor ">Naresh  Kumar</span>. </span><span class="cited-content_cbyCitation_article-title">A general and efficient synthesis of 5,6-dihydrodibenzo[b,h][1,6]naphthyridine derivatives. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2016,</strong> <em>57 </em>
                                    (49)
                                     , 5442-5445. <a href="https://doi.org/10.1016/j.tetlet.2016.10.067" title="DOI URL">https://doi.org/10.1016/j.tetlet.2016.10.067</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2016.10.067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2016.10.067%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DA%252Bgeneral%252Band%252Befficient%252Bsynthesis%252Bof%252B5%25252C6-dihydrodibenzo%25255Bb%25252Ch%25255D%25255B1%25252C6%25255Dnaphthyridine%252Bderivatives%26aulast%3DDobrowolski%26aufirst%3DJeremy%2BC.%26date%3D2016%26volume%3D57%26issue%3D49%26spage%3D5442%26epage%3D5445" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Georgy V.  Bodrin</span>, <span class="hlFld-ContribAuthor ">Anna G.  Matveeva</span>, <span class="hlFld-ContribAuthor ">Evgenii I.  Goryunov</span>, <span class="hlFld-ContribAuthor ">Margarita P.  Pasechnik</span>, <span class="hlFld-ContribAuthor ">Rinat R.  Aysin</span>, <span class="hlFld-ContribAuthor ">Alexander N.  Turanov</span>, <span class="hlFld-ContribAuthor ">Vasilii K.  Karandashev</span>, <span class="hlFld-ContribAuthor ">Evgeny D.  Savin</span>, <span class="hlFld-ContribAuthor ">Alexander S.  Peregudov</span>, <span class="hlFld-ContribAuthor ">Yulia V.  Nelyubina</span>, <span class="hlFld-ContribAuthor ">Valery K.  Brel</span>. </span><span class="cited-content_cbyCitation_article-title">The synthesis and extraction properties of new 2-(phosphorylalkyl)-and 2-(phosphorylalkenyl)-substituted 1,8- and 1,6-naphthyridines. </span><span class="cited-content_cbyCitation_journal-name">Chemistry of Heterocyclic Compounds</span><span> <strong>2016,</strong> <em>52 </em>
                                    (8)
                                     , 583-591. <a href="https://doi.org/10.1007/s10593-016-1936-1" title="DOI URL">https://doi.org/10.1007/s10593-016-1936-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10593-016-1936-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10593-016-1936-1%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520of%2520Heterocyclic%2520Compounds%26atitle%3DThe%252Bsynthesis%252Band%252Bextraction%252Bproperties%252Bof%252Bnew%252B2-%252528phosphorylalkyl%252529-and%252B2-%252528phosphorylalkenyl%252529-substituted%252B1%25252C8-%252Band%252B1%25252C6-naphthyridines%26aulast%3DBodrin%26aufirst%3DGeorgy%2BV.%26date%3D2016%26date%3D2016%26volume%3D52%26issue%3D8%26spage%3D583%26epage%3D591" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jay Bahadur  Singh</span>, <span class="hlFld-ContribAuthor ">Kishor  Chandra Bharadwaj</span>, <span class="hlFld-ContribAuthor ">Tanu  Gupta</span>, <span class="hlFld-ContribAuthor ">Radhey M.  Singh</span>. </span><span class="cited-content_cbyCitation_article-title">Ligand-free palladium-catalyzed facile construction of tetra cyclic dibenzo[
              b
              ,
              h
              ][1,6]naphthyridine derivatives: domino sequence of intramolecular CâH bond arylation and oxidation reactions. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2016,</strong> <em>6 </em>
                                    (32)
                                     , 26993-26999. <a href="https://doi.org/10.1039/C6RA00505E" title="DOI URL">https://doi.org/10.1039/C6RA00505E</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C6RA00505E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC6RA00505E%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DLigand-free%252Bpalladium-catalyzed%252Bfacile%252Bconstruction%252Bof%252Btetra%252Bcyclic%252Bdibenzo%25255B%252Bb%252B%25252C%252Bh%252B%25255D%25255B1%25252C6%25255Dnaphthyridine%252Bderivatives%25253A%252Bdomino%252Bsequence%252Bof%252Bintramolecular%252BC%2525E2%252580%252593H%252Bbond%252Barylation%252Band%252Boxidation%252Breactions%26aulast%3DSingh%26aufirst%3DJay%2BBahadur%26date%3D2016%26date%3D2016%26volume%3D6%26issue%3D32%26spage%3D26993%26epage%3D26999" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">JUN  HU</span>, <span class="hlFld-ContribAuthor ">JUNJIE  WANG</span>, <span class="hlFld-ContribAuthor ">GANG  WANG</span>, <span class="hlFld-ContribAuthor ">ZHONGJUN  YAO</span>, <span class="hlFld-ContribAuthor ">XIAOQIAN  DANG</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacokinetics and antitumor efficacy of DSPE-PEG2000 polymeric liposomes loaded with quercetin and temozolomide: Analysis of their effectiveness in enhancing the chemosensitization of drug-resistant glioma cells. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Medicine</span><span> <strong>2016,</strong> <em>37 </em>
                                    (3)
                                     , 690-702. <a href="https://doi.org/10.3892/ijmm.2016.2458" title="DOI URL">https://doi.org/10.3892/ijmm.2016.2458</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3892/ijmm.2016.2458&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3892%2Fijmm.2016.2458%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Medicine%26atitle%3DPharmacokinetics%252Band%252Bantitumor%252Befficacy%252Bof%252BDSPE-PEG2000%252Bpolymeric%252Bliposomes%252Bloaded%252Bwith%252Bquercetin%252Band%252Btemozolomide%25253A%252BAnalysis%252Bof%252Btheir%252Beffectiveness%252Bin%252Benhancing%252Bthe%252Bchemosensitization%252Bof%252Bdrug-resistant%252Bglioma%252Bcells%26aulast%3DHU%26aufirst%3DJUN%26date%3D2016%26date%3D2016%26volume%3D37%26issue%3D3%26spage%3D690%26epage%3D702" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kengo  Hanaya</span>, <span class="hlFld-ContribAuthor ">Shohei  Yoshioka</span>, <span class="hlFld-ContribAuthor ">Shinya  Ariyasu</span>, <span class="hlFld-ContribAuthor ">Shin  Aoki</span>, <span class="hlFld-ContribAuthor ">Mitsuru  Shoji</span>, <span class="hlFld-ContribAuthor ">Takeshi  Sugai</span>. </span><span class="cited-content_cbyCitation_article-title">Development of a novel sulfonate ester-based prodrug strategy. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2016,</strong> <em>26 </em>
                                    (2)
                                     , 545-550. <a href="https://doi.org/10.1016/j.bmcl.2015.11.074" title="DOI URL">https://doi.org/10.1016/j.bmcl.2015.11.074</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2015.11.074&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2015.11.074%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDevelopment%252Bof%252Ba%252Bnovel%252Bsulfonate%252Bester-based%252Bprodrug%252Bstrategy%26aulast%3DHanaya%26aufirst%3DKengo%26date%3D2016%26volume%3D26%26issue%3D2%26spage%3D545%26epage%3D550" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sonu  Kumar</span>, <span class="hlFld-ContribAuthor ">Rakesh K.  Saunthwal</span>, <span class="hlFld-ContribAuthor ">Trapti  Aggarwal</span>, <span class="hlFld-ContribAuthor ">Siva K. Reddy  Kotla</span>, <span class="hlFld-ContribAuthor ">Akhilesh K.  Verma</span>. </span><span class="cited-content_cbyCitation_article-title">Palladium meets copper: one-pot tandem synthesis of pyrido fused heterocycles via Sonogashira conjoined electrophilic cyclization. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2016,</strong> <em>14 </em>
                                    (38)
                                     , 9063-9071. <a href="https://doi.org/10.1039/C6OB01539E" title="DOI URL">https://doi.org/10.1039/C6OB01539E</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C6OB01539E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC6OB01539E%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DPalladium%252Bmeets%252Bcopper%25253A%252Bone-pot%252Btandem%252Bsynthesis%252Bof%252Bpyrido%252Bfused%252Bheterocycles%252Bvia%252BSonogashira%252Bconjoined%252Belectrophilic%252Bcyclization%26aulast%3DKumar%26aufirst%3DSonu%26date%3D2016%26date%3D2016%26volume%3D14%26issue%3D38%26spage%3D9063%26epage%3D9071" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">S  Xu</span>, <span class="hlFld-ContribAuthor ">H  Adisetiyo</span>, <span class="hlFld-ContribAuthor ">S  Tamura</span>, <span class="hlFld-ContribAuthor ">F  Grande</span>, <span class="hlFld-ContribAuthor ">A  Garofalo</span>, <span class="hlFld-ContribAuthor ">P  Roy-Burman</span>, <span class="hlFld-ContribAuthor ">N  Neamati</span>. </span><span class="cited-content_cbyCitation_article-title">Dual inhibition of survivin and MAOA synergistically impairs growth of PTEN-negative prostate cancer. </span><span class="cited-content_cbyCitation_journal-name">British Journal of Cancer</span><span> <strong>2015,</strong> <em>113 </em>
                                    (2)
                                     , 242-251. <a href="https://doi.org/10.1038/bjc.2015.228" title="DOI URL">https://doi.org/10.1038/bjc.2015.228</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/bjc.2015.228&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fbjc.2015.228%26sid%3Dliteratum%253Aachs%26jtitle%3DBritish%2520Journal%2520of%2520Cancer%26atitle%3DDual%252Binhibition%252Bof%252Bsurvivin%252Band%252BMAOA%252Bsynergistically%252Bimpairs%252Bgrowth%252Bof%252BPTEN-negative%252Bprostate%252Bcancer%26aulast%3DXu%26aufirst%3DS%26date%3D2015%26date%3D2015%26volume%3D113%26issue%3D2%26spage%3D242%26epage%3D251" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Adhiyaman Kottai Munusamy Magesh Se  Kumar</span>, <span class="hlFld-ContribAuthor ">Subramanian Parameswaran  Rajendran</span>, <span class="hlFld-ContribAuthor ">Selvaraj Mohana  Roopan</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of 3,13-dichlorobenzo[b]quino[4,3-h][1,6]naphthyridin-6(5H)-one derivatives from 2-oxoquinoline-3-carbonyl chloride and 2,6-dichloroquinolin-4-amine. </span><span class="cited-content_cbyCitation_journal-name">Chemistry of Heterocyclic Compounds</span><span> <strong>2015,</strong> <em>51 </em>
                                    (4)
                                     , 346-349. <a href="https://doi.org/10.1007/s10593-015-1706-5" title="DOI URL">https://doi.org/10.1007/s10593-015-1706-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10593-015-1706-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10593-015-1706-5%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520of%2520Heterocyclic%2520Compounds%26atitle%3DSynthesis%252Bof%252B3%25252C13-dichlorobenzo%25255Bb%25255Dquino%25255B4%25252C3-h%25255D%25255B1%25252C6%25255Dnaphthyridin-6%2525285H%252529-one%252Bderivatives%252Bfrom%252B2-oxoquinoline-3-carbonyl%252Bchloride%252Band%252B2%25252C6-dichloroquinolin-4-amine%26aulast%3DKumar%26aufirst%3DAdhiyaman%2BKottai%2BMunusamy%2BMagesh%2BSe%26date%3D2015%26date%3D2015%26volume%3D51%26issue%3D4%26spage%3D346%26epage%3D349" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiao-De  An</span>, <span class="hlFld-ContribAuthor ">Hongyan  Liu</span>, <span class="hlFld-ContribAuthor ">Zhong-Liang  Xu</span>, <span class="hlFld-ContribAuthor ">Yi  Jin</span>, <span class="hlFld-ContribAuthor ">Xia  Peng</span>, <span class="hlFld-ContribAuthor ">Ying-Ming  Yao</span>, <span class="hlFld-ContribAuthor ">Meiyu  Geng</span>, <span class="hlFld-ContribAuthor ">Ya-Qiu  Long</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of potent 1H-imidazo[4,5-b]pyridine-based c-Met kinase inhibitors via mechanism-directed structural optimization. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2015,</strong> <em>25 </em>
                                    (3)
                                     , 708-716. <a href="https://doi.org/10.1016/j.bmcl.2014.11.070" title="DOI URL">https://doi.org/10.1016/j.bmcl.2014.11.070</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2014.11.070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2014.11.070%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252Bpotent%252B1H-imidazo%25255B4%25252C5-b%25255Dpyridine-based%252Bc-Met%252Bkinase%252Binhibitors%252Bvia%252Bmechanism-directed%252Bstructural%252Boptimization%26aulast%3DAn%26aufirst%3DXiao-De%26date%3D2015%26volume%3D25%26issue%3D3%26spage%3D708%26epage%3D716" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dan  Mao</span>, <span class="hlFld-ContribAuthor ">Jun  Tang</span>, <span class="hlFld-ContribAuthor ">Wenbo  Wang</span>, <span class="hlFld-ContribAuthor ">Xin  Liu</span>, <span class="hlFld-ContribAuthor ">Shengying  Wu</span>, <span class="hlFld-ContribAuthor ">Jianjun  Yu</span>, <span class="hlFld-ContribAuthor ">Limin  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">A Sc(OTf)
              3
              -catalyzed cascade reaction of o-aminoacetophenone with methanamine: construction of dibenzo[b,h][1,6]naphthyridine derivatives. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2015,</strong> <em>13 </em>
                                    (7)
                                     , 2122-2128. <a href="https://doi.org/10.1039/C4OB02220C" title="DOI URL">https://doi.org/10.1039/C4OB02220C</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C4OB02220C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC4OB02220C%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DA%252BSc%252528OTf%252529%252B3%252B-catalyzed%252Bcascade%252Breaction%252Bof%252Bo-aminoacetophenone%252Bwith%252Bmethanamine%25253A%252Bconstruction%252Bof%252Bdibenzo%25255Bb%25252Ch%25255D%25255B1%25252C6%25255Dnaphthyridine%252Bderivatives%26aulast%3DMao%26aufirst%3DDan%26date%3D2015%26date%3D2015%26volume%3D13%26issue%3D7%26spage%3D2122%26epage%3D2128" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wen-Qiang  Lu</span>, <span class="hlFld-ContribAuthor ">Rong  Zhuang</span>, <span class="hlFld-ContribAuthor ">Dong-Sheng  Chen</span>, <span class="hlFld-ContribAuthor ">Xiang-Shan  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">An Efficient Synthesis of Polycyclic Heterocycles Containing Pyrazolo[3,4-
              f
              ]quinoline or Benzo[
              h
              ]indazolo[6,7-
              b
              ][1,6]naphthyridine Under Catalyst-Free Conditions. </span><span class="cited-content_cbyCitation_journal-name">Polycyclic Aromatic Compounds</span><span> <strong>2014,</strong> <em>34 </em>
                                    (5)
                                     , 606-619. <a href="https://doi.org/10.1080/10406638.2014.927774" title="DOI URL">https://doi.org/10.1080/10406638.2014.927774</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/10406638.2014.927774&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F10406638.2014.927774%26sid%3Dliteratum%253Aachs%26jtitle%3DPolycyclic%2520Aromatic%2520Compounds%26atitle%3DAn%252BEfficient%252BSynthesis%252Bof%252BPolycyclic%252BHeterocycles%252BContaining%252BPyrazolo%25255B3%25252C4-%252Bf%252B%25255Dquinoline%252Bor%252BBenzo%25255B%252Bh%252B%25255Dindazolo%25255B6%25252C7-%252Bb%252B%25255D%25255B1%25252C6%25255Dnaphthyridine%252BUnder%252BCatalyst-Free%252BConditions%26aulast%3DLu%26aufirst%3DWen-Qiang%26date%3D2014%26date%3D2014%26volume%3D34%26issue%3D5%26spage%3D606%26epage%3D619" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alisha  Sood</span>, <span class="hlFld-ContribAuthor ">Vishal  Sharma</span>, <span class="hlFld-ContribAuthor ">Ashun  Chaudhry</span>, <span class="hlFld-ContribAuthor ">Rakesh  Kumar</span>, <span class="hlFld-ContribAuthor ">Saroj  Arora</span>, <span class="hlFld-ContribAuthor ">Rajnikant</span>, <span class="hlFld-ContribAuthor ">Vivek  Gupta</span>, <span class="hlFld-ContribAuthor ">Mohan Paul S.  Ishar</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and evaluation of 3-salicyloylpyridine derivatives as cytotoxic mitochondrial apoptosis inducers. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2014,</strong> <em>24 </em>
                                    (19)
                                     , 4724-4728. <a href="https://doi.org/10.1016/j.bmcl.2014.08.010" title="DOI URL">https://doi.org/10.1016/j.bmcl.2014.08.010</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2014.08.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2014.08.010%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%252Band%252Bevaluation%252Bof%252B3-salicyloylpyridine%252Bderivatives%252Bas%252Bcytotoxic%252Bmitochondrial%252Bapoptosis%252Binducers%26aulast%3DSood%26aufirst%3DAlisha%26date%3D2014%26volume%3D24%26issue%3D19%26spage%3D4724%26epage%3D4728" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sammy E.  Metobo</span>, <span class="hlFld-ContribAuthor ">Salman Y.  Jabri</span>, <span class="hlFld-ContribAuthor ">Evangelos  Aktoudianakis</span>, <span class="hlFld-ContribAuthor ">Jared  Evans</span>, <span class="hlFld-ContribAuthor ">Haolun  Jin</span>, <span class="hlFld-ContribAuthor ">Choung U.  Kim</span>. </span><span class="cited-content_cbyCitation_article-title">Highly regioselective ring opening of quinolinic[2,3]anhydrides under mild conditions. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2013,</strong> <em>54 </em>
                                    (49)
                                     , 6782-6784. <a href="https://doi.org/10.1016/j.tetlet.2013.10.020" title="DOI URL">https://doi.org/10.1016/j.tetlet.2013.10.020</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2013.10.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2013.10.020%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DHighly%252Bregioselective%252Bring%252Bopening%252Bof%252Bquinolinic%25255B2%25252C3%25255Danhydrides%252Bunder%252Bmild%252Bconditions%26aulast%3DMetobo%26aufirst%3DSammy%2BE.%26date%3D2013%26volume%3D54%26issue%3D49%26spage%3D6782%26epage%3D6784" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yong  Wang</span>, <span class="hlFld-ContribAuthor ">Zhong-Liang  Xu</span>, <span class="hlFld-ContribAuthor ">Jing  Ai</span>, <span class="hlFld-ContribAuthor ">Xia  Peng</span>, <span class="hlFld-ContribAuthor ">Jian-Ping  Lin</span>, <span class="hlFld-ContribAuthor ">Yin-Chun  Ji</span>, <span class="hlFld-ContribAuthor ">Mei-Yu  Geng</span>, <span class="hlFld-ContribAuthor ">Ya-Qiu  Long</span>. </span><span class="cited-content_cbyCitation_article-title">Investigation on the 1,6-naphthyridine motif: discovery and SAR study of 1H-imidazo[4,5-h][1,6]naphthyridin-2(3H)-one-based c-Met kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Org. Biomol. Chem.</span><span> <strong>2013,</strong> <em>11 </em>
                                    (9)
                                     , 1545-1562. <a href="https://doi.org/10.1039/C2OB26710A" title="DOI URL">https://doi.org/10.1039/C2OB26710A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C2OB26710A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC2OB26710A%26sid%3Dliteratum%253Aachs%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26atitle%3DInvestigation%252Bon%252Bthe%252B1%25252C6-naphthyridine%252Bmotif%25253A%252Bdiscovery%252Band%252BSAR%252Bstudy%252Bof%252B1H-imidazo%25255B4%25252C5-h%25255D%25255B1%25252C6%25255Dnaphthyridin-2%2525283H%252529-one-based%252Bc-Met%252Bkinase%252Binhibitors%26aulast%3DWang%26aufirst%3DYong%26date%3D2013%26date%3D2013%26volume%3D11%26issue%3D9%26spage%3D1545%26epage%3D1562" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Benjamin N.  Roin</span>. </span><span class="cited-content_cbyCitation_article-title">Solving the Problem of New Uses. </span><span class="cited-content_cbyCitation_journal-name">SSRN Electronic Journal</span><span> <strong>2013,</strong> <em>570 </em><a href="https://doi.org/10.2139/ssrn.2337821" title="DOI URL">https://doi.org/10.2139/ssrn.2337821</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2139/ssrn.2337821&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2139%2Fssrn.2337821%26sid%3Dliteratum%253Aachs%26jtitle%3DSSRN%2520Electronic%2520Journal%26atitle%3DSolving%252Bthe%252BProblem%252Bof%252BNew%252BUses%26aulast%3DRoin%26aufirst%3DBenjamin%2BN.%26date%3D2013%26volume%3D570" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300667v/production/images/medium/jm-2012-00667v_0008.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300667v/production/images/large/jm-2012-00667v_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300667v&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300667v/production/images/medium/jm-2012-00667v_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300667v/production/images/large/jm-2012-00667v_0010.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Repurposing HIV-1 IN inhibitors 5,8-substitutions of 1,6-naphthyridine-7-carboxamide into novel cytotoxic agents useful for preclinical development for cancer treatment.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300667v/production/images/large/jm-2012-00667v_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300667v&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300667v/production/images/medium/jm-2012-00667v_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300667v/production/images/large/jm-2012-00667v_0015.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. General Synthetic Route toward the 5,8-Substituted 1,6-Naphthyridine-7-carboxamides<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300667v/production/images/large/jm-2012-00667v_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300667v&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <i>i</i>-PrOH, reflux, 16 h, 78%; (b) SOCl<sub>2</sub> (1.5 equiv), CH<sub>2</sub>Cl<sub>2</sub>, cat. DMF, reflux, 3 h; (c) NaBH<sub>4</sub>, THF, 0 Â°C, 40â50 min, overall yield 73% for two steps; (d) TsNHCH<sub>2</sub>COOCH<sub>3</sub>, DEAD, PPh<sub>3</sub>, anhydrous MgSO<sub>4</sub>, THF, 0 Â°C, 2 h; (e) NaOMe, CH<sub>3</sub>OH, 0 Â°C to rt, 3 h, overall yield 65% for two steps; (f) NBS, CH<sub>2</sub>Cl<sub>2</sub>, rt, 1 h, 85%; (g) 4-fluoro-benzylamine or other amines, toluene, reflux, 20 h, 65â98%, or 1N LiOH, methanol, reflux, 5 h, then bis(trichloromethyl)carbonate, DIPEA, aniline, DMF, 0 Â°C, 2h (for the preparation of (<b>III</b>-<b>15</b>)-<b>8</b>); (h) TsCl or MsCl, TEA, CH<sub>2</sub>Cl<sub>2</sub>, 5 h, 90%; (i) NHR<sub>1</sub>R<sub>2</sub>, THF, reflux, 8 h, 50â95%; (j) Râ²SO<sub>2</sub>NRH, pyridine, cuprous oxide, reflux, 16 h, 35â65%; (k) alcohol amine (neat), 130 Â°C, 9 h (for the preparation of <b>I</b>-<b>9</b>â<b>I</b>-<b>11</b>); RNH<sub>2</sub>, DMPU, 135 Â°C, 48 h (for the preparation of <b>I</b>-<b>7, I</b>-<b>8</b>); (l) <i>tert</i>-butyl (1<i>r</i>,4<i>r</i>)-4-aminocyclohexylcarbamate, Et<sub>3</sub>N, THF, reflux, 8 h, 70%; then piperidine, 110 Â°C, 48 h, 89%; finally, TFA, DCM, 2h, rt, 95%; (m)1N LiOH, THF, rt, 12 h; then Boc-protected amine, EDCI, HOBT, DIPEA, DCM, 3 h; finally, TFA, DCM, 2 h.</p></p></figure><figure data-id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300667v/production/images/medium/jm-2012-00667v_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300667v/production/images/large/jm-2012-00667v_0011.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Binding modes of Raltegravir, <b>I</b>-<b>1</b>, <b>I</b>-<b>4</b>, <b>I</b>-<b>9</b>, <b>I</b>-<b>12</b>, and <b>I</b>-<b>14</b> on the modeled IN active site based on the X-ray crystal structure of prototype foamy virus (PFV) intasome (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3OYA">3OYA</a>).<a onclick="showRef(event, 'ref34 ref35'); return false;" href="javascript:void(0);" class="ref ref34 ref35">(34, 35)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300667v/production/images/large/jm-2012-00667v_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300667v&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300667v/production/images/medium/jm-2012-00667v_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300667v/production/images/large/jm-2012-00667v_0012.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Structural optimization of hit compounds for their cytotoxic property with focus on amino substituent at the position 8.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300667v/production/images/large/jm-2012-00667v_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300667v&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300667v/production/images/medium/jm-2012-00667v_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300667v/production/images/large/jm-2012-00667v_0013.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. 8-Amino derivatives of 1,6-naphthyridine-7-carboxamide decrease cell proliferation and arrest cells in G<sub>0</sub>/G<sub>1</sub> phase. Colony formation assay was performed using highly invasive MDA-MB-435 cells treated continuously for 7 days with <b>I</b>-<b>18</b>, <b>II</b>-<b>6</b>, <b>II</b>-<b>10</b>, and <b>II</b>-<b>13</b>, at 10 Î¼M (A) and at various doses with <b>II</b>-<b>13</b> (B). DNA content was analyzed in propidium iodide stained MDA-MB-435. Cells were treated with 2 Ã IC<sub>50</sub> values of <b>I</b>-<b>18</b> (C) and <b>II</b>-<b>13</b> (D) at indicated time. Dark-blue bars represent the G<sub>0</sub>/G<sub>1</sub> fraction, light-cyan bars represent cells in S phase, and brown bars correspond to cells in the G<sub>2</sub>/M phase of the cell cycle.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300667v/production/images/large/jm-2012-00667v_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300667v&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300667v/production/images/medium/jm-2012-00667v_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300667v/production/images/large/jm-2012-00667v_0014.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Inhibition rate of compounds <b>III</b>-<b>2</b>, <b>III</b>-<b>8</b>, and <b>III</b>-<b>9</b> against 31 oncogenic kinases at the drug concentration of 10 Î¼M and at the <i>K</i><sub>m</sub> value for ATP for each kinase, by using KinaseProfiler techniques. All data are expressed as mean values of two independent experiments.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300667v/production/images/large/jm-2012-00667v_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300667v&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i125">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_63036" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_63036" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 44 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Ashburn, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thor, K. B.</span><span> </span><span class="NLM_article-title">Drug repositioning: identifying and developing new uses for existing drugs</span> <span class="citation_source-journal">Nature Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">673</span><span class="NLM_x">â</span> <span class="NLM_lpage">683</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=673-683&author=T.+T.+Ashburnauthor=K.+B.+Thor&title=Drug+repositioning%3A+identifying+and+developing+new+uses+for+existing+drugs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAshburn%26aufirst%3DT.%2BT.%26aulast%3DThor%26aufirst%3DK.%2BB.%26atitle%3DDrug%2520repositioning%253A%2520identifying%2520and%2520developing%2520new%2520uses%2520for%2520existing%2520drugs%26jtitle%3DNature%2520Rev.%2520Drug%2520Discovery%26date%3D2004%26volume%3D3%26spage%3D673%26epage%3D683" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Boguski, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandl, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sukhatme, V. P.</span><span> </span><span class="NLM_article-title">Drug discovery. Repurposing with a difference</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">324</span><span class="NLM_x">, </span> <span class="NLM_fpage">1394</span><span class="NLM_x">â</span> <span class="NLM_lpage">1395</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=324&publication_year=2009&pages=1394-1395&author=M.+S.+Boguskiauthor=K.+D.+Mandlauthor=V.+P.+Sukhatme&title=Drug+discovery.+Repurposing+with+a+difference"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBoguski%26aufirst%3DM.%2BS.%26aulast%3DMandl%26aufirst%3DK.%2BD.%26aulast%3DSukhatme%26aufirst%3DV.%2BP.%26atitle%3DDrug%2520discovery.%2520Repurposing%2520with%2520a%2520difference%26jtitle%3DScience%26date%3D2009%26volume%3D324%26spage%3D1394%26epage%3D1395" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Andronis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharma, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Virvilis, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deftereos, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Persidis, A.</span><span> </span><span class="NLM_article-title">Literature mining, ontologies and information visualization for drug repurposing</span> <span class="citation_source-journal">Briefings Bioinf.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">357</span><span class="NLM_x">â</span> <span class="NLM_lpage">368</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm300667v&amp;key=10.1093%2Fbib%2Fbbr005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm300667v&amp;key=21712342" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm300667v&amp;key=1%3ACAS%3A528%3ADC%252BC3MXptl2js74%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2011&pages=357-368&author=C.+Andronisauthor=A.+Sharmaauthor=V.+Virvilisauthor=S.+Deftereosauthor=A.+Persidis&title=Literature+mining%2C+ontologies+and+information+visualization+for+drug+repurposing"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Literature mining, ontologies and information visualization for drug repurposing</span></div><div class="casAuthors">Andronis, Christos; Sharma, Anuj; Virvilis, Vassilis; Deftereos, Spyros; Persidis, Aris</div><div class="citationInfo"><span class="NLM_cas:title">Briefings in Bioinformatics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">357-368</span>CODEN:
                <span class="NLM_cas:coden">BBIMFX</span>;
        ISSN:<span class="NLM_cas:issn">1467-5463</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">A review.  The immense growth of MEDLINE coupled with the realization that a vast amt. of biomedical knowledge is recorded in free-text format, has led to the appearance of a large no. of literature mining techniques aiming to ext. biomedical terms and their inter-relations from the scientific literature.  Ontologies have been extensively utilized in the biomedical domain either as controlled vocabularies or to provide the framework for mapping relations between concepts in biol. and medicine.  Literature-based approaches and ontologies have been used in the past for the purpose of hypothesis generation in connection with drug discovery.  Here, we review the application of literature mining and ontol. modeling and traversal to the area of drug repurposing (DR).  In recent years, DR has emerged as a noteworthy alternative to the traditional drug development process, in response to the decreased productivity of the biopharmaceutical industry.  Thus, systematic approaches to DR have been developed, involving a variety of in silico, genomic and high-throughput screening technologies.  Attempts to integrate literature mining with other types of data arising from the use of these technologies as well as visualization tools assisting in the discovery of novel assocns. between existing drugs and new indications will also be presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrV8oxc96asEbVg90H21EOLACvtfcHk0lgvGBQFg1H9LQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXptl2js74%253D&md5=f6f295e81e79091d8cf38218f9f56471</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1093%2Fbib%2Fbbr005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fbib%252Fbbr005%26sid%3Dliteratum%253Aachs%26aulast%3DAndronis%26aufirst%3DC.%26aulast%3DSharma%26aufirst%3DA.%26aulast%3DVirvilis%26aufirst%3DV.%26aulast%3DDeftereos%26aufirst%3DS.%26aulast%3DPersidis%26aufirst%3DA.%26atitle%3DLiterature%2520mining%252C%2520ontologies%2520and%2520information%2520visualization%2520for%2520drug%2520repurposing%26jtitle%3DBriefings%2520Bioinf.%26date%3D2011%26volume%3D12%26spage%3D357%26epage%3D368" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Dudley, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deshpande, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butte, A. J.</span><span> </span><span class="NLM_article-title">Exploiting drugâdisease relationships for computational drug repositioning</span> <span class="citation_source-journal">Briefings Bioinf.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">303</span><span class="NLM_x">â</span> <span class="NLM_lpage">311</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm300667v&amp;key=10.1093%2Fbib%2Fbbr013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm300667v&amp;key=21690101" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm300667v&amp;key=1%3ACAS%3A528%3ADC%252BC3MXptl2js70%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2011&pages=303-311&author=J.+T.+Dudleyauthor=T.+Deshpandeauthor=A.+J.+Butte&title=Exploiting+drug%E2%80%93disease+relationships+for+computational+drug+repositioning"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Exploiting drug-disease relationships for computational drug repositioning</span></div><div class="casAuthors">Dudley, Joel T.; Deshpande, Tarangini; Butte, Atul J.</div><div class="citationInfo"><span class="NLM_cas:title">Briefings in Bioinformatics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">303-311</span>CODEN:
                <span class="NLM_cas:coden">BBIMFX</span>;
        ISSN:<span class="NLM_cas:issn">1467-5463</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">A review.  Finding new uses for existing drugs, or drug repositioning, has been used as a strategy for decades to get drugs to more patients.  As the ability to measure mols. in high-throughput ways has improved over the past decade, it is logical that such data might be useful for enabling drug repositioning through computational methods.  Many computational predictions for new indications have been borne out in cellular model systems, though extensive animal model and clin. trial-based validation are still pending.  In this review, we show that computational methods for drug repositioning can be classified in two axes: drug based, where discovery initiates from the chem. perspective, or disease based, where discovery initiates from the clin. perspective of disease or its pathol.  Newer algorithms for computational drug repositioning will likely span these two axes, will take advantage of newer types of mol. measurements, and will certainly play a role in reducing the global burden of disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnt1U_gM2MorVg90H21EOLACvtfcHk0lgvGBQFg1H9LQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXptl2js70%253D&md5=94aa56229700289fcdfe16bb04448d7a</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1093%2Fbib%2Fbbr013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fbib%252Fbbr013%26sid%3Dliteratum%253Aachs%26aulast%3DDudley%26aufirst%3DJ.%2BT.%26aulast%3DDeshpande%26aufirst%3DT.%26aulast%3DButte%26aufirst%3DA.%2BJ.%26atitle%3DExploiting%2520drug%25E2%2580%2593disease%2520relationships%2520for%2520computational%2520drug%2520repositioning%26jtitle%3DBriefings%2520Bioinf.%26date%3D2011%26volume%3D12%26spage%3D303%26epage%3D311" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Haupt, V. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schroeder, M.</span><span> </span><span class="NLM_article-title">Old friends in new guise: repositioning of known drugs with structural bioinformatics</span> <span class="citation_source-journal">Briefings Bioinf.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">312</span><span class="NLM_x">â</span> <span class="NLM_lpage">326</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm300667v&amp;key=10.1093%2Fbib%2Fbbr011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm300667v&amp;key=21441562" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm300667v&amp;key=1%3ACAS%3A528%3ADC%252BC3MXptl2jsrc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2011&pages=312-326&author=V.+J.+Hauptauthor=M.+Schroeder&title=Old+friends+in+new+guise%3A+repositioning+of+known+drugs+with+structural+bioinformatics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Old friends in new guise: repositioning of known drugs with structural bioinformatics</span></div><div class="casAuthors">Haupt, V. Joachim; Schroeder, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Briefings in Bioinformatics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">312-326</span>CODEN:
                <span class="NLM_cas:coden">BBIMFX</span>;
        ISSN:<span class="NLM_cas:issn">1467-5463</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">A review.  Developing a drug de novo is a laborious and costly endeavor.  Thus, the repositioning of already approved drugs for the treatment of new diseases is promising and valuable.  One computational approach to repositioning exploits the structural similarity of binding sites of known and new targets.  Here, we review computational methods to represent and align binding sites.  We review available tools, present success stories and discuss limits of the approach.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpeO0NDH5GZrrVg90H21EOLACvtfcHk0lgvGBQFg1H9LQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXptl2jsrc%253D&md5=e50e0f4752302d91263af4803ef0f14d</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1093%2Fbib%2Fbbr011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fbib%252Fbbr011%26sid%3Dliteratum%253Aachs%26aulast%3DHaupt%26aufirst%3DV.%2BJ.%26aulast%3DSchroeder%26aufirst%3DM.%26atitle%3DOld%2520friends%2520in%2520new%2520guise%253A%2520repositioning%2520of%2520known%2520drugs%2520with%2520structural%2520bioinformatics%26jtitle%3DBriefings%2520Bioinf.%26date%3D2011%26volume%3D12%26spage%3D312%26epage%3D326" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Hazuda, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guare, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anthony, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomez, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wai, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacca, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Handt, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Motzel, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klein, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dornadula, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danovich, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witmer, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, K. A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tussey, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schleif, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabryelski, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, L. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casimiro, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emini, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiver, J. W.</span><span> </span><span class="NLM_article-title">Integrase inhibitors and cellular immunity suppress retroviral replication in rhesus macaques</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">305</span><span class="NLM_x">, </span> <span class="NLM_fpage">528</span><span class="NLM_x">â</span> <span class="NLM_lpage">532</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=305&publication_year=2004&pages=528-532&author=D.+J.+Hazudaauthor=S.+D.+Youngauthor=J.+P.+Guareauthor=N.+J.+Anthonyauthor=R.+P.+Gomezauthor=J.+S.+Waiauthor=J.+P.+Vaccaauthor=L.+Handtauthor=S.+L.+Motzelauthor=H.+J.+Kleinauthor=G.+Dornadulaauthor=R.+M.+Danovichauthor=M.+V.+Witmerauthor=K.+A.+A.+Wilsonauthor=L.+Tusseyauthor=W.+A.+Schleifauthor=L.+S.+Gabryelskiauthor=L.+X.+Jinauthor=M.+D.+Millerauthor=D.+R.+Casimiroauthor=E.+A.+Eminiauthor=J.+W.+Shiver&title=Integrase+inhibitors+and+cellular+immunity+suppress+retroviral+replication+in+rhesus+macaques"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHazuda%26aufirst%3DD.%2BJ.%26aulast%3DYoung%26aufirst%3DS.%2BD.%26aulast%3DGuare%26aufirst%3DJ.%2BP.%26aulast%3DAnthony%26aufirst%3DN.%2BJ.%26aulast%3DGomez%26aufirst%3DR.%2BP.%26aulast%3DWai%26aufirst%3DJ.%2BS.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26aulast%3DHandt%26aufirst%3DL.%26aulast%3DMotzel%26aufirst%3DS.%2BL.%26aulast%3DKlein%26aufirst%3DH.%2BJ.%26aulast%3DDornadula%26aufirst%3DG.%26aulast%3DDanovich%26aufirst%3DR.%2BM.%26aulast%3DWitmer%26aufirst%3DM.%2BV.%26aulast%3DWilson%26aufirst%3DK.%2BA.%2BA.%26aulast%3DTussey%26aufirst%3DL.%26aulast%3DSchleif%26aufirst%3DW.%2BA.%26aulast%3DGabryelski%26aufirst%3DL.%2BS.%26aulast%3DJin%26aufirst%3DL.%2BX.%26aulast%3DMiller%26aufirst%3DM.%2BD.%26aulast%3DCasimiro%26aufirst%3DD.%2BR.%26aulast%3DEmini%26aufirst%3DE.%2BA.%26aulast%3DShiver%26aufirst%3DJ.%2BW.%26atitle%3DIntegrase%2520inhibitors%2520and%2520cellular%2520immunity%2520suppress%2520retroviral%2520replication%2520in%2520rhesus%2520macaques%26jtitle%3DScience%26date%3D2004%26volume%3D305%26spage%3D528%26epage%3D532" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Hazuda, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anthony, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomez, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jolly, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wai, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhuang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Embrey, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guare, J. P.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egbertson, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacca, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huff, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felock, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witmer, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stillmock, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danovich, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grobler, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Espeseth, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, I. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kassahun, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellis, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pearson, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schleif, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cortese, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emini, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Summa, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holloway, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, S. D.</span><span> </span><span class="NLM_article-title">A naphthyridine carboxamide provides evidence for discordant resistance between mechanistically identical inhibitors of HIV-1 integrase</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">101</span><span class="NLM_x">, </span> <span class="NLM_fpage">11233</span><span class="NLM_x">â</span> <span class="NLM_lpage">11238</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm300667v&amp;key=10.1073%2Fpnas.0402357101" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm300667v&amp;key=15277684" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm300667v&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmvVKgtrY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2004&pages=11233-11238&author=D.+J.+Hazudaauthor=N.+J.+Anthonyauthor=R.+P.+Gomezauthor=S.+M.+Jollyauthor=J.+S.+Waiauthor=L.+Zhuangauthor=T.+E.+Fisherauthor=M.+Embreyauthor=J.+P.+Guareauthor=M.+S.+Egbertsonauthor=J.+P.+Vaccaauthor=J.+R.+Huffauthor=P.+J.+Felockauthor=M.+V.+Witmerauthor=K.+A.+Stillmockauthor=R.+Danovichauthor=J.+Groblerauthor=M.+D.+Millerauthor=A.+S.+Espesethauthor=L.+Jinauthor=I.+W.+Chenauthor=J.+H.+Linauthor=K.+Kassahunauthor=J.+D.+Ellisauthor=B.+K.+Wongauthor=W.+Xuauthor=P.+G.+Pearsonauthor=W.+A.+Schleifauthor=R.+Corteseauthor=E.+Eminiauthor=V.+Summaauthor=M.+K.+Hollowayauthor=S.+D.+Young&title=A+naphthyridine+carboxamide+provides+evidence+for+discordant+resistance+between+mechanistically+identical+inhibitors+of+HIV-1+integrase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">A naphthyridine carboxamide provides evidence for discordant resistance between mechanistically identical inhibitors of HIV-1 integrase</span></div><div class="casAuthors">Hazuda, Daria J.; Anthony, Neville J.; Gomez, Robert P.; Jolly, Samson M.; Wai, John S.; Zhuang, Linghang; Fisher, Thorsten E.; Embrey, Mark; Guare, James P., Jr.; Egbertson, Melissa S.; Vacca, Joseph P.; Huff, Joel R.; Felock, Peter J.; Witmer, Marc V.; Stillmock, Kara A.; Danovich, Robert; Grobler, Jay; Miller, Michael D.; Espeseth, Amy S.; Jin, Lixia; Chen, I-Wu; Lin, Jiunn H.; Kassahun, Kelem; Ellis, Joan D.; Wong, Bradley K.; Xu, Wei; Pearson, Paul G.; Schleif, William A.; Cortese, Riccardo; Emini, Emilio; Summa, Vincenzo; Holloway, M. Katharine; Young, Steven D.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue">31</span>),
    <span class="NLM_cas:pages">11233-11238</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The increasing incidence of resistance to current HIV-1 therapy underscores the need to develop antiretroviral agents with new mechanisms of action.  Integrase, one of three viral enzymes essential for HIV-1 replication, presents an important yet unexploited opportunity for drug development.  The authors describe here the identification and characterization of L-870,810, a small-mol. inhibitor of HIV-1 integrase with potent antiviral activity in cell culture and good pharmacokinetic properties.  L-870,810 is an inhibitor with an 8-hydroxy-(1,6)-naphthyridine-7-carboxamide pharmacophore.  The compd. inhibits HIV-1 integrase-mediated strand transfer, and its antiviral activity in vitro is a direct consequence of this ascribed effect on integration.  L-870,810 is mechanistically identical to previously described inhibitors from the diketo acid series; however, viruses selected for resistance to L-870,810 contain mutations (integrase residues 72, 121, and 125) that uniquely confer resistance to the naphthyridine.  Conversely, mutations assocd. with resistance to the diketo acid do not engender naphthyridine resistance.  Importantly, the mutations assocd. with resistance to each of these inhibitors map to distinct regions within the integrase active site.  Therefore, the authors propose a model of the two inhibitors that is consistent with this observation and suggests specific interactions with discrete binding sites for each ligand.  These studies provide a structural basis and rationale for developing integrase inhibitors with the potential for unique and nonoverlapping resistance profiles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRpHqKKxVFjLVg90H21EOLACvtfcHk0lh60XwT60hN6w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmvVKgtrY%253D&md5=a94bedb2c16c751c5a9298708504fa4d</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0402357101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0402357101%26sid%3Dliteratum%253Aachs%26aulast%3DHazuda%26aufirst%3DD.%2BJ.%26aulast%3DAnthony%26aufirst%3DN.%2BJ.%26aulast%3DGomez%26aufirst%3DR.%2BP.%26aulast%3DJolly%26aufirst%3DS.%2BM.%26aulast%3DWai%26aufirst%3DJ.%2BS.%26aulast%3DZhuang%26aufirst%3DL.%26aulast%3DFisher%26aufirst%3DT.%2BE.%26aulast%3DEmbrey%26aufirst%3DM.%26aulast%3DGuare%26aufirst%3DJ.%2BP.%26aulast%3DEgbertson%26aufirst%3DM.%2BS.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26aulast%3DHuff%26aufirst%3DJ.%2BR.%26aulast%3DFelock%26aufirst%3DP.%2BJ.%26aulast%3DWitmer%26aufirst%3DM.%2BV.%26aulast%3DStillmock%26aufirst%3DK.%2BA.%26aulast%3DDanovich%26aufirst%3DR.%26aulast%3DGrobler%26aufirst%3DJ.%26aulast%3DMiller%26aufirst%3DM.%2BD.%26aulast%3DEspeseth%26aufirst%3DA.%2BS.%26aulast%3DJin%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DI.%2BW.%26aulast%3DLin%26aufirst%3DJ.%2BH.%26aulast%3DKassahun%26aufirst%3DK.%26aulast%3DEllis%26aufirst%3DJ.%2BD.%26aulast%3DWong%26aufirst%3DB.%2BK.%26aulast%3DXu%26aufirst%3DW.%26aulast%3DPearson%26aufirst%3DP.%2BG.%26aulast%3DSchleif%26aufirst%3DW.%2BA.%26aulast%3DCortese%26aufirst%3DR.%26aulast%3DEmini%26aufirst%3DE.%26aulast%3DSumma%26aufirst%3DV.%26aulast%3DHolloway%26aufirst%3DM.%2BK.%26aulast%3DYoung%26aufirst%3DS.%2BD.%26atitle%3DA%2520naphthyridine%2520carboxamide%2520provides%2520evidence%2520for%2520discordant%2520resistance%2520between%2520mechanistically%2520identical%2520inhibitors%2520of%2520HIV-1%2520integrase%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2004%26volume%3D101%26spage%3D11233%26epage%3D11238" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Plasencia, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dayam, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinski, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burke, T. R.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quinn, D. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neamati, N.</span><span> </span><span class="NLM_article-title">Discovery and preclinical evaluation of a novel class of small-molecule compounds in hormone-dependent and -independent cancer cell lines</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">1105</span><span class="NLM_x">â</span> <span class="NLM_lpage">1113</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm300667v&amp;key=10.1158%2F1535-7163.MCT-04-0288" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm300667v&amp;key=16020668" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm300667v&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmtFSlt74%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2005&pages=1105-1113&author=C.+Plasenciaauthor=R.+Dayamauthor=Q.+Wangauthor=J.+Pinskiauthor=T.+R.+Burkeauthor=D.+I.+Quinnauthor=N.+Neamati&title=Discovery+and+preclinical+evaluation+of+a+novel+class+of+small-molecule+compounds+in+hormone-dependent+and+-independent+cancer+cell+lines"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and preclinical evaluation of a novel class of small-molecule compounds in hormone-dependent and -independent cancer cell lines</span></div><div class="casAuthors">Plasencia, Carmen; Dayam, Raveendra; Wang, Qingcai; Pinski, Jacek; Burke, Terrence R., Jr.; Quinn, David I.; Neamati, Nouri</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1105-1113</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">We discovered a series of salicylhydrazide class of compds. with remarkable anticancer activity against a panel of hormone receptor-pos. and -neg. cell lines.  In the present study, we evaluated the in vitro activity of SC21 and SC23 against a range of human tumor cell types and the in vivo efficacy of compd. SC21 in a PC3 human prostate cancer xenograft model in mice.  We also detd. the effects of SC21 on cell cycle regulation and apoptosis.  Our in vitro results show that salicylhydrazides are highly potent compds. effective in both hormone receptor-pos. and -neg. cancer cells.  SC21 induced apoptosis and blocked the cell cycle in G0/G1 or S phase, depending on the cell lines used and irresp. of p53, p21, pRb, and p16 status.  SC21 effectively reduced the tumor growth in mice without apparent toxicity.  Although the mechanism of action of SC21 is not completely elucidated, the effect on cell cycle, the induction of apoptosis and the activity against a panel of tumor cell lines of different origins prompted us to carry out an in-depth preclin. evaluation of SC21.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6w649-H6m2bVg90H21EOLACvtfcHk0lhb22QNToagUA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmtFSlt74%253D&md5=078b17b2737c9a65b651bb673d3cd743</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-04-0288&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-04-0288%26sid%3Dliteratum%253Aachs%26aulast%3DPlasencia%26aufirst%3DC.%26aulast%3DDayam%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DPinski%26aufirst%3DJ.%26aulast%3DBurke%26aufirst%3DT.%2BR.%26aulast%3DQuinn%26aufirst%3DD.%2BI.%26aulast%3DNeamati%26aufirst%3DN.%26atitle%3DDiscovery%2520and%2520preclinical%2520evaluation%2520of%2520a%2520novel%2520class%2520of%2520small-molecule%2520compounds%2520in%2520hormone-dependent%2520and%2520-independent%2520cancer%2520cell%2520lines%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2005%26volume%3D4%26spage%3D1105%26epage%3D1113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Cao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plasencia, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanzaki, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burke, T. R.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neamati, N.</span><span> </span><span class="NLM_article-title">Elucidation of the molecular mechanisms of a salicylhydrazide class of compounds by proteomic analysis</span> <span class="citation_source-journal">Curr. Cancer Drug Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">189</span><span class="NLM_x">â</span> <span class="NLM_lpage">201</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm300667v&amp;key=10.2174%2F156800909787580971" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm300667v&amp;key=19275759" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm300667v&amp;key=1%3ACAS%3A528%3ADC%252BD1MXks1Wjs7w%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=189-201&author=X.+Caoauthor=C.+Plasenciaauthor=A.+Kanzakiauthor=A.+Yangauthor=T.+R.+Burkeauthor=N.+Neamati&title=Elucidation+of+the+molecular+mechanisms+of+a+salicylhydrazide+class+of+compounds+by+proteomic+analysis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Elucidation of the molecular mechanisms of a salicylhydrazide class of compounds by proteomic analysis</span></div><div class="casAuthors">Cao, Xuefei; Plasencia, Carmen; Kanzaki, Atsuko; Yang, Austin; Burke, Terrence R., Jr.; Neamati, Nouri</div><div class="citationInfo"><span class="NLM_cas:title">Current Cancer Drug Targets</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">189-201</span>CODEN:
                <span class="NLM_cas:coden">CCDTB9</span>;
        ISSN:<span class="NLM_cas:issn">1568-0096</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Previously, we described a series of salicylhydrazide compds. with potent anti-cancer activities against a panel of human cancer cell lines derived from different origins.  Preclin. evaluation showing efficacy both in vitro and in vivo in human cancer models indicated that these agents may represent a promising class of anticancer drugs.  In the present study, we performed an in-depth investigation on the underlying mol. mechanisms of the most potent compds., SC21 and SC23, using a proteomic method and bioinformatics tools.  We demonstrated that SC23 induced apoptosis through multiple signaling pathways.  In particular, SC23 regulated the expression of Bcl-2, p21, acetylated histone H3 and Î²-tubulin and the combined modulation of these proteins may result in the induction of apoptosis.  We also examd. the effect of SC21 and SC23 on cell cycle progression and found that both compds. arrested cells in S-phase in most cell lines tested.  To better understand the signaling networks involved, we analyzed the SC21- and SC23-treated cell lysates by the Kinexus 628 antibody microarray.  The results were interpreted with the aid of Ingenuity Pathway Anal. (IPA) software.  It was found that SC21 interfered with JAK/STAT signaling and elicited apoptosis through Fas and caspases pathways.  Unlike SC21, SC23 induced RAR activation and caused cell cycle arrest.  The signaling networks identified by this work may provide the basis for future mechanistic studies.  The validation of the proposed pathways and the elucidation of the signaling cross-talk are currently under way.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotr1-VS2bzm7Vg90H21EOLACvtfcHk0lhb22QNToagUA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXks1Wjs7w%253D&md5=dc0df4565ed00bdf04c7c2f7bcf88797</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.2174%2F156800909787580971&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156800909787580971%26sid%3Dliteratum%253Aachs%26aulast%3DCao%26aufirst%3DX.%26aulast%3DPlasencia%26aufirst%3DC.%26aulast%3DKanzaki%26aufirst%3DA.%26aulast%3DYang%26aufirst%3DA.%26aulast%3DBurke%26aufirst%3DT.%2BR.%26aulast%3DNeamati%26aufirst%3DN.%26atitle%3DElucidation%2520of%2520the%2520molecular%2520mechanisms%2520of%2520a%2520salicylhydrazide%2520class%2520of%2520compounds%2520by%2520proteomic%2520analysis%26jtitle%3DCurr.%2520Cancer%2520Drug%2520Targets%26date%3D2009%26volume%3D9%26spage%3D189%26epage%3D201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Thompson, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Connolly, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamby, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boushelle, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartl, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amar, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kraker, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Driscoll, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinkampf, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patmore, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vincent, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elliott, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klohs, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leopold, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Showalter, H. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denny, W. A.</span><span> </span><span class="NLM_article-title">3-(3,5-Dimethoxyphenyl)-1,6-naphthyridine-2,7-diamines and related 2-urea derivatives are potent and selective inhibitors of the FGF receptor-1 tyrosine kinase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">4200</span><span class="NLM_x">â</span> <span class="NLM_lpage">4211</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm000161d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=4200-4211&author=A.+M.+Thompsonauthor=C.+J.+Connollyauthor=J.+M.+Hambyauthor=S.+Boushelleauthor=B.+G.+Hartlauthor=A.+M.+Amarauthor=A.+J.+Krakerauthor=D.+L.+Driscollauthor=R.+W.+Steinkampfauthor=S.+J.+Patmoreauthor=P.+W.+Vincentauthor=B.+J.+Robertsauthor=W.+L.+Elliottauthor=W.+Klohsauthor=W.+R.+Leopoldauthor=H.+D.+Showalterauthor=W.+A.+Denny&title=3-%283%2C5-Dimethoxyphenyl%29-1%2C6-naphthyridine-2%2C7-diamines+and+related+2-urea+derivatives+are+potent+and+selective+inhibitors+of+the+FGF+receptor-1+tyrosine+kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1021%2Fjm000161d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm000161d%26sid%3Dliteratum%253Aachs%26aulast%3DThompson%26aufirst%3DA.%2BM.%26aulast%3DConnolly%26aufirst%3DC.%2BJ.%26aulast%3DHamby%26aufirst%3DJ.%2BM.%26aulast%3DBoushelle%26aufirst%3DS.%26aulast%3DHartl%26aufirst%3DB.%2BG.%26aulast%3DAmar%26aufirst%3DA.%2BM.%26aulast%3DKraker%26aufirst%3DA.%2BJ.%26aulast%3DDriscoll%26aufirst%3DD.%2BL.%26aulast%3DSteinkampf%26aufirst%3DR.%2BW.%26aulast%3DPatmore%26aufirst%3DS.%2BJ.%26aulast%3DVincent%26aufirst%3DP.%2BW.%26aulast%3DRoberts%26aufirst%3DB.%2BJ.%26aulast%3DElliott%26aufirst%3DW.%2BL.%26aulast%3DKlohs%26aufirst%3DW.%26aulast%3DLeopold%26aufirst%3DW.%2BR.%26aulast%3DShowalter%26aufirst%3DH.%2BD.%26aulast%3DDenny%26aufirst%3DW.%2BA.%26atitle%3D3-%25283%252C5-Dimethoxyphenyl%2529-1%252C6-naphthyridine-2%252C7-diamines%2520and%2520related%25202-urea%2520derivatives%2520are%2520potent%2520and%2520selective%2520inhibitors%2520of%2520the%2520FGF%2520receptor-1%2520tyrosine%2520kinase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D4200%26epage%3D4211" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Thompson, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delaney, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamby, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schroeder, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spoon, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crean, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Showalter, H. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denny, W. A.</span><span> </span><span class="NLM_article-title">Synthesis and structureâactivity relationships of soluble 7-substituted 3-(3,5-dimethoxyphenyl)-1,6-naphthyridin-2-amines and related ureas as dual inhibitors of the fibroblast growth factor receptor-1 and vascular endothelial growth factor receptor-2 tyrosine kinases</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">4628</span><span class="NLM_x">â</span> <span class="NLM_lpage">4653</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0500931" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=4628-4653&author=A.+M.+Thompsonauthor=A.+M.+Delaneyauthor=J.+M.+Hambyauthor=M.+C.+Schroederauthor=T.+A.+Spoonauthor=S.+M.+Creanauthor=H.+D.+Showalterauthor=W.+A.+Denny&title=Synthesis+and+structure%E2%80%93activity+relationships+of+soluble+7-substituted+3-%283%2C5-dimethoxyphenyl%29-1%2C6-naphthyridin-2-amines+and+related+ureas+as+dual+inhibitors+of+the+fibroblast+growth+factor+receptor-1+and+vascular+endothelial+growth+factor+receptor-2+tyrosine+kinases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Fjm0500931&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0500931%26sid%3Dliteratum%253Aachs%26aulast%3DThompson%26aufirst%3DA.%2BM.%26aulast%3DDelaney%26aufirst%3DA.%2BM.%26aulast%3DHamby%26aufirst%3DJ.%2BM.%26aulast%3DSchroeder%26aufirst%3DM.%2BC.%26aulast%3DSpoon%26aufirst%3DT.%2BA.%26aulast%3DCrean%26aufirst%3DS.%2BM.%26aulast%3DShowalter%26aufirst%3DH.%2BD.%26aulast%3DDenny%26aufirst%3DW.%2BA.%26atitle%3DSynthesis%2520and%2520structure%25E2%2580%2593activity%2520relationships%2520of%2520soluble%25207-substituted%25203-%25283%252C5-dimethoxyphenyl%2529-1%252C6-naphthyridin-2-amines%2520and%2520related%2520ureas%2520as%2520dual%2520inhibitors%2520of%2520the%2520fibroblast%2520growth%2520factor%2520receptor-1%2520and%2520vascular%2520endothelial%2520growth%2520factor%2520receptor-2%2520tyrosine%2520kinases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D4628%26epage%3D4653" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Zartman, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bell, I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallicchio, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kane, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mallee, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rutledge, R. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salvatore, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacca, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, T. M.</span><span> </span><span class="NLM_article-title">Identification of a novel RAMP-independent CGRP receptor antagonist</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">6705</span><span class="NLM_x">â</span> <span class="NLM_lpage">6708</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=6705-6708&author=C.+B.+Zartmanauthor=I.+M.+Bellauthor=S.+N.+Gallicchioauthor=S.+L.+Grahamauthor=S.+A.+Kaneauthor=J.+J.+Malleeauthor=R.+Z.+Rutledgeauthor=C.+A.+Salvatoreauthor=J.+P.+Vaccaauthor=T.+M.+Williams&title=Identification+of+a+novel+RAMP-independent+CGRP+receptor+antagonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZartman%26aufirst%3DC.%2BB.%26aulast%3DBell%26aufirst%3DI.%2BM.%26aulast%3DGallicchio%26aufirst%3DS.%2BN.%26aulast%3DGraham%26aufirst%3DS.%2BL.%26aulast%3DKane%26aufirst%3DS.%2BA.%26aulast%3DMallee%26aufirst%3DJ.%2BJ.%26aulast%3DRutledge%26aufirst%3DR.%2BZ.%26aulast%3DSalvatore%26aufirst%3DC.%2BA.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26aulast%3DWilliams%26aufirst%3DT.%2BM.%26atitle%3DIdentification%2520of%2520a%2520novel%2520RAMP-independent%2520CGRP%2520receptor%2520antagonist%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D6705%26epage%3D6708" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Neamati, N.</span> <span class="citation_source-book">HIV-1 Integrase: Mechanism and Inhibitor Design</span>; <span class="NLM_publisher-name">Wiley</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm300667v&amp;key=10.1002%2F9781118015377" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=N.+Neamati&title=HIV-1+Integrase%3A+Mechanism+and+Inhibitor+Design"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1002%2F9781118015377&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F9781118015377%26sid%3Dliteratum%253Aachs%26aulast%3DNeamati%26aufirst%3DN.%26btitle%3DHIV-1%2520Integrase%253A%2520Mechanism%2520and%2520Inhibitor%2520Design%26pub%3DWiley%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Pendri, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meanwell, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peese, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, M. A.</span><span> </span><span class="NLM_article-title">New first and second generation inhibitors of human immunodeficiency virus-1 integrase</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">1173</span><span class="NLM_x">â</span> <span class="NLM_lpage">1189</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm300667v&amp;key=10.1517%2F13543776.2011.586631" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm300667v&amp;key=21599420" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm300667v&amp;key=1%3ACAS%3A528%3ADC%252BC3MXptVOrtL0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=1173-1189&author=A.+Pendriauthor=N.+A.+Meanwellauthor=K.+M.+Peeseauthor=M.+A.+Walker&title=New+first+and+second+generation+inhibitors+of+human+immunodeficiency+virus-1+integrase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">New first and second generation inhibitors of human immunodeficiency virus-1 integrase</span></div><div class="casAuthors">Pendri, Annapurna; Meanwell, Nicholas A.; Peese, Kevin M.; Walker, Michael A.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1173-1189</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: The use of inhibitors of HIV-1 integrase for treating HIV-1 infection has proven to be very beneficial.  Raltegravir, a strand transfer inhibitor, has been approved for use both as a first-line therapy and in treatment-experienced patients.  A second compd. in this class, elvitegravir, is in Phase III clin. trials and is being developed as part of a once daily fixed dose combination pill.  With widespread use of raltegravir, viral resistance has emerged with surprising facility.  Attempts to use raltegravir on a once daily dosing regimen have been unsuccessful while elvitegravir cannot be delivered daily without the aid of a pharmacokinetic (PK)-enhancing agent.  Thus, there is a need for second generation compds. to address these issues.Areas covered: Patent applications claiming compds. useful as inhibitors of HIV-1 integrase are reviewed in this paper, along with compds. related to the strand transfer inhibitors.Expert opinion: The field appears to be more focused on developing compds. which address the issues identified for the first generation compds., raltegravir and elvitegravir.  Patent activity around new strand transfer inhibitors claims compds. active against first generation resistant mutations and having PK profiles suitable for daily dosing.  Advancements in this area have been rapid and several compds. described in these patent applications are currently in clin. trials.  Bolstered by recent mechanistic discoveries, compds. inhibiting processes other than strand transfer have begun to emerge.  It is foreseeable that a second generation integrase inhibitor could be approved for treatment in the coming years.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlCiMRQTRcrrVg90H21EOLACvtfcHk0ljnUNqfT8-8Bw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXptVOrtL0%253D&md5=61799f44a62db917d07a931c1c872727</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1517%2F13543776.2011.586631&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2011.586631%26sid%3Dliteratum%253Aachs%26aulast%3DPendri%26aufirst%3DA.%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26aulast%3DPeese%26aufirst%3DK.%2BM.%26aulast%3DWalker%26aufirst%3DM.%2BA.%26atitle%3DNew%2520first%2520and%2520second%2520generation%2520inhibitors%2520of%2520human%2520immunodeficiency%2520virus-1%2520integrase%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2011%26volume%3D21%26spage%3D1173%26epage%3D1189" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Egbertson, M.; Anthony, N. J.; Vincenzo Summa, V.</span> <span class="citation_source-book">HIV Integrase Inhibitors: From Diketoacids to Heterocyclic Templates: A History of HIV Integrase Medicinal Chemistry at Merck West Point and Merck Rome (IRBM) Leading to the Discovery of Raltegravir</span>; In HIV-1 Integrase: Mechanism and Inhibitor Design. Ed (Neamati, N). <span class="NLM_publisher-loc">Wiley: New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=M.+Egbertson&author=N.+J.+Anthony&author=V.+Vincenzo+Summa&title=HIV+Integrase+Inhibitors%3A+From+Diketoacids+to+Heterocyclic+Templates%3A+A+History+of+HIV+Integrase+Medicinal+Chemistry+at+Merck+West+Point+and+Merck+Rome+%28IRBM%29+Leading+to+the+Discovery+of+Raltegravir"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DEgbertson%26aufirst%3DM.%26btitle%3DHIV%2520Integrase%2520Inhibitors%253A%2520From%2520Diketoacids%2520to%2520Heterocyclic%2520Templates%253A%2520A%2520History%2520of%2520HIV%2520Integrase%2520Medicinal%2520Chemistry%2520at%2520Merck%2520West%2520Point%2520and%2520Merck%2520Rome%2520%2528IRBM%2529%2520Leading%2520to%2520the%2520Discovery%2520of%2520Raltegravir%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Egbertson, M. S.</span><span> </span><span class="NLM_article-title">HIV integrase inhibitors: from diketoacids to heterocyclic templates: a history of HIV integrase medicinal chemistry at Merck West Point and Merck Rome (IRBM)</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1251</span><span class="NLM_x">â</span> <span class="NLM_lpage">1272</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm300667v&amp;key=10.2174%2F156802607781212248" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm300667v&amp;key=17627556" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm300667v&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVKqtrvN" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2007&pages=1251-1272&author=M.+S.+Egbertson&title=HIV+integrase+inhibitors%3A+from+diketoacids+to+heterocyclic+templates%3A+a+history+of+HIV+integrase+medicinal+chemistry+at+Merck+West+Point+and+Merck+Rome+%28IRBM%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">HIV integrase inhibitors: from diketoacids to heterocyclic templates: a history of HIV integrase medicinal chemistry at merck west point and merck rome (IRBM)</span></div><div class="casAuthors">Egbertson, Melissa S.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1251-1272</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Replication of the human immunodeficiency virus (HIV) is dependent upon the enzyme HIV integrase (IN), one of three essential enzymes encoded in the viral genome.  HIV-1 IN catalyzes the insertion of the proviral DNA into the host genome (strand transfer).  HIV-1 IN therefore presents an attractive chemotherapeutic target for the treatment of HIV infection and AIDS that could provide patients and physicians with an addnl. option for treatment.  Assays were developed to identify inhibitors of IN strand transfer.  Diketoacid lead compds. were explored and developed into a variety of heterocyclic templates that are potent inhibitors of integrase strand transfer with suitable medicinal chem. properties for treating HIV infection and AIDS.  The 1,6-naphthyridine L-870810 (Antiviral activity in cells IC95 NHS = 102 nM, n = 237), was shown to be efficacious in reducing viral RNA by 1.7 log units after doses of 400mg BID to HIV infected patients.  Optimization of phys. properties led to L-900564, an inhibitor of HIV IN that has excellent cell potency in the presence of protein (Antiviral activity in cells IC95 NHS = 16 nM, n = 15), excellent activity against mutants raised to HIV integrase inhibitors, and a very good pharmacokinetic profile.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLnZK4Ww16-rVg90H21EOLACvtfcHk0ljnUNqfT8-8Bw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVKqtrvN&md5=63978cc76f8e9036b73f0932d0470585</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.2174%2F156802607781212248&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802607781212248%26sid%3Dliteratum%253Aachs%26aulast%3DEgbertson%26aufirst%3DM.%2BS.%26atitle%3DHIV%2520integrase%2520inhibitors%253A%2520from%2520diketoacids%2520to%2520heterocyclic%2520templates%253A%2520a%2520history%2520of%2520HIV%2520integrase%2520medicinal%2520chemistry%2520at%2520Merck%2520West%2520Point%2520and%2520Merck%2520Rome%2520%2528IRBM%2529%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2007%26volume%3D7%26spage%3D1251%26epage%3D1272" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Egbertson, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moritz, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melamed, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perlow, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Embrey, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacca, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zrada, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cortes, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallace, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonard, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hazuda, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felock, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stillmock, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witmer, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schleif, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabryelski, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moyer, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellis, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braun, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kassahun, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsou, N. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, S. D.</span><span> </span><span class="NLM_article-title">A potent and orally active HIV-1 integrase inhibitor</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">1392</span><span class="NLM_x">â</span> <span class="NLM_lpage">1398</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm300667v&amp;key=10.1016%2Fj.bmcl.2006.11.080" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm300667v&amp;key=17194584" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm300667v&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhvVyjt7s%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=1392-1398&author=M.+S.+Egbertsonauthor=H.+M.+Moritzauthor=J.+Y.+Melamedauthor=W.+Hanauthor=D.+S.+Perlowauthor=M.+S.+Kuoauthor=M.+Embreyauthor=J.+P.+Vaccaauthor=M.+M.+Zradaauthor=A.+R.+Cortesauthor=A.+Wallaceauthor=Y.+Leonardauthor=D.+J.+Hazudaauthor=M.+D.+Millerauthor=P.+J.+Felockauthor=K.+A.+Stillmockauthor=M.+V.+Witmerauthor=W.+Schleifauthor=L.+J.+Gabryelskiauthor=G.+Moyerauthor=J.+D.+Ellisauthor=L.+Jinauthor=W.+Xuauthor=M.+P.+Braunauthor=K.+Kassahunauthor=N.+N.+Tsouauthor=S.+D.+Young&title=A+potent+and+orally+active+HIV-1+integrase+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">A potent and orally active HIV-1 integrase inhibitor</span></div><div class="casAuthors">Egbertson, Melissa S.; Moritz, H. Marie; Melamed, Jeffrey Y.; Han, Wei; Perlow, Debra S.; Kuo, Michelle S.; Embrey, Mark; Vacca, Joseph P.; Zrada, Matthew M.; Cortes, Amanda R.; Wallace, Audrey; Leonard, Yvonne; Hazuda, Daria J.; Miller, Michael D.; Felock, Peter J.; Stillmock, Kara A.; Witmer, Marc V.; Schleif, William; Gabryelski, Lori J.; Moyer, Gregory; Ellis, Joan D.; Jin, Lixia; Xu, Wei; Braun, Matthew P.; Kassahun, Kellem; Tsou, Nancy N.; Young, Steven D.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1392-1398</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A 1,6-naphthyridine inhibitor of HIV-1 integrase has been discovered with excellent inhibitory activity in cells, good pharmacokinetics, and an excellent ability to inhibit virus with mutant enzyme.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVTId1m0YgC7Vg90H21EOLACvtfcHk0lhLJ3mQZL2L5Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhvVyjt7s%253D&md5=5b718b54eae1ddfc33430472a0c3169c</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2006.11.080&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2006.11.080%26sid%3Dliteratum%253Aachs%26aulast%3DEgbertson%26aufirst%3DM.%2BS.%26aulast%3DMoritz%26aufirst%3DH.%2BM.%26aulast%3DMelamed%26aufirst%3DJ.%2BY.%26aulast%3DHan%26aufirst%3DW.%26aulast%3DPerlow%26aufirst%3DD.%2BS.%26aulast%3DKuo%26aufirst%3DM.%2BS.%26aulast%3DEmbrey%26aufirst%3DM.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26aulast%3DZrada%26aufirst%3DM.%2BM.%26aulast%3DCortes%26aufirst%3DA.%2BR.%26aulast%3DWallace%26aufirst%3DA.%26aulast%3DLeonard%26aufirst%3DY.%26aulast%3DHazuda%26aufirst%3DD.%2BJ.%26aulast%3DMiller%26aufirst%3DM.%2BD.%26aulast%3DFelock%26aufirst%3DP.%2BJ.%26aulast%3DStillmock%26aufirst%3DK.%2BA.%26aulast%3DWitmer%26aufirst%3DM.%2BV.%26aulast%3DSchleif%26aufirst%3DW.%26aulast%3DGabryelski%26aufirst%3DL.%2BJ.%26aulast%3DMoyer%26aufirst%3DG.%26aulast%3DEllis%26aufirst%3DJ.%2BD.%26aulast%3DJin%26aufirst%3DL.%26aulast%3DXu%26aufirst%3DW.%26aulast%3DBraun%26aufirst%3DM.%2BP.%26aulast%3DKassahun%26aufirst%3DK.%26aulast%3DTsou%26aufirst%3DN.%2BN.%26aulast%3DYoung%26aufirst%3DS.%2BD.%26atitle%3DA%2520potent%2520and%2520orally%2520active%2520HIV-1%2520integrase%2520inhibitor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D1392%26epage%3D1398" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Embrey, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wai, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Funk, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Homnick, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perlow, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacca, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hazuda, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felock, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stillmock, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witmer, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moyer, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schleif, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabryelski, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, I. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellis, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonard, Y. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsou, N. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhuang, L.</span><span> </span><span class="NLM_article-title">A series of 5-(5,6)-dihydrouracil substituted 8-hydroxy-[1,6]naphthyridine-7-carboxylic acid 4-fluorobenzylamide inhibitors of HIV-1 integrase and viral replication in cells</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">4550</span><span class="NLM_x">â</span> <span class="NLM_lpage">4554</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=4550-4554&author=M.+W.+Embreyauthor=J.+S.+Waiauthor=T.+W.+Funkauthor=C.+F.+Homnickauthor=D.+S.+Perlowauthor=S.+D.+Youngauthor=J.+P.+Vaccaauthor=D.+J.+Hazudaauthor=P.+J.+Felockauthor=K.+A.+Stillmockauthor=M.+V.+Witmerauthor=G.+Moyerauthor=W.+A.+Schleifauthor=L.+J.+Gabryelskiauthor=L.+Jinauthor=I.+W.+Chenauthor=J.+D.+Ellisauthor=B.+K.+Wongauthor=J.+H.+Linauthor=Y.+M.+Leonardauthor=N.+N.+Tsouauthor=L.+Zhuang&title=A+series+of+5-%285%2C6%29-dihydrouracil+substituted+8-hydroxy-%5B1%2C6%5Dnaphthyridine-7-carboxylic+acid+4-fluorobenzylamide+inhibitors+of+HIV-1+integrase+and+viral+replication+in+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEmbrey%26aufirst%3DM.%2BW.%26aulast%3DWai%26aufirst%3DJ.%2BS.%26aulast%3DFunk%26aufirst%3DT.%2BW.%26aulast%3DHomnick%26aufirst%3DC.%2BF.%26aulast%3DPerlow%26aufirst%3DD.%2BS.%26aulast%3DYoung%26aufirst%3DS.%2BD.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26aulast%3DHazuda%26aufirst%3DD.%2BJ.%26aulast%3DFelock%26aufirst%3DP.%2BJ.%26aulast%3DStillmock%26aufirst%3DK.%2BA.%26aulast%3DWitmer%26aufirst%3DM.%2BV.%26aulast%3DMoyer%26aufirst%3DG.%26aulast%3DSchleif%26aufirst%3DW.%2BA.%26aulast%3DGabryelski%26aufirst%3DL.%2BJ.%26aulast%3DJin%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DI.%2BW.%26aulast%3DEllis%26aufirst%3DJ.%2BD.%26aulast%3DWong%26aufirst%3DB.%2BK.%26aulast%3DLin%26aufirst%3DJ.%2BH.%26aulast%3DLeonard%26aufirst%3DY.%2BM.%26aulast%3DTsou%26aufirst%3DN.%2BN.%26aulast%3DZhuang%26aufirst%3DL.%26atitle%3DA%2520series%2520of%25205-%25285%252C6%2529-dihydrouracil%2520substituted%25208-hydroxy-%255B1%252C6%255Dnaphthyridine-7-carboxylic%2520acid%25204-fluorobenzylamide%2520inhibitors%2520of%2520HIV-1%2520integrase%2520and%2520viral%2520replication%2520in%2520cells%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D4550%26epage%3D4554" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Espeseth, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felock, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolfe, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witmer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grobler, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anthony, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egbertson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melamed, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamill, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hazuda, D. J.</span><span> </span><span class="NLM_article-title">HIV-1 integrase inhibitors that compete with the target DNA substrate define a unique strand transfer conformation for integrase</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">97</span><span class="NLM_x">, </span> <span class="NLM_fpage">11244</span><span class="NLM_x">â</span> <span class="NLM_lpage">11249</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2000&pages=11244-11249&author=A.+S.+Espesethauthor=P.+Felockauthor=A.+Wolfeauthor=M.+Witmerauthor=J.+Groblerauthor=N.+Anthonyauthor=M.+Egbertsonauthor=J.+Y.+Melamedauthor=S.+Youngauthor=T.+Hamillauthor=J.+L.+Coleauthor=D.+J.+Hazuda&title=HIV-1+integrase+inhibitors+that+compete+with+the+target+DNA+substrate+define+a+unique+strand+transfer+conformation+for+integrase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEspeseth%26aufirst%3DA.%2BS.%26aulast%3DFelock%26aufirst%3DP.%26aulast%3DWolfe%26aufirst%3DA.%26aulast%3DWitmer%26aufirst%3DM.%26aulast%3DGrobler%26aufirst%3DJ.%26aulast%3DAnthony%26aufirst%3DN.%26aulast%3DEgbertson%26aufirst%3DM.%26aulast%3DMelamed%26aufirst%3DJ.%2BY.%26aulast%3DYoung%26aufirst%3DS.%26aulast%3DHamill%26aufirst%3DT.%26aulast%3DCole%26aufirst%3DJ.%2BL.%26aulast%3DHazuda%26aufirst%3DD.%2BJ.%26atitle%3DHIV-1%2520integrase%2520inhibitors%2520that%2520compete%2520with%2520the%2520target%2520DNA%2520substrate%2520define%2520a%2520unique%2520strand%2520transfer%2520conformation%2520for%2520integrase%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2000%26volume%3D97%26spage%3D11244%26epage%3D11249" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Guare, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wai, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomez, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anthony, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jolly, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cortes, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacca, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felock, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stillmock, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schleif, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moyer, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabryelski, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, I. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hazuda, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, S. D.</span><span> </span><span class="NLM_article-title">A series of 5-aminosubstituted 4-fluorobenzyl-8-hydroxy-[1,6]naphthyridine-7-carboxamide HIV-1 integrase inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">2900</span><span class="NLM_x">â</span> <span class="NLM_lpage">2904</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=2900-2904&author=J.+P.+Guareauthor=J.+S.+Waiauthor=R.+P.+Gomezauthor=N.+J.+Anthonyauthor=S.+M.+Jollyauthor=A.+R.+Cortesauthor=J.+P.+Vaccaauthor=P.+J.+Felockauthor=K.+A.+Stillmockauthor=W.+A.+Schleifauthor=G.+Moyerauthor=L.+J.+Gabryelskiauthor=L.+Jinauthor=I.+W.+Chenauthor=D.+J.+Hazudaauthor=S.+D.+Young&title=A+series+of+5-aminosubstituted+4-fluorobenzyl-8-hydroxy-%5B1%2C6%5Dnaphthyridine-7-carboxamide+HIV-1+integrase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGuare%26aufirst%3DJ.%2BP.%26aulast%3DWai%26aufirst%3DJ.%2BS.%26aulast%3DGomez%26aufirst%3DR.%2BP.%26aulast%3DAnthony%26aufirst%3DN.%2BJ.%26aulast%3DJolly%26aufirst%3DS.%2BM.%26aulast%3DCortes%26aufirst%3DA.%2BR.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26aulast%3DFelock%26aufirst%3DP.%2BJ.%26aulast%3DStillmock%26aufirst%3DK.%2BA.%26aulast%3DSchleif%26aufirst%3DW.%2BA.%26aulast%3DMoyer%26aufirst%3DG.%26aulast%3DGabryelski%26aufirst%3DL.%2BJ.%26aulast%3DJin%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DI.%2BW.%26aulast%3DHazuda%26aufirst%3DD.%2BJ.%26aulast%3DYoung%26aufirst%3DS.%2BD.%26atitle%3DA%2520series%2520of%25205-aminosubstituted%25204-fluorobenzyl-8-hydroxy-%255B1%252C6%255Dnaphthyridine-7-carboxamide%2520HIV-1%2520integrase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D2900%26epage%3D2904" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Gudmundsson, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johns, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weatherhead, J.</span><span> </span><span class="NLM_article-title">Pyrazolopyrimidines and pyrazolotriazines with potent activity against herpesviruses</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">5689</span><span class="NLM_x">â</span> <span class="NLM_lpage">5692</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=5689-5692&author=K.+S.+Gudmundssonauthor=B.+A.+Johnsauthor=J.+Weatherhead&title=Pyrazolopyrimidines+and+pyrazolotriazines+with+potent+activity+against+herpesviruses"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGudmundsson%26aufirst%3DK.%2BS.%26aulast%3DJohns%26aufirst%3DB.%2BA.%26aulast%3DWeatherhead%26aufirst%3DJ.%26atitle%3DPyrazolopyrimidines%2520and%2520pyrazolotriazines%2520with%2520potent%2520activity%2520against%2520herpesviruses%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D5689%26epage%3D5692" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Johns, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weatherhead, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garvey, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foster, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeffrey, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, W. H.</span><span> </span><span class="NLM_article-title">The use of oxadiazole and triazole substituted naphthyridines as HIV-1 integrase inhibitors. Part 1: Establishing the pharmacophore</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1802</span><span class="NLM_x">â</span> <span class="NLM_lpage">1806</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm300667v&amp;key=10.1016%2Fj.bmcl.2009.01.090" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm300667v&amp;key=19217781" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm300667v&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjtVSltb0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=1802-1806&author=B.+A.+Johnsauthor=J.+G.+Weatherheadauthor=S.+H.+Allenauthor=J.+B.+Thompsonauthor=E.+P.+Garveyauthor=S.+A.+Fosterauthor=J.+L.+Jeffreyauthor=W.+H.+Miller&title=The+use+of+oxadiazole+and+triazole+substituted+naphthyridines+as+HIV-1+integrase+inhibitors.+Part+1%3A+Establishing+the+pharmacophore"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">The use of oxadiazole and triazole substituted naphthyridines as HIV-1 integrase inhibitors. Part 1: Establishing the pharmacophore</span></div><div class="casAuthors">Johns, Brian A.; Weatherhead, Jason G.; Allen, Scott H.; Thompson, James B.; Garvey, Edward P.; Foster, Scott A.; Jeffrey, Jerry L.; Miller, Wayne H.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1802-1806</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of HIV-1 integrase inhibitors contg. a novel metal binding motif consisting of the 8-hydroxy-1,6-naphthyridine core and either an oxadiazole or triazole has been identified.  The design of the key structural components was based on a two-metal coordination pharmacophore.  This report presents initial structure-activity data that shows the new chelation architecture delivers potent inhibition in both enzymic and antiviral assays.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqu2rzx6WTsI7Vg90H21EOLACvtfcHk0lilB40ktalzFA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjtVSltb0%253D&md5=78e7d1b81f1a889c901bb08678b932a7</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.01.090&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.01.090%26sid%3Dliteratum%253Aachs%26aulast%3DJohns%26aufirst%3DB.%2BA.%26aulast%3DWeatherhead%26aufirst%3DJ.%2BG.%26aulast%3DAllen%26aufirst%3DS.%2BH.%26aulast%3DThompson%26aufirst%3DJ.%2BB.%26aulast%3DGarvey%26aufirst%3DE.%2BP.%26aulast%3DFoster%26aufirst%3DS.%2BA.%26aulast%3DJeffrey%26aufirst%3DJ.%2BL.%26aulast%3DMiller%26aufirst%3DW.%2BH.%26atitle%3DThe%2520use%2520of%2520oxadiazole%2520and%2520triazole%2520substituted%2520naphthyridines%2520as%2520HIV-1%2520integrase%2520inhibitors.%2520Part%25201%253A%2520Establishing%2520the%2520pharmacophore%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D1802%26epage%3D1806" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Johns, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weatherhead, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garvey, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foster, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeffrey, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, W. H.</span><span> </span><span class="NLM_article-title">1,3,4-Oxadiazole substituted naphthyridines as HIV-1 integrase inhibitors. Part 2: SAR of the C5 position</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1807</span><span class="NLM_x">â</span> <span class="NLM_lpage">1810</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=1807-1810&author=B.+A.+Johnsauthor=J.+G.+Weatherheadauthor=S.+H.+Allenauthor=J.+B.+Thompsonauthor=E.+P.+Garveyauthor=S.+A.+Fosterauthor=J.+L.+Jeffreyauthor=W.+H.+Miller&title=1%2C3%2C4-Oxadiazole+substituted+naphthyridines+as+HIV-1+integrase+inhibitors.+Part+2%3A+SAR+of+the+C5+position"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJohns%26aufirst%3DB.%2BA.%26aulast%3DWeatherhead%26aufirst%3DJ.%2BG.%26aulast%3DAllen%26aufirst%3DS.%2BH.%26aulast%3DThompson%26aufirst%3DJ.%2BB.%26aulast%3DGarvey%26aufirst%3DE.%2BP.%26aulast%3DFoster%26aufirst%3DS.%2BA.%26aulast%3DJeffrey%26aufirst%3DJ.%2BL.%26aulast%3DMiller%26aufirst%3DW.%2BH.%26atitle%3D1%252C3%252C4-Oxadiazole%2520substituted%2520naphthyridines%2520as%2520HIV-1%2520integrase%2520inhibitors.%2520Part%25202%253A%2520SAR%2520of%2520the%2520C5%2520position%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D1807%26epage%3D1810" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Melamed, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egbertson, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varga, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacca, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moyer, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabryelski, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felock, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stillmock, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witmer, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schleif, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hazuda, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonard, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellis, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, S. D.</span><span> </span><span class="NLM_article-title">Synthesis of 5-(1-H or 1-alkyl-5-oxopyrrolidin-3-yl)-8-hydroxy-[1,6]-naphthyridine-7-carboxamide inhibitors of HIV-1 integrase</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">5307</span><span class="NLM_x">â</span> <span class="NLM_lpage">5310</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=5307-5310&author=J.+Y.+Melamedauthor=M.+S.+Egbertsonauthor=S.+Vargaauthor=J.+P.+Vaccaauthor=G.+Moyerauthor=L.+Gabryelskiauthor=P.+J.+Felockauthor=K.+A.+Stillmockauthor=M.+V.+Witmerauthor=W.+Schleifauthor=D.+J.+Hazudaauthor=Y.+Leonardauthor=L.+Jinauthor=J.+D.+Ellisauthor=S.+D.+Young&title=Synthesis+of+5-%281-H+or+1-alkyl-5-oxopyrrolidin-3-yl%29-8-hydroxy-%5B1%2C6%5D-naphthyridine-7-carboxamide+inhibitors+of+HIV-1+integrase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMelamed%26aufirst%3DJ.%2BY.%26aulast%3DEgbertson%26aufirst%3DM.%2BS.%26aulast%3DVarga%26aufirst%3DS.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26aulast%3DMoyer%26aufirst%3DG.%26aulast%3DGabryelski%26aufirst%3DL.%26aulast%3DFelock%26aufirst%3DP.%2BJ.%26aulast%3DStillmock%26aufirst%3DK.%2BA.%26aulast%3DWitmer%26aufirst%3DM.%2BV.%26aulast%3DSchleif%26aufirst%3DW.%26aulast%3DHazuda%26aufirst%3DD.%2BJ.%26aulast%3DLeonard%26aufirst%3DY.%26aulast%3DJin%26aufirst%3DL.%26aulast%3DEllis%26aufirst%3DJ.%2BD.%26aulast%3DYoung%26aufirst%3DS.%2BD.%26atitle%3DSynthesis%2520of%25205-%25281-H%2520or%25201-alkyl-5-oxopyrrolidin-3-yl%2529-8-hydroxy-%255B1%252C6%255D-naphthyridine-7-carboxamide%2520inhibitors%2520of%2520HIV-1%2520integrase%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D5307%26epage%3D5310" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Wai, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egbertson, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Payne, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Embrey, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, L. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melamed, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langford, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guare, J. P.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhuang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grey, V. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacca, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holloway, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naylor-Olsen, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hazuda, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felock, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolfe, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stillmock, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schleif, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabryelski, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, S. D.</span><span> </span><span class="NLM_article-title">4-Aryl-2,4-dioxobutanoic acid inhibitors of HIV-1 integrase and viral replication in cells</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">4923</span><span class="NLM_x">â</span> <span class="NLM_lpage">4926</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm000176b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=4923-4926&author=J.+S.+Waiauthor=M.+S.+Egbertsonauthor=L.+S.+Payneauthor=T.+E.+Fisherauthor=M.+W.+Embreyauthor=L.+O.+Tranauthor=J.+Y.+Melamedauthor=H.+M.+Langfordauthor=J.+P.+Guareauthor=L.+Zhuangauthor=V.+E.+Greyauthor=J.+P.+Vaccaauthor=M.+K.+Hollowayauthor=A.+M.+Naylor-Olsenauthor=D.+J.+Hazudaauthor=P.+J.+Felockauthor=A.+L.+Wolfeauthor=K.+A.+Stillmockauthor=W.+A.+Schleifauthor=L.+J.+Gabryelskiauthor=S.+D.+Young&title=4-Aryl-2%2C4-dioxobutanoic+acid+inhibitors+of+HIV-1+integrase+and+viral+replication+in+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm000176b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm000176b%26sid%3Dliteratum%253Aachs%26aulast%3DWai%26aufirst%3DJ.%2BS.%26aulast%3DEgbertson%26aufirst%3DM.%2BS.%26aulast%3DPayne%26aufirst%3DL.%2BS.%26aulast%3DFisher%26aufirst%3DT.%2BE.%26aulast%3DEmbrey%26aufirst%3DM.%2BW.%26aulast%3DTran%26aufirst%3DL.%2BO.%26aulast%3DMelamed%26aufirst%3DJ.%2BY.%26aulast%3DLangford%26aufirst%3DH.%2BM.%26aulast%3DGuare%26aufirst%3DJ.%2BP.%26aulast%3DZhuang%26aufirst%3DL.%26aulast%3DGrey%26aufirst%3DV.%2BE.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26aulast%3DHolloway%26aufirst%3DM.%2BK.%26aulast%3DNaylor-Olsen%26aufirst%3DA.%2BM.%26aulast%3DHazuda%26aufirst%3DD.%2BJ.%26aulast%3DFelock%26aufirst%3DP.%2BJ.%26aulast%3DWolfe%26aufirst%3DA.%2BL.%26aulast%3DStillmock%26aufirst%3DK.%2BA.%26aulast%3DSchleif%26aufirst%3DW.%2BA.%26aulast%3DGabryelski%26aufirst%3DL.%2BJ.%26aulast%3DYoung%26aufirst%3DS.%2BD.%26atitle%3D4-Aryl-2%252C4-dioxobutanoic%2520acid%2520inhibitors%2520of%2520HIV-1%2520integrase%2520and%2520viral%2520replication%2520in%2520cells%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D4923%26epage%3D4926" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Wai, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhuang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Embrey, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Staas, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Culberson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyle, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacca, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hazuda, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felock, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schleif, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabryelski, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, I. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellis, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mallai, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, S. D.</span><span> </span><span class="NLM_article-title">Dihydroxypyridopyrazine-1,6-dione HIV-1 integrase inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">5595</span><span class="NLM_x">â</span> <span class="NLM_lpage">5599</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=5595-5599&author=J.+S.+Waiauthor=B.+Kimauthor=T.+E.+Fisherauthor=L.+Zhuangauthor=M.+W.+Embreyauthor=P.+D.+Williamsauthor=D.+D.+Staasauthor=C.+Culbersonauthor=T.+A.+Lyleauthor=J.+P.+Vaccaauthor=D.+J.+Hazudaauthor=P.+J.+Felockauthor=W.+A.+Schleifauthor=L.+J.+Gabryelskiauthor=L.+Jinauthor=I.+W.+Chenauthor=J.+D.+Ellisauthor=R.+Mallaiauthor=S.+D.+Young&title=Dihydroxypyridopyrazine-1%2C6-dione+HIV-1+integrase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWai%26aufirst%3DJ.%2BS.%26aulast%3DKim%26aufirst%3DB.%26aulast%3DFisher%26aufirst%3DT.%2BE.%26aulast%3DZhuang%26aufirst%3DL.%26aulast%3DEmbrey%26aufirst%3DM.%2BW.%26aulast%3DWilliams%26aufirst%3DP.%2BD.%26aulast%3DStaas%26aufirst%3DD.%2BD.%26aulast%3DCulberson%26aufirst%3DC.%26aulast%3DLyle%26aufirst%3DT.%2BA.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26aulast%3DHazuda%26aufirst%3DD.%2BJ.%26aulast%3DFelock%26aufirst%3DP.%2BJ.%26aulast%3DSchleif%26aufirst%3DW.%2BA.%26aulast%3DGabryelski%26aufirst%3DL.%2BJ.%26aulast%3DJin%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DI.%2BW.%26aulast%3DEllis%26aufirst%3DJ.%2BD.%26aulast%3DMallai%26aufirst%3DR.%26aulast%3DYoung%26aufirst%3DS.%2BD.%26atitle%3DDihydroxypyridopyrazine-1%252C6-dione%2520HIV-1%2520integrase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D5595%26epage%3D5599" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Wiscount, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, L. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Embrey, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherman, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Homnick, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donnette Staas, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyle, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wai, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacca, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felock, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stillmock, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witmer, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hazuda, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Day, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabryelski, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ecto, L. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schleif, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiStefano, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kochansky, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anari, M. R.</span><span> </span><span class="NLM_article-title">10-Hydroxy-7,8-dihydropyrazino[1â²,2â²:1,5]pyrrolo[2,3-<i>d</i>]pyridazine-1,9(2<i>H</i>,6<i>H</i>)-diones: potent, orally bioavailable HIV-1 integrase strand-transfer inhibitors with activity against integrase mutants</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">4581</span><span class="NLM_x">â</span> <span class="NLM_lpage">4583</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=4581-4583&author=C.+M.+Wiscountauthor=P.+D.+Williamsauthor=L.+O.+Tranauthor=M.+W.+Embreyauthor=T.+E.+Fisherauthor=V.+Shermanauthor=C.+F.+Homnickauthor=D.+Donnette+Staasauthor=T.+A.+Lyleauthor=J.+S.+Waiauthor=J.+P.+Vaccaauthor=Z.+Wangauthor=P.+J.+Felockauthor=K.+A.+Stillmockauthor=M.+V.+Witmerauthor=M.+D.+Millerauthor=D.+J.+Hazudaauthor=A.+M.+Dayauthor=L.+J.+Gabryelskiauthor=L.+T.+Ectoauthor=W.+A.+Schleifauthor=D.+J.+DiStefanoauthor=C.+J.+Kochanskyauthor=M.+R.+Anari&title=10-Hydroxy-7%2C8-dihydropyrazino%5B1%E2%80%B2%2C2%E2%80%B2%3A1%2C5%5Dpyrrolo%5B2%2C3-d%5Dpyridazine-1%2C9%282H%2C6H%29-diones%3A+potent%2C+orally+bioavailable+HIV-1+integrase+strand-transfer+inhibitors+with+activity+against+integrase+mutants"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWiscount%26aufirst%3DC.%2BM.%26aulast%3DWilliams%26aufirst%3DP.%2BD.%26aulast%3DTran%26aufirst%3DL.%2BO.%26aulast%3DEmbrey%26aufirst%3DM.%2BW.%26aulast%3DFisher%26aufirst%3DT.%2BE.%26aulast%3DSherman%26aufirst%3DV.%26aulast%3DHomnick%26aufirst%3DC.%2BF.%26aulast%3DDonnette%2BStaas%26aufirst%3DD.%26aulast%3DLyle%26aufirst%3DT.%2BA.%26aulast%3DWai%26aufirst%3DJ.%2BS.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DFelock%26aufirst%3DP.%2BJ.%26aulast%3DStillmock%26aufirst%3DK.%2BA.%26aulast%3DWitmer%26aufirst%3DM.%2BV.%26aulast%3DMiller%26aufirst%3DM.%2BD.%26aulast%3DHazuda%26aufirst%3DD.%2BJ.%26aulast%3DDay%26aufirst%3DA.%2BM.%26aulast%3DGabryelski%26aufirst%3DL.%2BJ.%26aulast%3DEcto%26aufirst%3DL.%2BT.%26aulast%3DSchleif%26aufirst%3DW.%2BA.%26aulast%3DDiStefano%26aufirst%3DD.%2BJ.%26aulast%3DKochansky%26aufirst%3DC.%2BJ.%26aulast%3DAnari%26aufirst%3DM.%2BR.%26atitle%3D10-Hydroxy-7%252C8-dihydropyrazino%255B1%25E2%2580%25B2%252C2%25E2%2580%25B2%253A1%252C5%255Dpyrrolo%255B2%252C3-d%255Dpyridazine-1%252C9%25282H%252C6H%2529-diones%253A%2520potent%252C%2520orally%2520bioavailable%2520HIV-1%2520integrase%2520strand-transfer%2520inhibitors%2520with%2520activity%2520against%2520integrase%2520mutants%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D4581%26epage%3D4583" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Zhuang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wai, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Embrey, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egbertson, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Payne, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guare, J. P.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacca, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hazuda, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felock, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolfe, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stillmock, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witmer, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moyer, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schleif, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabryelski, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonard, Y. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, J. J.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michelson, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, S. D.</span><span> </span><span class="NLM_article-title">Design and synthesis of 8-hydroxy-[1,6]naphthyridines as novel inhibitors of HIV-1 integrase in vitro and in infected cells</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">453</span><span class="NLM_x">â</span> <span class="NLM_lpage">456</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm025553u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm300667v&amp;key=1%3ACAS%3A528%3ADC%252BD3sXitVCrsA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=453-456&author=L.+Zhuangauthor=J.+S.+Waiauthor=M.+W.+Embreyauthor=T.+E.+Fisherauthor=M.+S.+Egbertsonauthor=L.+S.+Payneauthor=J.+P.+Guareauthor=J.+P.+Vaccaauthor=D.+J.+Hazudaauthor=P.+J.+Felockauthor=A.+L.+Wolfeauthor=K.+A.+Stillmockauthor=M.+V.+Witmerauthor=G.+Moyerauthor=W.+A.+Schleifauthor=L.+J.+Gabryelskiauthor=Y.+M.+Leonardauthor=J.+J.+Lynchauthor=S.+R.+Michelsonauthor=S.+D.+Young&title=Design+and+synthesis+of+8-hydroxy-%5B1%2C6%5Dnaphthyridines+as+novel+inhibitors+of+HIV-1+integrase+in+vitro+and+in+infected+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Synthesis of 8-Hydroxy-[1,6]Naphthyridines as Novel Inhibitors of HIV-1 Integrase in Vitro and in Infected Cells</span></div><div class="casAuthors">Zhuang, Linghang; Wai, John S.; Embrey, Mark W.; Fisher, Thorsten E.; Egbertson, Melissa S.; Payne, Linda S.; Guare, James P., Jr.; Vacca, Joseph P.; Hazuda, Daria J.; Felock, Peter J.; Wolfe, Abigail L.; Stillmock, Kara A.; Witmer, Marc V.; Moyer, Gregory; Schleif, William A.; Gabryelski, Lori J.; Leonard, Yvonne M.; Lynch, Joseph J., Jr.; Michelson, Stuart R.; Young, Steven D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">453-456</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Naphthyridine I inhibits the strand transfer of the integration process catalyzed by integrase with an IC50 of 10 nM and inhibits 95% of the spread of HIV-1 infection in cell culture at 0.39 Î¼M.  I does not exhibit cytotoxicity in cell culture at â¤12.5 Î¼M and shows a good pharmacokinetic profile when dosed orally to rats.  The antiviral activity of I and its effect on integration were confirmed using viruses with specific integrase mutations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOoGGcZHiJMLVg90H21EOLACvtfcHk0lgGzz1QcuEtiw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXitVCrsA%253D%253D&md5=486db25666b872e6ae3613cf49c458f2</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fjm025553u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm025553u%26sid%3Dliteratum%253Aachs%26aulast%3DZhuang%26aufirst%3DL.%26aulast%3DWai%26aufirst%3DJ.%2BS.%26aulast%3DEmbrey%26aufirst%3DM.%2BW.%26aulast%3DFisher%26aufirst%3DT.%2BE.%26aulast%3DEgbertson%26aufirst%3DM.%2BS.%26aulast%3DPayne%26aufirst%3DL.%2BS.%26aulast%3DGuare%26aufirst%3DJ.%2BP.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26aulast%3DHazuda%26aufirst%3DD.%2BJ.%26aulast%3DFelock%26aufirst%3DP.%2BJ.%26aulast%3DWolfe%26aufirst%3DA.%2BL.%26aulast%3DStillmock%26aufirst%3DK.%2BA.%26aulast%3DWitmer%26aufirst%3DM.%2BV.%26aulast%3DMoyer%26aufirst%3DG.%26aulast%3DSchleif%26aufirst%3DW.%2BA.%26aulast%3DGabryelski%26aufirst%3DL.%2BJ.%26aulast%3DLeonard%26aufirst%3DY.%2BM.%26aulast%3DLynch%26aufirst%3DJ.%2BJ.%26aulast%3DMichelson%26aufirst%3DS.%2BR.%26aulast%3DYoung%26aufirst%3DS.%2BD.%26atitle%3DDesign%2520and%2520synthesis%2520of%25208-hydroxy-%255B1%252C6%255Dnaphthyridines%2520as%2520novel%2520inhibitors%2520of%2520HIV-1%2520integrase%2520in%2520vitro%2520and%2520in%2520infected%2520cells%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D453%26epage%3D456" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Chan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stefanac, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavallee, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falardeau, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bedard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">May, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuen, L.</span><span> </span><span class="NLM_article-title">Discovery of 1,6-naphthyridines as a novel class of potent and selective human cytomegalovirus inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">3023</span><span class="NLM_x">â</span> <span class="NLM_lpage">3025</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9902483" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=3023-3025&author=L.+Chanauthor=H.+Jinauthor=T.+Stefanacauthor=J.+F.+Lavalleeauthor=G.+Falardeauauthor=W.+Wangauthor=J.+Bedardauthor=S.+Mayauthor=L.+Yuen&title=Discovery+of+1%2C6-naphthyridines+as+a+novel+class+of+potent+and+selective+human+cytomegalovirus+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fjm9902483&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9902483%26sid%3Dliteratum%253Aachs%26aulast%3DChan%26aufirst%3DL.%26aulast%3DJin%26aufirst%3DH.%26aulast%3DStefanac%26aufirst%3DT.%26aulast%3DLavallee%26aufirst%3DJ.%2BF.%26aulast%3DFalardeau%26aufirst%3DG.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DBedard%26aufirst%3DJ.%26aulast%3DMay%26aufirst%3DS.%26aulast%3DYuen%26aufirst%3DL.%26atitle%3DDiscovery%2520of%25201%252C6-naphthyridines%2520as%2520a%2520novel%2520class%2520of%2520potent%2520and%2520selective%2520human%2520cytomegalovirus%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1999%26volume%3D42%26spage%3D3023%26epage%3D3025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Chan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stefanac, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavallee, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bedard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">May, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falardeau, G.</span><span> </span><span class="NLM_article-title">Design and synthesis of new potent human cytomegalovirus (HCMV) inhibitors based on internally hydrogen-bonded 1,6-naphthyridines</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">103</span><span class="NLM_x">â</span> <span class="NLM_lpage">105</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2001&pages=103-105&author=L.+Chanauthor=T.+Stefanacauthor=J.+F.+Lavalleeauthor=H.+Jinauthor=J.+Bedardauthor=S.+Mayauthor=G.+Falardeau&title=Design+and+synthesis+of+new+potent+human+cytomegalovirus+%28HCMV%29+inhibitors+based+on+internally+hydrogen-bonded+1%2C6-naphthyridines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChan%26aufirst%3DL.%26aulast%3DStefanac%26aufirst%3DT.%26aulast%3DLavallee%26aufirst%3DJ.%2BF.%26aulast%3DJin%26aufirst%3DH.%26aulast%3DBedard%26aufirst%3DJ.%26aulast%3DMay%26aufirst%3DS.%26aulast%3DFalardeau%26aufirst%3DG.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520new%2520potent%2520human%2520cytomegalovirus%2520%2528HCMV%2529%2520inhibitors%2520based%2520on%2520internally%2520hydrogen-bonded%25201%252C6-naphthyridines%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2001%26volume%3D11%26spage%3D103%26epage%3D105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Falardeau, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lachance, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">St-Pierre, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yannopoulos, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drouin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bedard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, L.</span><span> </span><span class="NLM_article-title">Design and synthesis of a potent macrocyclic 1,6-naphthyridine anti-human cytomegalovirus (HCMV) inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">1693</span><span class="NLM_x">â</span> <span class="NLM_lpage">1695</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=1693-1695&author=G.+Falardeauauthor=H.+Lachanceauthor=A.+St-Pierreauthor=C.+G.+Yannopoulosauthor=M.+Drouinauthor=J.+Bedardauthor=L.+Chan&title=Design+and+synthesis+of+a+potent+macrocyclic+1%2C6-naphthyridine+anti-human+cytomegalovirus+%28HCMV%29+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFalardeau%26aufirst%3DG.%26aulast%3DLachance%26aufirst%3DH.%26aulast%3DSt-Pierre%26aufirst%3DA.%26aulast%3DYannopoulos%26aufirst%3DC.%2BG.%26aulast%3DDrouin%26aufirst%3DM.%26aulast%3DBedard%26aufirst%3DJ.%26aulast%3DChan%26aufirst%3DL.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520a%2520potent%2520macrocyclic%25201%252C6-naphthyridine%2520anti-human%2520cytomegalovirus%2520%2528HCMV%2529%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D1693%26epage%3D1695" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Anthony, N. J.; Gomez, R. P.; Young, S. D.; Egbertson, M.; Wai, J. S.; Zhuang, L.; Embrey, M.; Tran, L.; Melamed, J. Y.; Langford, H. M.; Guare, J. P.; Fisher, T. E.; Jolly, S. M.; Kuo, M. S.; Perlow, D. S.; Bennett, J. J.; Funk, T. W.</span><span> </span><span class="NLM_article-title">Preparation of (Poly)azanaphthalenyl carboxamides as HIV Integrase Inhibitors</span>. Patent WO 2002/030930 A2<span class="NLM_x"> </span><span class="NLM_year">2002</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2002&author=N.+J.+Anthony&author=R.+P.+Gomez&author=S.+D.+Young&author=M.+Egbertson&author=J.+S.+Wai&author=L.+Zhuang&author=M.+Embrey&author=L.+Tran&author=J.+Y.+Melamed&author=H.+M.+Langford&author=J.+P.+Guare&author=T.+E.+Fisher&author=S.+M.+Jolly&author=M.+S.+Kuo&author=D.+S.+Perlow&author=J.+J.+Bennett&author=T.+W.+Funk&title=Preparation+of+%28Poly%29azanaphthalenyl+carboxamides+as+HIV+Integrase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAnthony%26aufirst%3DN.%2BJ.%26atitle%3DPreparation%2520of%2520%2528Poly%2529azanaphthalenyl%2520carboxamides%2520as%2520HIV%2520Integrase%2520Inhibitors%26date%3D2002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Pommier, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marchand, C.</span><span> </span><span class="NLM_article-title">Integrase inhibitors to treat HIV/AIDS</span> <span class="citation_source-journal">Nature Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">236</span><span class="NLM_x">â</span> <span class="NLM_lpage">248</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2005&pages=236-248&author=Y.+Pommierauthor=A.+A.+Johnsonauthor=C.+Marchand&title=Integrase+inhibitors+to+treat+HIV%2FAIDS"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPommier%26aufirst%3DY.%26aulast%3DJohnson%26aufirst%3DA.%2BA.%26aulast%3DMarchand%26aufirst%3DC.%26atitle%3DIntegrase%2520inhibitors%2520to%2520treat%2520HIV%252FAIDS%26jtitle%3DNature%2520Rev.%2520Drug%2520Discovery%26date%3D2005%26volume%3D4%26spage%3D236%26epage%3D248" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Hare, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gupta, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valkov, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engelman, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cherepanov, P.</span><span> </span><span class="NLM_article-title">Retroviral intasome assembly and inhibition of DNA strand transfer</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">464</span><span class="NLM_x">, </span> <span class="NLM_fpage">232</span><span class="NLM_x">â</span> <span class="NLM_lpage">236</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Fjm300667v&amp;key=10.1038%2Fnature08784" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Fjm300667v&amp;key=20118915" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm300667v&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1yntLg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=464&publication_year=2010&pages=232-236&author=S.+Hareauthor=S.+S.+Guptaauthor=E.+Valkovauthor=A.+Engelmanauthor=P.+Cherepanov&title=Retroviral+intasome+assembly+and+inhibition+of+DNA+strand+transfer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Retroviral intasome assembly and inhibition of DNA strand transfer</span></div><div class="casAuthors">Hare, Stephen; Gupta, Saumya Shree; Valkov, Eugene; Engelman, Alan; Cherepanov, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">464</span>
        (<span class="NLM_cas:issue">7286</span>),
    <span class="NLM_cas:pages">232-236</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Integrase is an essential retroviral enzyme that binds both termini of linear viral DNA and inserts them into a host cell chromosome.  The structure of full-length retroviral integrase, either sep. or in complex with DNA, has been lacking.  Furthermore, although clin. useful inhibitors of HIV integrase have been developed, their mechanism of action remains speculative.  Here the authors present a crystal structure of full-length integrase from the prototype foamy virus in complex with its cognate DNA.  The structure shows the organization of the retroviral intasome comprising an integrase tetramer tightly assocd. with a pair of viral DNA ends.  All three canonical integrase structural domains are involved in extensive protein-DNA and protein-protein interactions.  The binding of strand-transfer inhibitors displaces the reactive viral DNA end from the active site, disarming the viral nucleoprotein complex.  These findings define the structural basis of retroviral DNA integration, and will allow modeling of the HIV-1 intasome to aid in the development of antiretroviral drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqdEDTFdvZMbVg90H21EOLACvtfcHk0lgTOFfTke6kbA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1yntLg%253D&md5=9551e74b6bc33494855651c3b157d753</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1038%2Fnature08784&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature08784%26sid%3Dliteratum%253Aachs%26aulast%3DHare%26aufirst%3DS.%26aulast%3DGupta%26aufirst%3DS.%2BS.%26aulast%3DValkov%26aufirst%3DE.%26aulast%3DEngelman%26aufirst%3DA.%26aulast%3DCherepanov%26aufirst%3DP.%26atitle%3DRetroviral%2520intasome%2520assembly%2520and%2520inhibition%2520of%2520DNA%2520strand%2520transfer%26jtitle%3DNature%26date%3D2010%26volume%3D464%26spage%3D232%26epage%3D236" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Hare, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vos, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clayton, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thuring, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cummings, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cherepanov, P.</span><span> </span><span class="NLM_article-title">Molecular mechanisms of retroviral integrase inhibition and the evolution of viral resistance</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">107</span><span class="NLM_x">, </span> <span class="NLM_fpage">20057</span><span class="NLM_x">â</span> <span class="NLM_lpage">20062</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Fjm300667v&amp;key=10.1073%2Fpnas.1010246107" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Fjm300667v&amp;key=21030679" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Fjm300667v&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVyntrnF" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2010&pages=20057-20062&author=S.+Hareauthor=A.+M.+Vosauthor=R.+F.+Claytonauthor=J.+W.+Thuringauthor=M.+D.+Cummingsauthor=P.+Cherepanov&title=Molecular+mechanisms+of+retroviral+integrase+inhibition+and+the+evolution+of+viral+resistance"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular mechanisms of retroviral integrase inhibition and the evolution of viral resistance</span></div><div class="casAuthors">Hare, Stephen; Vos, Ann M.; Clayton, Reginald F.; Thuring, Jan W.; Cummings, Maxwell D.; Cherepanov, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">107</span>
        (<span class="NLM_cas:issue">46</span>),
    <span class="NLM_cas:pages">20057-20062, S20057/1-S20057/7</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The development of HIV integrase (IN) strand transfer inhibitors (INSTIs) and understanding of viral resistance to these mols. have been hampered by a paucity of available structural data.  Co-crystal structures of the prototype foamy virus (PFV) intasome with raltegravir and elvitegravir were recently reported, establishing the general INSTI binding mode.  Now an expanded set of co-crystal structures contg. PFV intasomes complexed with first- and second-generation INSTIs at resolns. of up to 2.5 Ã is presented.  Importantly, the improved resoln. allowed the authors to refine the complete coordination spheres of the catalytic metal cations within the INSTI-bound intasome active site.  It is shown that like the Q148H/G140S and N155H HIV-1 IN variants, the analogous S217H and N224H PFV INs display reduced sensitivity to raltegravir in vitro.  Crystal structures of the mutant PFV intasomes in INSTI-free and -bound forms revealed that the amino acid substitutions necessitate considerable conformational rearrangements within the IN active site to accommodate an INSTI, thus explaining their adverse effects on raltegravir antiviral activity.  Furthermore, the structures predict phys. proximity and an interaction between HIV-1 IN mutant residues His148 and Ser/Ala140, rationalizing the co-evolution of Q148H and G140S/A mutations in drug-resistant viral strains.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovxU36XC1DQrVg90H21EOLACvtfcHk0lgTOFfTke6kbA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVyntrnF&md5=5d66aa03a9478dad36e878d43c408099</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1010246107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1010246107%26sid%3Dliteratum%253Aachs%26aulast%3DHare%26aufirst%3DS.%26aulast%3DVos%26aufirst%3DA.%2BM.%26aulast%3DClayton%26aufirst%3DR.%2BF.%26aulast%3DThuring%26aufirst%3DJ.%2BW.%26aulast%3DCummings%26aufirst%3DM.%2BD.%26aulast%3DCherepanov%26aufirst%3DP.%26atitle%3DMolecular%2520mechanisms%2520of%2520retroviral%2520integrase%2520inhibition%2520and%2520the%2520evolution%2520of%2520viral%2520resistance%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2010%26volume%3D107%26spage%3D20057%26epage%3D20062" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span>Millipore UK Corporation web site: <a href="http://www.millipore.com" class="extLink">www.millipore.com</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Millipore+UK+Corporation+web+site%3A+www.millipore.com."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Wang, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Y. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, Y. T.</span><span> </span><span class="NLM_article-title">Mangiferin, an anti-HIV agent targeting protease and effective against resistant strains.</span> <span class="citation_source-journal">Molecules</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">4264</span><span class="NLM_x">â</span> <span class="NLM_lpage">4277</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2011&pages=4264-4277&author=R.+R.+Wangauthor=Y.+D.+Gaoauthor=C.+H.+Maauthor=X.+J.+Zhangauthor=C.+G.+Huangauthor=J.+F.+Huangauthor=Y.+T.+Zheng&title=Mangiferin%2C+an+anti-HIV+agent+targeting+protease+and+effective+against+resistant+strains."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DR.%2BR.%26aulast%3DGao%26aufirst%3DY.%2BD.%26aulast%3DMa%26aufirst%3DC.%2BH.%26aulast%3DZhang%26aufirst%3DX.%2BJ.%26aulast%3DHuang%26aufirst%3DC.%2BG.%26aulast%3DHuang%26aufirst%3DJ.%2BF.%26aulast%3DZheng%26aufirst%3DY.%2BT.%26atitle%3DMangiferin%252C%2520an%2520anti-HIV%2520agent%2520targeting%2520protease%2520and%2520effective%2520against%2520resistant%2520strains.%26jtitle%3DMolecules%26date%3D2011%26volume%3D16%26spage%3D4264%26epage%3D4277" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Fan, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, F. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Al-Safi, R. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shabaik, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Debnath, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanchez, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Odde, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neamati, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Long, Y. Q.</span><span> </span><span class="NLM_article-title">Design of HIV-1 integrase inhibitors targeting the catalytic domain as well as its interaction with LEDGF/p75: a scaffold hopping approach using salicylate and catechol groups</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">4935</span><span class="NLM_x">â</span> <span class="NLM_lpage">4952</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2011&pages=4935-4952&author=X.+Fanauthor=F.+H.+Zhangauthor=R.+I.+Al-Safiauthor=L.+F.+Zengauthor=Y.+Shabaikauthor=B.+Debnathauthor=T.+W.+Sanchezauthor=S.+Oddeauthor=N.+Neamatiauthor=Y.+Q.+Long&title=Design+of+HIV-1+integrase+inhibitors+targeting+the+catalytic+domain+as+well+as+its+interaction+with+LEDGF%2Fp75%3A+a+scaffold+hopping+approach+using+salicylate+and+catechol+groups"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFan%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DF.%2BH.%26aulast%3DAl-Safi%26aufirst%3DR.%2BI.%26aulast%3DZeng%26aufirst%3DL.%2BF.%26aulast%3DShabaik%26aufirst%3DY.%26aulast%3DDebnath%26aufirst%3DB.%26aulast%3DSanchez%26aufirst%3DT.%2BW.%26aulast%3DOdde%26aufirst%3DS.%26aulast%3DNeamati%26aufirst%3DN.%26aulast%3DLong%26aufirst%3DY.%2BQ.%26atitle%3DDesign%2520of%2520HIV-1%2520integrase%2520inhibitors%2520targeting%2520the%2520catalytic%2520domain%2520as%2520well%2520as%2520its%2520interaction%2520with%2520LEDGF%252Fp75%253A%2520a%2520scaffold%2520hopping%2520approach%2520using%2520salicylate%2520and%2520catechol%2520groups%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2011%26volume%3D19%26spage%3D4935%26epage%3D4952" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Jones, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willett, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glen, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leach, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, R.</span><span> </span><span class="NLM_article-title">Development and validation of a genetic algorithm for flexible docking</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">267</span><span class="NLM_x">, </span> <span class="NLM_fpage">727</span><span class="NLM_x">â</span> <span class="NLM_lpage">748</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Fjm300667v&amp;key=10.1006%2Fjmbi.1996.0897" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Fjm300667v&amp;key=9126849" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm300667v&amp;key=1%3ACAS%3A528%3ADyaK2sXis1KntLo%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=267&publication_year=1997&pages=727-748&author=G.+Jonesauthor=P.+Willettauthor=R.+C.+Glenauthor=A.+R.+Leachauthor=R.+Taylor&title=Development+and+validation+of+a+genetic+algorithm+for+flexible+docking"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Development and validation of a genetic algorithm for flexible docking</span></div><div class="casAuthors">Jones, Gareth; Willett, Peter; Glen, Robert C.; Leach, Andrew R.; Taylor, Robin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">267</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">727-748</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Academic</span>)
        </div><div class="casAbstract">Prediction of small mol. binding modes to macromols. of known three-dimensional structure is a problem of paramount importance in rational drug design (the "docking" problem).  We report the development and validation of the program GOLD (Genetic Optimization for Ligand Docking).  GOLD is an automated ligand docking program that uses a genetic algorithm to explore the full range of ligand conformational flexibility with partial flexibility of the protein and satisfies the fundamental requirement that the ligand must displace loosely bound water on binding.  Numerous enhancements and modifications have been applied to the original technique resulting in a substantial increase in the reliability and the applicability of the algorithm.  The advanced algorithm has been tested on a dataset of 100 complexes extd. from the Brookhaven Protein Data Bank.  When used to dock the ligand back into the binding site, GOLD achieved a 71% success rate in identifying the exptl. binding mode.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrP3I60Rl2uorVg90H21EOLACvtfcHk0ljPVfrQe6phKA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXis1KntLo%253D&md5=476a2b1d8f80f3ba418052fe29d735ca</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1006%2Fjmbi.1996.0897&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fjmbi.1996.0897%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DG.%26aulast%3DWillett%26aufirst%3DP.%26aulast%3DGlen%26aufirst%3DR.%2BC.%26aulast%3DLeach%26aufirst%3DA.%2BR.%26aulast%3DTaylor%26aufirst%3DR.%26atitle%3DDevelopment%2520and%2520validation%2520of%2520a%2520genetic%2520algorithm%2520for%2520flexible%2520docking%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D1997%26volume%3D267%26spage%3D727%26epage%3D748" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Jones, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willett, P.</span><span> </span><span class="NLM_article-title">Docking small-molecule ligands into active sites</span> <span class="citation_source-journal">Curr. Opin. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">652</span><span class="NLM_x">â</span> <span class="NLM_lpage">656</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Fjm300667v&amp;key=10.1016%2F0958-1669%2895%2980107-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Fjm300667v&amp;key=8527835" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Fjm300667v&amp;key=1%3ACAS%3A528%3ADyaK2MXpvVSrtL4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1995&pages=652-656&author=G.+Jonesauthor=P.+Willett&title=Docking+small-molecule+ligands+into+active+sites"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Docking small-mol. ligands into active sites</span></div><div class="casAuthors">Jones, Gareth; Willett, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Biotechnology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">652-6</span>CODEN:
                <span class="NLM_cas:coden">CUOBE3</span>;
        ISSN:<span class="NLM_cas:issn">0958-1669</span>.
    
            (<span class="NLM_cas:orgname">Current Biology</span>)
        </div><div class="casAbstract">A review with 28 refs.  Docking involves the development of computer algorithms that evaluate the binding modes of putative ligands in receptor sites.  The principal advances of the past yr have been the development of new algorithmic approaches, several of which incorporate conformational flexibility, and the increased use of docking to identify leads in drug-discovery programs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHGU6KHOkaW7Vg90H21EOLACvtfcHk0ljPVfrQe6phKA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXpvVSrtL4%253D&md5=86d38c0c58611fb2e786b7ef6eb3eb04</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2F0958-1669%2895%2980107-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0958-1669%252895%252980107-3%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DG.%26aulast%3DWillett%26aufirst%3DP.%26atitle%3DDocking%2520small-molecule%2520ligands%2520into%2520active%2520sites%26jtitle%3DCurr.%2520Opin.%2520Biotechnol.%26date%3D1995%26volume%3D6%26spage%3D652%26epage%3D656" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span>LigPrep, <span class="NLM_edition">version 2.5</span>; <span class="NLM_publisher-name">SchrÃ¶dinger, LLC</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=LigPrep%2C+version+2.5%3B+Schr%C3%B6dinger%2C+LLC%3A+New+York%2C+2011."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DLigPrep%26pub%3DSchr%25C3%25B6dinger%252C%2520LLC%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span>Epik, <span class="NLM_edition">version 2.2</span>; <span class="NLM_publisher-name">SchrÃ¶dinger, LLC</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Epik%2C+version+2.2%3B+Schr%C3%B6dinger%2C+LLC%3A+New+York%2C+2011."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DEpik%26pub%3DSchr%25C3%25B6dinger%252C%2520LLC%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Carmichael, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeGraff, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gazdar, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minna, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitchell, J. B.</span><span> </span><span class="NLM_article-title">Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">936</span><span class="NLM_x">â</span> <span class="NLM_lpage">942</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Fjm300667v&amp;key=3802100" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Fjm300667v&amp;key=1%3ACAS%3A528%3ADyaL2sXhsVyrtb0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=1987&pages=936-942&author=J.+Carmichaelauthor=W.+G.+DeGraffauthor=A.+F.+Gazdarauthor=J.+D.+Minnaauthor=J.+B.+Mitchell&title=Evaluation+of+a+tetrazolium-based+semiautomated+colorimetric+assay%3A+assessment+of+chemosensitivity+testing"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of a tetrazolium-based semiautomated colorimetric assay:  assessment of chemosensitivity testing</span></div><div class="casAuthors">Carmichael, James; DeGraff, William G.; Gazdar, Adi F.; Minna, John D.; Mitchell, James B.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">936-42</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    </div><div class="casAbstract">Drug sensitivity assays were performed using a variation of a colorimetric thiazolyl blue (MTT)  [298-93-1] assay on V79, CHO-AuxB1, CHRC5, NCI-H460, and NCI-H249 cell lines following optimization of exptl. conditions for each cell line.  Results from this assay were compared with data assimilated simultaneously by clonogenic assay and by dye exclusion assay.  Good correlation was obsd. using the CHO-AuxB1 cell line and the pleiotropic drug-resistant mutant CHRC5, with similar degrees of relative resistance obsd. with both the MTT and clonogenic assays.  Good correlation was obsd. between the clonogenic and MTT assays for 1-h drug exposures, although the MTT assay was more sensitive to vinblastine.  In general, the clonogenic assay was more sensitive when continuous drug exposures were utilized, although this was primarily related to the increased drug exposure time.  While the use of the MTT assay in drug sensitivity testing of primary tumor samples is limited, since contaminating normal cells may also reduce the tetrazolium, the MTT assay can be semiautomated, and therefore it offers a valid, simple method of assessing chemosensitivity in established cell lines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpj92XstI7WtLVg90H21EOLACvtfcHk0liqplw-rPc_lQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2sXhsVyrtb0%253D&md5=2414230269c9f4d5f2910764c65fc042</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCarmichael%26aufirst%3DJ.%26aulast%3DDeGraff%26aufirst%3DW.%2BG.%26aulast%3DGazdar%26aufirst%3DA.%2BF.%26aulast%3DMinna%26aufirst%3DJ.%2BD.%26aulast%3DMitchell%26aufirst%3DJ.%2BB.%26atitle%3DEvaluation%2520of%2520a%2520tetrazolium-based%2520semiautomated%2520colorimetric%2520assay%253A%2520assessment%2520of%2520chemosensitivity%2520testing%26jtitle%3DCancer%2520Res.%26date%3D1987%26volume%3D47%26spage%3D936%26epage%3D942" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Munshi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hobbs, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyn, R. E.</span><span> </span><span class="NLM_article-title">Clonogenic cell survival assay</span> <span class="citation_source-journal">Methods Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">110</span><span class="NLM_x">, </span> <span class="NLM_fpage">21</span><span class="NLM_x">â</span> <span class="NLM_lpage">28</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Fjm300667v&amp;key=15901923" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Fjm300667v&amp;key=1%3ACAS%3A280%3ADC%252BD2M3mtFemtg%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2005&pages=21-28&author=A.+Munshiauthor=M.+Hobbsauthor=R.+E.+Meyn&title=Clonogenic+cell+survival+assay"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Clonogenic cell survival assay</span></div><div class="casAuthors">Munshi Anupama; Hobbs Marvette; Meyn Raymond E</div><div class="citationInfo"><span class="NLM_cas:title">Methods in molecular medicine</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">21-8</span>
        ISSN:<span class="NLM_cas:issn">1543-1894</span>.
    </div><div class="casAbstract">The clonogenic cell survival assay determines the ability of a cell to proliferate indefinitely, thereby retaining its reproductive ability to form a large colony or a clone.  This cell is then said to be clonogenic.  A cell survival curve is therefore defined as a relationship between the dose of the agent used to produce an insult and the fraction of cells retaining their ability to reproduce.  Although clonogenic cell survival assays were initially described for studying the effects of radiation on cells and have played an essential role in radiobiology, they are now widely used to examine the effects of agents with potential applications in the clinic.  These include, in addition to ionizing radiation, chemotherapy agents such as etoposide and cisplatin, antiangiogenic agents such as endostatin and angiostatin, and cytokines and their receptors, either alone or in combination therapy.  Survival curves have been generated for many established cell lines growing in culture.  One can use cell lines from various origins including humans and rodents; these cells can be neoplastic or normal.  Because survival curves have wide application in evaluating the reproductive integrity of different cells, we provide here the steps involved in setting up a typical experiment using an established cell line in culture.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTUBOE0LtKCR5QHPYJuLg8TfW6udTcc2eaSqTbpPRcKJbntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2M3mtFemtg%253D%253D&md5=4b3b285f5ed64f7804c52312361d013e</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMunshi%26aufirst%3DA.%26aulast%3DHobbs%26aufirst%3DM.%26aulast%3DMeyn%26aufirst%3DR.%2BE.%26atitle%3DClonogenic%2520cell%2520survival%2520assay%26jtitle%3DMethods%2520Mol.%2520Med.%26date%3D2005%26volume%3D110%26spage%3D21%26epage%3D28" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3OYA" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3OYA','PDB','3OYA'); return false;">PDB: 3OYA</a></li></ul></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm300667v&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Barticle%3Aarticle%3A10.1021%2Fjm300667v%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2012.55.issue-22%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm300667v" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                5MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright Â© 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">Youâve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"677a96fd3f293d54","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
